*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 54 ASP^? -3.76 O ACT A 501s A 86 HIS A 65 HIS~? -3.60 O ACT A 501s A 250 ALA A 64 ALA~? 11.15 O ACT A 501 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 9.47 12.33 8.26 10.66 11.45 9.76 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 14.91 11.26 8.66 14.30 12.93 9.76 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 19.24 7.69 5.99 19.07 7.91 4.49 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 54 ASP^? -3.76 O ACT A 501s A 86 HIS A 65 HIS~? -3.60 O ACT A 501s A 250 ALA A 71 ALA~? 5.64 CH3 ACT A 501 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 9.47 12.33 8.26 10.66 11.45 9.76 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 14.91 11.26 8.66 14.30 12.93 9.76 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 19.26 13.81 13.63 19.24 12.28 13.23 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 54 ASP^? 4.46 O ACT B 502 A 86 HIS B 65 HIS~? -3.69 O ACT B 502s A 250 ALA B 64 ALA~? 11.22 O ACT B 502 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -8.30 11.03 33.15 -8.32 11.11 34.69 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 54 ASP^? 4.46 O ACT B 502 A 86 HIS B 65 HIS~? -3.69 O ACT B 502s A 250 ALA B 71 ALA~? 6.33 O ACT B 502 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -15.58 10.60 26.60 -14.06 10.51 26.75 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 86 HIS C 65 HIS~? -3.55 C ACT C 503s A 250 ALA C 64 ALA~? 10.90 CH3 ACT C 503 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -13.66 20.75 5.77 -13.26 21.25 4.37 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 86 HIS C 65 HIS~? -3.55 C ACT C 503s A 250 ALA C 71 ALA~? 3.85 CH3 ACT C 503 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -14.49 11.86 9.72 -14.32 13.36 10.09 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 250 ALA D 64 ALA~? 28.22 OXT ACT B 502 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -22.15 43.56 35.71 -22.30 43.07 37.15 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 250 ALA D 71 ALA~? 28.01 O ACT B 502 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -13.96 44.65 30.21 -15.47 44.54 30.10 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o00 naa= 3 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU B 92 GLU^? 19.37 O ACT B 502 A 280 GLU A 17 GLU~? 18.98 CH3 ACT A 501 A 283 LYS A 13 LYS.? 18.34 CH3 ACT A 501 A 288 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 5.76 85.47 37.35 6.76 85.56 39.24 -0.80 26.07 29.41 1.12 26.90 28.84 coo 4.25 95.66 42.75 4.18 93.57 42.69 8.46 25.60 25.93 9.21 26.72 27.59 coo 9.66 95.18 46.95 8.19 90.97 44.00 13.03 21.95 28.39 18.88 21.48 30.19 coo 13.49 92.75 43.16 12.39 91.15 42.33 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 A 232 GLU B 92 GLU^? 19.37 O ACT B 502 A 280 GLU B 89 GLU^? 13.28 O ACT B 502 A 283 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 288 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 5.76 85.47 37.35 6.76 85.56 39.24 -0.80 26.07 29.41 1.12 26.90 28.84 coo 4.25 95.66 42.75 4.18 93.57 42.69 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 9.66 95.18 46.95 8.19 90.97 44.00 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 13.49 92.75 43.16 12.39 91.15 42.33 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 3 4 # 3 A 232 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 280 GLU D 11 GLU.? 21.84 O ACT B 502 A 283 LYS D 13 LYS.? 35.09 O ACT B 502 A 288 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 5.76 85.47 37.35 6.76 85.56 39.24 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 4.25 95.66 42.75 4.18 93.57 42.69 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 9.66 95.18 46.95 8.19 90.97 44.00 -1.12 41.20 17.82 -1.77 47.26 17.33 coo 13.49 92.75 43.16 12.39 91.15 42.33 2.12 36.56 21.03 3.60 37.59 19.89 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 3 hits 1aq0_c00 naa= 4 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 B 232 GLU B 92 GLU^? 19.37 O ACT B 502 B 280 GLU A 17 GLU~? 18.98 CH3 ACT A 501 B 283 LYS A 13 LYS.? 18.34 CH3 ACT A 501 B 288 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -0.80 26.07 29.41 1.12 26.90 28.84 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 8.46 25.60 25.93 9.21 26.72 27.59 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 13.03 21.95 28.39 18.88 21.48 30.19 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 B 232 GLU B 92 GLU^? 19.37 O ACT B 502 B 280 GLU B 89 GLU^? 13.28 O ACT B 502 B 283 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 288 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -0.80 26.07 29.41 1.12 26.90 28.84 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -9.24 24.07 20.62 -9.79 26.07 20.27 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 3 4 # 3 B 232 GLU B 92 GLU^? 19.37 O ACT B 502 B 280 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 283 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 288 GLU B 89 GLU^? 13.28 O ACT B 502 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -0.80 26.07 29.41 1.12 26.90 28.84 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -0.44 25.21 15.82 -1.51 26.57 14.58 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -9.24 24.07 20.62 -9.79 26.07 20.27 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 4 4 # 4 B 232 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 280 GLU D 11 GLU.? 21.84 O ACT B 502 B 283 LYS D 13 LYS.? 35.09 O ACT B 502 B 288 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -0.44 25.21 15.82 -1.51 26.57 14.58 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -7.35 35.76 17.53 -6.53 33.80 17.57 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -1.12 41.20 17.82 -1.77 47.26 17.33 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 2.12 36.56 21.03 3.60 37.59 19.89 1aq0_c01 source 1aq0 1,3-1,4-BETA-GLUCANASE : 4 hits 1aq0_c01 naa= 4 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 A 231 GLU B 92 GLU^? 19.37 O ACT B 502 A 279 GLU A 11 GLU.? 15.43 CH3 ACT A 501 A 282 LYS A 13 LYS.? 18.34 CH3 ACT A 501 A 288 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -0.80 26.07 29.41 1.12 26.90 28.84 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 8.65 17.34 27.29 6.65 18.05 26.99 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 13.03 21.95 28.39 18.88 21.48 30.19 coo 54.40 -0.12 97.85 55.58 0.51 96.24 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 A 231 GLU B 92 GLU^? 19.37 O ACT B 502 A 279 GLU A 17 GLU~? 18.98 CH3 ACT A 501 A 282 LYS A 13 LYS.? 18.34 CH3 ACT A 501 A 288 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -0.80 26.07 29.41 1.12 26.90 28.84 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 8.46 25.60 25.93 9.21 26.72 27.59 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 13.03 21.95 28.39 18.88 21.48 30.19 coo 54.40 -0.12 97.85 55.58 0.51 96.24 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 4 # 3 A 231 GLU B 92 GLU^? 19.37 O ACT B 502 A 279 GLU B 89 GLU^? 13.28 O ACT B 502 A 282 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 288 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -0.80 26.07 29.41 1.12 26.90 28.84 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 4 # 4 A 231 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 279 GLU D 11 GLU.? 21.84 O ACT B 502 A 282 LYS D 13 LYS.? 35.09 O ACT B 502 A 288 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -1.12 41.20 17.82 -1.77 47.26 17.33 coo 54.40 -0.12 97.85 55.58 0.51 96.24 2.12 36.56 21.03 3.60 37.59 19.89 1ghs_c00 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 4 hits 1ghs_c00 naa= 4 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 B 231 GLU B 92 GLU^? 19.37 O ACT B 502 B 279 GLU A 17 GLU~? 18.98 CH3 ACT A 501 B 282 LYS A 13 LYS.? 18.34 CH3 ACT A 501 B 288 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -0.80 26.07 29.41 1.12 26.90 28.84 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 8.46 25.60 25.93 9.21 26.72 27.59 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 13.03 21.95 28.39 18.88 21.48 30.19 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 B 231 GLU B 92 GLU^? 19.37 O ACT B 502 B 279 GLU B 89 GLU^? 13.28 O ACT B 502 B 282 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 288 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -0.80 26.07 29.41 1.12 26.90 28.84 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 4 # 3 B 231 GLU B 92 GLU^? 19.37 O ACT B 502 B 279 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 282 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 288 GLU B 89 GLU^? 13.28 O ACT B 502 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -0.80 26.07 29.41 1.12 26.90 28.84 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -9.24 24.07 20.62 -9.79 26.07 20.27 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 4 # 4 B 231 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 279 GLU D 11 GLU.? 21.84 O ACT B 502 B 282 LYS D 13 LYS.? 35.09 O ACT B 502 B 288 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -1.12 41.20 17.82 -1.77 47.26 17.33 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 2.12 36.56 21.03 3.60 37.59 19.89 1ghs_c01 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 4 hits 1ghs_c01 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU A 89 GLU^? 13.34 O ACT A 501 A 485 LYS A 90 LYS^? 10.86 O ACT A 501 A 488 GLU A 92 GLU^? 18.57 O ACT A 501 A 603 LYS A 3 LYS.? 15.82 O ACT C 503 coo -7.79 3.39 10.29 -9.01 4.74 9.32 6.08 5.49 18.77 4.04 5.97 19.19 coo -9.44 10.08 8.58 -11.94 6.98 8.10 8.29 3.28 13.77 13.67 2.39 14.04 coo -13.30 11.40 4.76 -13.95 9.40 5.16 4.60 -0.94 9.20 4.21 -3.02 9.21 coo -21.26 6.97 3.81 -20.43 4.23 9.21 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 A 481 GLU B 89 GLU^? 13.28 O ACT B 502 A 485 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 488 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 603 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -9.24 24.07 20.62 -9.79 26.07 20.27 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -0.44 25.21 15.82 -1.51 26.57 14.58 coo -21.26 6.97 3.81 -20.43 4.23 9.21 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 A 481 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 485 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 488 GLU B 89 GLU^? 13.28 O ACT B 502 A 603 LYS D 44 LYS^? 22.72 O ACT B 502 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -3.72 14.77 20.03 -1.73 14.43 20.69 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -9.24 24.07 20.62 -9.79 26.07 20.27 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 4 # 4 A 481 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 485 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 488 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 603 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -3.72 14.77 20.03 -1.73 14.43 20.69 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -0.44 25.21 15.82 -1.51 26.57 14.58 coo -21.26 6.97 3.81 -20.43 4.23 9.21 0.38 25.07 8.12 -1.77 29.22 5.24 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 4 hits 1jxa_c01 naa= 4 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 1 4 # 1 C 181 ALA A 71 ALA~? 5.64 CH3 ACT A 501 C 182 GLN A 69 GLN~? 12.23 OXT ACT A 501 C 269 ASP A 54 ASP^? -3.76 O ACT A 501s C 298 HIS A 65 HIS~? -3.60 O ACT A 501s coo 19.41 78.76 44.53 18.61 79.22 45.75 19.26 13.81 13.63 19.24 12.28 13.23 coo 24.64 81.35 46.97 24.99 82.28 48.83 23.28 16.76 7.24 23.80 18.35 5.96 coo 10.40 79.73 42.00 12.16 80.19 43.16 9.47 12.33 8.26 10.66 11.45 9.76 coo 13.42 79.87 46.31 15.44 80.29 45.93 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 2 4 # 2 C 181 ALA C 71 ALA~? 3.85 CH3 ACT C 503 C 182 GLN C 69 GLN~? 11.79 CH3 ACT C 503 C 269 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 298 HIS C 65 HIS~? -3.55 C ACT C 503s coo 19.41 78.76 44.53 18.61 79.22 45.75 -14.49 11.86 9.72 -14.32 13.36 10.09 coo 24.64 81.35 46.97 24.99 82.28 48.83 -17.61 12.37 2.23 -19.64 11.97 2.70 coo 10.40 79.73 42.00 12.16 80.19 43.16 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 13.42 79.87 46.31 15.44 80.29 45.93 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 3 4 # 3 C 181 ALA D 71 ALA~? 28.01 O ACT B 502 C 182 GLN D 69 GLN~? 34.12 OXT ACT B 502 C 269 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 298 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 19.41 78.76 44.53 18.61 79.22 45.75 -13.96 44.65 30.21 -15.47 44.54 30.10 coo 24.64 81.35 46.97 24.99 82.28 48.83 -13.37 47.62 37.71 -13.64 49.59 36.95 coo 10.40 79.73 42.00 12.16 80.19 43.16 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 13.42 79.87 46.31 15.44 80.29 45.93 -17.61 39.97 33.46 -15.64 39.60 32.84 1odt_c00 source 1odt CEPHALOSPORIN C DEACETYLASE : 3 hits 1odt_c00 naa= 4 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 1 4 # 1 H 181 ALA A 71 ALA~? 5.64 CH3 ACT A 501 H 182 GLN A 69 GLN~? 12.23 OXT ACT A 501 H 269 ASP A 54 ASP^? -3.76 O ACT A 501s H 298 HIS A 65 HIS~? -3.60 O ACT A 501s coo 17.71 105.28 65.69 16.95 104.75 64.54 19.26 13.81 13.63 19.24 12.28 13.23 coo 23.16 103.35 63.17 23.71 102.54 61.29 23.28 16.76 7.24 23.80 18.35 5.96 coo 8.91 102.95 68.35 10.66 102.77 67.10 9.47 12.33 8.26 10.66 11.45 9.76 coo 11.89 103.25 63.94 13.96 103.24 64.24 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 2 4 # 2 H 181 ALA C 71 ALA~? 3.85 CH3 ACT C 503 H 182 GLN C 69 GLN~? 11.79 CH3 ACT C 503 H 269 ASP C 54 ASP^? -3.02 OXT ACT C 503s H 298 HIS C 65 HIS~? -3.55 C ACT C 503s coo 17.71 105.28 65.69 16.95 104.75 64.54 -14.49 11.86 9.72 -14.32 13.36 10.09 coo 23.16 103.35 63.17 23.71 102.54 61.29 -17.61 12.37 2.23 -19.64 11.97 2.70 coo 8.91 102.95 68.35 10.66 102.77 67.10 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 11.89 103.25 63.94 13.96 103.24 64.24 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 3 4 # 3 H 181 ALA D 71 ALA~? 28.01 O ACT B 502 H 182 GLN D 69 GLN~? 34.12 OXT ACT B 502 H 269 ASP D 54 ASP^? 19.49 OXT ACT B 502 H 298 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 17.71 105.28 65.69 16.95 104.75 64.54 -13.96 44.65 30.21 -15.47 44.54 30.10 coo 23.16 103.35 63.17 23.71 102.54 61.29 -13.37 47.62 37.71 -13.64 49.59 36.95 coo 8.91 102.95 68.35 10.66 102.77 67.10 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 11.89 103.25 63.94 13.96 103.24 64.24 -17.61 39.97 33.46 -15.64 39.60 32.84 1odt_c01 source 1odt CEPHALOSPORIN C DEACETYLASE : 3 hits 1odt_c01 naa= 4 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 1 4 # 1 A 147 SER A 48 SER.? 17.26 CH3 ACT A 501 A 159 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 184 ARG A 9 ARG^? 14.14 OXT ACT C 503 A 189 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 53.09 24.63 27.00 51.51 25.19 25.28 6.12 22.28 25.46 5.72 21.09 27.51 coo 52.64 14.17 18.05 51.99 14.09 16.04 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 45.78 18.05 21.49 44.51 17.88 18.72 4.15 12.93 21.45 1.14 13.40 20.88 coo 49.07 22.26 28.01 48.95 23.27 26.11 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 2 4 # 2 A 147 SER A 84 SER.? 13.58 CH3 ACT A 501 A 159 GLU A 89 GLU^? 13.34 O ACT A 501 A 184 ARG A 9 ARG^? 14.14 OXT ACT C 503 A 189 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 53.09 24.63 27.00 51.51 25.19 25.28 14.07 13.74 27.70 11.71 13.39 27.27 coo 52.64 14.17 18.05 51.99 14.09 16.04 6.08 5.49 18.77 4.04 5.97 19.19 coo 45.78 18.05 21.49 44.51 17.88 18.72 4.15 12.93 21.45 1.14 13.40 20.88 coo 49.07 22.26 28.01 48.95 23.27 26.11 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 3 4 # 3 A 147 SER B 48 SER.? 16.63 CH3 ACT B 502 A 159 GLU D 89 GLU^? 16.27 CH3 ACT B 502 A 184 ARG B 9 ARG^? 13.94 CH3 ACT B 502 A 189 GLU B 11 GLU.? 14.84 CH3 ACT B 502 coo 53.09 24.63 27.00 51.51 25.19 25.28 -27.05 23.61 17.32 -26.38 24.08 15.04 coo 52.64 14.17 18.05 51.99 14.09 16.04 -18.84 33.24 21.04 -18.05 31.37 20.48 coo 45.78 18.05 21.49 44.51 17.88 18.72 -17.57 25.75 18.49 -17.57 28.52 19.90 coo 49.07 22.26 28.01 48.95 23.27 26.11 -22.40 21.62 14.44 -23.19 23.50 15.06 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 4 4 # 4 A 147 SER B 84 SER.? 10.45 CH3 ACT C 503 A 159 GLU B 89 GLU^? 13.28 O ACT B 502 A 184 ARG B 9 ARG^? 13.94 CH3 ACT B 502 A 189 GLU B 11 GLU.? 14.84 CH3 ACT B 502 coo 53.09 24.63 27.00 51.51 25.19 25.28 -18.41 16.52 13.06 -18.12 18.87 13.61 coo 52.64 14.17 18.05 51.99 14.09 16.04 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 45.78 18.05 21.49 44.51 17.88 18.72 -17.57 25.75 18.49 -17.57 28.52 19.90 coo 49.07 22.26 28.01 48.95 23.27 26.11 -22.40 21.62 14.44 -23.19 23.50 15.06 1og1_c00 source 1og1 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2 : 4 hits 1og1_c00 naa= 4 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA A 73 ALA~? 8.76 CH3 ACT A 501 A 458 ALA A 76 ALA~? 12.33 CH3 ACT A 501 B 193 ALA A 71 ALA~? 5.64 CH3 ACT A 501 B 194 GLY A 68 GLY~? 8.65 OXT ACT A 501 coo 43.27 124.32 20.47 43.79 125.29 21.53 21.89 18.57 14.71 21.17 19.57 13.68 coo 39.57 123.53 20.89 38.42 124.25 20.20 24.33 18.07 19.05 24.92 18.80 17.87 coo 47.95 129.15 20.31 47.81 128.95 18.79 19.26 13.81 13.63 19.24 12.28 13.23 coo 50.40 126.23 20.48 50.46 127.00 20.75 21.13 12.33 8.60 21.18 12.38 9.43 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 457 ALA B 73 ALA~? 8.56 CH3 ACT B 502 A 458 ALA B 76 ALA~? 12.40 CH3 ACT B 502 B 193 ALA B 71 ALA~? 6.33 O ACT B 502 B 194 GLY B 68 GLY~? 8.88 O ACT B 502 coo 43.27 124.32 20.47 43.79 125.29 21.53 -20.50 8.04 26.45 -21.25 8.75 27.56 coo 39.57 123.53 20.89 38.42 124.25 20.20 -21.15 5.68 22.06 -21.63 5.18 23.39 coo 47.95 129.15 20.31 47.81 128.95 18.79 -15.58 10.60 26.60 -14.06 10.51 26.75 coo 50.40 126.23 20.48 50.46 127.00 20.75 -13.16 8.67 31.18 -13.37 8.79 30.42 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 457 ALA C 73 ALA~? 8.85 CH3 ACT C 503 A 458 ALA C 76 ALA~? 12.09 CH3 ACT C 503 B 193 ALA C 71 ALA~? 3.85 CH3 ACT C 503 B 194 GLY C 68 GLY~? 7.89 CH3 ACT C 503 coo 43.27 124.32 20.47 43.79 125.29 21.53 -17.50 7.43 8.36 -16.78 6.98 7.10 coo 39.57 123.53 20.89 38.42 124.25 20.20 -20.39 6.18 12.34 -20.87 6.14 10.90 coo 47.95 129.15 20.31 47.81 128.95 18.79 -14.49 11.86 9.72 -14.32 13.36 10.09 coo 50.40 126.23 20.48 50.46 127.00 20.75 -16.15 15.61 5.62 -16.28 15.25 6.33 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 457 ALA D 73 ALA~? 31.32 O ACT B 502 A 458 ALA D 76 ALA~? 35.11 O ACT B 502 B 193 ALA D 71 ALA~? 28.01 O ACT B 502 B 194 GLY D 68 GLY~? 30.11 OXT ACT B 502 coo 43.27 124.32 20.47 43.79 125.29 21.53 -9.37 47.67 30.90 -8.63 46.94 32.02 coo 39.57 123.53 20.89 38.42 124.25 20.20 -8.73 50.62 26.76 -8.42 51.05 28.20 coo 47.95 129.15 20.31 47.81 128.95 18.79 -13.96 44.65 30.21 -15.47 44.54 30.10 coo 50.40 126.23 20.48 50.46 127.00 20.75 -17.03 46.14 34.72 -16.83 46.23 34.01 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 4 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA A 71 ALA~? 5.64 CH3 ACT A 501 A 194 GLY A 68 GLY~? 8.65 OXT ACT A 501 B 457 ALA A 73 ALA~? 8.76 CH3 ACT A 501 B 458 ALA A 76 ALA~? 12.33 CH3 ACT A 501 coo 61.89 87.20 13.50 62.59 88.00 12.38 19.26 13.81 13.63 19.24 12.28 13.23 coo 59.34 89.99 13.88 59.24 89.18 13.73 21.13 12.33 8.60 21.18 12.38 9.43 coo 65.50 91.13 17.77 64.65 89.88 18.00 21.89 18.57 14.71 21.17 19.57 13.68 coo 68.56 91.15 20.03 69.95 90.68 19.64 24.33 18.07 19.05 24.92 18.80 17.87 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 193 ALA B 71 ALA~? 6.33 O ACT B 502 A 194 GLY B 68 GLY~? 8.88 O ACT B 502 B 457 ALA B 73 ALA~? 8.56 CH3 ACT B 502 B 458 ALA B 76 ALA~? 12.40 CH3 ACT B 502 coo 61.89 87.20 13.50 62.59 88.00 12.38 -15.58 10.60 26.60 -14.06 10.51 26.75 coo 59.34 89.99 13.88 59.24 89.18 13.73 -13.16 8.67 31.18 -13.37 8.79 30.42 coo 65.50 91.13 17.77 64.65 89.88 18.00 -20.50 8.04 26.45 -21.25 8.75 27.56 coo 68.56 91.15 20.03 69.95 90.68 19.64 -21.15 5.68 22.06 -21.63 5.18 23.39 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 193 ALA C 71 ALA~? 3.85 CH3 ACT C 503 A 194 GLY C 68 GLY~? 7.89 CH3 ACT C 503 B 457 ALA C 73 ALA~? 8.85 CH3 ACT C 503 B 458 ALA C 76 ALA~? 12.09 CH3 ACT C 503 coo 61.89 87.20 13.50 62.59 88.00 12.38 -14.49 11.86 9.72 -14.32 13.36 10.09 coo 59.34 89.99 13.88 59.24 89.18 13.73 -16.15 15.61 5.62 -16.28 15.25 6.33 coo 65.50 91.13 17.77 64.65 89.88 18.00 -17.50 7.43 8.36 -16.78 6.98 7.10 coo 68.56 91.15 20.03 69.95 90.68 19.64 -20.39 6.18 12.34 -20.87 6.14 10.90 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 193 ALA D 71 ALA~? 28.01 O ACT B 502 A 194 GLY D 68 GLY~? 30.11 OXT ACT B 502 B 457 ALA D 73 ALA~? 31.32 O ACT B 502 B 458 ALA D 76 ALA~? 35.11 O ACT B 502 coo 61.89 87.20 13.50 62.59 88.00 12.38 -13.96 44.65 30.21 -15.47 44.54 30.10 coo 59.34 89.99 13.88 59.24 89.18 13.73 -17.03 46.14 34.72 -16.83 46.23 34.01 coo 65.50 91.13 17.77 64.65 89.88 18.00 -9.37 47.67 30.90 -8.63 46.94 32.02 coo 68.56 91.15 20.03 69.95 90.68 19.64 -8.73 50.62 26.76 -8.42 51.05 28.20 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 4 hits 1pix_c03 naa= 4 ULMN 4 1pma_c00 PROTEASOME user 1 4 # 1 B 1 THR C 38 THR^? 13.13 OXT ACT C 503 B 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 B 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 B 129 SER C 35 SER.? 15.52 O ACT C 503 coo 145.45 99.84 111.72 143.76 98.56 112.07 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 136.79 102.27 111.59 142.67 100.98 109.47 0.38 25.07 8.12 -1.77 29.22 5.24 coo 140.77 93.29 113.52 140.45 93.77 112.93 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 148.45 97.25 114.98 149.72 97.25 112.90 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c00 PROTEASOME user 2 4 # 2 B 1 THR D 38 THR^? 19.44 OXT ACT B 502 B 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 B 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 B 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 145.45 99.84 111.72 143.76 98.56 112.07 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 136.79 102.27 111.59 142.67 100.98 109.47 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 140.77 93.29 113.52 140.45 93.77 112.93 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 148.45 97.25 114.98 149.72 97.25 112.90 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c00 source 1pma PROTEASOME : 2 hits 1pma_c00 naa= 4 ULMN 4 1pma_c01 PROTEASOME user 1 4 # 1 P 1 THR D 38 THR^? 19.44 OXT ACT B 502 P 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 P 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 P 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 142.15 84.99 86.79 140.56 84.37 88.13 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 133.38 85.70 85.38 139.26 83.66 84.60 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 138.10 81.91 93.37 137.75 81.71 92.63 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 145.29 86.16 90.67 146.68 84.74 89.28 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c01 source 1pma PROTEASOME : 1 hits 1pma_c01 naa= 4 ULMN 4 1pma_c02 PROTEASOME user 1 4 # 1 Q 1 THR C 38 THR^? 13.13 OXT ACT C 503 Q 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 Q 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 Q 129 SER C 35 SER.? 15.52 O ACT C 503 coo 140.73 55.93 82.67 139.31 56.56 84.17 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 131.97 54.44 81.72 138.04 53.15 82.45 0.38 25.07 8.12 -1.77 29.22 5.24 coo 136.89 58.65 89.43 136.55 57.93 89.18 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 143.72 59.85 83.98 145.20 57.91 84.07 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c02 PROTEASOME user 2 4 # 2 Q 1 THR D 38 THR^? 19.44 OXT ACT B 502 Q 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 Q 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 Q 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 140.73 55.93 82.67 139.31 56.56 84.17 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 131.97 54.44 81.72 138.04 53.15 82.45 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 136.89 58.65 89.43 136.55 57.93 89.18 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 143.72 59.85 83.98 145.20 57.91 84.07 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c02 source 1pma PROTEASOME : 2 hits 1pma_c02 naa= 4 ULMN 4 1pma_c03 PROTEASOME user 1 4 # 1 R 1 THR D 38 THR^? 19.44 OXT ACT B 502 R 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 R 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 R 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 142.38 34.41 102.60 140.86 35.75 103.29 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 133.82 32.17 103.65 140.06 32.45 104.82 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 137.84 41.34 104.86 137.70 40.63 105.29 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 144.81 38.28 100.19 146.44 37.17 101.53 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c03 source 1pma PROTEASOME : 1 hits 1pma_c03 naa= 4 ULMN 4 1pma_c04 PROTEASOME user 1 4 # 1 S 1 THR C 38 THR^? 13.13 OXT ACT C 503 S 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 S 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 S 129 SER C 35 SER.? 15.52 O ACT C 503 coo 145.99 36.73 131.50 144.29 37.93 131.05 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 137.54 35.66 134.42 143.74 36.95 134.69 0.38 25.07 8.12 -1.77 29.22 5.24 coo 140.84 42.46 127.91 140.66 42.32 128.74 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 148.11 37.39 126.83 149.93 38.14 128.30 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c04 PROTEASOME user 2 4 # 2 S 1 THR D 38 THR^? 19.44 OXT ACT B 502 S 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 S 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 S 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 145.99 36.73 131.50 144.29 37.93 131.05 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 137.54 35.66 134.42 143.74 36.95 134.69 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 140.84 42.46 127.91 140.66 42.32 128.74 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 148.11 37.39 126.83 149.93 38.14 128.30 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c04 source 1pma PROTEASOME : 2 hits 1pma_c04 naa= 4 ULMN 4 1pma_c05 PROTEASOME user 1 4 # 1 T 1 THR C 38 THR^? 13.13 OXT ACT C 503 T 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 T 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 T 129 SER C 35 SER.? 15.52 O ACT C 503 coo 148.59 61.06 147.60 146.72 61.19 146.49 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 140.35 62.12 151.02 146.27 63.46 149.54 0.38 25.07 8.12 -1.77 29.22 5.24 coo 142.85 61.51 141.28 142.70 62.06 141.93 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 150.80 57.97 144.10 152.46 59.79 144.30 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c05 PROTEASOME user 2 4 # 2 T 1 THR D 38 THR^? 19.44 OXT ACT B 502 T 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 T 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 T 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 148.59 61.06 147.60 146.72 61.19 146.49 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 140.35 62.12 151.02 146.27 63.46 149.54 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 142.85 61.51 141.28 142.70 62.06 141.93 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 150.80 57.97 144.10 152.46 59.79 144.30 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c05 source 1pma PROTEASOME : 2 hits 1pma_c05 naa= 4 ULMN 4 1pma_c06 PROTEASOME user 1 4 # 1 U 1 THR D 38 THR^? 19.44 OXT ACT B 502 U 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 U 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 U 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 148.42 89.29 138.93 146.59 88.50 138.15 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 140.15 91.82 140.86 145.77 92.05 138.33 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 143.01 84.16 135.00 142.77 84.96 134.97 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 150.85 84.74 138.83 152.35 86.20 137.62 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c06 source 1pma PROTEASOME : 1 hits 1pma_c06 naa= 4 ULMN 4 1pma_c07 PROTEASOME user 1 4 # 1 V 1 THR C 38 THR^? 13.13 OXT ACT C 503 V 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 V 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 V 129 SER C 35 SER.? 15.52 O ACT C 503 coo 160.31 31.63 111.03 162.05 32.90 110.99 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 168.58 29.07 108.83 162.49 30.41 108.07 0.38 25.07 8.12 -1.77 29.22 5.24 coo 165.30 38.28 111.45 165.51 37.78 110.79 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 158.15 34.28 114.77 156.42 34.20 113.07 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c07 PROTEASOME user 2 4 # 2 V 1 THR D 38 THR^? 19.44 OXT ACT B 502 V 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 V 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 V 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 160.31 31.63 111.03 162.05 32.90 110.99 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 168.58 29.07 108.83 162.49 30.41 108.07 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 165.30 38.28 111.45 165.51 37.78 110.79 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 158.15 34.28 114.77 156.42 34.20 113.07 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c07 source 1pma PROTEASOME : 2 hits 1pma_c07 naa= 4 ULMN 4 1pma_c08 PROTEASOME user 1 4 # 1 W 1 THR B 38 THR^? 13.93 OXT ACT B 502 W 33 LYS B 3 LYS.? 21.07 O ACT B 502 W 47 GLY B 61 GLY~? 11.96 O ACT B 502 W 129 SER B 35 SER.? 14.98 OXT ACT B 502 coo 157.95 45.66 85.32 159.70 46.33 86.38 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 166.07 44.81 82.01 160.13 46.94 82.57 -3.66 25.02 35.95 -1.49 26.64 40.22 coo 163.23 48.87 90.83 163.39 49.06 90.01 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 155.60 44.58 89.97 153.89 45.98 88.92 -11.93 13.69 41.33 -10.41 11.83 41.69 ULMN 4 1pma_c08 PROTEASOME user 2 4 # 2 W 1 THR C 38 THR^? 13.13 OXT ACT C 503 W 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 W 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 W 129 SER C 35 SER.? 15.52 O ACT C 503 coo 157.95 45.66 85.32 159.70 46.33 86.38 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 166.07 44.81 82.01 160.13 46.94 82.57 0.38 25.07 8.12 -1.77 29.22 5.24 coo 163.23 48.87 90.83 163.39 49.06 90.01 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 155.60 44.58 89.97 153.89 45.98 88.92 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c08 PROTEASOME user 3 4 # 3 W 1 THR D 38 THR^? 19.44 OXT ACT B 502 W 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 W 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 W 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 157.95 45.66 85.32 159.70 46.33 86.38 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 166.07 44.81 82.01 160.13 46.94 82.57 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 163.23 48.87 90.83 163.39 49.06 90.01 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 155.60 44.58 89.97 153.89 45.98 88.92 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c08 source 1pma PROTEASOME : 3 hits 1pma_c08 naa= 4 ULMN 4 1pma_c09 PROTEASOME user 1 4 # 1 X 1 THR A 38 THR^? 13.66 O ACT A 501 X 33 LYS A 3 LYS.? 15.82 O ACT C 503 X 47 GLY A 61 GLY~? 11.65 O ACT A 501 X 129 SER A 35 SER.? 14.88 OXT ACT A 501 coo 158.06 74.74 80.29 159.87 74.24 81.32 9.25 11.88 0.86 8.30 10.33 -0.29 coo 166.53 76.03 77.46 160.69 77.43 79.50 5.08 2.81 3.00 0.95 1.12 1.99 coo 163.43 71.87 86.14 163.64 72.61 85.77 15.25 6.14 3.18 15.29 5.59 3.87 coo 155.48 70.66 82.49 154.03 72.56 83.11 16.04 12.56 -1.31 17.97 11.29 -2.00 ULMN 4 1pma_c09 PROTEASOME user 2 4 # 2 X 1 THR B 38 THR^? 13.93 OXT ACT B 502 X 33 LYS B 3 LYS.? 21.07 O ACT B 502 X 47 GLY B 61 GLY~? 11.96 O ACT B 502 X 129 SER B 35 SER.? 14.98 OXT ACT B 502 coo 158.06 74.74 80.29 159.87 74.24 81.32 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 166.53 76.03 77.46 160.69 77.43 79.50 -3.66 25.02 35.95 -1.49 26.64 40.22 coo 163.43 71.87 86.14 163.64 72.61 85.77 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 155.48 70.66 82.49 154.03 72.56 83.11 -11.93 13.69 41.33 -10.41 11.83 41.69 ULMN 4 1pma_c09 PROTEASOME user 3 4 # 3 X 1 THR C 38 THR^? 13.13 OXT ACT C 503 X 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 X 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 X 129 SER C 35 SER.? 15.52 O ACT C 503 coo 158.06 74.74 80.29 159.87 74.24 81.32 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 166.53 76.03 77.46 160.69 77.43 79.50 0.38 25.07 8.12 -1.77 29.22 5.24 coo 163.43 71.87 86.14 163.64 72.61 85.77 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 155.48 70.66 82.49 154.03 72.56 83.11 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c09 PROTEASOME user 4 4 # 4 X 1 THR D 38 THR^? 19.44 OXT ACT B 502 X 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 X 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 X 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 158.06 74.74 80.29 159.87 74.24 81.32 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 166.53 76.03 77.46 160.69 77.43 79.50 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 163.43 71.87 86.14 163.64 72.61 85.77 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 155.48 70.66 82.49 154.03 72.56 83.11 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c09 source 1pma PROTEASOME : 4 hits 1pma_c09 naa= 4 ULMN 4 1pma_c10 PROTEASOME user 1 4 # 1 Y 1 THR C 38 THR^? 13.13 OXT ACT C 503 Y 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 Y 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 Y 129 SER C 35 SER.? 15.52 O ACT C 503 coo 161.01 96.61 99.53 162.71 95.26 99.85 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 169.59 99.02 98.57 163.79 98.75 101.06 0.38 25.07 8.12 -1.77 29.22 5.24 coo 165.73 89.82 100.87 166.04 90.54 101.24 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 157.98 92.90 97.78 156.61 93.86 99.58 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c10 PROTEASOME user 2 4 # 2 Y 1 THR D 38 THR^? 19.44 OXT ACT B 502 Y 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 Y 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 Y 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 161.01 96.61 99.53 162.71 95.26 99.85 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 169.59 99.02 98.57 163.79 98.75 101.06 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 165.73 89.82 100.87 166.04 90.54 101.24 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 157.98 92.90 97.78 156.61 93.86 99.58 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c10 source 1pma PROTEASOME : 2 hits 1pma_c10 naa= 4 ULMN 4 1pma_c11 PROTEASOME user 1 4 # 1 Z 1 THR B 38 THR^? 13.93 OXT ACT B 502 Z 33 LYS B 3 LYS.? 21.07 O ACT B 502 Z 47 GLY B 61 GLY~? 11.96 O ACT B 502 Z 129 SER B 35 SER.? 14.98 OXT ACT B 502 coo 164.44 95.20 128.49 165.90 93.95 127.46 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 173.04 96.56 129.40 167.10 95.22 131.11 -3.66 25.02 35.95 -1.49 26.64 40.22 coo 168.59 89.38 123.90 168.88 89.54 124.70 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 161.09 94.40 124.50 159.85 93.81 126.51 -11.93 13.69 41.33 -10.41 11.83 41.69 ULMN 4 1pma_c11 PROTEASOME user 2 4 # 2 Z 1 THR C 38 THR^? 13.13 OXT ACT C 503 Z 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 Z 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 Z 129 SER C 35 SER.? 15.52 O ACT C 503 coo 164.44 95.20 128.49 165.90 93.95 127.46 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 173.04 96.56 129.40 167.10 95.22 131.11 0.38 25.07 8.12 -1.77 29.22 5.24 coo 168.59 89.38 123.90 168.88 89.54 124.70 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 161.09 94.40 124.50 159.85 93.81 126.51 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c11 PROTEASOME user 3 4 # 3 Z 1 THR D 38 THR^? 19.44 OXT ACT B 502 Z 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 Z 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 Z 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 164.44 95.20 128.49 165.90 93.95 127.46 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 173.04 96.56 129.40 167.10 95.22 131.11 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 168.59 89.38 123.90 168.88 89.54 124.70 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 161.09 94.40 124.50 159.85 93.81 126.51 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c11 source 1pma PROTEASOME : 3 hits 1pma_c11 naa= 4 ULMN 4 1pma_c12 PROTEASOME user 1 4 # 1 1 1 THR C 38 THR^? 13.13 OXT ACT C 503 1 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 1 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 1 129 SER C 35 SER.? 15.52 O ACT C 503 coo 165.64 71.38 145.38 167.12 71.04 143.87 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 174.42 70.53 146.91 168.32 69.05 146.87 0.38 25.07 8.12 -1.77 29.22 5.24 coo 169.45 70.72 138.12 169.78 70.22 138.68 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 162.75 74.36 142.49 161.13 72.65 143.07 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c12 PROTEASOME user 2 4 # 2 1 1 THR D 38 THR^? 19.44 OXT ACT B 502 1 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 1 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 1 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 165.64 71.38 145.38 167.12 71.04 143.87 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 174.42 70.53 146.91 168.32 69.05 146.87 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 169.45 70.72 138.12 169.78 70.22 138.68 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 162.75 74.36 142.49 161.13 72.65 143.07 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c12 source 1pma PROTEASOME : 2 hits 1pma_c12 naa= 4 ULMN 4 1pma_c13 PROTEASOME user 1 4 # 1 2 1 THR C 38 THR^? 13.13 OXT ACT C 503 2 33 LYS C 3 LYS.? 18.11 OXT ACT C 503 2 47 GLY C 61 GLY~? 11.24 OXT ACT C 503 2 129 SER C 35 SER.? 15.52 O ACT C 503 coo 163.80 43.09 137.65 165.35 44.06 136.49 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 172.39 40.52 137.60 166.18 40.30 136.65 0.38 25.07 8.12 -1.77 29.22 5.24 coo 168.22 48.11 132.44 168.40 47.27 132.39 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 161.33 47.56 138.08 159.59 46.11 137.23 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 4 1pma_c13 PROTEASOME user 2 4 # 2 2 1 THR D 38 THR^? 19.44 OXT ACT B 502 2 33 LYS D 3 LYS.? 15.58 OXT ACT B 502 2 47 GLY D 61 GLY~? 24.96 OXT ACT B 502 2 129 SER D 35 SER.? 28.88 OXT ACT B 502 coo 163.80 43.09 137.65 165.35 44.06 136.49 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 172.39 40.52 137.60 166.18 40.30 136.65 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 168.22 48.11 132.44 168.40 47.27 132.39 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 161.33 47.56 138.08 159.59 46.11 137.23 -19.19 38.97 43.50 -19.09 40.18 45.58 1pma_c13 source 1pma PROTEASOME : 2 hits 1pma_c13 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 58 ASP~? 16.01 O ACT A 501 A 100 ARG A 62 ARG~? 11.91 O ACT A 501 A 116 GLN A 63 GLN~? 11.62 O ACT A 501 coo 32.24 20.09 5.34 30.38 19.04 5.27 12.40 1.57 0.95 13.75 2.83 -0.02 coo 26.40 25.34 6.28 26.15 22.33 7.25 11.34 4.43 9.06 9.97 1.81 9.84 coo 26.74 21.94 13.78 27.57 20.97 12.08 17.54 2.37 8.33 17.45 2.51 10.45 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP B 58 ASP~? 16.37 O ACT B 502 A 100 ARG B 62 ARG~? 12.26 O ACT B 502 A 116 GLN B 63 GLN~? 11.78 O ACT B 502 coo 32.24 20.09 5.34 30.38 19.04 5.27 -1.77 17.89 37.44 -2.74 16.22 38.35 coo 26.40 25.34 6.28 26.15 22.33 7.25 -6.19 18.92 29.62 -3.70 20.53 28.83 coo 26.74 21.94 13.78 27.57 20.97 12.08 -3.52 12.79 30.02 -4.05 13.09 27.99 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP C 58 ASP~? 15.48 OXT ACT C 503 A 100 ARG C 62 ARG~? 10.88 OXT ACT C 503 A 116 GLN C 63 GLN~? 10.84 CH3 ACT C 503 coo 32.24 20.09 5.34 30.38 19.04 5.27 -5.93 27.71 5.50 -7.21 27.13 3.90 coo 26.40 25.34 6.28 26.15 22.33 7.25 -6.61 21.24 11.49 -5.46 23.07 13.64 coo 26.74 21.94 13.78 27.57 20.97 12.08 -12.60 24.18 10.64 -12.59 22.90 12.36 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 4 3 # 4 A 46 ASP D 58 ASP~? 25.46 OXT ACT B 502 A 100 ARG D 62 ARG~? 20.52 OXT ACT B 502 A 116 GLN D 63 GLN~? 27.23 OXT ACT B 502 coo 32.24 20.09 5.34 30.38 19.04 5.27 -28.98 35.91 37.37 -28.15 37.30 38.76 coo 26.40 25.34 6.28 26.15 22.33 7.25 -23.58 36.44 30.28 -25.75 35.10 28.58 coo 26.74 21.94 13.78 27.57 20.97 12.08 -26.41 42.35 31.64 -25.64 42.37 29.63 12as_c00 source 12as ASPARAGINE SYNTHETASE : 4 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 58 ASP~? 16.01 O ACT A 501 B 100 ARG A 62 ARG~? 11.91 O ACT A 501 B 116 GLN A 63 GLN~? 11.62 O ACT A 501 coo 32.18 48.37 12.48 33.96 49.46 12.97 12.40 1.57 0.95 13.75 2.83 -0.02 coo 39.04 43.25 11.37 38.30 45.35 13.56 11.34 4.43 9.06 9.97 1.81 9.84 coo 37.43 42.63 19.41 36.76 44.08 17.97 17.54 2.37 8.33 17.45 2.51 10.45 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP B 58 ASP~? 16.37 O ACT B 502 B 100 ARG B 62 ARG~? 12.26 O ACT B 502 B 116 GLN B 63 GLN~? 11.78 O ACT B 502 coo 32.18 48.37 12.48 33.96 49.46 12.97 -1.77 17.89 37.44 -2.74 16.22 38.35 coo 39.04 43.25 11.37 38.30 45.35 13.56 -6.19 18.92 29.62 -3.70 20.53 28.83 coo 37.43 42.63 19.41 36.76 44.08 17.97 -3.52 12.79 30.02 -4.05 13.09 27.99 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP C 58 ASP~? 15.48 OXT ACT C 503 B 100 ARG C 62 ARG~? 10.88 OXT ACT C 503 B 116 GLN C 63 GLN~? 10.84 CH3 ACT C 503 coo 32.18 48.37 12.48 33.96 49.46 12.97 -5.93 27.71 5.50 -7.21 27.13 3.90 coo 39.04 43.25 11.37 38.30 45.35 13.56 -6.61 21.24 11.49 -5.46 23.07 13.64 coo 37.43 42.63 19.41 36.76 44.08 17.97 -12.60 24.18 10.64 -12.59 22.90 12.36 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP D 58 ASP~? 25.46 OXT ACT B 502 B 100 ARG D 62 ARG~? 20.52 OXT ACT B 502 B 116 GLN D 63 GLN~? 27.23 OXT ACT B 502 coo 32.18 48.37 12.48 33.96 49.46 12.97 -28.98 35.91 37.37 -28.15 37.30 38.76 coo 39.04 43.25 11.37 38.30 45.35 13.56 -23.58 36.44 30.28 -25.75 35.10 28.58 coo 37.43 42.63 19.41 36.76 44.08 17.97 -26.41 42.35 31.64 -25.64 42.37 29.63 12as_c01 source 12as ASPARAGINE SYNTHETASE : 4 hits 12as_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN B 87 ASN^? 12.23 OXT ACT C 503 63 ARG C 62 ARG~? 10.88 OXT ACT C 503 255 ARG D 9 ARG^? 15.08 O ACT B 502 coo 42.10 13.02 11.14 41.85 11.12 10.23 -13.79 21.31 17.73 -12.12 22.50 17.15 coo 44.36 11.24 3.39 41.81 12.78 4.00 -6.61 21.24 11.49 -5.46 23.07 13.64 coo 38.40 3.83 10.26 40.02 6.30 9.25 -10.16 31.68 19.32 -10.74 28.83 20.23 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 1 hits 1aj0_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 22 ASP~? 16.31 OXT ACT A 501 187 GLU A 17 GLU~? 18.98 CH3 ACT A 501 229 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo -52.57 56.60 47.75 -51.52 54.87 46.95 13.66 28.66 16.58 12.51 30.39 17.11 coo -45.08 48.37 46.81 -46.53 49.74 45.96 8.46 25.60 25.93 9.21 26.72 27.59 coo -47.40 44.36 48.48 -50.80 49.18 46.20 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP B 22 ASP~? 15.53 CH3 ACT B 502 187 GLU B 17 GLU~? 18.31 CH3 ACT B 502 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -31.00 15.29 26.70 -32.94 16.13 26.51 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -30.37 21.21 17.22 -31.47 20.28 15.66 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP C 22 ASP~? 16.98 O ACT C 503 187 GLU C 17 GLU~? 20.89 O ACT C 503 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP D 22 ASP~? 30.56 O ACT B 502 187 GLU D 17 GLU~? 25.97 OXT ACT A 501 229 LYS D 13 LYS.? 35.09 O ACT B 502 coo -52.57 56.60 47.75 -51.52 54.87 46.95 1.48 40.46 31.50 1.79 41.35 33.38 coo -45.08 48.37 46.81 -46.53 49.74 45.96 2.12 36.56 21.03 3.60 37.59 19.89 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -1.12 41.20 17.82 -1.77 47.26 17.33 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 4 hits 1ald_c00 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 7 PHE^? 10.76 O ACT A 501 A 159 ASP A 54 ASP^? -3.76 O ACT A 501s A 188 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 13.91 34.58 14.67 12.95 36.00 12.47 4.11 9.93 15.65 2.48 11.68 17.17 coo 20.97 28.40 16.26 20.19 30.15 15.34 9.47 12.33 8.26 10.66 11.45 9.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 7 PHE^? 10.76 O ACT A 501 A 159 ASP A 54 ASP^? -3.76 O ACT A 501s A 188 LYS C 44 LYS^? 18.40 O ACT C 503 coo 13.91 34.58 14.67 12.95 36.00 12.47 4.11 9.93 15.65 2.48 11.68 17.17 coo 20.97 28.40 16.26 20.19 30.15 15.34 9.47 12.33 8.26 10.66 11.45 9.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 41 PHE^? 11.20 OXT ACT A 501 A 159 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 188 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 13.91 34.58 14.67 12.95 36.00 12.47 4.28 16.86 7.90 2.95 16.20 5.48 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 22.55 41.65 15.60 18.92 37.20 14.63 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 50 PHE^? 12.40 CH3 ACT A 501 A 159 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 188 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo 13.91 34.58 14.67 12.95 36.00 12.47 7.69 21.36 19.99 7.24 23.96 20.97 coo 20.97 28.40 16.26 20.19 30.15 15.34 13.66 28.66 16.58 12.51 30.39 17.11 coo 22.55 41.65 15.60 18.92 37.20 14.63 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 53 PHE^? 10.03 O ACT A 501 A 159 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 188 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 13.91 34.58 14.67 12.95 36.00 12.47 4.01 11.96 10.37 3.05 9.75 8.94 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 22.55 41.65 15.60 18.92 37.20 14.63 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE A 53 PHE^? 10.03 O ACT A 501 A 159 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 188 LYS C 44 LYS^? 18.40 O ACT C 503 coo 13.91 34.58 14.67 12.95 36.00 12.47 4.01 11.96 10.37 3.05 9.75 8.94 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 22.55 41.65 15.60 18.92 37.20 14.63 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE A 53 PHE^? 10.03 O ACT A 501 A 159 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 188 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 13.91 34.58 14.67 12.95 36.00 12.47 4.01 11.96 10.37 3.05 9.75 8.94 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 22.55 41.65 15.60 18.92 37.20 14.63 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE A 56 PHE^? 7.67 O ACT A 501 A 159 ASP A 58 ASP~? 16.01 O ACT A 501 A 188 LYS A 90 LYS^? 10.86 O ACT A 501 coo 13.91 34.58 14.67 12.95 36.00 12.47 11.12 7.53 5.32 11.82 9.21 7.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 12.40 1.57 0.95 13.75 2.83 -0.02 coo 22.55 41.65 15.60 18.92 37.20 14.63 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE B 7 PHE^? 10.67 O ACT B 502 A 159 ASP B 54 ASP^? 4.46 O ACT B 502 A 188 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE B 7 PHE^? 10.67 O ACT B 502 A 159 ASP B 54 ASP^? 4.46 O ACT B 502 A 188 LYS D 44 LYS^? 22.72 O ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 22.55 41.65 15.60 18.92 37.20 14.63 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE B 41 PHE^? 11.14 OXT ACT B 502 A 159 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 188 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE B 50 PHE^? 11.63 CH3 ACT B 502 A 159 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 188 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 13.91 34.58 14.67 12.95 36.00 12.47 -25.01 22.05 22.40 -27.79 22.30 21.98 coo 20.97 28.40 16.26 20.19 30.15 15.34 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 22.55 41.65 15.60 18.92 37.20 14.63 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE B 53 PHE^? 10.51 O ACT B 502 A 159 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 188 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE B 53 PHE^? 10.51 O ACT B 502 A 159 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 188 LYS D 44 LYS^? 22.72 O ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE B 53 PHE^? 10.51 O ACT B 502 A 159 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 188 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 -19.69 21.43 38.53 -15.42 16.83 39.89 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE B 56 PHE^? 8.17 O ACT B 502 A 159 ASP B 58 ASP~? 16.37 O ACT B 502 A 188 LYS B 90 LYS^? 12.84 O ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -8.47 18.95 34.13 -10.44 18.22 32.28 coo 20.97 28.40 16.26 20.19 30.15 15.34 -1.77 17.89 37.44 -2.74 16.22 38.35 coo 22.55 41.65 15.60 18.92 37.20 14.63 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 17 3 # 17 A 88 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 159 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 188 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 13.91 34.58 14.67 12.95 36.00 12.47 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 22.55 41.65 15.60 18.92 37.20 14.63 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 18 3 # 18 A 88 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 159 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 188 LYS C 44 LYS^? 18.40 O ACT C 503 coo 13.91 34.58 14.67 12.95 36.00 12.47 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 22.55 41.65 15.60 18.92 37.20 14.63 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 19 3 # 19 A 88 PHE C 41 PHE^? 10.92 O ACT C 503 A 159 ASP A 54 ASP^? -3.76 O ACT A 501s A 188 LYS C 44 LYS^? 18.40 O ACT C 503 coo 13.91 34.58 14.67 12.95 36.00 12.47 0.59 10.20 5.98 2.26 11.80 4.40 coo 20.97 28.40 16.26 20.19 30.15 15.34 9.47 12.33 8.26 10.66 11.45 9.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 20 3 # 20 A 88 PHE C 50 PHE^? 13.69 O ACT C 503 A 159 ASP C 22 ASP~? 16.98 O ACT C 503 A 188 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo 20.97 28.40 16.26 20.19 30.15 15.34 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 21 3 # 21 A 88 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 159 ASP A 54 ASP^? -3.76 O ACT A 501s A 188 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 13.91 34.58 14.67 12.95 36.00 12.47 0.16 13.32 10.36 1.32 15.86 10.31 coo 20.97 28.40 16.26 20.19 30.15 15.34 9.47 12.33 8.26 10.66 11.45 9.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 22 3 # 22 A 88 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 159 ASP A 54 ASP^? -3.76 O ACT A 501s A 188 LYS A 97 LYS^? 11.17 O ACT C 503 coo 13.91 34.58 14.67 12.95 36.00 12.47 0.16 13.32 10.36 1.32 15.86 10.31 coo 20.97 28.40 16.26 20.19 30.15 15.34 9.47 12.33 8.26 10.66 11.45 9.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 23 3 # 23 A 88 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 159 ASP A 54 ASP^? -3.76 O ACT A 501s A 188 LYS C 44 LYS^? 18.40 O ACT C 503 coo 13.91 34.58 14.67 12.95 36.00 12.47 0.16 13.32 10.36 1.32 15.86 10.31 coo 20.97 28.40 16.26 20.19 30.15 15.34 9.47 12.33 8.26 10.66 11.45 9.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 24 3 # 24 A 88 PHE C 56 PHE^? 6.93 OXT ACT C 503 A 159 ASP C 58 ASP~? 15.48 OXT ACT C 503 A 188 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 13.91 34.58 14.67 12.95 36.00 12.47 -5.73 20.22 6.86 -6.80 17.78 7.80 coo 20.97 28.40 16.26 20.19 30.15 15.34 -5.93 27.71 5.50 -7.21 27.13 3.90 coo 22.55 41.65 15.60 18.92 37.20 14.63 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 25 3 # 25 A 88 PHE D 7 PHE^? 14.53 O ACT B 502 A 159 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 188 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 26 3 # 26 A 88 PHE D 7 PHE^? 14.53 O ACT B 502 A 159 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 188 LYS D 44 LYS^? 22.72 O ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 27 3 # 27 A 88 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 159 ASP B 54 ASP^? 4.46 O ACT B 502 A 188 LYS B 3 LYS.? 21.07 O ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 22.55 41.65 15.60 18.92 37.20 14.63 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 28 3 # 28 A 88 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 159 ASP B 54 ASP^? 4.46 O ACT B 502 A 188 LYS D 44 LYS^? 22.72 O ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 22.55 41.65 15.60 18.92 37.20 14.63 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 29 3 # 29 A 88 PHE D 50 PHE^? 22.38 O ACT B 502 A 159 ASP D 22 ASP~? 30.56 O ACT B 502 A 188 LYS D 13 LYS.? 35.09 O ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -3.75 34.75 25.13 -0.96 34.63 25.02 coo 20.97 28.40 16.26 20.19 30.15 15.34 1.48 40.46 31.50 1.79 41.35 33.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 -1.12 41.20 17.82 -1.77 47.26 17.33 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 30 3 # 30 A 88 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 159 ASP B 54 ASP^? 4.46 O ACT B 502 A 188 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 31 3 # 31 A 88 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 159 ASP B 54 ASP^? 4.46 O ACT B 502 A 188 LYS B 97 LYS^? 23.77 OXT ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 22.55 41.65 15.60 18.92 37.20 14.63 -11.27 32.20 40.12 -15.59 36.50 41.95 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 32 3 # 32 A 88 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 159 ASP B 54 ASP^? 4.46 O ACT B 502 A 188 LYS D 44 LYS^? 22.72 O ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 22.55 41.65 15.60 18.92 37.20 14.63 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 33 3 # 33 A 88 PHE D 56 PHE^? 20.59 OXT ACT B 502 A 159 ASP D 58 ASP~? 25.46 OXT ACT B 502 A 188 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 13.91 34.58 14.67 12.95 36.00 12.47 -21.86 35.60 34.83 -19.58 36.71 33.57 coo 20.97 28.40 16.26 20.19 30.15 15.34 -28.98 35.91 37.37 -28.15 37.30 38.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 -23.03 34.53 25.25 -26.25 39.79 25.56 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 33 hits 1b9h_c02 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP C 54 ASP^? -3.02 OXT ACT C 503s 16 HIS C 65 HIS~? -3.55 C ACT C 503s 67 GLY B 51 GLY^? 6.97 CH3 ACT B 502 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -19.61 22.48 24.23 -20.21 22.46 24.78 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP C 54 ASP^? -3.02 OXT ACT C 503s 16 HIS C 65 HIS~? -3.55 C ACT C 503s 67 GLY D 46 GLY^? 19.42 O ACT B 502 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.44 28.82 21.75 -1.65 29.54 22.23 1be1_c02 source 1be1 GLUTAMATE MUTASE : 2 hits 1be1_c02 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 45 PHE.? 13.07 O ACT A 501 A 205 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 236 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 4.14 2.10 36.34 6.69 3.08 36.92 1.73 17.38 19.47 2.25 15.34 17.62 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 45 PHE.? 12.46 CH3 ACT B 502 A 205 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 236 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 4.14 2.10 36.34 6.69 3.08 36.92 -21.33 28.13 22.13 -18.90 27.61 23.45 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 205 ASP A 54 ASP^? -3.76 O ACT A 501s A 236 LYS A 90 LYS^? 10.86 O ACT A 501 coo 4.14 2.10 36.34 6.69 3.08 36.92 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 9.47 12.33 8.26 10.66 11.45 9.76 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE C 45 PHE^? 13.49 OXT ACT C 503 A 205 ASP A 54 ASP^? -3.76 O ACT A 501s A 236 LYS A 3 LYS.? 15.82 O ACT C 503 coo 4.14 2.10 36.34 6.69 3.08 36.92 1.23 3.65 15.97 1.00 6.45 15.50 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 9.47 12.33 8.26 10.66 11.45 9.76 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE D 45 PHE^? 14.56 O ACT B 502 A 205 ASP B 54 ASP^? 4.46 O ACT B 502 A 236 LYS B 3 LYS.? 21.07 O ACT B 502 coo 4.14 2.10 36.34 6.69 3.08 36.92 -7.17 28.78 23.13 -9.80 28.82 24.18 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -3.66 25.02 35.95 -1.49 26.64 40.22 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 5 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 16 GLN~? 17.48 CH3 ACT A 501 A 91 LEU A 81 LEU~? 11.48 CH3 ACT A 501 A 133 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 43.58 43.67 66.73 42.32 42.78 68.15 15.58 25.35 26.58 16.93 26.84 25.93 coo 38.58 45.09 70.44 38.28 45.21 72.59 16.37 21.67 22.57 16.91 23.14 21.07 coo 44.05 36.87 70.65 43.15 38.64 69.97 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 16 GLN~? 17.48 CH3 ACT A 501 A 91 LEU A 82 LEU~? 10.04 CH3 ACT A 501 A 133 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 43.58 43.67 66.73 42.32 42.78 68.15 15.58 25.35 26.58 16.93 26.84 25.93 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.23 17.39 24.58 14.71 17.16 22.49 coo 44.05 36.87 70.65 43.15 38.64 69.97 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 16 GLN~? 17.16 CH3 ACT B 502 A 91 LEU B 81 LEU~? 10.91 CH3 ACT B 502 A 133 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 43.58 43.67 66.73 42.32 42.78 68.15 -29.57 14.07 16.21 -31.04 12.73 16.95 coo 38.58 45.09 70.44 38.28 45.21 72.59 -25.04 13.21 19.33 -26.14 13.15 21.16 coo 44.05 36.87 70.65 43.15 38.64 69.97 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 16 GLN~? 17.16 CH3 ACT B 502 A 91 LEU B 82 LEU~? 9.83 CH3 ACT B 502 A 133 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 43.58 43.67 66.73 42.32 42.78 68.15 -29.57 14.07 16.21 -31.04 12.73 16.95 coo 38.58 45.09 70.44 38.28 45.21 72.59 -21.48 14.87 16.70 -20.88 15.47 18.74 coo 44.05 36.87 70.65 43.15 38.64 69.97 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN C 16 GLN~? 19.21 O ACT C 503 A 91 LEU C 81 LEU~? 13.31 CH3 ACT C 503 A 133 GLU C 17 GLU~? 20.89 O ACT C 503 coo 43.58 43.67 66.73 42.32 42.78 68.15 -14.20 -5.05 15.96 -15.36 -5.78 14.33 coo 38.58 45.09 70.44 38.28 45.21 72.59 -13.81 0.26 14.63 -14.07 -0.23 12.45 coo 44.05 36.87 70.65 43.15 38.64 69.97 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN D 16 GLN~? 33.43 O ACT B 502 A 91 LEU D 81 LEU~? 29.87 O ACT B 502 A 133 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 43.58 43.67 66.73 42.32 42.78 68.15 0.95 43.74 21.20 1.95 44.81 22.72 coo 38.58 45.09 70.44 38.28 45.21 72.59 -3.68 43.73 23.64 -2.93 43.88 25.65 coo 44.05 36.87 70.65 43.15 38.64 69.97 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN D 16 GLN~? 33.43 O ACT B 502 A 91 LEU D 82 LEU~? 27.60 O ACT B 502 A 133 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 43.58 43.67 66.73 42.32 42.78 68.15 0.95 43.74 21.20 1.95 44.81 22.72 coo 38.58 45.09 70.44 38.28 45.21 72.59 -6.91 42.58 20.08 -7.69 41.73 21.96 coo 44.05 36.87 70.65 43.15 38.64 69.97 2.12 36.56 21.03 3.60 37.59 19.89 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 16 GLN~? 17.48 CH3 ACT A 501 B 591 LEU A 81 LEU~? 11.48 CH3 ACT A 501 B 633 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 88.06 44.34 57.19 89.06 45.53 55.74 15.58 25.35 26.58 16.93 26.84 25.93 coo 86.70 48.66 52.61 87.15 48.69 50.51 16.37 21.67 22.57 16.91 23.14 21.07 coo 95.42 44.52 54.43 93.46 45.31 54.70 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 16 GLN~? 17.48 CH3 ACT A 501 B 591 LEU A 82 LEU~? 10.04 CH3 ACT A 501 B 633 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 88.06 44.34 57.19 89.06 45.53 55.74 15.58 25.35 26.58 16.93 26.84 25.93 coo 86.70 48.66 52.61 87.15 48.69 50.51 15.23 17.39 24.58 14.71 17.16 22.49 coo 95.42 44.52 54.43 93.46 45.31 54.70 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 16 GLN~? 17.16 CH3 ACT B 502 B 591 LEU B 81 LEU~? 10.91 CH3 ACT B 502 B 633 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 88.06 44.34 57.19 89.06 45.53 55.74 -29.57 14.07 16.21 -31.04 12.73 16.95 coo 86.70 48.66 52.61 87.15 48.69 50.51 -25.04 13.21 19.33 -26.14 13.15 21.16 coo 95.42 44.52 54.43 93.46 45.31 54.70 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 16 GLN~? 17.16 CH3 ACT B 502 B 591 LEU B 82 LEU~? 9.83 CH3 ACT B 502 B 633 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 88.06 44.34 57.19 89.06 45.53 55.74 -29.57 14.07 16.21 -31.04 12.73 16.95 coo 86.70 48.66 52.61 87.15 48.69 50.51 -21.48 14.87 16.70 -20.88 15.47 18.74 coo 95.42 44.52 54.43 93.46 45.31 54.70 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN C 16 GLN~? 19.21 O ACT C 503 B 591 LEU C 81 LEU~? 13.31 CH3 ACT C 503 B 633 GLU C 17 GLU~? 20.89 O ACT C 503 coo 88.06 44.34 57.19 89.06 45.53 55.74 -14.20 -5.05 15.96 -15.36 -5.78 14.33 coo 86.70 48.66 52.61 87.15 48.69 50.51 -13.81 0.26 14.63 -14.07 -0.23 12.45 coo 95.42 44.52 54.43 93.46 45.31 54.70 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN D 16 GLN~? 33.43 O ACT B 502 B 591 LEU D 81 LEU~? 29.87 O ACT B 502 B 633 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 88.06 44.34 57.19 89.06 45.53 55.74 0.95 43.74 21.20 1.95 44.81 22.72 coo 86.70 48.66 52.61 87.15 48.69 50.51 -3.68 43.73 23.64 -2.93 43.88 25.65 coo 95.42 44.52 54.43 93.46 45.31 54.70 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN D 16 GLN~? 33.43 O ACT B 502 B 591 LEU D 82 LEU~? 27.60 O ACT B 502 B 633 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 88.06 44.34 57.19 89.06 45.53 55.74 0.95 43.74 21.20 1.95 44.81 22.72 coo 86.70 48.66 52.61 87.15 48.69 50.51 -6.91 42.58 20.08 -7.69 41.73 21.96 coo 95.42 44.52 54.43 93.46 45.31 54.70 2.12 36.56 21.03 3.60 37.59 19.89 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 16 GLN~? 17.48 CH3 ACT A 501 C1091 LEU A 81 LEU~? 11.48 CH3 ACT A 501 C1133 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 68.29 34.44 43.03 66.67 34.74 44.37 15.58 25.35 26.58 16.93 26.84 25.93 coo 65.83 38.95 47.05 65.46 38.90 49.20 16.37 21.67 22.57 16.91 23.14 21.07 coo 63.14 29.39 46.25 63.84 31.31 45.74 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 16 GLN~? 17.48 CH3 ACT A 501 C1091 LEU A 82 LEU~? 10.04 CH3 ACT A 501 C1133 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 68.29 34.44 43.03 66.67 34.74 44.37 15.58 25.35 26.58 16.93 26.84 25.93 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.23 17.39 24.58 14.71 17.16 22.49 coo 63.14 29.39 46.25 63.84 31.31 45.74 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 16 GLN~? 17.16 CH3 ACT B 502 C1091 LEU B 81 LEU~? 10.91 CH3 ACT B 502 C1133 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 68.29 34.44 43.03 66.67 34.74 44.37 -29.57 14.07 16.21 -31.04 12.73 16.95 coo 65.83 38.95 47.05 65.46 38.90 49.20 -25.04 13.21 19.33 -26.14 13.15 21.16 coo 63.14 29.39 46.25 63.84 31.31 45.74 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 16 GLN~? 17.16 CH3 ACT B 502 C1091 LEU B 82 LEU~? 9.83 CH3 ACT B 502 C1133 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 68.29 34.44 43.03 66.67 34.74 44.37 -29.57 14.07 16.21 -31.04 12.73 16.95 coo 65.83 38.95 47.05 65.46 38.90 49.20 -21.48 14.87 16.70 -20.88 15.47 18.74 coo 63.14 29.39 46.25 63.84 31.31 45.74 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN C 16 GLN~? 19.21 O ACT C 503 C1091 LEU C 81 LEU~? 13.31 CH3 ACT C 503 C1133 GLU C 17 GLU~? 20.89 O ACT C 503 coo 68.29 34.44 43.03 66.67 34.74 44.37 -14.20 -5.05 15.96 -15.36 -5.78 14.33 coo 65.83 38.95 47.05 65.46 38.90 49.20 -13.81 0.26 14.63 -14.07 -0.23 12.45 coo 63.14 29.39 46.25 63.84 31.31 45.74 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN C 16 GLN~? 19.21 O ACT C 503 C1091 LEU C 82 LEU~? 12.10 CH3 ACT C 503 C1133 GLU C 17 GLU~? 20.89 O ACT C 503 coo 68.29 34.44 43.03 66.67 34.74 44.37 -14.20 -5.05 15.96 -15.36 -5.78 14.33 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.52 2.70 18.75 -11.60 3.75 17.08 coo 63.14 29.39 46.25 63.84 31.31 45.74 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN D 16 GLN~? 33.43 O ACT B 502 C1091 LEU D 81 LEU~? 29.87 O ACT B 502 C1133 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 68.29 34.44 43.03 66.67 34.74 44.37 0.95 43.74 21.20 1.95 44.81 22.72 coo 65.83 38.95 47.05 65.46 38.90 49.20 -3.68 43.73 23.64 -2.93 43.88 25.65 coo 63.14 29.39 46.25 63.84 31.31 45.74 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 8 3 # 8 C1050 GLN D 16 GLN~? 33.43 O ACT B 502 C1091 LEU D 82 LEU~? 27.60 O ACT B 502 C1133 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 68.29 34.44 43.03 66.67 34.74 44.37 0.95 43.74 21.20 1.95 44.81 22.72 coo 65.83 38.95 47.05 65.46 38.90 49.20 -6.91 42.58 20.08 -7.69 41.73 21.96 coo 63.14 29.39 46.25 63.84 31.31 45.74 2.12 36.56 21.03 3.60 37.59 19.89 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 8 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 16 GLN~? 17.48 CH3 ACT A 501 A 91 LEU A 81 LEU~? 11.48 CH3 ACT A 501 A 133 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 38.23 53.34 67.59 38.84 53.87 69.56 15.58 25.35 26.58 16.93 26.84 25.93 coo 35.40 53.22 73.30 35.37 54.87 74.74 16.37 21.67 22.57 16.91 23.14 21.07 coo 45.08 56.04 70.60 43.15 55.19 70.77 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 16 GLN~? 17.48 CH3 ACT A 501 A 91 LEU A 82 LEU~? 10.04 CH3 ACT A 501 A 133 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 38.23 53.34 67.59 38.84 53.87 69.56 15.58 25.35 26.58 16.93 26.84 25.93 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.23 17.39 24.58 14.71 17.16 22.49 coo 45.08 56.04 70.60 43.15 55.19 70.77 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 16 GLN~? 17.16 CH3 ACT B 502 A 91 LEU B 81 LEU~? 10.91 CH3 ACT B 502 A 133 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 38.23 53.34 67.59 38.84 53.87 69.56 -29.57 14.07 16.21 -31.04 12.73 16.95 coo 35.40 53.22 73.30 35.37 54.87 74.74 -25.04 13.21 19.33 -26.14 13.15 21.16 coo 45.08 56.04 70.60 43.15 55.19 70.77 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 16 GLN~? 17.16 CH3 ACT B 502 A 91 LEU B 82 LEU~? 9.83 CH3 ACT B 502 A 133 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 38.23 53.34 67.59 38.84 53.87 69.56 -29.57 14.07 16.21 -31.04 12.73 16.95 coo 35.40 53.22 73.30 35.37 54.87 74.74 -21.48 14.87 16.70 -20.88 15.47 18.74 coo 45.08 56.04 70.60 43.15 55.19 70.77 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN C 16 GLN~? 19.21 O ACT C 503 A 91 LEU C 81 LEU~? 13.31 CH3 ACT C 503 A 133 GLU C 17 GLU~? 20.89 O ACT C 503 coo 38.23 53.34 67.59 38.84 53.87 69.56 -14.20 -5.05 15.96 -15.36 -5.78 14.33 coo 35.40 53.22 73.30 35.37 54.87 74.74 -13.81 0.26 14.63 -14.07 -0.23 12.45 coo 45.08 56.04 70.60 43.15 55.19 70.77 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN D 16 GLN~? 33.43 O ACT B 502 A 91 LEU D 81 LEU~? 29.87 O ACT B 502 A 133 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 38.23 53.34 67.59 38.84 53.87 69.56 0.95 43.74 21.20 1.95 44.81 22.72 coo 35.40 53.22 73.30 35.37 54.87 74.74 -3.68 43.73 23.64 -2.93 43.88 25.65 coo 45.08 56.04 70.60 43.15 55.19 70.77 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN D 16 GLN~? 33.43 O ACT B 502 A 91 LEU D 82 LEU~? 27.60 O ACT B 502 A 133 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 38.23 53.34 67.59 38.84 53.87 69.56 0.95 43.74 21.20 1.95 44.81 22.72 coo 35.40 53.22 73.30 35.37 54.87 74.74 -6.91 42.58 20.08 -7.69 41.73 21.96 coo 45.08 56.04 70.60 43.15 55.19 70.77 2.12 36.56 21.03 3.60 37.59 19.89 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 7 hits 1bsj_c00 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN B 87 ASN^? 12.23 OXT ACT C 503 192 ASP C 54 ASP^? -3.02 OXT ACT C 503s 195 HIS C 65 HIS~? -3.55 C ACT C 503s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -13.79 21.31 17.73 -12.12 22.50 17.15 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN C 32 ASN~? 12.55 O ACT C 503 192 ASP C 54 ASP^? -3.02 OXT ACT C 503s 195 HIS C 65 HIS~? -3.55 C ACT C 503s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -7.80 11.04 -3.58 -6.14 9.70 -3.27 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN C 87 ASN.? 10.16 O ACT B 502 192 ASP B 54 ASP^? 4.46 O ACT B 502 195 HIS B 65 HIS~? -3.69 O ACT B 502s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -7.54 12.49 22.38 -6.86 14.54 22.53 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -12.58 15.14 31.21 -14.46 15.75 30.51 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 3 hits 1bwp_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU B 59 GLU~? 13.30 O ACT B 502 A 89 GLU B 92 GLU^? 19.37 O ACT B 502 A 120 SER A 48 SER.? 17.26 CH3 ACT A 501 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -1.11 15.84 31.13 -2.15 17.21 29.83 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -0.80 26.07 29.41 1.12 26.90 28.84 coo -34.73 8.57 68.21 -33.63 9.08 70.28 6.12 22.28 25.46 5.72 21.09 27.51 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 89 GLU D 11 GLU.? 21.84 O ACT B 502 A 120 SER D 48 SER.? 23.18 OXT ACT C 503 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -0.44 25.21 15.82 -1.51 26.57 14.58 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -7.35 35.76 17.53 -6.53 33.80 17.57 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -0.72 34.09 20.26 -1.13 33.83 17.85 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU D 17 GLU~? 25.97 OXT ACT A 501 A 89 GLU D 11 GLU.? 21.84 O ACT B 502 A 120 SER D 83 SER.? 27.11 OXT ACT C 503 coo -24.35 9.53 67.64 -25.07 11.29 68.60 2.12 36.56 21.03 3.60 37.59 19.89 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -7.35 35.76 17.53 -6.53 33.80 17.57 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -4.98 41.81 16.11 -5.10 39.49 15.62 1cns_c00 source 1cns CHITINASE : 3 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU B 59 GLU~? 13.30 O ACT B 502 B 89 GLU B 92 GLU^? 19.37 O ACT B 502 B 120 SER A 48 SER.? 17.26 CH3 ACT A 501 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -0.80 26.07 29.41 1.12 26.90 28.84 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 6.12 22.28 25.46 5.72 21.09 27.51 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 92 GLU^? 19.37 O ACT B 502 B 89 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 120 SER D 48 SER.? 23.18 OXT ACT C 503 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -0.80 26.07 29.41 1.12 26.90 28.84 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -0.72 34.09 20.26 -1.13 33.83 17.85 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 89 GLU B 92 GLU^? 19.37 O ACT B 502 B 120 SER A 48 SER.? 17.26 CH3 ACT A 501 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -0.80 26.07 29.41 1.12 26.90 28.84 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 6.12 22.28 25.46 5.72 21.09 27.51 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 89 GLU D 11 GLU.? 21.84 O ACT B 502 B 120 SER D 48 SER.? 23.18 OXT ACT C 503 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -0.72 34.09 20.26 -1.13 33.83 17.85 1cns_c01 source 1cns CHITINASE : 4 hits 1cns_c01 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA B 64 ALA~? 11.22 O ACT B 502 A 74 ASN B 67 ASN~? 11.44 O ACT B 502 A 75 GLY B 68 GLY~? 8.88 O ACT B 502 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -8.30 11.03 33.15 -8.32 11.11 34.69 coo 1.20 66.40 122.20 2.03 64.53 121.46 -8.90 8.17 29.36 -7.21 8.51 28.12 coo 4.68 65.84 125.52 4.11 65.60 126.05 -13.16 8.67 31.18 -13.37 8.79 30.42 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA C 64 ALA~? 10.90 CH3 ACT C 503 A 74 ASN C 67 ASN~? 10.88 CH3 ACT C 503 A 75 GLY C 68 GLY~? 7.89 CH3 ACT C 503 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -13.66 20.75 5.77 -13.26 21.25 4.37 coo 1.20 66.40 122.20 2.03 64.53 121.46 -17.40 19.51 8.11 -17.74 20.65 9.88 coo 4.68 65.84 125.52 4.11 65.60 126.05 -16.15 15.61 5.62 -16.28 15.25 6.33 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 3 3 # 3 A 1 ALA D 64 ALA~? 28.22 OXT ACT B 502 A 74 ASN D 67 ASN~? 31.47 OXT ACT B 502 A 75 GLY D 68 GLY~? 30.11 OXT ACT B 502 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -22.15 43.56 35.71 -22.30 43.07 37.15 coo 1.20 66.40 122.20 2.03 64.53 121.46 -21.35 47.13 33.03 -22.85 47.39 31.52 coo 4.68 65.84 125.52 4.11 65.60 126.05 -17.03 46.14 34.72 -16.83 46.23 34.01 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 3 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 64 ALA~? 11.15 O ACT A 501 B 74 ASN A 67 ASN~? 11.66 O ACT A 501 B 75 GLY A 68 GLY~? 8.65 OXT ACT A 501 coo 39.21 14.97 27.55 40.19 16.01 27.08 19.24 7.69 5.99 19.07 7.91 4.49 coo 43.06 12.94 25.74 42.26 11.81 27.44 22.25 7.80 9.68 22.12 6.01 10.80 coo 46.38 13.54 29.18 46.14 14.29 29.26 21.13 12.33 8.60 21.18 12.38 9.43 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA B 64 ALA~? 11.22 O ACT B 502 B 74 ASN B 67 ASN~? 11.44 O ACT B 502 B 75 GLY B 68 GLY~? 8.88 O ACT B 502 coo 39.21 14.97 27.55 40.19 16.01 27.08 -8.30 11.03 33.15 -8.32 11.11 34.69 coo 43.06 12.94 25.74 42.26 11.81 27.44 -8.90 8.17 29.36 -7.21 8.51 28.12 coo 46.38 13.54 29.18 46.14 14.29 29.26 -13.16 8.67 31.18 -13.37 8.79 30.42 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA C 64 ALA~? 10.90 CH3 ACT C 503 B 74 ASN C 67 ASN~? 10.88 CH3 ACT C 503 B 75 GLY C 68 GLY~? 7.89 CH3 ACT C 503 coo 39.21 14.97 27.55 40.19 16.01 27.08 -13.66 20.75 5.77 -13.26 21.25 4.37 coo 43.06 12.94 25.74 42.26 11.81 27.44 -17.40 19.51 8.11 -17.74 20.65 9.88 coo 46.38 13.54 29.18 46.14 14.29 29.26 -16.15 15.61 5.62 -16.28 15.25 6.33 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 4 3 # 4 B 1 ALA D 64 ALA~? 28.22 OXT ACT B 502 B 74 ASN D 67 ASN~? 31.47 OXT ACT B 502 B 75 GLY D 68 GLY~? 30.11 OXT ACT B 502 coo 39.21 14.97 27.55 40.19 16.01 27.08 -22.15 43.56 35.71 -22.30 43.07 37.15 coo 43.06 12.94 25.74 42.26 11.81 27.44 -21.35 47.13 33.03 -22.85 47.39 31.52 coo 46.38 13.54 29.18 46.14 14.29 29.26 -17.03 46.14 34.72 -16.83 46.23 34.01 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 64 ALA~? 11.15 O ACT A 501 C 74 ASN A 67 ASN~? 11.66 O ACT A 501 C 75 GLY A 68 GLY~? 8.65 OXT ACT A 501 coo 16.14 15.08 36.63 15.28 14.65 37.81 19.24 7.69 5.99 19.07 7.91 4.49 coo 11.60 16.13 36.70 12.80 17.74 35.96 22.25 7.80 9.68 22.12 6.01 10.80 coo 10.99 19.23 40.32 11.50 18.77 40.74 21.13 12.33 8.60 21.18 12.38 9.43 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA B 64 ALA~? 11.22 O ACT B 502 C 74 ASN B 67 ASN~? 11.44 O ACT B 502 C 75 GLY B 68 GLY~? 8.88 O ACT B 502 coo 16.14 15.08 36.63 15.28 14.65 37.81 -8.30 11.03 33.15 -8.32 11.11 34.69 coo 11.60 16.13 36.70 12.80 17.74 35.96 -8.90 8.17 29.36 -7.21 8.51 28.12 coo 10.99 19.23 40.32 11.50 18.77 40.74 -13.16 8.67 31.18 -13.37 8.79 30.42 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA C 64 ALA~? 10.90 CH3 ACT C 503 C 74 ASN C 67 ASN~? 10.88 CH3 ACT C 503 C 75 GLY C 68 GLY~? 7.89 CH3 ACT C 503 coo 16.14 15.08 36.63 15.28 14.65 37.81 -13.66 20.75 5.77 -13.26 21.25 4.37 coo 11.60 16.13 36.70 12.80 17.74 35.96 -17.40 19.51 8.11 -17.74 20.65 9.88 coo 10.99 19.23 40.32 11.50 18.77 40.74 -16.15 15.61 5.62 -16.28 15.25 6.33 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 4 3 # 4 C 1 ALA D 64 ALA~? 28.22 OXT ACT B 502 C 74 ASN D 67 ASN~? 31.47 OXT ACT B 502 C 75 GLY D 68 GLY~? 30.11 OXT ACT B 502 coo 16.14 15.08 36.63 15.28 14.65 37.81 -22.15 43.56 35.71 -22.30 43.07 37.15 coo 11.60 16.13 36.70 12.80 17.74 35.96 -21.35 47.13 33.03 -22.85 47.39 31.52 coo 10.99 19.23 40.32 11.50 18.77 40.74 -17.03 46.14 34.72 -16.83 46.23 34.01 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 64 ALA~? 11.15 O ACT A 501 D 74 ASN A 67 ASN~? 11.66 O ACT A 501 D 75 GLY A 68 GLY~? 8.65 OXT ACT A 501 coo -13.31 41.90 116.45 -13.05 40.39 116.25 19.24 7.69 5.99 19.07 7.91 4.49 coo -16.85 39.36 115.26 -17.55 40.58 116.90 22.25 7.80 9.68 22.12 6.01 10.80 coo -17.65 36.37 119.00 -16.85 36.22 119.00 21.13 12.33 8.60 21.18 12.38 9.43 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA B 64 ALA~? 11.22 O ACT B 502 D 74 ASN B 67 ASN~? 11.44 O ACT B 502 D 75 GLY B 68 GLY~? 8.88 O ACT B 502 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -8.30 11.03 33.15 -8.32 11.11 34.69 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -8.90 8.17 29.36 -7.21 8.51 28.12 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -13.16 8.67 31.18 -13.37 8.79 30.42 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 3 3 # 3 D 1 ALA C 64 ALA~? 10.90 CH3 ACT C 503 D 74 ASN C 67 ASN~? 10.88 CH3 ACT C 503 D 75 GLY C 68 GLY~? 7.89 CH3 ACT C 503 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -13.66 20.75 5.77 -13.26 21.25 4.37 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -17.40 19.51 8.11 -17.74 20.65 9.88 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -16.15 15.61 5.62 -16.28 15.25 6.33 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 4 3 # 4 D 1 ALA D 64 ALA~? 28.22 OXT ACT B 502 D 74 ASN D 67 ASN~? 31.47 OXT ACT B 502 D 75 GLY D 68 GLY~? 30.11 OXT ACT B 502 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -22.15 43.56 35.71 -22.30 43.07 37.15 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -21.35 47.13 33.03 -22.85 47.39 31.52 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -17.03 46.14 34.72 -16.83 46.23 34.01 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c07 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 3 LYS.? 15.82 O ACT C 503 A 177 GLU A 59 GLU~? 13.04 O ACT A 501 A 201 LEU A 4 LEU^? 13.25 O ACT A 501 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 5.08 2.81 3.00 0.95 1.12 1.99 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 14.64 -0.22 6.93 13.24 0.65 8.32 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 8.55 3.15 6.15 9.04 1.07 6.04 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 90 LYS^? 10.86 O ACT A 501 A 177 GLU A 59 GLU~? 13.04 O ACT A 501 A 201 LEU A 4 LEU^? 13.25 O ACT A 501 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 8.29 3.28 13.77 13.67 2.39 14.04 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 14.64 -0.22 6.93 13.24 0.65 8.32 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 8.55 3.15 6.15 9.04 1.07 6.04 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS B 3 LYS.? 21.07 O ACT B 502 A 177 GLU B 59 GLU~? 13.30 O ACT B 502 A 201 LEU B 4 LEU^? 13.79 O ACT B 502 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -3.66 25.02 35.95 -1.49 26.64 40.22 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -4.33 21.83 32.71 -2.25 21.43 32.20 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS B 90 LYS^? 12.84 O ACT B 502 A 177 GLU B 59 GLU~? 13.30 O ACT B 502 A 201 LEU B 4 LEU^? 13.79 O ACT B 502 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -4.33 21.83 32.71 -2.25 21.43 32.20 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS C 3 LYS.? 18.11 OXT ACT C 503 A 177 GLU C 59 GLU~? 12.18 OXT ACT C 503 A 201 LEU C 4 LEU^? 12.31 OXT ACT C 503 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 0.38 25.07 8.12 -1.77 29.22 5.24 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -3.44 23.59 10.14 -4.00 25.47 11.11 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 177 GLU C 59 GLU~? 12.18 OXT ACT C 503 A 201 LEU C 4 LEU^? 12.31 OXT ACT C 503 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -3.44 23.59 10.14 -4.00 25.47 11.11 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS D 3 LYS.? 15.58 OXT ACT B 502 A 177 GLU D 59 GLU~? 24.17 OXT ACT B 502 A 201 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -28.95 39.32 31.59 -27.70 38.19 30.22 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -25.67 33.10 32.16 -27.76 33.61 31.64 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS D 90 LYS^? 25.07 CH3 ACT B 502 A 177 GLU D 59 GLU~? 24.17 OXT ACT B 502 A 201 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -28.95 39.32 31.59 -27.70 38.19 30.22 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -25.67 33.10 32.16 -27.76 33.61 31.64 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS D 90 LYS^? 25.07 CH3 ACT B 502 A 177 GLU D 92 GLU^? 17.21 CH3 ACT B 502 A 201 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -25.67 33.10 32.16 -27.76 33.61 31.64 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 9 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 3 LYS.? 15.82 O ACT C 503 B 177 GLU A 59 GLU~? 13.04 O ACT A 501 B 201 LEU A 4 LEU^? 13.25 O ACT A 501 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 5.08 2.81 3.00 0.95 1.12 1.99 coo 27.00 6.35 51.01 26.30 4.53 50.18 14.64 -0.22 6.93 13.24 0.65 8.32 coo 23.74 1.68 49.50 22.87 -0.24 49.97 8.55 3.15 6.15 9.04 1.07 6.04 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 90 LYS^? 10.86 O ACT A 501 B 177 GLU A 59 GLU~? 13.04 O ACT A 501 B 201 LEU A 4 LEU^? 13.25 O ACT A 501 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 8.29 3.28 13.77 13.67 2.39 14.04 coo 27.00 6.35 51.01 26.30 4.53 50.18 14.64 -0.22 6.93 13.24 0.65 8.32 coo 23.74 1.68 49.50 22.87 -0.24 49.97 8.55 3.15 6.15 9.04 1.07 6.04 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 3 LYS.? 21.07 O ACT B 502 B 177 GLU B 59 GLU~? 13.30 O ACT B 502 B 201 LEU B 4 LEU^? 13.79 O ACT B 502 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -3.66 25.02 35.95 -1.49 26.64 40.22 coo 27.00 6.35 51.01 26.30 4.53 50.18 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -4.33 21.83 32.71 -2.25 21.43 32.20 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS B 90 LYS^? 12.84 O ACT B 502 B 177 GLU B 59 GLU~? 13.30 O ACT B 502 B 201 LEU B 4 LEU^? 13.79 O ACT B 502 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 27.00 6.35 51.01 26.30 4.53 50.18 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -4.33 21.83 32.71 -2.25 21.43 32.20 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS C 3 LYS.? 18.11 OXT ACT C 503 B 177 GLU C 59 GLU~? 12.18 OXT ACT C 503 B 201 LEU C 4 LEU^? 12.31 OXT ACT C 503 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 0.38 25.07 8.12 -1.77 29.22 5.24 coo 27.00 6.35 51.01 26.30 4.53 50.18 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -3.44 23.59 10.14 -4.00 25.47 11.11 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 177 GLU C 59 GLU~? 12.18 OXT ACT C 503 B 201 LEU C 4 LEU^? 12.31 OXT ACT C 503 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.00 6.35 51.01 26.30 4.53 50.18 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -3.44 23.59 10.14 -4.00 25.47 11.11 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS D 3 LYS.? 15.58 OXT ACT B 502 B 177 GLU D 59 GLU~? 24.17 OXT ACT B 502 B 201 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 27.00 6.35 51.01 26.30 4.53 50.18 -28.95 39.32 31.59 -27.70 38.19 30.22 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -25.67 33.10 32.16 -27.76 33.61 31.64 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS D 90 LYS^? 25.07 CH3 ACT B 502 B 177 GLU D 59 GLU~? 24.17 OXT ACT B 502 B 201 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 27.00 6.35 51.01 26.30 4.53 50.18 -28.95 39.32 31.59 -27.70 38.19 30.22 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -25.67 33.10 32.16 -27.76 33.61 31.64 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 B 145 LYS D 90 LYS^? 25.07 CH3 ACT B 502 B 177 GLU D 92 GLU^? 17.21 CH3 ACT B 502 B 201 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 27.00 6.35 51.01 26.30 4.53 50.18 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -25.67 33.10 32.16 -27.76 33.61 31.64 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 9 hits 1daa_c01 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 34 GLU.? 6.40 OXT ACT A 501 A 226 THR A 80 THR~? 15.79 CH3 ACT A 501 A 229 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo 9.66 102.78 70.07 9.79 101.18 71.42 17.44 14.34 4.36 16.78 13.78 6.33 coo 7.24 97.46 49.60 8.11 95.69 48.80 20.05 22.35 25.44 21.20 23.89 24.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU B 11 GLU.? 14.84 CH3 ACT B 502 A 226 THR C 37 THR^? 7.26 O ACT C 503 A 229 LYS A 97 LYS^? 11.17 O ACT C 503 coo 9.66 102.78 70.07 9.79 101.18 71.42 -22.40 21.62 14.44 -23.19 23.50 15.06 coo 7.24 97.46 49.60 8.11 95.69 48.80 -6.53 17.89 2.50 -7.37 16.24 3.61 coo 10.53 97.56 43.71 9.33 93.71 47.17 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU B 11 GLU.? 14.84 CH3 ACT B 502 A 226 THR C 80 THR~? 17.11 CH3 ACT C 503 A 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 9.66 102.78 70.07 9.79 101.18 71.42 -22.40 21.62 14.44 -23.19 23.50 15.06 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.04 -0.75 16.62 -19.11 -1.61 14.91 coo 10.53 97.56 43.71 9.33 93.71 47.17 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 34 GLU.? 6.39 OXT ACT B 502 A 226 THR B 80 THR~? 15.89 CH3 ACT B 502 A 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 9.66 102.78 70.07 9.79 101.18 71.42 -14.54 12.40 35.90 -14.50 13.22 33.94 coo 7.24 97.46 49.60 8.11 95.69 48.80 -26.14 9.92 15.93 -26.92 8.20 16.95 coo 10.53 97.56 43.71 9.33 93.71 47.17 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 89 GLU^? 13.28 O ACT B 502 A 226 THR C 37 THR^? 7.26 O ACT C 503 A 229 LYS A 97 LYS^? 11.17 O ACT C 503 coo 9.66 102.78 70.07 9.79 101.18 71.42 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 7.24 97.46 49.60 8.11 95.69 48.80 -6.53 17.89 2.50 -7.37 16.24 3.61 coo 10.53 97.56 43.71 9.33 93.71 47.17 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 89 GLU^? 13.28 O ACT B 502 A 226 THR C 38 THR^? 13.13 OXT ACT C 503 A 229 LYS A 97 LYS^? 11.17 O ACT C 503 coo 9.66 102.78 70.07 9.79 101.18 71.42 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 7.24 97.46 49.60 8.11 95.69 48.80 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 10.53 97.56 43.71 9.33 93.71 47.17 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU C 11 GLU^? 15.94 OXT ACT C 503 A 226 THR B 80 THR~? 15.89 CH3 ACT B 502 A 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 9.66 102.78 70.07 9.79 101.18 71.42 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 -26.14 9.92 15.93 -26.92 8.20 16.95 coo 10.53 97.56 43.71 9.33 93.71 47.17 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU C 34 GLU~? 6.63 O ACT C 503 A 226 THR B 49 THR^? 13.99 CH3 ACT B 502 A 229 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 9.66 102.78 70.07 9.79 101.18 71.42 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 7.24 97.46 49.60 8.11 95.69 48.80 -23.73 24.57 18.85 -22.40 25.83 17.72 coo 10.53 97.56 43.71 9.33 93.71 47.17 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU C 34 GLU~? 6.63 O ACT C 503 A 226 THR C 80 THR~? 17.11 CH3 ACT C 503 A 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 9.66 102.78 70.07 9.79 101.18 71.42 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.04 -0.75 16.62 -19.11 -1.61 14.91 coo 10.53 97.56 43.71 9.33 93.71 47.17 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 226 THR B 38 THR^? 13.93 OXT ACT B 502 A 229 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 9.66 102.78 70.07 9.79 101.18 71.42 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 7.24 97.46 49.60 8.11 95.69 48.80 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 10.53 97.56 43.71 9.33 93.71 47.17 -19.69 21.43 38.53 -15.42 16.83 39.89 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU D 11 GLU.? 21.84 O ACT B 502 A 226 THR C 2 THR.? 13.94 OXT ACT C 503 A 229 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 9.66 102.78 70.07 9.79 101.18 71.42 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 7.24 97.46 49.60 8.11 95.69 48.80 0.78 23.36 4.70 1.16 21.29 4.14 coo 10.53 97.56 43.71 9.33 93.71 47.17 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU D 17 GLU~? 25.97 OXT ACT A 501 A 226 THR C 2 THR.? 13.94 OXT ACT C 503 A 229 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 9.66 102.78 70.07 9.79 101.18 71.42 2.12 36.56 21.03 3.60 37.59 19.89 coo 7.24 97.46 49.60 8.11 95.69 48.80 0.78 23.36 4.70 1.16 21.29 4.14 coo 10.53 97.56 43.71 9.33 93.71 47.17 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 57 GLU D 34 GLU.? 25.91 OXT ACT B 502 A 226 THR D 80 THR~? 35.52 O ACT B 502 A 229 LYS D 13 LYS.? 35.09 O ACT B 502 coo 9.66 102.78 70.07 9.79 101.18 71.42 -16.00 41.58 38.86 -16.04 41.30 36.71 coo 7.24 97.46 49.60 8.11 95.69 48.80 -2.66 47.73 21.27 -1.60 49.00 22.69 coo 10.53 97.56 43.71 9.33 93.71 47.17 -1.12 41.20 17.82 -1.77 47.26 17.33 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 13 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 34 GLU.? 6.40 OXT ACT A 501 B 226 THR A 80 THR~? 15.79 CH3 ACT A 501 B 229 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo 15.90 87.61 49.61 13.92 86.96 49.36 17.44 14.34 4.36 16.78 13.78 6.33 coo 20.74 95.78 68.68 19.29 96.84 69.83 20.05 22.35 25.44 21.20 23.89 24.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU B 11 GLU.? 14.84 CH3 ACT B 502 B 226 THR C 80 THR~? 17.11 CH3 ACT C 503 B 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 15.90 87.61 49.61 13.92 86.96 49.36 -22.40 21.62 14.44 -23.19 23.50 15.06 coo 20.74 95.78 68.68 19.29 96.84 69.83 -18.04 -0.75 16.62 -19.11 -1.61 14.91 coo 22.32 101.61 71.64 17.89 98.63 71.55 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU B 34 GLU.? 6.39 OXT ACT B 502 B 226 THR B 80 THR~? 15.89 CH3 ACT B 502 B 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 15.90 87.61 49.61 13.92 86.96 49.36 -14.54 12.40 35.90 -14.50 13.22 33.94 coo 20.74 95.78 68.68 19.29 96.84 69.83 -26.14 9.92 15.93 -26.92 8.20 16.95 coo 22.32 101.61 71.64 17.89 98.63 71.55 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 89 GLU^? 13.28 O ACT B 502 B 226 THR C 38 THR^? 13.13 OXT ACT C 503 B 229 LYS A 97 LYS^? 11.17 O ACT C 503 coo 15.90 87.61 49.61 13.92 86.96 49.36 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 20.74 95.78 68.68 19.29 96.84 69.83 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 22.32 101.61 71.64 17.89 98.63 71.55 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU C 11 GLU^? 15.94 OXT ACT C 503 B 226 THR B 80 THR~? 15.89 CH3 ACT B 502 B 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 15.90 87.61 49.61 13.92 86.96 49.36 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 20.74 95.78 68.68 19.29 96.84 69.83 -26.14 9.92 15.93 -26.92 8.20 16.95 coo 22.32 101.61 71.64 17.89 98.63 71.55 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU C 34 GLU~? 6.63 O ACT C 503 B 226 THR B 49 THR^? 13.99 CH3 ACT B 502 B 229 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 15.90 87.61 49.61 13.92 86.96 49.36 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 20.74 95.78 68.68 19.29 96.84 69.83 -23.73 24.57 18.85 -22.40 25.83 17.72 coo 22.32 101.61 71.64 17.89 98.63 71.55 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU C 34 GLU~? 6.63 O ACT C 503 B 226 THR C 80 THR~? 17.11 CH3 ACT C 503 B 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 15.90 87.61 49.61 13.92 86.96 49.36 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 20.74 95.78 68.68 19.29 96.84 69.83 -18.04 -0.75 16.62 -19.11 -1.61 14.91 coo 22.32 101.61 71.64 17.89 98.63 71.55 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU C 89 GLU^? 12.32 OXT ACT C 503 B 226 THR B 38 THR^? 13.93 OXT ACT B 502 B 229 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 15.90 87.61 49.61 13.92 86.96 49.36 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 20.74 95.78 68.68 19.29 96.84 69.83 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 22.32 101.61 71.64 17.89 98.63 71.55 -19.69 21.43 38.53 -15.42 16.83 39.89 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU D 11 GLU.? 21.84 O ACT B 502 B 226 THR C 2 THR.? 13.94 OXT ACT C 503 B 229 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 15.90 87.61 49.61 13.92 86.96 49.36 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 20.74 95.78 68.68 19.29 96.84 69.83 0.78 23.36 4.70 1.16 21.29 4.14 coo 22.32 101.61 71.64 17.89 98.63 71.55 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 57 GLU D 17 GLU~? 25.97 OXT ACT A 501 B 226 THR C 2 THR.? 13.94 OXT ACT C 503 B 229 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 15.90 87.61 49.61 13.92 86.96 49.36 2.12 36.56 21.03 3.60 37.59 19.89 coo 20.74 95.78 68.68 19.29 96.84 69.83 0.78 23.36 4.70 1.16 21.29 4.14 coo 22.32 101.61 71.64 17.89 98.63 71.55 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 57 GLU D 34 GLU.? 25.91 OXT ACT B 502 B 226 THR D 80 THR~? 35.52 O ACT B 502 B 229 LYS D 13 LYS.? 35.09 O ACT B 502 coo 15.90 87.61 49.61 13.92 86.96 49.36 -16.00 41.58 38.86 -16.04 41.30 36.71 coo 20.74 95.78 68.68 19.29 96.84 69.83 -2.66 47.73 21.27 -1.60 49.00 22.69 coo 22.32 101.61 71.64 17.89 98.63 71.55 -1.12 41.20 17.82 -1.77 47.26 17.33 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 11 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 34 GLU.? 6.40 OXT ACT A 501 C 226 THR A 80 THR~? 15.79 CH3 ACT A 501 C 229 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo 5.43 40.40 61.63 4.27 41.99 60.90 17.44 14.34 4.36 16.78 13.78 6.33 coo 22.16 45.88 73.63 23.23 47.70 73.25 20.05 22.35 25.44 21.20 23.89 24.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU B 11 GLU.? 14.84 CH3 ACT B 502 C 226 THR C 80 THR~? 17.11 CH3 ACT C 503 C 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 5.43 40.40 61.63 4.27 41.99 60.90 -22.40 21.62 14.44 -23.19 23.50 15.06 coo 22.16 45.88 73.63 23.23 47.70 73.25 -18.04 -0.75 16.62 -19.11 -1.61 14.91 coo 28.90 45.91 73.55 25.22 49.72 72.97 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU B 34 GLU.? 6.39 OXT ACT B 502 C 226 THR B 80 THR~? 15.89 CH3 ACT B 502 C 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 5.43 40.40 61.63 4.27 41.99 60.90 -14.54 12.40 35.90 -14.50 13.22 33.94 coo 22.16 45.88 73.63 23.23 47.70 73.25 -26.14 9.92 15.93 -26.92 8.20 16.95 coo 28.90 45.91 73.55 25.22 49.72 72.97 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 89 GLU^? 13.28 O ACT B 502 C 226 THR C 38 THR^? 13.13 OXT ACT C 503 C 229 LYS A 97 LYS^? 11.17 O ACT C 503 coo 5.43 40.40 61.63 4.27 41.99 60.90 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 22.16 45.88 73.63 23.23 47.70 73.25 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 28.90 45.91 73.55 25.22 49.72 72.97 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU C 11 GLU^? 15.94 OXT ACT C 503 C 226 THR B 80 THR~? 15.89 CH3 ACT B 502 C 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 5.43 40.40 61.63 4.27 41.99 60.90 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 22.16 45.88 73.63 23.23 47.70 73.25 -26.14 9.92 15.93 -26.92 8.20 16.95 coo 28.90 45.91 73.55 25.22 49.72 72.97 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU C 34 GLU~? 6.63 O ACT C 503 C 226 THR B 49 THR^? 13.99 CH3 ACT B 502 C 229 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 5.43 40.40 61.63 4.27 41.99 60.90 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 22.16 45.88 73.63 23.23 47.70 73.25 -23.73 24.57 18.85 -22.40 25.83 17.72 coo 28.90 45.91 73.55 25.22 49.72 72.97 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU C 34 GLU~? 6.63 O ACT C 503 C 226 THR C 80 THR~? 17.11 CH3 ACT C 503 C 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 5.43 40.40 61.63 4.27 41.99 60.90 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 22.16 45.88 73.63 23.23 47.70 73.25 -18.04 -0.75 16.62 -19.11 -1.61 14.91 coo 28.90 45.91 73.55 25.22 49.72 72.97 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU C 89 GLU^? 12.32 OXT ACT C 503 C 226 THR B 38 THR^? 13.93 OXT ACT B 502 C 229 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 5.43 40.40 61.63 4.27 41.99 60.90 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 22.16 45.88 73.63 23.23 47.70 73.25 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 28.90 45.91 73.55 25.22 49.72 72.97 -19.69 21.43 38.53 -15.42 16.83 39.89 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU D 11 GLU.? 21.84 O ACT B 502 C 226 THR C 2 THR.? 13.94 OXT ACT C 503 C 229 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 5.43 40.40 61.63 4.27 41.99 60.90 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 22.16 45.88 73.63 23.23 47.70 73.25 0.78 23.36 4.70 1.16 21.29 4.14 coo 28.90 45.91 73.55 25.22 49.72 72.97 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 57 GLU D 17 GLU~? 25.97 OXT ACT A 501 C 226 THR C 2 THR.? 13.94 OXT ACT C 503 C 229 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 5.43 40.40 61.63 4.27 41.99 60.90 2.12 36.56 21.03 3.60 37.59 19.89 coo 22.16 45.88 73.63 23.23 47.70 73.25 0.78 23.36 4.70 1.16 21.29 4.14 coo 28.90 45.91 73.55 25.22 49.72 72.97 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 57 GLU D 34 GLU.? 25.91 OXT ACT B 502 C 226 THR D 80 THR~? 35.52 O ACT B 502 C 229 LYS D 13 LYS.? 35.09 O ACT B 502 coo 5.43 40.40 61.63 4.27 41.99 60.90 -16.00 41.58 38.86 -16.04 41.30 36.71 coo 22.16 45.88 73.63 23.23 47.70 73.25 -2.66 47.73 21.27 -1.60 49.00 22.69 coo 28.90 45.91 73.55 25.22 49.72 72.97 -1.12 41.20 17.82 -1.77 47.26 17.33 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 11 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 34 GLU.? 6.40 OXT ACT A 501 D 226 THR A 80 THR~? 15.79 CH3 ACT A 501 D 229 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo 26.07 55.89 66.14 25.33 56.50 68.01 17.44 14.34 4.36 16.78 13.78 6.33 coo 11.79 47.62 52.67 10.10 46.51 53.39 20.05 22.35 25.44 21.20 23.89 24.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU B 11 GLU.? 14.84 CH3 ACT B 502 D 226 THR C 80 THR~? 17.11 CH3 ACT C 503 D 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 26.07 55.89 66.14 25.33 56.50 68.01 -22.40 21.62 14.44 -23.19 23.50 15.06 coo 11.79 47.62 52.67 10.10 46.51 53.39 -18.04 -0.75 16.62 -19.11 -1.61 14.91 coo 10.05 41.79 49.80 7.94 44.71 53.76 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU B 34 GLU.? 6.39 OXT ACT B 502 D 226 THR B 80 THR~? 15.89 CH3 ACT B 502 D 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 26.07 55.89 66.14 25.33 56.50 68.01 -14.54 12.40 35.90 -14.50 13.22 33.94 coo 11.79 47.62 52.67 10.10 46.51 53.39 -26.14 9.92 15.93 -26.92 8.20 16.95 coo 10.05 41.79 49.80 7.94 44.71 53.76 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 89 GLU^? 13.28 O ACT B 502 D 226 THR C 38 THR^? 13.13 OXT ACT C 503 D 229 LYS A 97 LYS^? 11.17 O ACT C 503 coo 26.07 55.89 66.14 25.33 56.50 68.01 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 11.79 47.62 52.67 10.10 46.51 53.39 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 10.05 41.79 49.80 7.94 44.71 53.76 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU C 11 GLU^? 15.94 OXT ACT C 503 D 226 THR B 80 THR~? 15.89 CH3 ACT B 502 D 229 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 26.07 55.89 66.14 25.33 56.50 68.01 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 11.79 47.62 52.67 10.10 46.51 53.39 -26.14 9.92 15.93 -26.92 8.20 16.95 coo 10.05 41.79 49.80 7.94 44.71 53.76 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU C 34 GLU~? 6.63 O ACT C 503 D 226 THR B 49 THR^? 13.99 CH3 ACT B 502 D 229 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 26.07 55.89 66.14 25.33 56.50 68.01 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 11.79 47.62 52.67 10.10 46.51 53.39 -23.73 24.57 18.85 -22.40 25.83 17.72 coo 10.05 41.79 49.80 7.94 44.71 53.76 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU C 34 GLU~? 6.63 O ACT C 503 D 226 THR C 80 THR~? 17.11 CH3 ACT C 503 D 229 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 26.07 55.89 66.14 25.33 56.50 68.01 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 11.79 47.62 52.67 10.10 46.51 53.39 -18.04 -0.75 16.62 -19.11 -1.61 14.91 coo 10.05 41.79 49.80 7.94 44.71 53.76 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU C 89 GLU^? 12.32 OXT ACT C 503 D 226 THR B 38 THR^? 13.93 OXT ACT B 502 D 229 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 26.07 55.89 66.14 25.33 56.50 68.01 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 11.79 47.62 52.67 10.10 46.51 53.39 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 10.05 41.79 49.80 7.94 44.71 53.76 -19.69 21.43 38.53 -15.42 16.83 39.89 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU D 11 GLU.? 21.84 O ACT B 502 D 226 THR C 2 THR.? 13.94 OXT ACT C 503 D 229 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 26.07 55.89 66.14 25.33 56.50 68.01 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 11.79 47.62 52.67 10.10 46.51 53.39 0.78 23.36 4.70 1.16 21.29 4.14 coo 10.05 41.79 49.80 7.94 44.71 53.76 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 57 GLU D 17 GLU~? 25.97 OXT ACT A 501 D 226 THR C 2 THR.? 13.94 OXT ACT C 503 D 229 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 26.07 55.89 66.14 25.33 56.50 68.01 2.12 36.56 21.03 3.60 37.59 19.89 coo 11.79 47.62 52.67 10.10 46.51 53.39 0.78 23.36 4.70 1.16 21.29 4.14 coo 10.05 41.79 49.80 7.94 44.71 53.76 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 57 GLU D 34 GLU.? 25.91 OXT ACT B 502 D 226 THR D 80 THR~? 35.52 O ACT B 502 D 229 LYS D 13 LYS.? 35.09 O ACT B 502 coo 26.07 55.89 66.14 25.33 56.50 68.01 -16.00 41.58 38.86 -16.04 41.30 36.71 coo 11.79 47.62 52.67 10.10 46.51 53.39 -2.66 47.73 21.27 -1.60 49.00 22.69 coo 10.05 41.79 49.80 7.94 44.71 53.76 -1.12 41.20 17.82 -1.77 47.26 17.33 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 11 hits 1dfo_c07 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 37 THR^? 7.38 OXT ACT A 501 A 45 THR A 38 THR^? 13.66 O ACT A 501 A 161 LYS A 90 LYS^? 10.86 O ACT A 501 coo 26.16 88.25 79.16 25.22 89.47 80.71 12.45 11.59 2.88 13.04 12.51 4.77 coo 27.73 89.90 76.08 29.24 91.46 75.95 9.25 11.88 0.86 8.30 10.33 -0.29 coo 33.83 91.15 88.62 31.07 91.06 83.02 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 38 THR^? 13.66 O ACT A 501 A 45 THR A 37 THR^? 7.38 OXT ACT A 501 A 161 LYS A 97 LYS^? 11.17 O ACT C 503 coo 26.16 88.25 79.16 25.22 89.47 80.71 9.25 11.88 0.86 8.30 10.33 -0.29 coo 27.73 89.90 76.08 29.24 91.46 75.95 12.45 11.59 2.88 13.04 12.51 4.77 coo 33.83 91.15 88.62 31.07 91.06 83.02 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR B 37 THR^? 7.60 OXT ACT B 502 A 45 THR B 38 THR^? 13.93 OXT ACT B 502 A 161 LYS B 90 LYS^? 12.84 O ACT B 502 coo 26.16 88.25 79.16 25.22 89.47 80.71 -11.91 17.46 37.30 -13.16 16.95 35.64 coo 27.73 89.90 76.08 29.24 91.46 75.95 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 33.83 91.15 88.62 31.07 91.06 83.02 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR B 38 THR^? 13.93 OXT ACT B 502 A 45 THR B 37 THR^? 7.60 OXT ACT B 502 A 161 LYS B 97 LYS^? 23.77 OXT ACT B 502 coo 26.16 88.25 79.16 25.22 89.47 80.71 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 27.73 89.90 76.08 29.24 91.46 75.95 -11.91 17.46 37.30 -13.16 16.95 35.64 coo 33.83 91.15 88.62 31.07 91.06 83.02 -11.27 32.20 40.12 -15.59 36.50 41.95 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR C 37 THR^? 7.26 O ACT C 503 A 45 THR C 38 THR^? 13.13 OXT ACT C 503 A 161 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 26.16 88.25 79.16 25.22 89.47 80.71 -6.53 17.89 2.50 -7.37 16.24 3.61 coo 27.73 89.90 76.08 29.24 91.46 75.95 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR C 38 THR^? 13.13 OXT ACT C 503 A 45 THR C 37 THR^? 7.26 O ACT C 503 A 161 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 26.16 88.25 79.16 25.22 89.47 80.71 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 27.73 89.90 76.08 29.24 91.46 75.95 -6.53 17.89 2.50 -7.37 16.24 3.61 coo 33.83 91.15 88.62 31.07 91.06 83.02 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 44 THR D 37 THR^? 22.30 OXT ACT B 502 A 45 THR D 38 THR^? 19.44 OXT ACT B 502 A 161 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 26.16 88.25 79.16 25.22 89.47 80.71 -18.75 36.43 38.66 -17.35 37.30 37.28 coo 27.73 89.90 76.08 29.24 91.46 75.95 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 33.83 91.15 88.62 31.07 91.06 83.02 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 44 THR D 38 THR^? 19.44 OXT ACT B 502 A 45 THR D 37 THR^? 22.30 OXT ACT B 502 A 161 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 26.16 88.25 79.16 25.22 89.47 80.71 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 27.73 89.90 76.08 29.24 91.46 75.95 -18.75 36.43 38.66 -17.35 37.30 37.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 -19.69 21.43 38.53 -15.42 16.83 39.89 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 8 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 37 THR^? 7.38 OXT ACT A 501 B 45 THR A 38 THR^? 13.66 O ACT A 501 B 161 LYS A 90 LYS^? 10.86 O ACT A 501 coo 7.39 128.28 94.56 8.34 126.36 94.79 12.45 11.59 2.88 13.04 12.51 4.77 coo 5.75 129.25 91.25 4.29 128.16 90.07 9.25 11.88 0.86 8.30 10.33 -0.29 coo -0.17 119.75 99.65 2.51 123.83 95.70 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 38 THR^? 13.66 O ACT A 501 B 45 THR A 37 THR^? 7.38 OXT ACT A 501 B 161 LYS A 97 LYS^? 11.17 O ACT C 503 coo 7.39 128.28 94.56 8.34 126.36 94.79 9.25 11.88 0.86 8.30 10.33 -0.29 coo 5.75 129.25 91.25 4.29 128.16 90.07 12.45 11.59 2.88 13.04 12.51 4.77 coo -0.17 119.75 99.65 2.51 123.83 95.70 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR B 37 THR^? 7.60 OXT ACT B 502 B 45 THR B 38 THR^? 13.93 OXT ACT B 502 B 161 LYS B 90 LYS^? 12.84 O ACT B 502 coo 7.39 128.28 94.56 8.34 126.36 94.79 -11.91 17.46 37.30 -13.16 16.95 35.64 coo 5.75 129.25 91.25 4.29 128.16 90.07 -12.00 20.67 39.32 -10.38 21.81 40.17 coo -0.17 119.75 99.65 2.51 123.83 95.70 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR B 38 THR^? 13.93 OXT ACT B 502 B 45 THR B 37 THR^? 7.60 OXT ACT B 502 B 161 LYS B 97 LYS^? 23.77 OXT ACT B 502 coo 7.39 128.28 94.56 8.34 126.36 94.79 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 5.75 129.25 91.25 4.29 128.16 90.07 -11.91 17.46 37.30 -13.16 16.95 35.64 coo -0.17 119.75 99.65 2.51 123.83 95.70 -11.27 32.20 40.12 -15.59 36.50 41.95 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR C 37 THR^? 7.26 O ACT C 503 B 45 THR C 38 THR^? 13.13 OXT ACT C 503 B 161 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 7.39 128.28 94.56 8.34 126.36 94.79 -6.53 17.89 2.50 -7.37 16.24 3.61 coo 5.75 129.25 91.25 4.29 128.16 90.07 -2.96 18.29 1.33 -1.80 20.06 1.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR C 38 THR^? 13.13 OXT ACT C 503 B 45 THR C 37 THR^? 7.26 O ACT C 503 B 161 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 7.39 128.28 94.56 8.34 126.36 94.79 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 5.75 129.25 91.25 4.29 128.16 90.07 -6.53 17.89 2.50 -7.37 16.24 3.61 coo -0.17 119.75 99.65 2.51 123.83 95.70 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 44 THR D 37 THR^? 22.30 OXT ACT B 502 B 45 THR D 38 THR^? 19.44 OXT ACT B 502 B 161 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 7.39 128.28 94.56 8.34 126.36 94.79 -18.75 36.43 38.66 -17.35 37.30 37.28 coo 5.75 129.25 91.25 4.29 128.16 90.07 -18.99 32.97 40.14 -20.81 31.88 40.43 coo -0.17 119.75 99.65 2.51 123.83 95.70 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 44 THR D 38 THR^? 19.44 OXT ACT B 502 B 45 THR D 37 THR^? 22.30 OXT ACT B 502 B 161 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 7.39 128.28 94.56 8.34 126.36 94.79 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 5.75 129.25 91.25 4.29 128.16 90.07 -18.75 36.43 38.66 -17.35 37.30 37.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 -19.69 21.43 38.53 -15.42 16.83 39.89 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 8 hits 1dhp_c03 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 97 LYS^? 11.17 O ACT C 503 A 215 LYS C 44 LYS^? 18.40 O ACT C 503 A 277 LYS A 90 LYS^? 10.86 O ACT A 501 coo 0.50 24.09 51.68 1.51 29.34 52.35 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo 13.06 30.79 51.73 11.40 35.76 53.48 -0.37 1.29 11.81 -0.77 -4.95 10.90 coo 13.04 31.88 60.72 10.57 35.34 57.49 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 97 LYS^? 11.17 O ACT C 503 A 215 LYS C 97 LYS^? 10.89 OXT ACT A 501 A 277 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 0.50 24.09 51.68 1.51 29.34 52.35 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo 13.06 30.79 51.73 11.40 35.76 53.48 8.20 19.20 3.14 12.89 15.65 0.85 coo 13.04 31.88 60.72 10.57 35.34 57.49 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS B 90 LYS^? 12.84 O ACT B 502 A 215 LYS A 44 LYS^? 17.14 CH3 ACT A 501 A 277 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 0.50 24.09 51.68 1.51 29.34 52.35 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 13.06 30.79 51.73 11.40 35.76 53.48 3.76 21.56 17.68 3.38 25.65 21.29 coo 13.04 31.88 60.72 10.57 35.34 57.49 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS B 97 LYS^? 23.77 OXT ACT B 502 A 215 LYS D 44 LYS^? 22.72 O ACT B 502 A 277 LYS B 90 LYS^? 12.84 O ACT B 502 coo 0.50 24.09 51.68 1.51 29.34 52.35 -11.27 32.20 40.12 -15.59 36.50 41.95 coo 13.06 30.79 51.73 11.40 35.76 53.48 -4.01 30.39 26.69 2.27 30.95 26.10 coo 13.04 31.88 60.72 10.57 35.34 57.49 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS C 97 LYS^? 10.89 OXT ACT A 501 A 215 LYS A 44 LYS^? 17.14 CH3 ACT A 501 A 277 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 0.50 24.09 51.68 1.51 29.34 52.35 8.20 19.20 3.14 12.89 15.65 0.85 coo 13.06 30.79 51.73 11.40 35.76 53.48 3.76 21.56 17.68 3.38 25.65 21.29 coo 13.04 31.88 60.72 10.57 35.34 57.49 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS D 97 LYS^? 10.92 OXT ACT B 502 A 215 LYS B 44 LYS^? 16.99 CH3 ACT B 502 A 277 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 0.50 24.09 51.68 1.51 29.34 52.35 -19.69 21.43 38.53 -15.42 16.83 39.89 coo 13.06 30.79 51.73 11.40 35.76 53.48 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 13.04 31.88 60.72 10.57 35.34 57.49 -23.03 34.53 25.25 -26.25 39.79 25.56 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 6 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 44 LYS^? 17.14 CH3 ACT A 501 B 215 LYS B 90 LYS^? 12.84 O ACT B 502 B 277 LYS D 44 LYS^? 22.72 O ACT B 502 coo 6.78 45.91 16.15 7.82 40.81 15.84 3.76 21.56 17.68 3.38 25.65 21.29 coo 17.88 38.77 19.81 16.38 34.23 17.24 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 20.33 37.78 11.20 16.77 34.53 13.47 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 97 LYS^? 11.17 O ACT C 503 B 215 LYS C 97 LYS^? 10.89 OXT ACT A 501 B 277 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 6.78 45.91 16.15 7.82 40.81 15.84 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo 17.88 38.77 19.81 16.38 34.23 17.24 8.20 19.20 3.14 12.89 15.65 0.85 coo 20.33 37.78 11.20 16.77 34.53 13.47 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS B 90 LYS^? 12.84 O ACT B 502 B 215 LYS A 44 LYS^? 17.14 CH3 ACT A 501 B 277 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 6.78 45.91 16.15 7.82 40.81 15.84 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 17.88 38.77 19.81 16.38 34.23 17.24 3.76 21.56 17.68 3.38 25.65 21.29 coo 20.33 37.78 11.20 16.77 34.53 13.47 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS D 44 LYS^? 22.72 O ACT B 502 B 215 LYS A 44 LYS^? 17.14 CH3 ACT A 501 B 277 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 6.78 45.91 16.15 7.82 40.81 15.84 -4.01 30.39 26.69 2.27 30.95 26.10 coo 17.88 38.77 19.81 16.38 34.23 17.24 3.76 21.56 17.68 3.38 25.65 21.29 coo 20.33 37.78 11.20 16.77 34.53 13.47 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS D 44 LYS^? 22.72 O ACT B 502 B 215 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 277 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 6.78 45.91 16.15 7.82 40.81 15.84 -4.01 30.39 26.69 2.27 30.95 26.10 coo 17.88 38.77 19.81 16.38 34.23 17.24 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 20.33 37.78 11.20 16.77 34.53 13.47 3.76 21.56 17.68 3.38 25.65 21.29 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 5 hits 1e19_c01 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 65 HIS~? -3.60 O ACT A 501s A 197 ASP A 54 ASP^? -3.76 O ACT A 501s A 223 LYS A 3 LYS.? 15.82 O ACT C 503 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 14.91 11.26 8.66 14.30 12.93 9.76 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 9.47 12.33 8.26 10.66 11.45 9.76 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 65 HIS~? -3.69 O ACT B 502s A 197 ASP B 54 ASP^? 4.46 O ACT B 502 A 223 LYS B 3 LYS.? 21.07 O ACT B 502 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS C 65 HIS~? -3.55 C ACT C 503s A 197 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 223 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 197 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 223 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -26.73 29.41 34.74 -28.62 25.37 34.54 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 4 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 65 HIS~? -3.60 O ACT A 501s B 197 ASP A 54 ASP^? -3.76 O ACT A 501s B 223 LYS A 3 LYS.? 15.82 O ACT C 503 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 14.91 11.26 8.66 14.30 12.93 9.76 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 9.47 12.33 8.26 10.66 11.45 9.76 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 65 HIS~? -3.69 O ACT B 502s B 197 ASP B 54 ASP^? 4.46 O ACT B 502 B 223 LYS B 3 LYS.? 21.07 O ACT B 502 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS C 65 HIS~? -3.55 C ACT C 503s B 197 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 223 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 197 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 223 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -26.73 29.41 34.74 -28.62 25.37 34.54 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 4 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 5 ALA^? 10.14 O ACT A 501 A 257 ALA A 55 ALA^? 10.68 O ACT A 501 A 328 ASP A 58 ASP~? 16.01 O ACT A 501 coo 39.84 24.12 8.44 38.50 24.23 9.11 7.07 6.48 8.63 5.64 7.02 8.72 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.41 9.36 5.53 6.02 9.63 4.91 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 27 ALA~? 6.30 OXT ACT A 501 A 257 ALA A 31 ALA~? 6.46 OXT ACT A 501 A 328 ASP A 54 ASP^? -3.76 O ACT A 501s coo 39.84 24.12 8.44 38.50 24.23 9.11 15.68 22.14 9.94 15.41 21.01 11.01 coo 43.22 26.73 5.37 41.81 27.09 5.79 14.76 17.72 5.17 13.41 17.92 5.92 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 42 ALA^? 7.49 OXT ACT A 501 A 257 ALA C 96 ALA^? 11.88 OXT ACT A 501 A 328 ASP A 54 ASP^? -3.76 O ACT A 501s coo 39.84 24.12 8.44 38.50 24.23 9.11 7.67 19.66 12.07 8.71 20.77 12.00 coo 43.22 26.73 5.37 41.81 27.09 5.79 6.58 20.91 6.05 5.04 20.90 5.79 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 55 ALA^? 10.68 O ACT A 501 A 257 ALA A 5 ALA^? 10.14 O ACT A 501 A 328 ASP A 58 ASP~? 16.01 O ACT A 501 coo 39.84 24.12 8.44 38.50 24.23 9.11 7.41 9.36 5.53 6.02 9.63 4.91 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.07 6.48 8.63 5.64 7.02 8.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 95 ALA^? 10.73 O ACT C 503 A 257 ALA A 96 ALA^? 12.09 O ACT C 503 A 328 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 39.84 24.12 8.44 38.50 24.23 9.11 -2.38 4.21 2.77 -3.93 4.25 2.63 coo 43.22 26.73 5.37 41.81 27.09 5.79 -1.09 7.70 1.97 0.41 7.66 2.09 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 95 ALA^? 10.73 O ACT C 503 A 257 ALA C 42 ALA^? 8.18 O ACT C 503 A 328 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 39.84 24.12 8.44 38.50 24.23 9.11 -2.38 4.21 2.77 -3.93 4.25 2.63 coo 43.22 26.73 5.37 41.81 27.09 5.79 -3.35 5.95 7.54 -4.26 5.03 6.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 96 ALA^? 12.09 O ACT C 503 A 257 ALA C 42 ALA^? 8.18 O ACT C 503 A 328 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 39.84 24.12 8.44 38.50 24.23 9.11 -1.09 7.70 1.97 0.41 7.66 2.09 coo 43.22 26.73 5.37 41.81 27.09 5.79 -3.35 5.95 7.54 -4.26 5.03 6.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 5 ALA^? 10.59 O ACT B 502 A 257 ALA B 55 ALA^? 11.29 O ACT B 502 A 328 ASP B 58 ASP~? 16.37 O ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.23 23.07 30.89 -8.86 24.45 30.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.47 22.59 34.42 -10.69 23.88 35.17 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 27 ALA~? 5.95 OXT ACT B 502 A 257 ALA B 31 ALA~? 6.26 OXT ACT B 502 A 328 ASP B 54 ASP^? 4.46 O ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -23.16 13.98 32.00 -22.30 14.57 30.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 -18.22 15.01 35.83 -18.55 16.36 35.14 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA B 42 ALA^? 7.62 OXT ACT B 502 A 257 ALA D 96 ALA^? 11.93 OXT ACT B 502 A 328 ASP B 54 ASP^? 4.46 O ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -21.91 22.04 29.80 -23.07 21.03 30.12 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.05 23.01 36.06 -22.04 24.54 36.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA B 55 ALA^? 11.29 O ACT B 502 A 257 ALA B 5 ALA^? 10.59 O ACT B 502 A 328 ASP B 58 ASP~? 16.37 O ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.47 22.59 34.42 -10.69 23.88 35.17 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.23 23.07 30.89 -8.86 24.45 30.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA B 95 ALA^? 21.74 O ACT B 502 A 257 ALA B 96 ALA^? 17.59 O ACT B 502 A 328 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.29 32.43 36.25 -5.34 33.96 36.39 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.60 31.05 37.66 -8.47 29.51 37.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.29 34.40 33.40 -16.55 35.85 31.87 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA B 95 ALA^? 21.74 O ACT B 502 A 257 ALA D 42 ALA^? 20.06 O ACT B 502 A 328 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.29 32.43 36.25 -5.34 33.96 36.39 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.87 33.35 31.82 -6.85 34.23 32.48 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.29 34.40 33.40 -16.55 35.85 31.87 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA B 96 ALA^? 17.59 O ACT B 502 A 257 ALA D 42 ALA^? 20.06 O ACT B 502 A 328 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.60 31.05 37.66 -8.47 29.51 37.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.87 33.35 31.82 -6.85 34.23 32.48 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.29 34.40 33.40 -16.55 35.85 31.87 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA C 5 ALA^? 9.06 OXT ACT C 503 A 257 ALA C 55 ALA^? 9.92 OXT ACT C 503 A 328 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 39.84 24.12 8.44 38.50 24.23 9.11 -2.55 19.26 10.92 -1.13 18.63 10.99 coo 43.22 26.73 5.37 41.81 27.09 5.79 -2.12 18.19 6.82 -0.67 18.10 6.39 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA C 27 ALA~? 6.88 O ACT C 503 A 257 ALA C 31 ALA~? 7.01 O ACT C 503 A 328 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.71 5.86 3.04 -10.60 6.45 4.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.94 11.70 1.14 -7.76 11.12 1.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA C 42 ALA^? 8.18 O ACT C 503 A 257 ALA A 96 ALA^? 12.09 O ACT C 503 A 328 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 39.84 24.12 8.44 38.50 24.23 9.11 -3.35 5.95 7.54 -4.26 5.03 6.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -1.09 7.70 1.97 0.41 7.66 2.09 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA C 55 ALA^? 9.92 OXT ACT C 503 A 257 ALA C 5 ALA^? 9.06 OXT ACT C 503 A 328 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 39.84 24.12 8.44 38.50 24.23 9.11 -2.12 18.19 6.82 -0.67 18.10 6.39 coo 43.22 26.73 5.37 41.81 27.09 5.79 -2.55 19.26 10.92 -1.13 18.63 10.99 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA C 95 ALA^? 10.09 OXT ACT A 501 A 257 ALA A 42 ALA^? 7.49 OXT ACT A 501 A 328 ASP A 54 ASP^? -3.76 O ACT A 501s coo 39.84 24.12 8.44 38.50 24.23 9.11 7.44 23.59 8.64 8.96 23.56 8.82 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.67 19.66 12.07 8.71 20.77 12.00 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA C 95 ALA^? 10.09 OXT ACT A 501 A 257 ALA C 96 ALA^? 11.88 OXT ACT A 501 A 328 ASP A 54 ASP^? -3.76 O ACT A 501s coo 39.84 24.12 8.44 38.50 24.23 9.11 7.44 23.59 8.64 8.96 23.56 8.82 coo 43.22 26.73 5.37 41.81 27.09 5.79 6.58 20.91 6.05 5.04 20.90 5.79 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA C 96 ALA^? 11.88 OXT ACT A 501 A 257 ALA A 42 ALA^? 7.49 OXT ACT A 501 A 328 ASP A 54 ASP^? -3.76 O ACT A 501s coo 39.84 24.12 8.44 38.50 24.23 9.11 6.58 20.91 6.05 5.04 20.90 5.79 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.67 19.66 12.07 8.71 20.77 12.00 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA D 5 ALA^? 14.91 OXT ACT B 502 A 257 ALA D 55 ALA^? 15.53 OXT ACT B 502 A 328 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -21.50 32.26 30.89 -20.92 30.85 30.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 -19.84 32.00 34.67 -19.79 30.59 35.12 coo 38.17 34.10 6.67 37.72 32.06 6.84 -28.98 35.91 37.37 -28.15 37.30 38.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 23 3 # 23 A 229 ALA D 27 ALA~? 25.87 O ACT B 502 A 257 ALA D 31 ALA~? 23.53 OXT ACT B 502 A 328 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.92 40.67 35.86 -7.72 40.44 34.55 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.33 38.97 38.82 -11.89 37.76 37.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.29 34.40 33.40 -16.55 35.85 31.87 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 24 3 # 24 A 229 ALA D 42 ALA^? 20.06 O ACT B 502 A 257 ALA B 96 ALA^? 17.59 O ACT B 502 A 328 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.87 33.35 31.82 -6.85 34.23 32.48 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.60 31.05 37.66 -8.47 29.51 37.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.29 34.40 33.40 -16.55 35.85 31.87 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 25 3 # 25 A 229 ALA D 55 ALA^? 15.53 OXT ACT B 502 A 257 ALA D 5 ALA^? 14.91 OXT ACT B 502 A 328 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -19.84 32.00 34.67 -19.79 30.59 35.12 coo 43.22 26.73 5.37 41.81 27.09 5.79 -21.50 32.26 30.89 -20.92 30.85 30.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -28.98 35.91 37.37 -28.15 37.30 38.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 26 3 # 26 A 229 ALA D 95 ALA^? 10.13 OXT ACT B 502 A 257 ALA B 42 ALA^? 7.62 OXT ACT B 502 A 328 ASP B 54 ASP^? 4.46 O ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -25.11 22.09 33.92 -25.07 20.56 33.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 -21.91 22.04 29.80 -23.07 21.03 30.12 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 27 3 # 27 A 229 ALA D 95 ALA^? 10.13 OXT ACT B 502 A 257 ALA D 96 ALA^? 11.93 OXT ACT B 502 A 328 ASP B 54 ASP^? 4.46 O ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -25.11 22.09 33.92 -25.07 20.56 33.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.05 23.01 36.06 -22.04 24.54 36.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 28 3 # 28 A 229 ALA D 96 ALA^? 11.93 OXT ACT B 502 A 257 ALA B 42 ALA^? 7.62 OXT ACT B 502 A 328 ASP B 54 ASP^? 4.46 O ACT B 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.05 23.01 36.06 -22.04 24.54 36.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -21.91 22.04 29.80 -23.07 21.03 30.12 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.85 20.61 32.18 -13.16 19.46 30.55 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 28 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 44 LYS^? 17.14 CH3 ACT A 501 A 193 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 217 VAL C 91 VAL^? 10.98 OXT ACT C 503 coo 2.10 10.68 61.44 -2.14 13.16 60.61 3.76 21.56 17.68 3.38 25.65 21.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -1.36 20.26 15.48 -0.12 18.41 15.18 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 44 LYS^? 16.99 CH3 ACT B 502 A 193 GLU D 89 GLU^? 16.27 CH3 ACT B 502 A 217 VAL D 91 VAL^? 14.94 CH3 ACT B 502 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.96 26.06 24.81 -31.04 25.82 23.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -18.84 33.24 21.04 -18.05 31.37 20.48 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -23.38 31.04 26.64 -21.58 29.78 26.75 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS C 44 LYS^? 18.40 O ACT C 503 A 193 GLU A 89 GLU^? 13.34 O ACT A 501 A 217 VAL A 91 VAL^? 12.29 O ACT A 501 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -0.37 1.29 11.81 -0.77 -4.95 10.90 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.08 5.49 18.77 4.04 5.97 19.19 coo 0.07 12.29 66.53 -0.24 11.95 64.38 5.07 3.40 11.79 3.73 5.11 12.19 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS D 44 LYS^? 22.72 O ACT B 502 A 193 GLU B 89 GLU^? 13.28 O ACT B 502 A 217 VAL B 91 VAL^? 12.57 O ACT B 502 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -4.01 30.39 26.69 2.27 30.95 26.10 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -5.72 25.10 27.22 -7.55 26.37 27.21 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 38 THR^? 13.66 O ACT A 501 A 159 LYS A 3 LYS.? 15.82 O ACT C 503 A 193 GLU A 59 GLU~? 13.04 O ACT A 501 coo -2.58 16.31 54.79 -4.02 14.93 55.64 9.25 11.88 0.86 8.30 10.33 -0.29 coo 2.10 10.68 61.44 -2.14 13.16 60.61 5.08 2.81 3.00 0.95 1.12 1.99 coo -5.33 11.71 69.72 -4.62 11.92 67.73 14.64 -0.22 6.93 13.24 0.65 8.32 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 38 THR^? 13.93 OXT ACT B 502 A 159 LYS B 3 LYS.? 21.07 O ACT B 502 A 193 GLU B 59 GLU~? 13.30 O ACT B 502 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -3.66 25.02 35.95 -1.49 26.64 40.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR C 38 THR^? 13.13 OXT ACT C 503 A 159 LYS C 3 LYS.? 18.11 OXT ACT C 503 A 193 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.38 25.07 8.12 -1.77 29.22 5.24 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR D 38 THR^? 19.44 OXT ACT B 502 A 159 LYS D 3 LYS.? 15.58 OXT ACT B 502 A 193 GLU D 59 GLU~? 24.17 OXT ACT B 502 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -26.73 29.41 34.74 -28.62 25.37 34.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -28.95 39.32 31.59 -27.70 38.19 30.22 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 17 GLU~? 18.98 CH3 ACT A 501 A 260 ARG A 9 ARG^? 14.14 OXT ACT C 503 A 270 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 50.99 29.43 12.86 52.11 29.45 14.65 8.46 25.60 25.93 9.21 26.72 27.59 coo 39.80 27.50 22.98 42.20 26.56 21.34 4.15 12.93 21.45 1.14 13.40 20.88 coo 48.83 21.70 19.50 47.44 24.99 15.25 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU B 17 GLU~? 18.31 CH3 ACT B 502 A 260 ARG B 9 ARG^? 13.94 CH3 ACT B 502 A 270 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 50.99 29.43 12.86 52.11 29.45 14.65 -30.37 21.21 17.22 -31.47 20.28 15.66 coo 39.80 27.50 22.98 42.20 26.56 21.34 -17.57 25.75 18.49 -17.57 28.52 19.90 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU C 17 GLU~? 20.89 O ACT C 503 A 260 ARG C 9 ARG^? 14.66 OXT ACT C 503 A 270 LYS C 44 LYS^? 18.40 O ACT C 503 coo 50.99 29.43 12.86 52.11 29.45 14.65 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo 39.80 27.50 22.98 42.20 26.56 21.34 -1.72 5.89 20.10 1.21 6.47 19.35 coo 48.83 21.70 19.50 47.44 24.99 15.25 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU D 17 GLU~? 25.97 OXT ACT A 501 A 260 ARG D 9 ARG^? 15.08 O ACT B 502 A 270 LYS D 44 LYS^? 22.72 O ACT B 502 coo 50.99 29.43 12.86 52.11 29.45 14.65 2.12 36.56 21.03 3.60 37.59 19.89 coo 39.80 27.50 22.98 42.20 26.56 21.34 -10.16 31.68 19.32 -10.74 28.83 20.23 coo 48.83 21.70 19.50 47.44 24.99 15.25 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU D 92 GLU^? 17.21 CH3 ACT B 502 A 260 ARG B 9 ARG^? 13.94 CH3 ACT B 502 A 270 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 50.99 29.43 12.86 52.11 29.45 14.65 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 39.80 27.50 22.98 42.20 26.56 21.34 -17.57 25.75 18.49 -17.57 28.52 19.90 coo 48.83 21.70 19.50 47.44 24.99 15.25 -23.03 34.53 25.25 -26.25 39.79 25.56 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 5 hits 1euy_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS B 65 HIS~? -3.69 O ACT B 502s C 62 LYS B 3 LYS.? 21.07 O ACT B 502 F 35 ASP B 54 ASP^? 4.46 O ACT B 502 coo 15.40 22.79 16.66 13.93 24.10 15.98 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 19.95 18.98 4.81 18.82 20.94 10.49 -3.66 25.02 35.95 -1.49 26.64 40.22 coo 16.32 15.30 17.19 17.71 14.73 18.69 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS C 65 HIS~? -3.55 C ACT C 503s C 62 LYS C 3 LYS.? 18.11 OXT ACT C 503 F 35 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 15.40 22.79 16.66 13.93 24.10 15.98 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 19.95 18.98 4.81 18.82 20.94 10.49 0.38 25.07 8.12 -1.77 29.22 5.24 coo 16.32 15.30 17.19 17.71 14.73 18.69 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS D 65 HIS~? 23.58 OXT ACT B 502 C 62 LYS D 3 LYS.? 15.58 OXT ACT B 502 F 35 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 15.40 22.79 16.66 13.93 24.10 15.98 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 19.95 18.98 4.81 18.82 20.94 10.49 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 16.32 15.30 17.19 17.71 14.73 18.69 -16.29 34.40 33.40 -16.55 35.85 31.87 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 3 hits 1f80_c03 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 7 PHE^? 10.76 O ACT A 501 A 210 ASP A 54 ASP^? -3.76 O ACT A 501s A 244 LYS A 3 LYS.? 15.82 O ACT C 503 coo 9.23 46.77 25.11 11.48 48.39 24.76 4.11 9.93 15.65 2.48 11.68 17.17 coo 10.51 37.86 19.71 9.07 39.38 20.04 9.47 12.33 8.26 10.66 11.45 9.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 7 PHE^? 10.76 O ACT A 501 A 210 ASP A 54 ASP^? -3.76 O ACT A 501s A 244 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 9.23 46.77 25.11 11.48 48.39 24.76 4.11 9.93 15.65 2.48 11.68 17.17 coo 10.51 37.86 19.71 9.07 39.38 20.04 9.47 12.33 8.26 10.66 11.45 9.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 53 PHE^? 10.03 O ACT A 501 A 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 244 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 9.23 46.77 25.11 11.48 48.39 24.76 4.01 11.96 10.37 3.05 9.75 8.94 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -1.20 42.34 17.67 3.19 45.13 19.06 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 53 PHE^? 10.03 O ACT A 501 A 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 244 LYS C 44 LYS^? 18.40 O ACT C 503 coo 9.23 46.77 25.11 11.48 48.39 24.76 4.01 11.96 10.37 3.05 9.75 8.94 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -1.20 42.34 17.67 3.19 45.13 19.06 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE B 7 PHE^? 10.67 O ACT B 502 A 210 ASP B 54 ASP^? 4.46 O ACT B 502 A 244 LYS B 3 LYS.? 21.07 O ACT B 502 coo 9.23 46.77 25.11 11.48 48.39 24.76 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 7 PHE^? 10.67 O ACT B 502 A 210 ASP B 54 ASP^? 4.46 O ACT B 502 A 244 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 9.23 46.77 25.11 11.48 48.39 24.76 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -1.20 42.34 17.67 3.19 45.13 19.06 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE B 53 PHE^? 10.51 O ACT B 502 A 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 244 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 9.23 46.77 25.11 11.48 48.39 24.76 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 10.51 37.86 19.71 9.07 39.38 20.04 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 53 PHE^? 10.51 O ACT B 502 A 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 244 LYS D 44 LYS^? 22.72 O ACT B 502 coo 9.23 46.77 25.11 11.48 48.39 24.76 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 10.51 37.86 19.71 9.07 39.38 20.04 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 244 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 9.23 46.77 25.11 11.48 48.39 24.76 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -1.20 42.34 17.67 3.19 45.13 19.06 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 244 LYS C 44 LYS^? 18.40 O ACT C 503 coo 9.23 46.77 25.11 11.48 48.39 24.76 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -1.20 42.34 17.67 3.19 45.13 19.06 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 210 ASP A 54 ASP^? -3.76 O ACT A 501s A 244 LYS A 3 LYS.? 15.82 O ACT C 503 coo 9.23 46.77 25.11 11.48 48.39 24.76 0.16 13.32 10.36 1.32 15.86 10.31 coo 10.51 37.86 19.71 9.07 39.38 20.04 9.47 12.33 8.26 10.66 11.45 9.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE D 7 PHE^? 14.53 O ACT B 502 A 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 244 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 10.51 37.86 19.71 9.07 39.38 20.04 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE D 7 PHE^? 14.53 O ACT B 502 A 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 244 LYS D 44 LYS^? 22.72 O ACT B 502 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 10.51 37.86 19.71 9.07 39.38 20.04 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 210 ASP B 54 ASP^? 4.46 O ACT B 502 A 244 LYS B 3 LYS.? 21.07 O ACT B 502 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.66 25.02 35.95 -1.49 26.64 40.22 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 14 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 7 PHE^? 10.76 O ACT A 501 B 210 ASP A 54 ASP^? -3.76 O ACT A 501s B 244 LYS A 3 LYS.? 15.82 O ACT C 503 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.11 9.93 15.65 2.48 11.68 17.17 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.47 12.33 8.26 10.66 11.45 9.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 7 PHE^? 10.76 O ACT A 501 B 210 ASP A 54 ASP^? -3.76 O ACT A 501s B 244 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.11 9.93 15.65 2.48 11.68 17.17 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.47 12.33 8.26 10.66 11.45 9.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 41 PHE^? 11.20 OXT ACT A 501 B 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 244 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.28 16.86 7.90 2.95 16.20 5.48 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 53 PHE^? 10.03 O ACT A 501 B 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 244 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.01 11.96 10.37 3.05 9.75 8.94 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 53 PHE^? 10.03 O ACT A 501 B 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 244 LYS C 44 LYS^? 18.40 O ACT C 503 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.01 11.96 10.37 3.05 9.75 8.94 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE A 53 PHE^? 10.03 O ACT A 501 B 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 244 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.01 11.96 10.37 3.05 9.75 8.94 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 7 PHE^? 10.67 O ACT B 502 B 210 ASP B 54 ASP^? 4.46 O ACT B 502 B 244 LYS B 3 LYS.? 21.07 O ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 7 PHE^? 10.67 O ACT B 502 B 210 ASP B 54 ASP^? 4.46 O ACT B 502 B 244 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE B 53 PHE^? 10.51 O ACT B 502 B 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 244 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 9.06 56.85 40.30 7.71 55.27 39.90 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE B 53 PHE^? 10.51 O ACT B 502 B 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 244 LYS D 44 LYS^? 22.72 O ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 9.06 56.85 40.30 7.71 55.27 39.90 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE C 7 PHE^? 9.59 OXT ACT C 503 B 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 244 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 8.76 47.85 34.91 11.08 46.36 35.41 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE C 7 PHE^? 9.59 OXT ACT C 503 B 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 244 LYS C 44 LYS^? 18.40 O ACT C 503 coo 8.76 47.85 34.91 11.08 46.36 35.41 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE C 41 PHE^? 10.92 O ACT C 503 B 210 ASP A 54 ASP^? -3.76 O ACT A 501s B 244 LYS A 90 LYS^? 10.86 O ACT A 501 coo 8.76 47.85 34.91 11.08 46.36 35.41 0.59 10.20 5.98 2.26 11.80 4.40 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.47 12.33 8.26 10.66 11.45 9.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE C 53 PHE^? 9.13 OXT ACT C 503 B 210 ASP A 54 ASP^? -3.76 O ACT A 501s B 244 LYS A 3 LYS.? 15.82 O ACT C 503 coo 8.76 47.85 34.91 11.08 46.36 35.41 0.16 13.32 10.36 1.32 15.86 10.31 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.47 12.33 8.26 10.66 11.45 9.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 112 PHE C 53 PHE^? 9.13 OXT ACT C 503 B 210 ASP A 54 ASP^? -3.76 O ACT A 501s B 244 LYS A 90 LYS^? 10.86 O ACT A 501 coo 8.76 47.85 34.91 11.08 46.36 35.41 0.16 13.32 10.36 1.32 15.86 10.31 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.47 12.33 8.26 10.66 11.45 9.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 112 PHE D 7 PHE^? 14.53 O ACT B 502 B 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 244 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 9.06 56.85 40.30 7.71 55.27 39.90 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 112 PHE D 7 PHE^? 14.53 O ACT B 502 B 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 244 LYS D 44 LYS^? 22.72 O ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 9.06 56.85 40.30 7.71 55.27 39.90 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 112 PHE D 41 PHE^? 14.15 OXT ACT B 502 B 210 ASP B 54 ASP^? 4.46 O ACT B 502 B 244 LYS B 90 LYS^? 12.84 O ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 112 PHE D 53 PHE^? 12.57 OXT ACT B 502 B 210 ASP B 54 ASP^? 4.46 O ACT B 502 B 244 LYS B 3 LYS.? 21.07 O ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 112 PHE D 53 PHE^? 12.57 OXT ACT B 502 B 210 ASP B 54 ASP^? 4.46 O ACT B 502 B 244 LYS B 90 LYS^? 12.84 O ACT B 502 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -6.01 21.92 25.13 -2.78 16.45 24.93 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 20 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 65 HIS~? -3.60 O ACT A 501s A 210 ASP A 54 ASP^? -3.76 O ACT A 501s A 244 LYS A 3 LYS.? 15.82 O ACT C 503 coo 11.28 44.53 18.60 9.91 46.00 19.20 14.91 11.26 8.66 14.30 12.93 9.76 coo 10.51 37.86 19.71 9.07 39.38 20.04 9.47 12.33 8.26 10.66 11.45 9.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS B 65 HIS~? -3.69 O ACT B 502s A 210 ASP B 54 ASP^? 4.46 O ACT B 502 A 244 LYS B 3 LYS.? 21.07 O ACT B 502 coo 11.28 44.53 18.60 9.91 46.00 19.20 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS C 65 HIS~? -3.55 C ACT C 503s A 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 244 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 11.28 44.53 18.60 9.91 46.00 19.20 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -1.20 42.34 17.67 3.19 45.13 19.06 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 244 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 11.28 44.53 18.60 9.91 46.00 19.20 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 10.51 37.86 19.71 9.07 39.38 20.04 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -26.73 29.41 34.74 -28.62 25.37 34.54 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 65 HIS~? -3.60 O ACT A 501s B 210 ASP A 54 ASP^? -3.76 O ACT A 501s B 244 LYS A 3 LYS.? 15.82 O ACT C 503 coo 10.08 50.18 41.78 8.91 48.61 41.04 14.91 11.26 8.66 14.30 12.93 9.76 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.47 12.33 8.26 10.66 11.45 9.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 65 HIS~? -3.60 O ACT A 501s B 210 ASP A 54 ASP^? -3.76 O ACT A 501s B 244 LYS A 90 LYS^? 10.86 O ACT A 501 coo 10.08 50.18 41.78 8.91 48.61 41.04 14.91 11.26 8.66 14.30 12.93 9.76 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.47 12.33 8.26 10.66 11.45 9.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS B 65 HIS~? -3.69 O ACT B 502s B 210 ASP B 54 ASP^? 4.46 O ACT B 502 B 244 LYS B 3 LYS.? 21.07 O ACT B 502 coo 10.08 50.18 41.78 8.91 48.61 41.04 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS B 65 HIS~? -3.69 O ACT B 502s B 210 ASP B 54 ASP^? 4.46 O ACT B 502 B 244 LYS B 90 LYS^? 12.84 O ACT B 502 coo 10.08 50.18 41.78 8.91 48.61 41.04 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS C 65 HIS~? -3.55 C ACT C 503s B 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 244 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 10.08 50.18 41.78 8.91 48.61 41.04 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS C 65 HIS~? -3.55 C ACT C 503s B 210 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 244 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 10.08 50.18 41.78 8.91 48.61 41.04 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 210 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 244 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 10.08 50.18 41.78 8.91 48.61 41.04 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 9.06 56.85 40.30 7.71 55.27 39.90 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -26.73 29.41 34.74 -28.62 25.37 34.54 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 7 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 48 SER.? 17.26 CH3 ACT A 501 A 48 THR A 49 THR^? 14.48 CH3 ACT A 501 A 165 LYS B 90 LYS^? 12.84 O ACT B 502 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 6.12 22.28 25.46 5.72 21.09 27.51 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 5.33 19.29 23.23 4.17 17.62 24.03 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 48 SER.? 17.26 CH3 ACT A 501 A 48 THR A 49 THR^? 14.48 CH3 ACT A 501 A 165 LYS D 44 LYS^? 22.72 O ACT B 502 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 6.12 22.28 25.46 5.72 21.09 27.51 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 5.33 19.29 23.23 4.17 17.62 24.03 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER B 48 SER.? 16.63 CH3 ACT B 502 A 48 THR B 49 THR^? 13.99 CH3 ACT B 502 A 165 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -27.05 23.61 17.32 -26.38 24.08 15.04 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -23.73 24.57 18.85 -22.40 25.83 17.72 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER D 48 SER.? 23.18 OXT ACT C 503 A 48 THR D 49 THR^? 20.03 O ACT B 502 A 165 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -0.72 34.09 20.26 -1.13 33.83 17.85 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -4.26 32.92 21.10 -5.30 31.86 19.49 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER D 48 SER.? 23.18 OXT ACT C 503 A 48 THR D 49 THR^? 20.03 O ACT B 502 A 165 LYS B 90 LYS^? 12.84 O ACT B 502 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -0.72 34.09 20.26 -1.13 33.83 17.85 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -4.26 32.92 21.10 -5.30 31.86 19.49 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -6.01 21.92 25.13 -2.78 16.45 24.93 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 48 SER.? 17.26 CH3 ACT A 501 B 48 THR A 49 THR^? 14.48 CH3 ACT A 501 B 165 LYS B 90 LYS^? 12.84 O ACT B 502 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 6.12 22.28 25.46 5.72 21.09 27.51 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 5.33 19.29 23.23 4.17 17.62 24.03 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER A 48 SER.? 17.26 CH3 ACT A 501 B 48 THR A 49 THR^? 14.48 CH3 ACT A 501 B 165 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 6.12 22.28 25.46 5.72 21.09 27.51 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 5.33 19.29 23.23 4.17 17.62 24.03 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER A 48 SER.? 17.26 CH3 ACT A 501 B 48 THR A 49 THR^? 14.48 CH3 ACT A 501 B 165 LYS D 44 LYS^? 22.72 O ACT B 502 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 6.12 22.28 25.46 5.72 21.09 27.51 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 5.33 19.29 23.23 4.17 17.62 24.03 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER B 48 SER.? 16.63 CH3 ACT B 502 B 48 THR B 49 THR^? 13.99 CH3 ACT B 502 B 165 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -27.05 23.61 17.32 -26.38 24.08 15.04 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -23.73 24.57 18.85 -22.40 25.83 17.72 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER D 48 SER.? 23.18 OXT ACT C 503 B 48 THR D 49 THR^? 20.03 O ACT B 502 B 165 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -0.72 34.09 20.26 -1.13 33.83 17.85 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -4.26 32.92 21.10 -5.30 31.86 19.49 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 47 SER D 48 SER.? 23.18 OXT ACT C 503 B 48 THR D 49 THR^? 20.03 O ACT B 502 B 165 LYS B 90 LYS^? 12.84 O ACT B 502 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -0.72 34.09 20.26 -1.13 33.83 17.85 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -4.26 32.92 21.10 -5.30 31.86 19.49 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -6.01 21.92 25.13 -2.78 16.45 24.93 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 48 SER.? 17.26 CH3 ACT A 501 C 48 THR A 49 THR^? 14.48 CH3 ACT A 501 C 165 LYS B 90 LYS^? 12.84 O ACT B 502 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 6.12 22.28 25.46 5.72 21.09 27.51 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 5.33 19.29 23.23 4.17 17.62 24.03 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 48 SER.? 17.26 CH3 ACT A 501 C 48 THR A 49 THR^? 14.48 CH3 ACT A 501 C 165 LYS D 44 LYS^? 22.72 O ACT B 502 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 6.12 22.28 25.46 5.72 21.09 27.51 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 5.33 19.29 23.23 4.17 17.62 24.03 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER B 48 SER.? 16.63 CH3 ACT B 502 C 48 THR B 49 THR^? 13.99 CH3 ACT B 502 C 165 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -27.05 23.61 17.32 -26.38 24.08 15.04 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -23.73 24.57 18.85 -22.40 25.83 17.72 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER D 48 SER.? 23.18 OXT ACT C 503 C 48 THR D 49 THR^? 20.03 O ACT B 502 C 165 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -0.72 34.09 20.26 -1.13 33.83 17.85 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -4.26 32.92 21.10 -5.30 31.86 19.49 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER D 48 SER.? 23.18 OXT ACT C 503 C 48 THR D 49 THR^? 20.03 O ACT B 502 C 165 LYS B 90 LYS^? 12.84 O ACT B 502 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -0.72 34.09 20.26 -1.13 33.83 17.85 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -4.26 32.92 21.10 -5.30 31.86 19.49 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -6.01 21.92 25.13 -2.78 16.45 24.93 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 48 SER.? 17.26 CH3 ACT A 501 D 48 THR A 49 THR^? 14.48 CH3 ACT A 501 D 165 LYS B 90 LYS^? 12.84 O ACT B 502 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 6.12 22.28 25.46 5.72 21.09 27.51 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 5.33 19.29 23.23 4.17 17.62 24.03 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER A 48 SER.? 17.26 CH3 ACT A 501 D 48 THR A 49 THR^? 14.48 CH3 ACT A 501 D 165 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 6.12 22.28 25.46 5.72 21.09 27.51 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 5.33 19.29 23.23 4.17 17.62 24.03 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER A 48 SER.? 17.26 CH3 ACT A 501 D 48 THR A 49 THR^? 14.48 CH3 ACT A 501 D 165 LYS D 44 LYS^? 22.72 O ACT B 502 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 6.12 22.28 25.46 5.72 21.09 27.51 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 5.33 19.29 23.23 4.17 17.62 24.03 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER B 48 SER.? 16.63 CH3 ACT B 502 D 48 THR B 49 THR^? 13.99 CH3 ACT B 502 D 165 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -27.05 23.61 17.32 -26.38 24.08 15.04 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -23.73 24.57 18.85 -22.40 25.83 17.72 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 47 SER D 48 SER.? 23.18 OXT ACT C 503 D 48 THR D 49 THR^? 20.03 O ACT B 502 D 165 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -0.72 34.09 20.26 -1.13 33.83 17.85 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -4.26 32.92 21.10 -5.30 31.86 19.49 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 47 SER D 48 SER.? 23.18 OXT ACT C 503 D 48 THR D 49 THR^? 20.03 O ACT B 502 D 165 LYS B 90 LYS^? 12.84 O ACT B 502 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -0.72 34.09 20.26 -1.13 33.83 17.85 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -4.26 32.92 21.10 -5.30 31.86 19.49 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -6.01 21.92 25.13 -2.78 16.45 24.93 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c07 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 34 GLU.? 6.40 OXT ACT A 501 B 319 ASP A 54 ASP^? -3.76 O ACT A 501s B 359 ARG A 62 ARG~? 11.91 O ACT A 501 coo 10.77 13.13 40.94 11.03 14.73 39.51 17.44 14.34 4.36 16.78 13.78 6.33 coo 3.77 12.64 38.21 3.35 14.53 37.39 9.47 12.33 8.26 10.66 11.45 9.76 coo -1.16 15.32 35.60 -3.32 13.56 36.98 11.34 4.43 9.06 9.97 1.81 9.84 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU C 34 GLU~? 6.63 O ACT C 503 B 319 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 359 ARG C 62 ARG~? 10.88 OXT ACT C 503 coo 10.77 13.13 40.94 11.03 14.73 39.51 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 3.77 12.64 38.21 3.35 14.53 37.39 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -6.61 21.24 11.49 -5.46 23.07 13.64 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU D 34 GLU.? 25.91 OXT ACT B 502 B 319 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 359 ARG D 62 ARG~? 20.52 OXT ACT B 502 coo 10.77 13.13 40.94 11.03 14.73 39.51 -16.00 41.58 38.86 -16.04 41.30 36.71 coo 3.77 12.64 38.21 3.35 14.53 37.39 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -23.58 36.44 30.28 -25.75 35.10 28.58 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 3 hits 1fr8_c01 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 40 TRP^? -4.11 OXT ACT A 501s A 317 GLU A 34 GLU.? 6.40 OXT ACT A 501 A 365 ARG A 62 ARG~? 11.91 O ACT A 501 coo 79.91 26.87 38.77 78.95 23.18 37.81 11.31 15.47 8.53 11.49 19.29 9.59 coo 85.55 26.30 41.25 85.59 24.97 39.65 17.44 14.34 4.36 16.78 13.78 6.33 coo 83.47 25.30 27.10 83.44 27.82 25.29 11.34 4.43 9.06 9.97 1.81 9.84 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP B 40 TRP^? -4.17 OXT ACT B 502s A 317 GLU B 34 GLU.? 6.39 OXT ACT B 502 A 365 ARG B 62 ARG~? 12.26 O ACT B 502 coo 79.91 26.87 38.77 78.95 23.18 37.81 -16.95 18.54 32.38 -20.88 18.36 32.14 coo 85.55 26.30 41.25 85.59 24.97 39.65 -14.54 12.40 35.90 -14.50 13.22 33.94 coo 83.47 25.30 27.10 83.44 27.82 25.29 -6.19 18.92 29.62 -3.70 20.53 28.83 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP C 40 TRP^? -4.44 O ACT C 503s A 317 GLU C 34 GLU~? 6.63 O ACT C 503 A 365 ARG C 62 ARG~? 10.88 OXT ACT C 503 coo 79.91 26.87 38.77 78.95 23.18 37.81 -6.43 11.77 5.82 -6.69 7.89 5.04 coo 85.55 26.30 41.25 85.59 24.97 39.65 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 83.47 25.30 27.10 83.44 27.82 25.29 -6.61 21.24 11.49 -5.46 23.07 13.64 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP D 40 TRP^? 21.29 O ACT B 502 A 317 GLU D 34 GLU.? 25.91 OXT ACT B 502 A 365 ARG D 62 ARG~? 20.52 OXT ACT B 502 coo 79.91 26.87 38.77 78.95 23.18 37.81 -13.32 36.33 34.40 -9.38 36.60 34.55 coo 85.55 26.30 41.25 85.59 24.97 39.65 -16.00 41.58 38.86 -16.04 41.30 36.71 coo 83.47 25.30 27.10 83.44 27.82 25.29 -23.58 36.44 30.28 -25.75 35.10 28.58 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 4 hits 1g8o_c01 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP B 54 ASP^? 4.46 O ACT B 502 A 64 HIS B 65 HIS~? -3.69 O ACT B 502s A 155 ASN C 87 ASN.? 10.16 O ACT B 502 coo 3.12 38.70 24.20 3.24 38.59 26.33 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 1.90 38.00 29.77 3.91 38.35 29.95 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 9.89 36.55 37.38 9.27 37.99 36.08 -7.54 12.49 22.38 -6.86 14.54 22.53 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 64 HIS C 65 HIS~? -3.55 C ACT C 503s A 155 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 3.12 38.70 24.20 3.24 38.59 26.33 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 1.90 38.00 29.77 3.91 38.35 29.95 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 9.89 36.55 37.38 9.27 37.99 36.08 -13.79 21.31 17.73 -12.12 22.50 17.15 1gns_c00 source 1gns SUBTILISIN BPN' : 2 hits 1gns_c00 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 67 ASN~? 11.66 O ACT A 501 B 108 HIS A 65 HIS~? -3.60 O ACT A 501s B 144 ASP A 58 ASP~? 16.01 O ACT A 501 coo 36.64 101.02 13.15 38.55 101.84 12.78 22.25 7.80 9.68 22.12 6.01 10.80 coo 41.00 107.18 12.86 42.70 107.82 11.96 14.91 11.26 8.66 14.30 12.93 9.76 coo 31.60 110.69 6.14 29.69 109.74 5.94 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN B 67 ASN~? 11.44 O ACT B 502 B 108 HIS B 65 HIS~? -3.69 O ACT B 502s B 144 ASP B 58 ASP~? 16.37 O ACT B 502 coo 36.64 101.02 13.15 38.55 101.84 12.78 -8.90 8.17 29.36 -7.21 8.51 28.12 coo 41.00 107.18 12.86 42.70 107.82 11.96 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 31.60 110.69 6.14 29.69 109.74 5.94 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN C 67 ASN~? 10.88 CH3 ACT C 503 B 108 HIS C 65 HIS~? -3.55 C ACT C 503s B 144 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 36.64 101.02 13.15 38.55 101.84 12.78 -17.40 19.51 8.11 -17.74 20.65 9.88 coo 41.00 107.18 12.86 42.70 107.82 11.96 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 31.60 110.69 6.14 29.69 109.74 5.94 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN D 67 ASN~? 31.47 OXT ACT B 502 B 108 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 144 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 36.64 101.02 13.15 38.55 101.84 12.78 -21.35 47.13 33.03 -22.85 47.39 31.52 coo 41.00 107.18 12.86 42.70 107.82 11.96 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 31.60 110.69 6.14 29.69 109.74 5.94 -28.98 35.91 37.37 -28.15 37.30 38.76 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 4 hits 1grc_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 7 PHE^? 10.76 O ACT A 501 A 298 ASP A 54 ASP^? -3.76 O ACT A 501s A 329 LYS A 3 LYS.? 15.82 O ACT C 503 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 4.11 9.93 15.65 2.48 11.68 17.17 coo 2.59 0.29 25.55 4.65 0.18 25.07 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.42 6.10 23.27 9.95 1.57 20.16 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 41 PHE^? 11.20 OXT ACT A 501 A 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 329 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 4.28 16.86 7.90 2.95 16.20 5.48 coo 2.59 0.29 25.55 4.65 0.18 25.07 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.42 6.10 23.27 9.95 1.57 20.16 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 53 PHE^? 10.03 O ACT A 501 A 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 329 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 4.01 11.96 10.37 3.05 9.75 8.94 coo 2.59 0.29 25.55 4.65 0.18 25.07 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.42 6.10 23.27 9.95 1.57 20.16 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE A 53 PHE^? 10.03 O ACT A 501 A 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 329 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 4.01 11.96 10.37 3.05 9.75 8.94 coo 2.59 0.29 25.55 4.65 0.18 25.07 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.42 6.10 23.27 9.95 1.57 20.16 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 41 PHE^? 11.14 OXT ACT B 502 A 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 329 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 2.59 0.29 25.55 4.65 0.18 25.07 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.42 6.10 23.27 9.95 1.57 20.16 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE B 53 PHE^? 10.51 O ACT B 502 A 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 329 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 2.59 0.29 25.55 4.65 0.18 25.07 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.42 6.10 23.27 9.95 1.57 20.16 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE B 53 PHE^? 10.51 O ACT B 502 A 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 329 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 2.59 0.29 25.55 4.65 0.18 25.07 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.42 6.10 23.27 9.95 1.57 20.16 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE C 41 PHE^? 10.92 O ACT C 503 A 298 ASP A 54 ASP^? -3.76 O ACT A 501s A 329 LYS A 90 LYS^? 10.86 O ACT A 501 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 0.59 10.20 5.98 2.26 11.80 4.40 coo 2.59 0.29 25.55 4.65 0.18 25.07 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.42 6.10 23.27 9.95 1.57 20.16 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 298 ASP A 54 ASP^? -3.76 O ACT A 501s A 329 LYS A 3 LYS.? 15.82 O ACT C 503 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 0.16 13.32 10.36 1.32 15.86 10.31 coo 2.59 0.29 25.55 4.65 0.18 25.07 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.42 6.10 23.27 9.95 1.57 20.16 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 298 ASP A 54 ASP^? -3.76 O ACT A 501s A 329 LYS A 90 LYS^? 10.86 O ACT A 501 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 0.16 13.32 10.36 1.32 15.86 10.31 coo 2.59 0.29 25.55 4.65 0.18 25.07 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.42 6.10 23.27 9.95 1.57 20.16 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 A 189 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 298 ASP B 54 ASP^? 4.46 O ACT B 502 A 329 LYS B 90 LYS^? 12.84 O ACT B 502 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 2.59 0.29 25.55 4.65 0.18 25.07 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.42 6.10 23.27 9.95 1.57 20.16 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 A 189 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 298 ASP B 54 ASP^? 4.46 O ACT B 502 A 329 LYS B 3 LYS.? 21.07 O ACT B 502 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 2.59 0.29 25.55 4.65 0.18 25.07 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.42 6.10 23.27 9.95 1.57 20.16 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 A 189 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 298 ASP B 54 ASP^? 4.46 O ACT B 502 A 329 LYS B 90 LYS^? 12.84 O ACT B 502 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 2.59 0.29 25.55 4.65 0.18 25.07 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.42 6.10 23.27 9.95 1.57 20.16 -6.01 21.92 25.13 -2.78 16.45 24.93 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 13 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 7 PHE^? 10.76 O ACT A 501 B 298 ASP A 54 ASP^? -3.76 O ACT A 501s B 329 LYS A 3 LYS.? 15.82 O ACT C 503 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 4.11 9.93 15.65 2.48 11.68 17.17 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 9.47 12.33 8.26 10.66 11.45 9.76 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 41 PHE^? 11.20 OXT ACT A 501 B 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 329 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 4.28 16.86 7.90 2.95 16.20 5.48 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 53 PHE^? 10.03 O ACT A 501 B 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 329 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE A 53 PHE^? 10.03 O ACT A 501 B 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 329 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 41 PHE^? 11.14 OXT ACT B 502 B 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 329 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE B 53 PHE^? 10.51 O ACT B 502 B 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 329 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE B 53 PHE^? 10.51 O ACT B 502 B 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 329 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE C 41 PHE^? 10.92 O ACT C 503 B 298 ASP A 54 ASP^? -3.76 O ACT A 501s B 329 LYS A 90 LYS^? 10.86 O ACT A 501 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 0.59 10.20 5.98 2.26 11.80 4.40 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 9.47 12.33 8.26 10.66 11.45 9.76 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE C 53 PHE^? 9.13 OXT ACT C 503 B 298 ASP A 54 ASP^? -3.76 O ACT A 501s B 329 LYS A 3 LYS.? 15.82 O ACT C 503 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 0.16 13.32 10.36 1.32 15.86 10.31 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 9.47 12.33 8.26 10.66 11.45 9.76 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE C 53 PHE^? 9.13 OXT ACT C 503 B 298 ASP A 54 ASP^? -3.76 O ACT A 501s B 329 LYS A 90 LYS^? 10.86 O ACT A 501 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 0.16 13.32 10.36 1.32 15.86 10.31 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 9.47 12.33 8.26 10.66 11.45 9.76 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 B 189 PHE D 41 PHE^? 14.15 OXT ACT B 502 B 298 ASP B 54 ASP^? 4.46 O ACT B 502 B 329 LYS B 90 LYS^? 12.84 O ACT B 502 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 B 189 PHE D 53 PHE^? 12.57 OXT ACT B 502 B 298 ASP B 54 ASP^? 4.46 O ACT B 502 B 329 LYS B 3 LYS.? 21.07 O ACT B 502 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 B 189 PHE D 53 PHE^? 12.57 OXT ACT B 502 B 298 ASP B 54 ASP^? 4.46 O ACT B 502 B 329 LYS B 90 LYS^? 12.84 O ACT B 502 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -6.01 21.92 25.13 -2.78 16.45 24.93 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 13 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 7 PHE^? 10.76 O ACT A 501 C 298 ASP A 54 ASP^? -3.76 O ACT A 501s C 329 LYS A 3 LYS.? 15.82 O ACT C 503 coo 17.41 60.57 64.39 18.40 58.12 65.34 4.11 9.93 15.65 2.48 11.68 17.17 coo 24.10 66.43 63.33 24.18 64.30 63.40 9.47 12.33 8.26 10.66 11.45 9.76 coo 27.64 56.61 58.17 22.18 57.92 60.36 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 41 PHE^? 11.20 OXT ACT A 501 C 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 329 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 17.41 60.57 64.39 18.40 58.12 65.34 4.28 16.86 7.90 2.95 16.20 5.48 coo 24.10 66.43 63.33 24.18 64.30 63.40 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 27.64 56.61 58.17 22.18 57.92 60.36 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 53 PHE^? 10.03 O ACT A 501 C 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 329 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 17.41 60.57 64.39 18.40 58.12 65.34 4.01 11.96 10.37 3.05 9.75 8.94 coo 24.10 66.43 63.33 24.18 64.30 63.40 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 27.64 56.61 58.17 22.18 57.92 60.36 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE A 53 PHE^? 10.03 O ACT A 501 C 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 329 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 17.41 60.57 64.39 18.40 58.12 65.34 4.01 11.96 10.37 3.05 9.75 8.94 coo 24.10 66.43 63.33 24.18 64.30 63.40 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 27.64 56.61 58.17 22.18 57.92 60.36 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 41 PHE^? 11.14 OXT ACT B 502 C 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 329 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 17.41 60.57 64.39 18.40 58.12 65.34 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 24.10 66.43 63.33 24.18 64.30 63.40 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 27.64 56.61 58.17 22.18 57.92 60.36 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE B 53 PHE^? 10.51 O ACT B 502 C 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 329 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 17.41 60.57 64.39 18.40 58.12 65.34 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 24.10 66.43 63.33 24.18 64.30 63.40 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 27.64 56.61 58.17 22.18 57.92 60.36 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE B 53 PHE^? 10.51 O ACT B 502 C 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 329 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 17.41 60.57 64.39 18.40 58.12 65.34 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 24.10 66.43 63.33 24.18 64.30 63.40 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 27.64 56.61 58.17 22.18 57.92 60.36 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE C 41 PHE^? 10.92 O ACT C 503 C 298 ASP A 54 ASP^? -3.76 O ACT A 501s C 329 LYS A 90 LYS^? 10.86 O ACT A 501 coo 17.41 60.57 64.39 18.40 58.12 65.34 0.59 10.20 5.98 2.26 11.80 4.40 coo 24.10 66.43 63.33 24.18 64.30 63.40 9.47 12.33 8.26 10.66 11.45 9.76 coo 27.64 56.61 58.17 22.18 57.92 60.36 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE C 53 PHE^? 9.13 OXT ACT C 503 C 298 ASP A 54 ASP^? -3.76 O ACT A 501s C 329 LYS A 3 LYS.? 15.82 O ACT C 503 coo 17.41 60.57 64.39 18.40 58.12 65.34 0.16 13.32 10.36 1.32 15.86 10.31 coo 24.10 66.43 63.33 24.18 64.30 63.40 9.47 12.33 8.26 10.66 11.45 9.76 coo 27.64 56.61 58.17 22.18 57.92 60.36 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE C 53 PHE^? 9.13 OXT ACT C 503 C 298 ASP A 54 ASP^? -3.76 O ACT A 501s C 329 LYS A 90 LYS^? 10.86 O ACT A 501 coo 17.41 60.57 64.39 18.40 58.12 65.34 0.16 13.32 10.36 1.32 15.86 10.31 coo 24.10 66.43 63.33 24.18 64.30 63.40 9.47 12.33 8.26 10.66 11.45 9.76 coo 27.64 56.61 58.17 22.18 57.92 60.36 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 C 189 PHE D 41 PHE^? 14.15 OXT ACT B 502 C 298 ASP B 54 ASP^? 4.46 O ACT B 502 C 329 LYS B 90 LYS^? 12.84 O ACT B 502 coo 17.41 60.57 64.39 18.40 58.12 65.34 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 24.10 66.43 63.33 24.18 64.30 63.40 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 27.64 56.61 58.17 22.18 57.92 60.36 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 C 189 PHE D 53 PHE^? 12.57 OXT ACT B 502 C 298 ASP B 54 ASP^? 4.46 O ACT B 502 C 329 LYS B 3 LYS.? 21.07 O ACT B 502 coo 17.41 60.57 64.39 18.40 58.12 65.34 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 24.10 66.43 63.33 24.18 64.30 63.40 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 27.64 56.61 58.17 22.18 57.92 60.36 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 C 189 PHE D 53 PHE^? 12.57 OXT ACT B 502 C 298 ASP B 54 ASP^? 4.46 O ACT B 502 C 329 LYS B 90 LYS^? 12.84 O ACT B 502 coo 17.41 60.57 64.39 18.40 58.12 65.34 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 24.10 66.43 63.33 24.18 64.30 63.40 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 27.64 56.61 58.17 22.18 57.92 60.36 -6.01 21.92 25.13 -2.78 16.45 24.93 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 13 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 7 PHE^? 10.76 O ACT A 501 D 298 ASP A 54 ASP^? -3.76 O ACT A 501s D 329 LYS A 3 LYS.? 15.82 O ACT C 503 coo 35.44 53.35 83.81 35.65 54.53 81.28 4.11 9.93 15.65 2.48 11.68 17.17 coo 29.72 46.46 83.60 30.79 47.36 81.99 9.47 12.33 8.26 10.66 11.45 9.76 coo 36.89 44.91 74.55 37.33 48.94 79.01 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 41 PHE^? 11.20 OXT ACT A 501 D 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s D 329 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 35.44 53.35 83.81 35.65 54.53 81.28 4.28 16.86 7.90 2.95 16.20 5.48 coo 29.72 46.46 83.60 30.79 47.36 81.99 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 36.89 44.91 74.55 37.33 48.94 79.01 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 53 PHE^? 10.03 O ACT A 501 D 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s D 329 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 35.44 53.35 83.81 35.65 54.53 81.28 4.01 11.96 10.37 3.05 9.75 8.94 coo 29.72 46.46 83.60 30.79 47.36 81.99 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 36.89 44.91 74.55 37.33 48.94 79.01 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE A 53 PHE^? 10.03 O ACT A 501 D 298 ASP C 54 ASP^? -3.02 OXT ACT C 503s D 329 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 35.44 53.35 83.81 35.65 54.53 81.28 4.01 11.96 10.37 3.05 9.75 8.94 coo 29.72 46.46 83.60 30.79 47.36 81.99 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 36.89 44.91 74.55 37.33 48.94 79.01 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 41 PHE^? 11.14 OXT ACT B 502 D 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 D 329 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 35.44 53.35 83.81 35.65 54.53 81.28 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 29.72 46.46 83.60 30.79 47.36 81.99 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 36.89 44.91 74.55 37.33 48.94 79.01 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE B 53 PHE^? 10.51 O ACT B 502 D 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 D 329 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 35.44 53.35 83.81 35.65 54.53 81.28 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 29.72 46.46 83.60 30.79 47.36 81.99 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 36.89 44.91 74.55 37.33 48.94 79.01 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE B 53 PHE^? 10.51 O ACT B 502 D 298 ASP D 54 ASP^? 19.49 OXT ACT B 502 D 329 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 35.44 53.35 83.81 35.65 54.53 81.28 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 29.72 46.46 83.60 30.79 47.36 81.99 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 36.89 44.91 74.55 37.33 48.94 79.01 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE C 41 PHE^? 10.92 O ACT C 503 D 298 ASP A 54 ASP^? -3.76 O ACT A 501s D 329 LYS A 90 LYS^? 10.86 O ACT A 501 coo 35.44 53.35 83.81 35.65 54.53 81.28 0.59 10.20 5.98 2.26 11.80 4.40 coo 29.72 46.46 83.60 30.79 47.36 81.99 9.47 12.33 8.26 10.66 11.45 9.76 coo 36.89 44.91 74.55 37.33 48.94 79.01 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE C 53 PHE^? 9.13 OXT ACT C 503 D 298 ASP A 54 ASP^? -3.76 O ACT A 501s D 329 LYS A 3 LYS.? 15.82 O ACT C 503 coo 35.44 53.35 83.81 35.65 54.53 81.28 0.16 13.32 10.36 1.32 15.86 10.31 coo 29.72 46.46 83.60 30.79 47.36 81.99 9.47 12.33 8.26 10.66 11.45 9.76 coo 36.89 44.91 74.55 37.33 48.94 79.01 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE C 53 PHE^? 9.13 OXT ACT C 503 D 298 ASP A 54 ASP^? -3.76 O ACT A 501s D 329 LYS A 90 LYS^? 10.86 O ACT A 501 coo 35.44 53.35 83.81 35.65 54.53 81.28 0.16 13.32 10.36 1.32 15.86 10.31 coo 29.72 46.46 83.60 30.79 47.36 81.99 9.47 12.33 8.26 10.66 11.45 9.76 coo 36.89 44.91 74.55 37.33 48.94 79.01 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 D 189 PHE D 41 PHE^? 14.15 OXT ACT B 502 D 298 ASP B 54 ASP^? 4.46 O ACT B 502 D 329 LYS B 90 LYS^? 12.84 O ACT B 502 coo 35.44 53.35 83.81 35.65 54.53 81.28 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 29.72 46.46 83.60 30.79 47.36 81.99 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 36.89 44.91 74.55 37.33 48.94 79.01 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 D 189 PHE D 53 PHE^? 12.57 OXT ACT B 502 D 298 ASP B 54 ASP^? 4.46 O ACT B 502 D 329 LYS B 3 LYS.? 21.07 O ACT B 502 coo 35.44 53.35 83.81 35.65 54.53 81.28 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 29.72 46.46 83.60 30.79 47.36 81.99 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 36.89 44.91 74.55 37.33 48.94 79.01 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 D 189 PHE D 53 PHE^? 12.57 OXT ACT B 502 D 298 ASP B 54 ASP^? 4.46 O ACT B 502 D 329 LYS B 90 LYS^? 12.84 O ACT B 502 coo 35.44 53.35 83.81 35.65 54.53 81.28 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 29.72 46.46 83.60 30.79 47.36 81.99 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 36.89 44.91 74.55 37.33 48.94 79.01 -6.01 21.92 25.13 -2.78 16.45 24.93 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 13 hits 1gtx_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 327 GLU A 92 GLU^? 18.57 O ACT A 501 A 339 ARG A 62 ARG~? 11.91 O ACT A 501 coo 85.81 57.99 116.01 86.03 55.86 115.89 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 75.11 41.01 160.30 76.65 40.06 161.41 4.60 -0.94 9.20 4.21 -3.02 9.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 11.34 4.43 9.06 9.97 1.81 9.84 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 1 hits 1hto_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 200 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 226 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 23.24 46.58 4.39 24.43 46.59 2.66 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 24.51 43.28 11.18 25.17 44.50 9.58 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 34.47 51.09 7.19 28.58 51.18 7.53 -26.73 29.41 34.74 -28.62 25.37 34.54 1i29_c01 source 1i29 CSDB : 1 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 91 VAL^? 12.29 O ACT A 501 A 200 ASP A 54 ASP^? -3.76 O ACT A 501s A 226 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 19.13 38.05 1.41 19.72 38.80 -0.53 5.07 3.40 11.79 3.73 5.11 12.19 coo 24.51 43.28 11.18 25.17 44.50 9.58 9.47 12.33 8.26 10.66 11.45 9.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL B 91 VAL^? 12.57 O ACT B 502 A 200 ASP B 54 ASP^? 4.46 O ACT B 502 A 226 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.72 25.10 27.22 -7.55 26.37 27.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 34.47 51.09 7.19 28.58 51.18 7.53 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL C 91 VAL^? 10.98 OXT ACT C 503 A 200 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 226 LYS C 44 LYS^? 18.40 O ACT C 503 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -1.36 20.26 15.48 -0.12 18.41 15.18 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL D 91 VAL^? 14.94 CH3 ACT B 502 A 200 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 226 LYS D 44 LYS^? 22.72 O ACT B 502 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.38 31.04 26.64 -21.58 29.78 26.75 coo 24.51 43.28 11.18 25.17 44.50 9.58 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 34.47 51.09 7.19 28.58 51.18 7.53 -4.01 30.39 26.69 2.27 30.95 26.10 1i29_c03 source 1i29 CSDB : 4 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 44 LYS^? 17.14 CH3 ACT A 501 A 74 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 165 GLU B 59 GLU~? 13.30 O ACT B 502 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 3.76 21.56 17.68 3.38 25.65 21.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 44 LYS^? 17.14 CH3 ACT A 501 A 74 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 165 GLU B 92 GLU^? 19.37 O ACT B 502 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 3.76 21.56 17.68 3.38 25.65 21.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS B 90 LYS^? 12.84 O ACT B 502 A 74 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 165 GLU D 11 GLU.? 21.84 O ACT B 502 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -7.35 35.76 17.53 -6.53 33.80 17.57 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 90 LYS^? 12.84 O ACT B 502 A 74 LYS D 44 LYS^? 22.72 O ACT B 502 A 165 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -4.01 30.39 26.69 2.27 30.95 26.10 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 74 LYS A 44 LYS^? 17.14 CH3 ACT A 501 A 165 GLU B 59 GLU~? 13.30 O ACT B 502 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 3.76 21.56 17.68 3.38 25.65 21.29 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 74 LYS A 44 LYS^? 17.14 CH3 ACT A 501 A 165 GLU B 92 GLU^? 19.37 O ACT B 502 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 3.76 21.56 17.68 3.38 25.65 21.29 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 74 LYS B 90 LYS^? 12.84 O ACT B 502 A 165 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 74 LYS B 90 LYS^? 12.84 O ACT B 502 A 165 GLU D 11 GLU.? 21.84 O ACT B 502 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -7.35 35.76 17.53 -6.53 33.80 17.57 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS D 44 LYS^? 22.72 O ACT B 502 A 74 LYS B 90 LYS^? 12.84 O ACT B 502 A 165 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -4.01 30.39 26.69 2.27 30.95 26.10 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS D 44 LYS^? 22.72 O ACT B 502 A 74 LYS B 90 LYS^? 12.84 O ACT B 502 A 165 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -4.01 30.39 26.69 2.27 30.95 26.10 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -9.42 26.68 11.15 -8.43 25.11 12.27 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 10 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS B 90 LYS^? 12.84 O ACT B 502 B 74 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 165 GLU D 11 GLU.? 21.84 O ACT B 502 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -7.35 35.76 17.53 -6.53 33.80 17.57 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS B 90 LYS^? 12.84 O ACT B 502 B 74 LYS D 44 LYS^? 22.72 O ACT B 502 B 165 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -4.01 30.39 26.69 2.27 30.95 26.10 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 90 LYS^? 12.84 O ACT B 502 B 74 LYS D 44 LYS^? 22.72 O ACT B 502 B 165 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -4.01 30.39 26.69 2.27 30.95 26.10 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS B 90 LYS^? 12.84 O ACT B 502 B 74 LYS D 44 LYS^? 22.72 O ACT B 502 B 165 GLU D 89 GLU^? 16.27 CH3 ACT B 502 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -4.01 30.39 26.69 2.27 30.95 26.10 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -18.84 33.24 21.04 -18.05 31.37 20.48 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 74 LYS B 90 LYS^? 12.84 O ACT B 502 B 165 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 74 LYS B 90 LYS^? 12.84 O ACT B 502 B 165 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 74 LYS B 90 LYS^? 12.84 O ACT B 502 B 165 GLU D 11 GLU.? 21.84 O ACT B 502 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -7.35 35.76 17.53 -6.53 33.80 17.57 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS D 44 LYS^? 22.72 O ACT B 502 B 74 LYS B 90 LYS^? 12.84 O ACT B 502 B 165 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -4.01 30.39 26.69 2.27 30.95 26.10 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -9.42 26.68 11.15 -8.43 25.11 12.27 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 8 hits 1idt_c01 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 54 ASP^? -3.76 O ACT A 501s 158 THR A 38 THR^? 13.66 O ACT A 501 317 ASP A 58 ASP~? 16.01 O ACT A 501 coo -2.63 8.40 35.07 -3.66 9.81 36.17 9.47 12.33 8.26 10.66 11.45 9.76 coo -5.30 12.75 41.86 -4.34 13.05 39.99 9.25 11.88 0.86 8.30 10.33 -0.29 coo -12.63 17.64 33.66 -10.65 17.90 34.40 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 58 ASP~? 16.01 O ACT A 501 158 THR A 2 THR.? 15.11 O ACT A 501 317 ASP A 54 ASP^? -3.76 O ACT A 501s coo -2.63 8.40 35.07 -3.66 9.81 36.17 12.40 1.57 0.95 13.75 2.83 -0.02 coo -5.30 12.75 41.86 -4.34 13.05 39.99 5.28 5.47 0.38 4.81 7.57 0.79 coo -12.63 17.64 33.66 -10.65 17.90 34.40 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP B 54 ASP^? 4.46 O ACT B 502 158 THR B 38 THR^? 13.93 OXT ACT B 502 317 ASP B 58 ASP~? 16.37 O ACT B 502 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -12.00 20.67 39.32 -10.38 21.81 40.17 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP B 58 ASP~? 16.37 O ACT B 502 158 THR B 2 THR.? 15.37 O ACT B 502 317 ASP B 54 ASP^? 4.46 O ACT B 502 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -1.77 17.89 37.44 -2.74 16.22 38.35 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.19 24.78 38.76 -8.31 24.86 38.78 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP C 54 ASP^? -3.02 OXT ACT C 503s 158 THR C 38 THR^? 13.13 OXT ACT C 503 317 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -2.96 18.29 1.33 -1.80 20.06 1.28 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP C 58 ASP~? 15.48 OXT ACT C 503 158 THR C 2 THR.? 13.94 OXT ACT C 503 317 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -5.93 27.71 5.50 -7.21 27.13 3.90 coo -5.30 12.75 41.86 -4.34 13.05 39.99 0.78 23.36 4.70 1.16 21.29 4.14 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 3 # 7 54 ASP D 54 ASP^? 19.49 OXT ACT B 502 158 THR D 38 THR^? 19.44 OXT ACT B 502 317 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -18.99 32.97 40.14 -20.81 31.88 40.43 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -28.98 35.91 37.37 -28.15 37.30 38.76 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 3 # 8 54 ASP D 58 ASP~? 25.46 OXT ACT B 502 158 THR D 2 THR.? 16.35 OXT ACT B 502 317 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -28.98 35.91 37.37 -28.15 37.30 38.76 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -24.65 28.96 37.92 -22.54 28.87 38.29 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -16.29 34.40 33.40 -16.55 35.85 31.87 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 8 hits 1inp_c02 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU B 34 GLU.? 6.39 OXT ACT B 502 A 61 GLU B 59 GLU~? 13.30 O ACT B 502 A 162 HIS B 65 HIS~? -3.69 O ACT B 502s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -14.54 12.40 35.90 -14.50 13.22 33.94 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -1.11 15.84 31.13 -2.15 17.21 29.83 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -12.58 15.14 31.21 -14.46 15.75 30.51 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 1 hits 1j53_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU B 59 GLU~? 13.30 O ACT B 502 A 56 LYS B 90 LYS^? 12.84 O ACT B 502 A 258 ARG A 9 ARG^? 14.14 OXT ACT C 503 coo 42.33 1.56 26.99 42.38 2.91 28.66 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.15 12.93 21.45 1.14 13.40 20.88 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU C 59 GLU~? 12.18 OXT ACT C 503 A 56 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 258 ARG B 9 ARG^? 13.94 CH3 ACT B 502 coo 42.33 1.56 26.99 42.38 2.91 28.66 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -17.57 25.75 18.49 -17.57 28.52 19.90 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 56 LYS B 90 LYS^? 12.84 O ACT B 502 A 258 ARG C 9 ARG^? 14.66 OXT ACT C 503 coo 42.33 1.56 26.99 42.38 2.91 28.66 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -1.72 5.89 20.10 1.21 6.47 19.35 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 56 LYS C 3 LYS.? 18.11 OXT ACT C 503 A 258 ARG D 9 ARG^? 15.08 O ACT B 502 coo 42.33 1.56 26.99 42.38 2.91 28.66 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.38 25.07 8.12 -1.77 29.22 5.24 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -10.16 31.68 19.32 -10.74 28.83 20.23 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU D 89 GLU^? 16.27 CH3 ACT B 502 A 56 LYS B 44 LYS^? 16.99 CH3 ACT B 502 A 258 ARG D 9 ARG^? 15.08 O ACT B 502 coo 42.33 1.56 26.99 42.38 2.91 28.66 -18.84 33.24 21.04 -18.05 31.37 20.48 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -10.16 31.68 19.32 -10.74 28.83 20.23 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 5 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU B 59 GLU~? 13.30 O ACT B 502 B 56 LYS B 90 LYS^? 12.84 O ACT B 502 B 258 ARG A 9 ARG^? 14.14 OXT ACT C 503 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 2.64 1.83 34.81 1.56 1.13 32.02 4.15 12.93 21.45 1.14 13.40 20.88 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU C 59 GLU~? 12.18 OXT ACT C 503 B 56 LYS C 3 LYS.? 18.11 OXT ACT C 503 B 258 ARG D 9 ARG^? 15.08 O ACT B 502 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.38 25.07 8.12 -1.77 29.22 5.24 coo 2.64 1.83 34.81 1.56 1.13 32.02 -10.16 31.68 19.32 -10.74 28.83 20.23 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU C 59 GLU~? 12.18 OXT ACT C 503 B 56 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 258 ARG B 9 ARG^? 13.94 CH3 ACT B 502 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 2.64 1.83 34.81 1.56 1.13 32.02 -17.57 25.75 18.49 -17.57 28.52 19.90 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 B 56 LYS A 44 LYS^? 17.14 CH3 ACT A 501 B 258 ARG B 62 ARG~? 12.26 O ACT B 502 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 3.76 21.56 17.68 3.38 25.65 21.29 coo 2.64 1.83 34.81 1.56 1.13 32.02 -6.19 18.92 29.62 -3.70 20.53 28.83 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 B 56 LYS A 44 LYS^? 17.14 CH3 ACT A 501 B 258 ARG C 9 ARG^? 14.66 OXT ACT C 503 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 3.76 21.56 17.68 3.38 25.65 21.29 coo 2.64 1.83 34.81 1.56 1.13 32.02 -1.72 5.89 20.10 1.21 6.47 19.35 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 B 56 LYS B 90 LYS^? 12.84 O ACT B 502 B 258 ARG C 9 ARG^? 14.66 OXT ACT C 503 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 2.64 1.83 34.81 1.56 1.13 32.02 -1.72 5.89 20.10 1.21 6.47 19.35 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 56 LYS C 3 LYS.? 18.11 OXT ACT C 503 B 258 ARG D 9 ARG^? 15.08 O ACT B 502 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.38 25.07 8.12 -1.77 29.22 5.24 coo 2.64 1.83 34.81 1.56 1.13 32.02 -10.16 31.68 19.32 -10.74 28.83 20.23 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 7 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU B 59 GLU~? 13.30 O ACT B 502 C 56 LYS B 90 LYS^? 12.84 O ACT B 502 C 258 ARG A 9 ARG^? 14.14 OXT ACT C 503 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 4.15 12.93 21.45 1.14 13.40 20.88 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU C 59 GLU~? 12.18 OXT ACT C 503 C 56 LYS C 3 LYS.? 18.11 OXT ACT C 503 C 258 ARG D 9 ARG^? 15.08 O ACT B 502 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.38 25.07 8.12 -1.77 29.22 5.24 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -10.16 31.68 19.32 -10.74 28.83 20.23 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU C 59 GLU~? 12.18 OXT ACT C 503 C 56 LYS C 90 LYS^? 10.56 OXT ACT C 503 C 258 ARG B 9 ARG^? 13.94 CH3 ACT B 502 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -17.57 25.75 18.49 -17.57 28.52 19.90 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 C 56 LYS A 44 LYS^? 17.14 CH3 ACT A 501 C 258 ARG B 62 ARG~? 12.26 O ACT B 502 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 3.76 21.56 17.68 3.38 25.65 21.29 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -6.19 18.92 29.62 -3.70 20.53 28.83 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 C 56 LYS A 44 LYS^? 17.14 CH3 ACT A 501 C 258 ARG C 9 ARG^? 14.66 OXT ACT C 503 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 3.76 21.56 17.68 3.38 25.65 21.29 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -1.72 5.89 20.10 1.21 6.47 19.35 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 C 56 LYS B 90 LYS^? 12.84 O ACT B 502 C 258 ARG C 9 ARG^? 14.66 OXT ACT C 503 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -1.72 5.89 20.10 1.21 6.47 19.35 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU C 92 GLU^? 15.67 OXT ACT C 503 C 56 LYS C 3 LYS.? 18.11 OXT ACT C 503 C 258 ARG D 9 ARG^? 15.08 O ACT B 502 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.38 25.07 8.12 -1.77 29.22 5.24 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -10.16 31.68 19.32 -10.74 28.83 20.23 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 7 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU B 59 GLU~? 13.30 O ACT B 502 D 56 LYS B 90 LYS^? 12.84 O ACT B 502 D 258 ARG A 9 ARG^? 14.14 OXT ACT C 503 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 4.15 12.93 21.45 1.14 13.40 20.88 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU C 59 GLU~? 12.18 OXT ACT C 503 D 56 LYS C 3 LYS.? 18.11 OXT ACT C 503 D 258 ARG D 9 ARG^? 15.08 O ACT B 502 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.38 25.07 8.12 -1.77 29.22 5.24 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -10.16 31.68 19.32 -10.74 28.83 20.23 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU C 59 GLU~? 12.18 OXT ACT C 503 D 56 LYS C 90 LYS^? 10.56 OXT ACT C 503 D 258 ARG B 9 ARG^? 13.94 CH3 ACT B 502 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -17.57 25.75 18.49 -17.57 28.52 19.90 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 D 56 LYS A 44 LYS^? 17.14 CH3 ACT A 501 D 258 ARG B 62 ARG~? 12.26 O ACT B 502 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 3.76 21.56 17.68 3.38 25.65 21.29 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -6.19 18.92 29.62 -3.70 20.53 28.83 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 D 56 LYS A 44 LYS^? 17.14 CH3 ACT A 501 D 258 ARG C 9 ARG^? 14.66 OXT ACT C 503 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 3.76 21.56 17.68 3.38 25.65 21.29 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -1.72 5.89 20.10 1.21 6.47 19.35 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU C 89 GLU^? 12.32 OXT ACT C 503 D 56 LYS B 90 LYS^? 12.84 O ACT B 502 D 258 ARG C 9 ARG^? 14.66 OXT ACT C 503 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -1.72 5.89 20.10 1.21 6.47 19.35 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU C 92 GLU^? 15.67 OXT ACT C 503 D 56 LYS C 3 LYS.? 18.11 OXT ACT C 503 D 258 ARG D 9 ARG^? 15.08 O ACT B 502 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.38 25.07 8.12 -1.77 29.22 5.24 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -10.16 31.68 19.32 -10.74 28.83 20.23 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 7 hits 1k82_c03 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 62 ARG~? 11.91 O ACT A 501 A 351 HIS A 65 HIS~? -3.60 O ACT A 501s A 386 LEU A 6 LEU^? 5.77 O ACT A 501 coo 57.36 53.34 128.83 58.45 50.56 128.34 11.34 4.43 9.06 9.97 1.81 9.84 coo 60.60 50.64 133.59 60.63 48.82 132.56 14.91 11.26 8.66 14.30 12.93 9.76 coo 63.28 54.23 126.45 63.53 52.07 126.70 9.80 8.35 12.04 11.56 7.21 11.88 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG B 62 ARG~? 12.26 O ACT B 502 A 351 HIS B 65 HIS~? -3.69 O ACT B 502s A 386 LEU B 6 LEU^? 5.98 O ACT B 502 coo 57.36 53.34 128.83 58.45 50.56 128.34 -6.19 18.92 29.62 -3.70 20.53 28.83 coo 60.60 50.64 133.59 60.63 48.82 132.56 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 63.28 54.23 126.45 63.53 52.07 126.70 -10.51 20.28 27.81 -9.39 18.40 27.56 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 3 3 # 3 A 290 ARG C 62 ARG~? 10.88 OXT ACT C 503 A 351 HIS C 65 HIS~? -3.55 C ACT C 503s A 386 LEU C 6 LEU^? 4.67 OXT ACT C 503 coo 57.36 53.34 128.83 58.45 50.56 128.34 -6.61 21.24 11.49 -5.46 23.07 13.64 coo 60.60 50.64 133.59 60.63 48.82 132.56 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 63.28 54.23 126.45 63.53 52.07 126.70 -5.91 16.33 12.41 -7.68 17.61 12.51 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 4 3 # 4 A 290 ARG D 62 ARG~? 20.52 OXT ACT B 502 A 351 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 386 LEU D 6 LEU^? 20.17 OXT ACT B 502 coo 57.36 53.34 128.83 58.45 50.56 128.34 -23.58 36.44 30.28 -25.75 35.10 28.58 coo 60.60 50.64 133.59 60.63 48.82 132.56 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 63.28 54.23 126.45 63.53 52.07 126.70 -19.04 35.64 28.72 -20.20 37.46 28.76 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 4 hits 1knp_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS B 90 LYS^? 12.84 O ACT B 502 A 74 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 165 GLU D 11 GLU.? 21.84 O ACT B 502 coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -7.35 35.76 17.53 -6.53 33.80 17.57 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 74 LYS B 90 LYS^? 12.84 O ACT B 502 A 165 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 24.97 5.82 58.78 26.79 1.97 55.46 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 74 LYS B 90 LYS^? 12.84 O ACT B 502 A 165 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 24.97 5.82 58.78 26.79 1.97 55.46 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 74 LYS B 90 LYS^? 12.84 O ACT B 502 A 165 GLU D 11 GLU.? 21.84 O ACT B 502 coo 24.97 5.82 58.78 26.79 1.97 55.46 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -7.35 35.76 17.53 -6.53 33.80 17.57 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS B 90 LYS^? 12.84 O ACT B 502 D 74 LYS C 90 LYS^? 10.56 OXT ACT C 503 D 165 GLU D 11 GLU.? 21.84 O ACT B 502 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -7.35 35.76 17.53 -6.53 33.80 17.57 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 D 74 LYS B 90 LYS^? 12.84 O ACT B 502 D 165 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 D 74 LYS B 90 LYS^? 12.84 O ACT B 502 D 165 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS C 90 LYS^? 10.56 OXT ACT C 503 D 74 LYS B 90 LYS^? 12.84 O ACT B 502 D 165 GLU D 11 GLU.? 21.84 O ACT B 502 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -7.35 35.76 17.53 -6.53 33.80 17.57 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c03 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 60 ALA~? 15.50 O ACT A 501 A 317 GLY A 61 GLY~? 11.65 O ACT A 501 A 318 ASP A 58 ASP~? 16.01 O ACT A 501 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 16.92 2.68 3.35 17.44 2.38 1.97 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 15.25 6.14 3.18 15.29 5.59 3.87 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 60 ALA~? 15.70 O ACT B 502 A 317 GLY B 61 GLY~? 11.96 O ACT B 502 A 318 ASP B 58 ASP~? 16.37 O ACT B 502 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -3.13 13.34 34.99 -2.65 12.71 36.31 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 60 ALA~? 15.14 OXT ACT C 503 A 317 GLY C 61 GLY~? 11.24 OXT ACT C 503 A 318 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -10.85 26.04 6.18 -11.08 26.98 4.99 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 60 ALA~? 28.12 OXT ACT B 502 A 317 GLY D 61 GLY~? 24.96 OXT ACT B 502 A 318 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -27.42 40.78 36.27 -28.14 40.94 37.58 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -28.98 35.91 37.37 -28.15 37.30 38.76 1lij_c01 source 1lij ADENOSINE KINASE : 4 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 60 ALA~? 15.50 O ACT A 501 A 317 GLY A 61 GLY~? 11.65 O ACT A 501 A 318 ASP A 58 ASP~? 16.01 O ACT A 501 coo 27.04 23.54 41.85 25.72 24.19 42.18 16.92 2.68 3.35 17.44 2.38 1.97 coo 27.87 23.16 38.17 28.43 22.97 38.87 15.25 6.14 3.18 15.29 5.59 3.87 coo 32.11 22.71 40.58 33.42 24.22 39.78 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 60 ALA~? 15.70 O ACT B 502 A 317 GLY B 61 GLY~? 11.96 O ACT B 502 A 318 ASP B 58 ASP~? 16.37 O ACT B 502 coo 27.04 23.54 41.85 25.72 24.19 42.18 -3.13 13.34 34.99 -2.65 12.71 36.31 coo 27.87 23.16 38.17 28.43 22.97 38.87 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 32.11 22.71 40.58 33.42 24.22 39.78 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 60 ALA~? 15.14 OXT ACT C 503 A 317 GLY C 61 GLY~? 11.24 OXT ACT C 503 A 318 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 27.04 23.54 41.85 25.72 24.19 42.18 -10.85 26.04 6.18 -11.08 26.98 4.99 coo 27.87 23.16 38.17 28.43 22.97 38.87 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 32.11 22.71 40.58 33.42 24.22 39.78 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 60 ALA~? 28.12 OXT ACT B 502 A 317 GLY D 61 GLY~? 24.96 OXT ACT B 502 A 318 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 27.04 23.54 41.85 25.72 24.19 42.18 -27.42 40.78 36.27 -28.14 40.94 37.58 coo 27.87 23.16 38.17 28.43 22.97 38.87 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 32.11 22.71 40.58 33.42 24.22 39.78 -28.98 35.91 37.37 -28.15 37.30 38.76 1lio_c01 source 1lio ADENOSINE KINASE : 4 hits 1lio_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG C 9 ARG^? 14.66 OXT ACT C 503 229 SER C 48 SER.? 19.11 O ACT C 503 325 GLU C 11 GLU^? 15.94 OXT ACT C 503 coo 2.54 15.84 18.57 3.24 17.85 16.30 -1.72 5.89 20.10 1.21 6.47 19.35 coo 10.17 13.48 15.92 9.61 15.76 15.27 -4.38 -3.19 17.46 -4.11 -3.50 19.78 coo 5.42 13.04 19.75 5.74 13.81 17.79 -6.14 2.53 21.46 -4.11 2.08 21.09 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG D 9 ARG^? 15.08 O ACT B 502 229 SER D 48 SER.? 23.18 OXT ACT C 503 325 GLU D 11 GLU.? 21.84 O ACT B 502 coo 2.54 15.84 18.57 3.24 17.85 16.30 -10.16 31.68 19.32 -10.74 28.83 20.23 coo 10.17 13.48 15.92 9.61 15.76 15.27 -0.72 34.09 20.26 -1.13 33.83 17.85 coo 5.42 13.04 19.75 5.74 13.81 17.79 -7.35 35.76 17.53 -6.53 33.80 17.57 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 2 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS B 90 LYS^? 12.84 O ACT B 502 166 LYS C 90 LYS^? 10.56 OXT ACT C 503 324 SER A 83 SER.? 15.27 CH3 ACT A 501 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 46.32 14.55 19.93 45.95 12.72 21.27 13.81 17.41 28.85 11.46 17.47 28.69 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS B 90 LYS^? 12.84 O ACT B 502 166 LYS C 90 LYS^? 10.56 OXT ACT C 503 324 SER A 84 SER.? 13.58 CH3 ACT A 501 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 46.32 14.55 19.93 45.95 12.72 21.27 14.07 13.74 27.70 11.71 13.39 27.27 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS B 90 LYS^? 12.84 O ACT B 502 166 LYS C 90 LYS^? 10.56 OXT ACT C 503 324 SER B 48 SER.? 16.63 CH3 ACT B 502 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 46.32 14.55 19.93 45.95 12.72 21.27 -27.05 23.61 17.32 -26.38 24.08 15.04 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS B 90 LYS^? 12.84 O ACT B 502 166 LYS C 90 LYS^? 10.56 OXT ACT C 503 324 SER D 83 SER.? 27.11 OXT ACT C 503 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 46.32 14.55 19.93 45.95 12.72 21.27 -4.98 41.81 16.11 -5.10 39.49 15.62 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS B 90 LYS^? 12.84 O ACT B 502 166 LYS C 90 LYS^? 10.56 OXT ACT C 503 324 SER D 84 SER.? 26.78 O ACT B 502 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 46.32 14.55 19.93 45.95 12.72 21.27 -8.77 41.84 15.60 -9.23 39.48 15.25 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS C 90 LYS^? 10.56 OXT ACT C 503 166 LYS B 90 LYS^? 12.84 O ACT B 502 324 SER A 84 SER.? 13.58 CH3 ACT A 501 coo 25.93 8.11 25.51 26.40 7.80 19.66 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 14.07 13.74 27.70 11.71 13.39 27.27 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS C 90 LYS^? 10.56 OXT ACT C 503 166 LYS B 90 LYS^? 12.84 O ACT B 502 324 SER B 48 SER.? 16.63 CH3 ACT B 502 coo 25.93 8.11 25.51 26.40 7.80 19.66 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 -27.05 23.61 17.32 -26.38 24.08 15.04 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS C 90 LYS^? 10.56 OXT ACT C 503 166 LYS B 90 LYS^? 12.84 O ACT B 502 324 SER C 83 SER.? 17.75 CH3 ACT C 503 coo 25.93 8.11 25.51 26.40 7.80 19.66 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 -11.89 0.03 22.35 -9.55 -0.34 22.50 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS C 90 LYS^? 10.56 OXT ACT C 503 166 LYS B 90 LYS^? 12.84 O ACT B 502 324 SER D 83 SER.? 27.11 OXT ACT C 503 coo 25.93 8.11 25.51 26.40 7.80 19.66 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 -4.98 41.81 16.11 -5.10 39.49 15.62 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS C 90 LYS^? 10.56 OXT ACT C 503 166 LYS B 90 LYS^? 12.84 O ACT B 502 324 SER D 84 SER.? 26.78 O ACT B 502 coo 25.93 8.11 25.51 26.40 7.80 19.66 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 -8.77 41.84 15.60 -9.23 39.48 15.25 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 10 hits 1mdr_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS B 65 HIS~? -3.69 O ACT B 502s A 197 ASP B 54 ASP^? 4.46 O ACT B 502 A 223 ALA B 25 ALA~? 11.68 OXT ACT B 502 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -26.92 17.85 31.18 -28.32 18.45 31.16 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS B 65 HIS~? -3.69 O ACT B 502s A 197 ASP B 54 ASP^? 4.46 O ACT B 502 A 223 ALA B 73 ALA~? 8.56 CH3 ACT B 502 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -20.50 8.04 26.45 -21.25 8.75 27.56 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 65 HIS~? -3.69 O ACT B 502s A 197 ASP B 54 ASP^? 4.46 O ACT B 502 A 223 ALA D 95 ALA^? 10.13 OXT ACT B 502 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -25.11 22.09 33.92 -25.07 20.56 33.70 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS C 65 HIS~? -3.55 C ACT C 503s A 197 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 223 ALA A 95 ALA^? 10.73 O ACT C 503 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -2.38 4.21 2.77 -3.93 4.25 2.63 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS C 65 HIS~? -3.55 C ACT C 503s A 197 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 223 ALA C 25 ALA~? 12.43 O ACT C 503 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -7.08 1.83 3.91 -6.57 0.39 3.68 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS C 65 HIS~? -3.55 C ACT C 503s A 197 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 223 ALA C 73 ALA~? 8.85 CH3 ACT C 503 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -17.50 7.43 8.36 -16.78 6.98 7.10 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 197 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 223 ALA B 95 ALA^? 21.74 O ACT B 502 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -5.29 32.43 36.25 -5.34 33.96 36.39 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 197 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 223 ALA D 25 ALA~? 25.08 O ACT B 502 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -3.07 37.00 34.49 -1.58 36.55 34.48 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 197 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 223 ALA D 73 ALA~? 31.32 O ACT B 502 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -9.37 47.67 30.90 -8.63 46.94 32.02 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 9 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS B 65 HIS~? -3.69 O ACT B 502s B 197 ASP B 54 ASP^? 4.46 O ACT B 502 B 223 ALA B 25 ALA~? 11.68 OXT ACT B 502 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -26.92 17.85 31.18 -28.32 18.45 31.16 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS B 65 HIS~? -3.69 O ACT B 502s B 197 ASP B 54 ASP^? 4.46 O ACT B 502 B 223 ALA B 73 ALA~? 8.56 CH3 ACT B 502 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -20.50 8.04 26.45 -21.25 8.75 27.56 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 65 HIS~? -3.69 O ACT B 502s B 197 ASP B 54 ASP^? 4.46 O ACT B 502 B 223 ALA D 95 ALA^? 10.13 OXT ACT B 502 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -25.11 22.09 33.92 -25.07 20.56 33.70 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS C 65 HIS~? -3.55 C ACT C 503s B 197 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 223 ALA A 95 ALA^? 10.73 O ACT C 503 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -2.38 4.21 2.77 -3.93 4.25 2.63 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS C 65 HIS~? -3.55 C ACT C 503s B 197 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 223 ALA C 25 ALA~? 12.43 O ACT C 503 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -7.08 1.83 3.91 -6.57 0.39 3.68 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS C 65 HIS~? -3.55 C ACT C 503s B 197 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 223 ALA C 73 ALA~? 8.85 CH3 ACT C 503 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -17.50 7.43 8.36 -16.78 6.98 7.10 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 197 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 223 ALA B 95 ALA^? 21.74 O ACT B 502 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -5.29 32.43 36.25 -5.34 33.96 36.39 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 197 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 223 ALA D 25 ALA~? 25.08 O ACT B 502 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -3.07 37.00 34.49 -1.58 36.55 34.48 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 197 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 223 ALA D 73 ALA~? 31.32 O ACT B 502 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -9.37 47.67 30.90 -8.63 46.94 32.02 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 9 hits 1n2t_c03 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 90 LYS^? 10.86 O ACT A 501 631 LYS A 13 LYS.? 18.34 CH3 ACT A 501 708 LYS A 3 LYS.? 15.82 O ACT C 503 coo 8.61 33.06 11.15 10.12 29.19 8.82 8.29 3.28 13.77 13.67 2.39 14.04 coo -11.99 27.40 17.14 -13.60 24.52 11.71 13.03 21.95 28.39 18.88 21.48 30.19 coo 18.16 32.86 9.85 16.06 28.20 13.56 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 90 LYS^? 10.86 O ACT A 501 631 LYS A 13 LYS.? 18.34 CH3 ACT A 501 708 LYS C 44 LYS^? 18.40 O ACT C 503 coo 8.61 33.06 11.15 10.12 29.19 8.82 8.29 3.28 13.77 13.67 2.39 14.04 coo -11.99 27.40 17.14 -13.60 24.52 11.71 13.03 21.95 28.39 18.88 21.48 30.19 coo 18.16 32.86 9.85 16.06 28.20 13.56 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS B 44 LYS^? 16.99 CH3 ACT B 502 631 LYS C 90 LYS^? 10.56 OXT ACT C 503 708 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 8.61 33.06 11.15 10.12 29.19 8.82 -24.96 26.06 24.81 -31.04 25.82 23.05 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 18.16 32.86 9.85 16.06 28.20 13.56 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS B 90 LYS^? 12.84 O ACT B 502 631 LYS D 3 LYS.? 15.58 OXT ACT B 502 708 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 8.61 33.06 11.15 10.12 29.19 8.82 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -26.73 29.41 34.74 -28.62 25.37 34.54 coo 18.16 32.86 9.85 16.06 28.20 13.56 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS C 90 LYS^? 10.56 OXT ACT C 503 631 LYS A 3 LYS.? 15.82 O ACT C 503 708 LYS B 90 LYS^? 12.84 O ACT B 502 coo 8.61 33.06 11.15 10.12 29.19 8.82 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -11.99 27.40 17.14 -13.60 24.52 11.71 5.08 2.81 3.00 0.95 1.12 1.99 coo 18.16 32.86 9.85 16.06 28.20 13.56 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS C 90 LYS^? 10.56 OXT ACT C 503 631 LYS B 13 LYS.? 14.39 CH3 ACT C 503 708 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 8.61 33.06 11.15 10.12 29.19 8.82 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -26.83 16.89 13.78 -24.80 11.17 11.99 coo 18.16 32.86 9.85 16.06 28.20 13.56 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS C 90 LYS^? 10.56 OXT ACT C 503 631 LYS B 44 LYS^? 16.99 CH3 ACT B 502 708 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 8.61 33.06 11.15 10.12 29.19 8.82 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 18.16 32.86 9.85 16.06 28.20 13.56 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 8 3 # 8 549 LYS C 90 LYS^? 10.56 OXT ACT C 503 631 LYS B 44 LYS^? 16.99 CH3 ACT B 502 708 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 8.61 33.06 11.15 10.12 29.19 8.82 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 18.16 32.86 9.85 16.06 28.20 13.56 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 9 3 # 9 549 LYS D 90 LYS^? 25.07 CH3 ACT B 502 631 LYS D 13 LYS.? 35.09 O ACT B 502 708 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 8.61 33.06 11.15 10.12 29.19 8.82 -23.03 34.53 25.25 -26.25 39.79 25.56 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -1.12 41.20 17.82 -1.77 47.26 17.33 coo 18.16 32.86 9.85 16.06 28.20 13.56 -26.73 29.41 34.74 -28.62 25.37 34.54 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 9 hits 1nsf_c00 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 96 GLU A 17 GLU~? 18.98 CH3 ACT A 501 A 132 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo 31.23 12.29 16.44 30.82 11.56 18.39 13.66 28.66 16.58 12.51 30.39 17.11 coo 26.82 3.20 24.36 27.99 4.86 24.98 8.46 25.60 25.93 9.21 26.72 27.59 coo 29.99 0.62 22.18 30.38 6.69 20.81 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 96 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 132 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 31.23 12.29 16.44 30.82 11.56 18.39 13.66 28.66 16.58 12.51 30.39 17.11 coo 26.82 3.20 24.36 27.99 4.86 24.98 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 29.99 0.62 22.18 30.38 6.69 20.81 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 96 GLU B 17 GLU~? 18.31 CH3 ACT B 502 A 132 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 31.23 12.29 16.44 30.82 11.56 18.39 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 26.82 3.20 24.36 27.99 4.86 24.98 -30.37 21.21 17.22 -31.47 20.28 15.66 coo 29.99 0.62 22.18 30.38 6.69 20.81 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 96 GLU D 92 GLU^? 17.21 CH3 ACT B 502 A 132 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 31.23 12.29 16.44 30.82 11.56 18.39 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 26.82 3.20 24.36 27.99 4.86 24.98 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 29.99 0.62 22.18 30.38 6.69 20.81 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP B 54 ASP^? 4.46 O ACT B 502 A 96 GLU B 92 GLU^? 19.37 O ACT B 502 A 132 LYS D 44 LYS^? 22.72 O ACT B 502 coo 31.23 12.29 16.44 30.82 11.56 18.39 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 26.82 3.20 24.36 27.99 4.86 24.98 -0.80 26.07 29.41 1.12 26.90 28.84 coo 29.99 0.62 22.18 30.38 6.69 20.81 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP C 22 ASP~? 16.98 O ACT C 503 A 96 GLU C 17 GLU~? 20.89 O ACT C 503 A 132 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 31.23 12.29 16.44 30.82 11.56 18.39 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 26.82 3.20 24.36 27.99 4.86 24.98 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo 29.99 0.62 22.18 30.38 6.69 20.81 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 96 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 132 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 31.23 12.29 16.44 30.82 11.56 18.39 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 26.82 3.20 24.36 27.99 4.86 24.98 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 29.99 0.62 22.18 30.38 6.69 20.81 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP D 22 ASP~? 30.56 O ACT B 502 A 96 GLU B 92 GLU^? 19.37 O ACT B 502 A 132 LYS D 44 LYS^? 22.72 O ACT B 502 coo 31.23 12.29 16.44 30.82 11.56 18.39 1.48 40.46 31.50 1.79 41.35 33.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 -0.80 26.07 29.41 1.12 26.90 28.84 coo 29.99 0.62 22.18 30.38 6.69 20.81 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP D 22 ASP~? 30.56 O ACT B 502 A 96 GLU D 17 GLU~? 25.97 OXT ACT A 501 A 132 LYS D 13 LYS.? 35.09 O ACT B 502 coo 31.23 12.29 16.44 30.82 11.56 18.39 1.48 40.46 31.50 1.79 41.35 33.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 2.12 36.56 21.03 3.60 37.59 19.89 coo 29.99 0.62 22.18 30.38 6.69 20.81 -1.12 41.20 17.82 -1.77 47.26 17.33 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 96 GLU D 92 GLU^? 17.21 CH3 ACT B 502 A 132 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 31.23 12.29 16.44 30.82 11.56 18.39 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 26.82 3.20 24.36 27.99 4.86 24.98 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 29.99 0.62 22.18 30.38 6.69 20.81 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1onr_c00 TRANSALDOLASE B user 11 3 # 11 A 17 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 96 GLU D 92 GLU^? 17.21 CH3 ACT B 502 A 132 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 31.23 12.29 16.44 30.82 11.56 18.39 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 26.82 3.20 24.36 27.99 4.86 24.98 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 29.99 0.62 22.18 30.38 6.69 20.81 -26.73 29.41 34.74 -28.62 25.37 34.54 1onr_c00 source 1onr TRANSALDOLASE B : 11 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 22 ASP~? 16.31 OXT ACT A 501 B 96 GLU A 17 GLU~? 18.98 CH3 ACT A 501 B 132 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo 31.16 57.31 -0.94 30.73 56.64 1.01 13.66 28.66 16.58 12.51 30.39 17.11 coo 26.69 48.45 7.18 27.85 50.13 7.74 8.46 25.60 25.93 9.21 26.72 27.59 coo 29.82 45.80 5.07 30.26 51.81 3.56 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 22 ASP~? 16.31 OXT ACT A 501 B 96 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 132 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 31.16 57.31 -0.94 30.73 56.64 1.01 13.66 28.66 16.58 12.51 30.39 17.11 coo 26.69 48.45 7.18 27.85 50.13 7.74 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 29.82 45.80 5.07 30.26 51.81 3.56 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP B 22 ASP~? 15.53 CH3 ACT B 502 B 96 GLU B 17 GLU~? 18.31 CH3 ACT B 502 B 132 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 26.69 48.45 7.18 27.85 50.13 7.74 -30.37 21.21 17.22 -31.47 20.28 15.66 coo 29.82 45.80 5.07 30.26 51.81 3.56 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 22 ASP~? 15.53 CH3 ACT B 502 B 96 GLU D 92 GLU^? 17.21 CH3 ACT B 502 B 132 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 26.69 48.45 7.18 27.85 50.13 7.74 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 29.82 45.80 5.07 30.26 51.81 3.56 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP B 54 ASP^? 4.46 O ACT B 502 B 96 GLU B 92 GLU^? 19.37 O ACT B 502 B 132 LYS D 44 LYS^? 22.72 O ACT B 502 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 26.69 48.45 7.18 27.85 50.13 7.74 -0.80 26.07 29.41 1.12 26.90 28.84 coo 29.82 45.80 5.07 30.26 51.81 3.56 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP C 22 ASP~? 16.98 O ACT C 503 B 96 GLU C 17 GLU~? 20.89 O ACT C 503 B 132 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 26.69 48.45 7.18 27.85 50.13 7.74 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo 29.82 45.80 5.07 30.26 51.81 3.56 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 96 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 132 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 26.69 48.45 7.18 27.85 50.13 7.74 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 29.82 45.80 5.07 30.26 51.81 3.56 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP D 22 ASP~? 30.56 O ACT B 502 B 96 GLU B 92 GLU^? 19.37 O ACT B 502 B 132 LYS D 44 LYS^? 22.72 O ACT B 502 coo 31.16 57.31 -0.94 30.73 56.64 1.01 1.48 40.46 31.50 1.79 41.35 33.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 -0.80 26.07 29.41 1.12 26.90 28.84 coo 29.82 45.80 5.07 30.26 51.81 3.56 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP D 22 ASP~? 30.56 O ACT B 502 B 96 GLU D 17 GLU~? 25.97 OXT ACT A 501 B 132 LYS D 13 LYS.? 35.09 O ACT B 502 coo 31.16 57.31 -0.94 30.73 56.64 1.01 1.48 40.46 31.50 1.79 41.35 33.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 2.12 36.56 21.03 3.60 37.59 19.89 coo 29.82 45.80 5.07 30.26 51.81 3.56 -1.12 41.20 17.82 -1.77 47.26 17.33 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 96 GLU D 92 GLU^? 17.21 CH3 ACT B 502 B 132 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 26.69 48.45 7.18 27.85 50.13 7.74 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 29.82 45.80 5.07 30.26 51.81 3.56 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1onr_c01 TRANSALDOLASE B user 11 3 # 11 B 17 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 96 GLU D 92 GLU^? 17.21 CH3 ACT B 502 B 132 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 26.69 48.45 7.18 27.85 50.13 7.74 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 29.82 45.80 5.07 30.26 51.81 3.56 -26.73 29.41 34.74 -28.62 25.37 34.54 1onr_c01 source 1onr TRANSALDOLASE B : 11 hits 1onr_c01 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 5 ALA^? 10.14 O ACT A 501 A 126 LEU A 4 LEU^? 13.25 O ACT A 501 A 158 GLU A 59 GLU~? 13.04 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.07 6.48 8.63 5.64 7.02 8.72 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.55 3.15 6.15 9.04 1.07 6.04 coo -0.83 29.57 149.77 -0.39 31.47 148.95 14.64 -0.22 6.93 13.24 0.65 8.32 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 5 ALA^? 10.14 O ACT A 501 A 126 LEU A 4 LEU^? 13.25 O ACT A 501 A 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.07 6.48 8.63 5.64 7.02 8.72 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.55 3.15 6.15 9.04 1.07 6.04 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 5 ALA^? 10.14 O ACT A 501 A 126 LEU A 93 LEU^? 13.32 O ACT C 503 A 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.07 6.48 8.63 5.64 7.02 8.72 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.06 4.27 5.34 2.90 6.18 5.99 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 19 ALA~? 15.35 CH3 ACT A 501 A 126 LEU A 20 LEU~? 10.28 CH3 ACT A 501 A 158 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.13 27.60 20.84 15.17 27.48 21.97 coo -4.62 32.83 147.14 -5.50 32.85 149.12 12.31 23.05 20.96 12.31 20.90 20.50 coo -0.83 29.57 149.77 -0.39 31.47 148.95 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 21 ALA~? 13.50 CH3 ACT A 501 A 126 LEU A 20 LEU~? 10.28 CH3 ACT A 501 A 158 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 10.21 25.33 17.67 9.13 26.32 18.07 coo -4.62 32.83 147.14 -5.50 32.85 149.12 12.31 23.05 20.96 12.31 20.90 20.50 coo -0.83 29.57 149.77 -0.39 31.47 148.95 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA A 27 ALA~? 6.30 OXT ACT A 501 A 126 LEU A 30 LEU~? 8.67 OXT ACT A 501 A 158 GLU A 34 GLU.? 6.40 OXT ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 15.68 22.14 9.94 15.41 21.01 11.01 coo -4.62 32.83 147.14 -5.50 32.85 149.12 18.36 19.67 7.14 20.10 20.58 8.04 coo -0.83 29.57 149.77 -0.39 31.47 148.95 17.44 14.34 4.36 16.78 13.78 6.33 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA A 42 ALA^? 7.49 OXT ACT A 501 A 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 A 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.67 19.66 12.07 8.71 20.77 12.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.58 22.38 10.06 1.90 20.48 9.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA A 55 ALA^? 10.68 O ACT A 501 A 126 LEU A 4 LEU^? 13.25 O ACT A 501 A 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.41 9.36 5.53 6.02 9.63 4.91 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.55 3.15 6.15 9.04 1.07 6.04 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA A 55 ALA^? 10.68 O ACT A 501 A 126 LEU A 93 LEU^? 13.32 O ACT C 503 A 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.41 9.36 5.53 6.02 9.63 4.91 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.06 4.27 5.34 2.90 6.18 5.99 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA A 57 ALA.? 15.81 O ACT A 501 A 126 LEU A 4 LEU^? 13.25 O ACT A 501 A 158 GLU A 59 GLU~? 13.04 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 9.41 4.77 0.35 10.03 4.98 -1.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.55 3.15 6.15 9.04 1.07 6.04 coo -0.83 29.57 149.77 -0.39 31.47 148.95 14.64 -0.22 6.93 13.24 0.65 8.32 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA A 57 ALA.? 15.81 O ACT A 501 A 126 LEU A 4 LEU^? 13.25 O ACT A 501 A 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 9.41 4.77 0.35 10.03 4.98 -1.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.55 3.15 6.15 9.04 1.07 6.04 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA A 95 ALA^? 10.73 O ACT C 503 A 126 LEU A 93 LEU^? 13.32 O ACT C 503 A 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -2.38 4.21 2.77 -3.93 4.25 2.63 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.06 4.27 5.34 2.90 6.18 5.99 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA B 5 ALA^? 10.59 O ACT B 502 A 126 LEU B 4 LEU^? 13.79 O ACT B 502 A 158 GLU B 59 GLU~? 13.30 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -8.23 23.07 30.89 -8.86 24.45 30.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA B 5 ALA^? 10.59 O ACT B 502 A 126 LEU B 4 LEU^? 13.79 O ACT B 502 A 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -8.23 23.07 30.89 -8.86 24.45 30.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 A 70 ALA B 5 ALA^? 10.59 O ACT B 502 A 126 LEU B 93 LEU^? 15.03 O ACT B 502 A 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -8.23 23.07 30.89 -8.86 24.45 30.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.64 27.87 33.78 -7.65 27.10 33.44 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 A 70 ALA B 19 ALA~? 14.51 CH3 ACT B 502 A 126 LEU B 20 LEU~? 9.69 CH3 ACT B 502 A 158 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -30.70 15.16 22.26 -30.61 14.22 21.09 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.53 17.55 21.49 -24.31 17.63 21.33 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 A 70 ALA B 21 ALA~? 12.87 CH3 ACT B 502 A 126 LEU B 20 LEU~? 9.69 CH3 ACT B 502 A 158 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -28.48 19.17 25.23 -29.56 20.27 25.13 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.53 17.55 21.49 -24.31 17.63 21.33 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 A 70 ALA B 21 ALA~? 12.87 CH3 ACT B 502 A 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -28.48 19.17 25.23 -29.56 20.27 25.13 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.70 22.40 29.65 -27.56 22.74 27.68 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 A 70 ALA B 25 ALA~? 11.68 OXT ACT B 502 A 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -26.92 17.85 31.18 -28.32 18.45 31.16 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.70 22.40 29.65 -27.56 22.74 27.68 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 A 70 ALA B 27 ALA~? 5.95 OXT ACT B 502 A 126 LEU B 30 LEU~? 8.46 OXT ACT B 502 A 158 GLU B 34 GLU.? 6.39 OXT ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -23.16 13.98 32.00 -22.30 14.57 30.90 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -20.16 11.39 34.08 -21.25 9.64 33.31 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -14.54 12.40 35.90 -14.50 13.22 33.94 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 A 70 ALA B 42 ALA^? 7.62 OXT ACT B 502 A 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -21.91 22.04 29.80 -23.07 21.03 30.12 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 A 70 ALA B 42 ALA^? 7.62 OXT ACT B 502 A 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -21.91 22.04 29.80 -23.07 21.03 30.12 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.70 22.40 29.65 -27.56 22.74 27.68 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 A 70 ALA B 55 ALA^? 11.29 O ACT B 502 A 126 LEU B 4 LEU^? 13.79 O ACT B 502 A 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -10.47 22.59 34.42 -10.69 23.88 35.17 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 A 70 ALA B 55 ALA^? 11.29 O ACT B 502 A 126 LEU B 93 LEU^? 15.03 O ACT B 502 A 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -10.47 22.59 34.42 -10.69 23.88 35.17 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.64 27.87 33.78 -7.65 27.10 33.44 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 A 70 ALA B 57 ALA.? 16.24 O ACT B 502 A 126 LEU B 4 LEU^? 13.79 O ACT B 502 A 158 GLU B 59 GLU~? 13.30 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.07 20.59 38.68 -5.03 19.85 40.01 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 A 70 ALA B 57 ALA.? 16.24 O ACT B 502 A 126 LEU B 4 LEU^? 13.79 O ACT B 502 A 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.07 20.59 38.68 -5.03 19.85 40.01 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 A 70 ALA B 95 ALA^? 21.74 O ACT B 502 A 126 LEU B 93 LEU^? 15.03 O ACT B 502 A 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.29 32.43 36.25 -5.34 33.96 36.39 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.64 27.87 33.78 -7.65 27.10 33.44 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 A 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 A 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 A 158 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -2.55 19.26 10.92 -1.13 18.63 10.99 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -3.44 23.59 10.14 -4.00 25.47 11.11 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 A 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 A 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 A 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -2.55 19.26 10.92 -1.13 18.63 10.99 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -3.44 23.59 10.14 -4.00 25.47 11.11 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 A 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 A 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 A 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -2.55 19.26 10.92 -1.13 18.63 10.99 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.58 22.38 10.06 1.90 20.48 9.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 A 70 ALA C 19 ALA~? 16.63 O ACT C 503 A 126 LEU C 20 LEU~? 11.98 O ACT C 503 A 158 GLU C 17 GLU~? 20.89 O ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -11.90 -4.29 10.11 -13.13 -4.48 10.96 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -9.72 -0.76 12.76 -9.40 1.30 13.45 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 A 70 ALA C 21 ALA~? 14.41 O ACT C 503 A 126 LEU C 20 LEU~? 11.98 O ACT C 503 A 158 GLU C 17 GLU~? 20.89 O ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -7.13 -1.49 9.10 -6.18 -2.70 9.16 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -9.72 -0.76 12.76 -9.40 1.30 13.45 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 A 70 ALA C 27 ALA~? 6.88 O ACT C 503 A 126 LEU C 30 LEU~? 9.18 O ACT C 503 A 158 GLU C 34 GLU~? 6.63 O ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -10.71 5.86 3.04 -10.60 6.45 4.49 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -12.78 9.39 1.52 -14.70 8.36 1.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -11.68 15.33 1.66 -11.38 14.84 3.76 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 A 70 ALA C 42 ALA^? 8.18 O ACT C 503 A 126 LEU A 93 LEU^? 13.32 O ACT C 503 A 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -3.35 5.95 7.54 -4.26 5.03 6.74 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.06 4.27 5.34 2.90 6.18 5.99 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 A 70 ALA C 55 ALA^? 9.92 OXT ACT C 503 A 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 A 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -2.12 18.19 6.82 -0.67 18.10 6.39 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -3.44 23.59 10.14 -4.00 25.47 11.11 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 A 70 ALA C 55 ALA^? 9.92 OXT ACT C 503 A 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 A 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -2.12 18.19 6.82 -0.67 18.10 6.39 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.58 22.38 10.06 1.90 20.48 9.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 A 70 ALA C 57 ALA.? 15.19 OXT ACT C 503 A 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 A 158 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -3.08 24.68 4.00 -3.38 25.21 2.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -3.44 23.59 10.14 -4.00 25.47 11.11 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 A 70 ALA C 78 ALA~? 10.81 CH3 ACT C 503 A 126 LEU C 82 LEU~? 12.10 CH3 ACT C 503 A 158 GLU C 11 GLU^? 15.94 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -16.17 4.26 16.08 -16.08 5.69 16.63 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -12.52 2.70 18.75 -11.60 3.75 17.08 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -6.14 2.53 21.46 -4.11 2.08 21.09 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 A 70 ALA C 95 ALA^? 10.09 OXT ACT A 501 A 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 A 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.44 23.59 8.64 8.96 23.56 8.82 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.58 22.38 10.06 1.90 20.48 9.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 A 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 A 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 A 158 GLU D 59 GLU~? 24.17 OXT ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -21.50 32.26 30.89 -20.92 30.85 30.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.95 39.32 31.59 -27.70 38.19 30.22 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 41 3 # 41 A 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 A 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -21.50 32.26 30.89 -20.92 30.85 30.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 42 3 # 42 A 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 A 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -21.50 32.26 30.89 -20.92 30.85 30.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 43 3 # 43 A 70 ALA D 19 ALA~? 31.29 O ACT B 502 A 126 LEU D 20 LEU~? 25.79 O ACT B 502 A 158 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 1.65 41.64 27.12 1.68 42.87 26.22 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -2.30 39.44 25.21 -4.48 39.25 24.91 coo -0.83 29.57 149.77 -0.39 31.47 148.95 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 44 3 # 44 A 70 ALA D 21 ALA~? 24.89 O ACT B 502 A 126 LEU D 20 LEU~? 25.79 O ACT B 502 A 158 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.84 37.06 28.89 0.29 36.02 28.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -2.30 39.44 25.21 -4.48 39.25 24.91 coo -0.83 29.57 149.77 -0.39 31.47 148.95 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 45 3 # 45 A 70 ALA D 27 ALA~? 25.87 O ACT B 502 A 126 LEU D 30 LEU~? 29.42 O ACT B 502 A 158 GLU D 34 GLU.? 25.91 OXT ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -6.92 40.67 35.86 -7.72 40.44 34.55 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -10.15 42.90 38.04 -8.66 44.45 37.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -16.00 41.58 38.86 -16.04 41.30 36.71 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 46 3 # 46 A 70 ALA D 42 ALA^? 20.06 O ACT B 502 A 126 LEU B 93 LEU^? 15.03 O ACT B 502 A 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -7.87 33.35 31.82 -6.85 34.23 32.48 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.64 27.87 33.78 -7.65 27.10 33.44 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 47 3 # 47 A 70 ALA D 55 ALA^? 15.53 OXT ACT B 502 A 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -19.84 32.00 34.67 -19.79 30.59 35.12 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 48 3 # 48 A 70 ALA D 55 ALA^? 15.53 OXT ACT B 502 A 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -19.84 32.00 34.67 -19.79 30.59 35.12 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 49 3 # 49 A 70 ALA D 57 ALA.? 22.00 OXT ACT B 502 A 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 A 158 GLU D 59 GLU~? 24.17 OXT ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.78 33.10 38.45 -26.02 33.44 39.92 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.95 39.32 31.59 -27.70 38.19 30.22 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 50 3 # 50 A 70 ALA D 57 ALA.? 22.00 OXT ACT B 502 A 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.78 33.10 38.45 -26.02 33.44 39.92 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 51 3 # 51 A 70 ALA D 95 ALA^? 10.13 OXT ACT B 502 A 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.11 22.09 33.92 -25.07 20.56 33.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 52 3 # 52 A 70 ALA D 95 ALA^? 10.13 OXT ACT B 502 A 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.11 22.09 33.92 -25.07 20.56 33.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.70 22.40 29.65 -27.56 22.74 27.68 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 53 3 # 53 A 70 ALA D 96 ALA^? 11.93 OXT ACT B 502 A 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 A 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -22.05 23.01 36.06 -22.04 24.54 36.37 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.60 28.26 28.67 -30.38 27.63 27.65 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 53 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 5 ALA^? 10.14 O ACT A 501 B 126 LEU A 4 LEU^? 13.25 O ACT A 501 B 158 GLU A 59 GLU~? 13.04 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.07 6.48 8.63 5.64 7.02 8.72 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.55 3.15 6.15 9.04 1.07 6.04 coo -33.03 9.93 151.71 -34.98 9.38 151.11 14.64 -0.22 6.93 13.24 0.65 8.32 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 5 ALA^? 10.14 O ACT A 501 B 126 LEU A 4 LEU^? 13.25 O ACT A 501 B 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.07 6.48 8.63 5.64 7.02 8.72 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.55 3.15 6.15 9.04 1.07 6.04 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 5 ALA^? 10.14 O ACT A 501 B 126 LEU A 93 LEU^? 13.32 O ACT C 503 B 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.07 6.48 8.63 5.64 7.02 8.72 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.06 4.27 5.34 2.90 6.18 5.99 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 19 ALA~? 15.35 CH3 ACT A 501 B 126 LEU A 20 LEU~? 10.28 CH3 ACT A 501 B 158 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.13 27.60 20.84 15.17 27.48 21.97 coo -34.22 5.06 149.25 -33.65 4.24 151.15 12.31 23.05 20.96 12.31 20.90 20.50 coo -33.03 9.93 151.71 -34.98 9.38 151.11 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 21 ALA~? 13.50 CH3 ACT A 501 B 126 LEU A 20 LEU~? 10.28 CH3 ACT A 501 B 158 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 10.21 25.33 17.67 9.13 26.32 18.07 coo -34.22 5.06 149.25 -33.65 4.24 151.15 12.31 23.05 20.96 12.31 20.90 20.50 coo -33.03 9.93 151.71 -34.98 9.38 151.11 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA A 27 ALA~? 6.30 OXT ACT A 501 B 126 LEU A 30 LEU~? 8.67 OXT ACT A 501 B 158 GLU A 34 GLU.? 6.40 OXT ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 15.68 22.14 9.94 15.41 21.01 11.01 coo -34.22 5.06 149.25 -33.65 4.24 151.15 18.36 19.67 7.14 20.10 20.58 8.04 coo -33.03 9.93 151.71 -34.98 9.38 151.11 17.44 14.34 4.36 16.78 13.78 6.33 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA A 42 ALA^? 7.49 OXT ACT A 501 B 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 B 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.67 19.66 12.07 8.71 20.77 12.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.58 22.38 10.06 1.90 20.48 9.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA A 55 ALA^? 10.68 O ACT A 501 B 126 LEU A 4 LEU^? 13.25 O ACT A 501 B 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.41 9.36 5.53 6.02 9.63 4.91 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.55 3.15 6.15 9.04 1.07 6.04 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA A 55 ALA^? 10.68 O ACT A 501 B 126 LEU A 93 LEU^? 13.32 O ACT C 503 B 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.41 9.36 5.53 6.02 9.63 4.91 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.06 4.27 5.34 2.90 6.18 5.99 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA A 57 ALA.? 15.81 O ACT A 501 B 126 LEU A 4 LEU^? 13.25 O ACT A 501 B 158 GLU A 59 GLU~? 13.04 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 9.41 4.77 0.35 10.03 4.98 -1.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.55 3.15 6.15 9.04 1.07 6.04 coo -33.03 9.93 151.71 -34.98 9.38 151.11 14.64 -0.22 6.93 13.24 0.65 8.32 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA A 57 ALA.? 15.81 O ACT A 501 B 126 LEU A 4 LEU^? 13.25 O ACT A 501 B 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 9.41 4.77 0.35 10.03 4.98 -1.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.55 3.15 6.15 9.04 1.07 6.04 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA A 95 ALA^? 10.73 O ACT C 503 B 126 LEU A 93 LEU^? 13.32 O ACT C 503 B 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -2.38 4.21 2.77 -3.93 4.25 2.63 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.06 4.27 5.34 2.90 6.18 5.99 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA B 5 ALA^? 10.59 O ACT B 502 B 126 LEU B 4 LEU^? 13.79 O ACT B 502 B 158 GLU B 59 GLU~? 13.30 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -8.23 23.07 30.89 -8.86 24.45 30.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA B 5 ALA^? 10.59 O ACT B 502 B 126 LEU B 4 LEU^? 13.79 O ACT B 502 B 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -8.23 23.07 30.89 -8.86 24.45 30.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 B 70 ALA B 5 ALA^? 10.59 O ACT B 502 B 126 LEU B 93 LEU^? 15.03 O ACT B 502 B 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -8.23 23.07 30.89 -8.86 24.45 30.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.64 27.87 33.78 -7.65 27.10 33.44 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 B 70 ALA B 19 ALA~? 14.51 CH3 ACT B 502 B 126 LEU B 20 LEU~? 9.69 CH3 ACT B 502 B 158 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -30.70 15.16 22.26 -30.61 14.22 21.09 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.53 17.55 21.49 -24.31 17.63 21.33 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 B 70 ALA B 21 ALA~? 12.87 CH3 ACT B 502 B 126 LEU B 20 LEU~? 9.69 CH3 ACT B 502 B 158 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -28.48 19.17 25.23 -29.56 20.27 25.13 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.53 17.55 21.49 -24.31 17.63 21.33 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 B 70 ALA B 21 ALA~? 12.87 CH3 ACT B 502 B 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -28.48 19.17 25.23 -29.56 20.27 25.13 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.70 22.40 29.65 -27.56 22.74 27.68 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 B 70 ALA B 25 ALA~? 11.68 OXT ACT B 502 B 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -26.92 17.85 31.18 -28.32 18.45 31.16 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.70 22.40 29.65 -27.56 22.74 27.68 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 B 70 ALA B 27 ALA~? 5.95 OXT ACT B 502 B 126 LEU B 30 LEU~? 8.46 OXT ACT B 502 B 158 GLU B 34 GLU.? 6.39 OXT ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -23.16 13.98 32.00 -22.30 14.57 30.90 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -20.16 11.39 34.08 -21.25 9.64 33.31 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -14.54 12.40 35.90 -14.50 13.22 33.94 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 B 70 ALA B 42 ALA^? 7.62 OXT ACT B 502 B 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -21.91 22.04 29.80 -23.07 21.03 30.12 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 B 70 ALA B 42 ALA^? 7.62 OXT ACT B 502 B 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -21.91 22.04 29.80 -23.07 21.03 30.12 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.70 22.40 29.65 -27.56 22.74 27.68 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 B 70 ALA B 55 ALA^? 11.29 O ACT B 502 B 126 LEU B 4 LEU^? 13.79 O ACT B 502 B 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -10.47 22.59 34.42 -10.69 23.88 35.17 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 B 70 ALA B 55 ALA^? 11.29 O ACT B 502 B 126 LEU B 93 LEU^? 15.03 O ACT B 502 B 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -10.47 22.59 34.42 -10.69 23.88 35.17 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.64 27.87 33.78 -7.65 27.10 33.44 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 B 70 ALA B 57 ALA.? 16.24 O ACT B 502 B 126 LEU B 4 LEU^? 13.79 O ACT B 502 B 158 GLU B 59 GLU~? 13.30 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.07 20.59 38.68 -5.03 19.85 40.01 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 B 70 ALA B 57 ALA.? 16.24 O ACT B 502 B 126 LEU B 4 LEU^? 13.79 O ACT B 502 B 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.07 20.59 38.68 -5.03 19.85 40.01 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -4.33 21.83 32.71 -2.25 21.43 32.20 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 B 70 ALA B 95 ALA^? 21.74 O ACT B 502 B 126 LEU B 93 LEU^? 15.03 O ACT B 502 B 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.29 32.43 36.25 -5.34 33.96 36.39 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.64 27.87 33.78 -7.65 27.10 33.44 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 B 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 B 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 B 158 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -2.55 19.26 10.92 -1.13 18.63 10.99 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -3.44 23.59 10.14 -4.00 25.47 11.11 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 B 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 B 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 B 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -2.55 19.26 10.92 -1.13 18.63 10.99 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -3.44 23.59 10.14 -4.00 25.47 11.11 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 B 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 B 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 B 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -2.55 19.26 10.92 -1.13 18.63 10.99 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.58 22.38 10.06 1.90 20.48 9.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 B 70 ALA C 19 ALA~? 16.63 O ACT C 503 B 126 LEU C 20 LEU~? 11.98 O ACT C 503 B 158 GLU C 17 GLU~? 20.89 O ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -11.90 -4.29 10.11 -13.13 -4.48 10.96 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -9.72 -0.76 12.76 -9.40 1.30 13.45 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 B 70 ALA C 21 ALA~? 14.41 O ACT C 503 B 126 LEU C 20 LEU~? 11.98 O ACT C 503 B 158 GLU C 17 GLU~? 20.89 O ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -7.13 -1.49 9.10 -6.18 -2.70 9.16 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -9.72 -0.76 12.76 -9.40 1.30 13.45 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 B 70 ALA C 27 ALA~? 6.88 O ACT C 503 B 126 LEU C 30 LEU~? 9.18 O ACT C 503 B 158 GLU C 34 GLU~? 6.63 O ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -10.71 5.86 3.04 -10.60 6.45 4.49 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -12.78 9.39 1.52 -14.70 8.36 1.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -11.68 15.33 1.66 -11.38 14.84 3.76 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 B 70 ALA C 42 ALA^? 8.18 O ACT C 503 B 126 LEU A 93 LEU^? 13.32 O ACT C 503 B 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -3.35 5.95 7.54 -4.26 5.03 6.74 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.06 4.27 5.34 2.90 6.18 5.99 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 B 70 ALA C 55 ALA^? 9.92 OXT ACT C 503 B 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 B 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -2.12 18.19 6.82 -0.67 18.10 6.39 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -3.44 23.59 10.14 -4.00 25.47 11.11 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 B 70 ALA C 55 ALA^? 9.92 OXT ACT C 503 B 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 B 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -2.12 18.19 6.82 -0.67 18.10 6.39 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.58 22.38 10.06 1.90 20.48 9.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 B 70 ALA C 57 ALA.? 15.19 OXT ACT C 503 B 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 B 158 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -3.08 24.68 4.00 -3.38 25.21 2.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -3.44 23.59 10.14 -4.00 25.47 11.11 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 B 70 ALA C 78 ALA~? 10.81 CH3 ACT C 503 B 126 LEU C 82 LEU~? 12.10 CH3 ACT C 503 B 158 GLU C 11 GLU^? 15.94 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -16.17 4.26 16.08 -16.08 5.69 16.63 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -12.52 2.70 18.75 -11.60 3.75 17.08 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -6.14 2.53 21.46 -4.11 2.08 21.09 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 B 70 ALA C 95 ALA^? 10.09 OXT ACT A 501 B 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 B 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.44 23.59 8.64 8.96 23.56 8.82 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.58 22.38 10.06 1.90 20.48 9.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 B 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 B 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 B 158 GLU D 59 GLU~? 24.17 OXT ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -21.50 32.26 30.89 -20.92 30.85 30.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.95 39.32 31.59 -27.70 38.19 30.22 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 41 3 # 41 B 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 B 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -21.50 32.26 30.89 -20.92 30.85 30.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 42 3 # 42 B 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 B 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -21.50 32.26 30.89 -20.92 30.85 30.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 43 3 # 43 B 70 ALA D 19 ALA~? 31.29 O ACT B 502 B 126 LEU D 20 LEU~? 25.79 O ACT B 502 B 158 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 1.65 41.64 27.12 1.68 42.87 26.22 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -2.30 39.44 25.21 -4.48 39.25 24.91 coo -33.03 9.93 151.71 -34.98 9.38 151.11 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 44 3 # 44 B 70 ALA D 21 ALA~? 24.89 O ACT B 502 B 126 LEU D 20 LEU~? 25.79 O ACT B 502 B 158 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.84 37.06 28.89 0.29 36.02 28.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -2.30 39.44 25.21 -4.48 39.25 24.91 coo -33.03 9.93 151.71 -34.98 9.38 151.11 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 45 3 # 45 B 70 ALA D 27 ALA~? 25.87 O ACT B 502 B 126 LEU D 30 LEU~? 29.42 O ACT B 502 B 158 GLU D 34 GLU.? 25.91 OXT ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -6.92 40.67 35.86 -7.72 40.44 34.55 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -10.15 42.90 38.04 -8.66 44.45 37.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -16.00 41.58 38.86 -16.04 41.30 36.71 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 46 3 # 46 B 70 ALA D 42 ALA^? 20.06 O ACT B 502 B 126 LEU B 93 LEU^? 15.03 O ACT B 502 B 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -7.87 33.35 31.82 -6.85 34.23 32.48 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.64 27.87 33.78 -7.65 27.10 33.44 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 47 3 # 47 B 70 ALA D 55 ALA^? 15.53 OXT ACT B 502 B 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -19.84 32.00 34.67 -19.79 30.59 35.12 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 48 3 # 48 B 70 ALA D 55 ALA^? 15.53 OXT ACT B 502 B 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -19.84 32.00 34.67 -19.79 30.59 35.12 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 49 3 # 49 B 70 ALA D 57 ALA.? 22.00 OXT ACT B 502 B 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 B 158 GLU D 59 GLU~? 24.17 OXT ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.78 33.10 38.45 -26.02 33.44 39.92 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.95 39.32 31.59 -27.70 38.19 30.22 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 50 3 # 50 B 70 ALA D 57 ALA.? 22.00 OXT ACT B 502 B 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.78 33.10 38.45 -26.02 33.44 39.92 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.67 33.10 32.16 -27.76 33.61 31.64 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 51 3 # 51 B 70 ALA D 95 ALA^? 10.13 OXT ACT B 502 B 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.11 22.09 33.92 -25.07 20.56 33.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 52 3 # 52 B 70 ALA D 95 ALA^? 10.13 OXT ACT B 502 B 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.11 22.09 33.92 -25.07 20.56 33.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.70 22.40 29.65 -27.56 22.74 27.68 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 53 3 # 53 B 70 ALA D 96 ALA^? 11.93 OXT ACT B 502 B 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 B 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -22.05 23.01 36.06 -22.04 24.54 36.37 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -24.48 27.17 32.37 -22.40 27.80 32.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.60 28.26 28.67 -30.38 27.63 27.65 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 53 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 5 ALA^? 10.14 O ACT A 501 C 126 LEU A 4 LEU^? 13.25 O ACT A 501 C 158 GLU A 59 GLU~? 13.04 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.07 6.48 8.63 5.64 7.02 8.72 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.55 3.15 6.15 9.04 1.07 6.04 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 14.64 -0.22 6.93 13.24 0.65 8.32 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 5 ALA^? 10.14 O ACT A 501 C 126 LEU A 4 LEU^? 13.25 O ACT A 501 C 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.07 6.48 8.63 5.64 7.02 8.72 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.55 3.15 6.15 9.04 1.07 6.04 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 5 ALA^? 10.14 O ACT A 501 C 126 LEU A 93 LEU^? 13.32 O ACT C 503 C 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.07 6.48 8.63 5.64 7.02 8.72 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.06 4.27 5.34 2.90 6.18 5.99 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 19 ALA~? 15.35 CH3 ACT A 501 C 126 LEU A 20 LEU~? 10.28 CH3 ACT A 501 C 158 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.13 27.60 20.84 15.17 27.48 21.97 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 12.31 23.05 20.96 12.31 20.90 20.50 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 21 ALA~? 13.50 CH3 ACT A 501 C 126 LEU A 20 LEU~? 10.28 CH3 ACT A 501 C 158 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 10.21 25.33 17.67 9.13 26.32 18.07 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 12.31 23.05 20.96 12.31 20.90 20.50 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA A 27 ALA~? 6.30 OXT ACT A 501 C 126 LEU A 30 LEU~? 8.67 OXT ACT A 501 C 158 GLU A 34 GLU.? 6.40 OXT ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 15.68 22.14 9.94 15.41 21.01 11.01 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 18.36 19.67 7.14 20.10 20.58 8.04 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 17.44 14.34 4.36 16.78 13.78 6.33 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA A 42 ALA^? 7.49 OXT ACT A 501 C 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 C 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.67 19.66 12.07 8.71 20.77 12.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.58 22.38 10.06 1.90 20.48 9.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA A 55 ALA^? 10.68 O ACT A 501 C 126 LEU A 4 LEU^? 13.25 O ACT A 501 C 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.41 9.36 5.53 6.02 9.63 4.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.55 3.15 6.15 9.04 1.07 6.04 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA A 55 ALA^? 10.68 O ACT A 501 C 126 LEU A 93 LEU^? 13.32 O ACT C 503 C 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.41 9.36 5.53 6.02 9.63 4.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.06 4.27 5.34 2.90 6.18 5.99 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA A 57 ALA.? 15.81 O ACT A 501 C 126 LEU A 4 LEU^? 13.25 O ACT A 501 C 158 GLU A 59 GLU~? 13.04 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 9.41 4.77 0.35 10.03 4.98 -1.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.55 3.15 6.15 9.04 1.07 6.04 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 14.64 -0.22 6.93 13.24 0.65 8.32 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA A 57 ALA.? 15.81 O ACT A 501 C 126 LEU A 4 LEU^? 13.25 O ACT A 501 C 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 9.41 4.77 0.35 10.03 4.98 -1.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.55 3.15 6.15 9.04 1.07 6.04 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA A 95 ALA^? 10.73 O ACT C 503 C 126 LEU A 93 LEU^? 13.32 O ACT C 503 C 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -2.38 4.21 2.77 -3.93 4.25 2.63 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.06 4.27 5.34 2.90 6.18 5.99 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA B 5 ALA^? 10.59 O ACT B 502 C 126 LEU B 4 LEU^? 13.79 O ACT B 502 C 158 GLU B 59 GLU~? 13.30 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -8.23 23.07 30.89 -8.86 24.45 30.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -4.33 21.83 32.71 -2.25 21.43 32.20 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA B 5 ALA^? 10.59 O ACT B 502 C 126 LEU B 4 LEU^? 13.79 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -8.23 23.07 30.89 -8.86 24.45 30.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -4.33 21.83 32.71 -2.25 21.43 32.20 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 C 70 ALA B 5 ALA^? 10.59 O ACT B 502 C 126 LEU B 93 LEU^? 15.03 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -8.23 23.07 30.89 -8.86 24.45 30.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.64 27.87 33.78 -7.65 27.10 33.44 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 C 70 ALA B 19 ALA~? 14.51 CH3 ACT B 502 C 126 LEU B 20 LEU~? 9.69 CH3 ACT B 502 C 158 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -30.70 15.16 22.26 -30.61 14.22 21.09 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.53 17.55 21.49 -24.31 17.63 21.33 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 C 70 ALA B 21 ALA~? 12.87 CH3 ACT B 502 C 126 LEU B 20 LEU~? 9.69 CH3 ACT B 502 C 158 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -28.48 19.17 25.23 -29.56 20.27 25.13 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.53 17.55 21.49 -24.31 17.63 21.33 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 C 70 ALA B 21 ALA~? 12.87 CH3 ACT B 502 C 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -28.48 19.17 25.23 -29.56 20.27 25.13 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.70 22.40 29.65 -27.56 22.74 27.68 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 C 70 ALA B 25 ALA~? 11.68 OXT ACT B 502 C 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -26.92 17.85 31.18 -28.32 18.45 31.16 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.70 22.40 29.65 -27.56 22.74 27.68 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 C 70 ALA B 27 ALA~? 5.95 OXT ACT B 502 C 126 LEU B 30 LEU~? 8.46 OXT ACT B 502 C 158 GLU B 34 GLU.? 6.39 OXT ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -23.16 13.98 32.00 -22.30 14.57 30.90 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -20.16 11.39 34.08 -21.25 9.64 33.31 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -14.54 12.40 35.90 -14.50 13.22 33.94 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 C 70 ALA B 42 ALA^? 7.62 OXT ACT B 502 C 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -21.91 22.04 29.80 -23.07 21.03 30.12 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -24.48 27.17 32.37 -22.40 27.80 32.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 C 70 ALA B 42 ALA^? 7.62 OXT ACT B 502 C 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -21.91 22.04 29.80 -23.07 21.03 30.12 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.70 22.40 29.65 -27.56 22.74 27.68 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 C 70 ALA B 55 ALA^? 11.29 O ACT B 502 C 126 LEU B 4 LEU^? 13.79 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -10.47 22.59 34.42 -10.69 23.88 35.17 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -4.33 21.83 32.71 -2.25 21.43 32.20 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 C 70 ALA B 55 ALA^? 11.29 O ACT B 502 C 126 LEU B 93 LEU^? 15.03 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -10.47 22.59 34.42 -10.69 23.88 35.17 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.64 27.87 33.78 -7.65 27.10 33.44 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 C 70 ALA B 57 ALA.? 16.24 O ACT B 502 C 126 LEU B 4 LEU^? 13.79 O ACT B 502 C 158 GLU B 59 GLU~? 13.30 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.07 20.59 38.68 -5.03 19.85 40.01 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -4.33 21.83 32.71 -2.25 21.43 32.20 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 C 70 ALA B 57 ALA.? 16.24 O ACT B 502 C 126 LEU B 4 LEU^? 13.79 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.07 20.59 38.68 -5.03 19.85 40.01 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -4.33 21.83 32.71 -2.25 21.43 32.20 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 C 70 ALA B 95 ALA^? 21.74 O ACT B 502 C 126 LEU B 93 LEU^? 15.03 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.29 32.43 36.25 -5.34 33.96 36.39 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.64 27.87 33.78 -7.65 27.10 33.44 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 C 70 ALA B 95 ALA^? 21.74 O ACT B 502 C 126 LEU B 94 LEU^? 21.11 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.29 32.43 36.25 -5.34 33.96 36.39 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -2.99 32.95 32.24 -1.90 33.08 30.38 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 C 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 C 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 C 158 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -2.55 19.26 10.92 -1.13 18.63 10.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -3.44 23.59 10.14 -4.00 25.47 11.11 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 C 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 C 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 C 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -2.55 19.26 10.92 -1.13 18.63 10.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -3.44 23.59 10.14 -4.00 25.47 11.11 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 C 70 ALA C 5 ALA^? 9.06 OXT ACT C 503 C 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 C 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -2.55 19.26 10.92 -1.13 18.63 10.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.58 22.38 10.06 1.90 20.48 9.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 C 70 ALA C 19 ALA~? 16.63 O ACT C 503 C 126 LEU C 20 LEU~? 11.98 O ACT C 503 C 158 GLU C 17 GLU~? 20.89 O ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -11.90 -4.29 10.11 -13.13 -4.48 10.96 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -9.72 -0.76 12.76 -9.40 1.30 13.45 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 C 70 ALA C 21 ALA~? 14.41 O ACT C 503 C 126 LEU C 20 LEU~? 11.98 O ACT C 503 C 158 GLU C 17 GLU~? 20.89 O ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -7.13 -1.49 9.10 -6.18 -2.70 9.16 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -9.72 -0.76 12.76 -9.40 1.30 13.45 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 C 70 ALA C 27 ALA~? 6.88 O ACT C 503 C 126 LEU C 30 LEU~? 9.18 O ACT C 503 C 158 GLU C 34 GLU~? 6.63 O ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -10.71 5.86 3.04 -10.60 6.45 4.49 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -12.78 9.39 1.52 -14.70 8.36 1.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -11.68 15.33 1.66 -11.38 14.84 3.76 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 C 70 ALA C 42 ALA^? 8.18 O ACT C 503 C 126 LEU A 93 LEU^? 13.32 O ACT C 503 C 158 GLU A 92 GLU^? 18.57 O ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -3.35 5.95 7.54 -4.26 5.03 6.74 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.06 4.27 5.34 2.90 6.18 5.99 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.60 -0.94 9.20 4.21 -3.02 9.21 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 C 70 ALA C 55 ALA^? 9.92 OXT ACT C 503 C 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 C 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -2.12 18.19 6.82 -0.67 18.10 6.39 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -3.44 23.59 10.14 -4.00 25.47 11.11 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 C 70 ALA C 55 ALA^? 9.92 OXT ACT C 503 C 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 C 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -2.12 18.19 6.82 -0.67 18.10 6.39 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.58 22.38 10.06 1.90 20.48 9.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 C 70 ALA C 57 ALA.? 15.19 OXT ACT C 503 C 126 LEU C 4 LEU^? 12.31 OXT ACT C 503 C 158 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -3.08 24.68 4.00 -3.38 25.21 2.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -3.44 23.59 10.14 -4.00 25.47 11.11 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 C 70 ALA C 78 ALA~? 10.81 CH3 ACT C 503 C 126 LEU C 82 LEU~? 12.10 CH3 ACT C 503 C 158 GLU C 11 GLU^? 15.94 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -16.17 4.26 16.08 -16.08 5.69 16.63 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -12.52 2.70 18.75 -11.60 3.75 17.08 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -6.14 2.53 21.46 -4.11 2.08 21.09 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 C 70 ALA C 95 ALA^? 10.09 OXT ACT A 501 C 126 LEU C 93 LEU^? 13.11 OXT ACT A 501 C 158 GLU C 92 GLU^? 15.67 OXT ACT C 503 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.44 23.59 8.64 8.96 23.56 8.82 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.58 22.38 10.06 1.90 20.48 9.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.44 25.21 15.82 -1.51 26.57 14.58 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 41 3 # 41 C 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 C 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 C 158 GLU D 59 GLU~? 24.17 OXT ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -21.50 32.26 30.89 -20.92 30.85 30.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.67 33.10 32.16 -27.76 33.61 31.64 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.95 39.32 31.59 -27.70 38.19 30.22 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 42 3 # 42 C 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 C 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -21.50 32.26 30.89 -20.92 30.85 30.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.67 33.10 32.16 -27.76 33.61 31.64 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 43 3 # 43 C 70 ALA D 5 ALA^? 14.91 OXT ACT B 502 C 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -21.50 32.26 30.89 -20.92 30.85 30.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -24.48 27.17 32.37 -22.40 27.80 32.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 44 3 # 44 C 70 ALA D 19 ALA~? 31.29 O ACT B 502 C 126 LEU D 20 LEU~? 25.79 O ACT B 502 C 158 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 1.65 41.64 27.12 1.68 42.87 26.22 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -2.30 39.44 25.21 -4.48 39.25 24.91 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 45 3 # 45 C 70 ALA D 21 ALA~? 24.89 O ACT B 502 C 126 LEU B 94 LEU^? 21.11 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.84 37.06 28.89 0.29 36.02 28.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -2.99 32.95 32.24 -1.90 33.08 30.38 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 46 3 # 46 C 70 ALA D 21 ALA~? 24.89 O ACT B 502 C 126 LEU D 20 LEU~? 25.79 O ACT B 502 C 158 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.84 37.06 28.89 0.29 36.02 28.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -2.30 39.44 25.21 -4.48 39.25 24.91 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 47 3 # 47 C 70 ALA D 27 ALA~? 25.87 O ACT B 502 C 126 LEU D 30 LEU~? 29.42 O ACT B 502 C 158 GLU D 34 GLU.? 25.91 OXT ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -6.92 40.67 35.86 -7.72 40.44 34.55 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -10.15 42.90 38.04 -8.66 44.45 37.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -16.00 41.58 38.86 -16.04 41.30 36.71 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 48 3 # 48 C 70 ALA D 42 ALA^? 20.06 O ACT B 502 C 126 LEU B 93 LEU^? 15.03 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -7.87 33.35 31.82 -6.85 34.23 32.48 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.64 27.87 33.78 -7.65 27.10 33.44 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 49 3 # 49 C 70 ALA D 42 ALA^? 20.06 O ACT B 502 C 126 LEU B 94 LEU^? 21.11 O ACT B 502 C 158 GLU B 92 GLU^? 19.37 O ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -7.87 33.35 31.82 -6.85 34.23 32.48 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -2.99 32.95 32.24 -1.90 33.08 30.38 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 50 3 # 50 C 70 ALA D 55 ALA^? 15.53 OXT ACT B 502 C 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -19.84 32.00 34.67 -19.79 30.59 35.12 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.67 33.10 32.16 -27.76 33.61 31.64 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 51 3 # 51 C 70 ALA D 55 ALA^? 15.53 OXT ACT B 502 C 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -19.84 32.00 34.67 -19.79 30.59 35.12 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -24.48 27.17 32.37 -22.40 27.80 32.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 52 3 # 52 C 70 ALA D 57 ALA.? 22.00 OXT ACT B 502 C 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 C 158 GLU D 59 GLU~? 24.17 OXT ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.78 33.10 38.45 -26.02 33.44 39.92 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.67 33.10 32.16 -27.76 33.61 31.64 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.95 39.32 31.59 -27.70 38.19 30.22 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 53 3 # 53 C 70 ALA D 57 ALA.? 22.00 OXT ACT B 502 C 126 LEU D 4 LEU^? 19.61 OXT ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.78 33.10 38.45 -26.02 33.44 39.92 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.67 33.10 32.16 -27.76 33.61 31.64 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 54 3 # 54 C 70 ALA D 95 ALA^? 10.13 OXT ACT B 502 C 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.11 22.09 33.92 -25.07 20.56 33.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -24.48 27.17 32.37 -22.40 27.80 32.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 55 3 # 55 C 70 ALA D 95 ALA^? 10.13 OXT ACT B 502 C 126 LEU D 94 LEU^? 11.70 CH3 ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.11 22.09 33.92 -25.07 20.56 33.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.70 22.40 29.65 -27.56 22.74 27.68 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 56 3 # 56 C 70 ALA D 96 ALA^? 11.93 OXT ACT B 502 C 126 LEU D 93 LEU^? 13.12 OXT ACT B 502 C 158 GLU D 92 GLU^? 17.21 CH3 ACT B 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -22.05 23.01 36.06 -22.04 24.54 36.37 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -24.48 27.17 32.37 -22.40 27.80 32.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.60 28.26 28.67 -30.38 27.63 27.65 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 56 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 54 ASP^? -3.76 O ACT A 501s A 270 LYS C 97 LYS^? 10.89 OXT ACT A 501 A 382 MET A 1 MET?? 22.30 O ACT C 503 coo -27.63 121.99 45.48 -26.66 123.86 45.68 9.47 12.33 8.26 10.66 11.45 9.76 coo -32.20 115.91 49.56 -31.37 121.03 53.12 8.20 19.20 3.14 12.89 15.65 0.85 coo -23.75 127.89 58.42 -26.02 128.79 55.12 4.54 3.77 -2.96 5.24 1.77 -5.45 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 54 ASP^? 4.46 O ACT B 502 A 270 LYS D 97 LYS^? 10.92 OXT ACT B 502 A 382 MET B 1 MET?? 22.46 O ACT B 502 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -19.69 21.43 38.53 -15.42 16.83 39.89 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -4.06 24.89 41.93 -2.43 24.46 44.51 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 270 LYS A 97 LYS^? 11.17 O ACT C 503 A 382 MET C 1 MET?? 13.84 OXT ACT A 501 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo -23.75 127.89 58.42 -26.02 128.79 55.12 2.98 25.48 2.47 6.68 25.10 5.11 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 270 LYS B 97 LYS^? 23.77 OXT ACT B 502 A 382 MET D 1 MET?? 18.36 OXT ACT B 502 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -11.27 32.20 40.12 -15.59 36.50 41.95 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -27.01 27.93 40.75 -29.38 24.67 39.93 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 270 LYS D 90 LYS^? 25.07 CH3 ACT B 502 A 382 MET D 1 MET?? 18.36 OXT ACT B 502 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -23.03 34.53 25.25 -26.25 39.79 25.56 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -27.01 27.93 40.75 -29.38 24.67 39.93 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 270 LYS D 90 LYS^? 25.07 CH3 ACT B 502 A 382 MET D 75 MET?? 31.91 O ACT B 502 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -23.03 34.53 25.25 -26.25 39.79 25.56 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -11.34 47.97 25.80 -15.59 48.47 25.72 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 6 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP B 54 ASP^? 4.46 O ACT B 502 B 270 LYS D 97 LYS^? 10.92 OXT ACT B 502 B 382 MET B 1 MET?? 22.46 O ACT B 502 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -19.69 21.43 38.53 -15.42 16.83 39.89 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -4.06 24.89 41.93 -2.43 24.46 44.51 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 270 LYS A 97 LYS^? 11.17 O ACT C 503 B 382 MET C 1 MET?? 13.84 OXT ACT A 501 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo -2.79 145.52 50.38 -5.75 148.14 51.66 2.98 25.48 2.47 6.68 25.10 5.11 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 270 LYS B 97 LYS^? 23.77 OXT ACT B 502 B 382 MET D 1 MET?? 18.36 OXT ACT B 502 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -11.27 32.20 40.12 -15.59 36.50 41.95 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -27.01 27.93 40.75 -29.38 24.67 39.93 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 3 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN C 63 GLN~? 10.84 CH3 ACT C 503 294 GLU B 11 GLU.? 14.84 CH3 ACT B 502 304 ARG C 62 ARG~? 10.88 OXT ACT C 503 coo 15.89 18.45 46.53 15.82 16.91 48.02 -12.60 24.18 10.64 -12.59 22.90 12.36 coo 22.84 13.44 52.91 20.84 13.18 52.38 -22.40 21.62 14.44 -23.19 23.50 15.06 coo 8.71 17.11 46.51 7.23 17.64 49.20 -6.61 21.24 11.49 -5.46 23.07 13.64 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 1 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER C 84 SER.? 14.87 O ACT B 502 B 69 ALA B 71 ALA~? 6.33 O ACT B 502 B 241 ASN B 67 ASN~? 11.44 O ACT B 502 coo 13.24 41.94 33.13 13.08 39.54 33.17 -11.34 3.54 23.77 -9.02 3.92 23.31 coo 9.15 37.89 36.69 10.55 37.76 37.22 -15.58 10.60 26.60 -14.06 10.51 26.75 coo 10.91 43.03 38.47 11.81 41.82 36.93 -8.90 8.17 29.36 -7.21 8.51 28.12 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 1 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG D 9 ARG^? 15.08 O ACT B 502 A 479 PHE D 45 PHE^? 14.56 O ACT B 502 A 483 GLU B 89 GLU^? 13.28 O ACT B 502 coo 17.33 52.29 2.24 18.71 54.03 0.18 -10.16 31.68 19.32 -10.74 28.83 20.23 coo 20.06 57.44 1.28 18.39 56.19 3.12 -7.17 28.78 23.13 -9.80 28.82 24.18 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -9.24 24.07 20.62 -9.79 26.07 20.27 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 1 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG D 9 ARG^? 15.08 O ACT B 502 B 479 PHE D 45 PHE^? 14.56 O ACT B 502 B 483 GLU B 89 GLU^? 13.28 O ACT B 502 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -10.16 31.68 19.32 -10.74 28.83 20.23 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -7.17 28.78 23.13 -9.80 28.82 24.18 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -9.24 24.07 20.62 -9.79 26.07 20.27 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 1 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 32 ASN~? 11.90 OXT ACT A 501 A 192 ASP A 54 ASP^? -3.76 O ACT A 501s A 195 HIS A 65 HIS~? -3.60 O ACT A 501s coo -4.84 51.77 30.37 -3.89 50.12 29.46 14.28 20.69 1.30 12.48 21.71 1.89 coo 2.03 47.14 19.75 1.72 46.26 21.64 9.47 12.33 8.26 10.66 11.45 9.76 coo 1.41 44.84 24.92 -0.49 45.70 25.19 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 32 ASN~? 11.83 OXT ACT B 502 A 192 ASP B 54 ASP^? 4.46 O ACT B 502 A 195 HIS B 65 HIS~? -3.69 O ACT B 502s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -20.40 15.31 40.23 -21.60 17.04 39.97 coo 2.03 47.14 19.75 1.72 46.26 21.64 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN B 87 ASN^? 12.23 OXT ACT C 503 A 192 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 195 HIS C 65 HIS~? -3.55 C ACT C 503s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -13.79 21.31 17.73 -12.12 22.50 17.15 coo 2.03 47.14 19.75 1.72 46.26 21.64 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN C 32 ASN~? 12.55 O ACT C 503 A 192 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 195 HIS C 65 HIS~? -3.55 C ACT C 503s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -7.80 11.04 -3.58 -6.14 9.70 -3.27 coo 2.03 47.14 19.75 1.72 46.26 21.64 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 A 74 ASN C 87 ASN.? 10.16 O ACT B 502 A 192 ASP B 54 ASP^? 4.46 O ACT B 502 A 195 HIS B 65 HIS~? -3.69 O ACT B 502s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -7.54 12.49 22.38 -6.86 14.54 22.53 coo 2.03 47.14 19.75 1.72 46.26 21.64 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 A 74 ASN D 32 ASN~? 25.03 OXT ACT B 502 A 192 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 195 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -10.82 37.91 43.31 -9.73 36.12 42.91 coo 2.03 47.14 19.75 1.72 46.26 21.64 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -17.61 39.97 33.46 -15.64 39.60 32.84 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 6 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 32 ASN~? 11.90 OXT ACT A 501 B 192 ASP A 54 ASP^? -3.76 O ACT A 501s B 195 HIS A 65 HIS~? -3.60 O ACT A 501s coo -1.08 51.41 10.34 0.65 52.62 10.17 14.28 20.69 1.30 12.48 21.71 1.89 coo 11.36 52.33 5.59 10.18 53.87 6.47 9.47 12.33 8.26 10.66 11.45 9.76 coo 7.99 56.74 7.55 6.88 55.39 8.70 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 32 ASN~? 11.83 OXT ACT B 502 B 192 ASP B 54 ASP^? 4.46 O ACT B 502 B 195 HIS B 65 HIS~? -3.69 O ACT B 502s coo -1.08 51.41 10.34 0.65 52.62 10.17 -20.40 15.31 40.23 -21.60 17.04 39.97 coo 11.36 52.33 5.59 10.18 53.87 6.47 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 7.99 56.74 7.55 6.88 55.39 8.70 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN C 32 ASN~? 12.55 O ACT C 503 B 192 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 195 HIS C 65 HIS~? -3.55 C ACT C 503s coo -1.08 51.41 10.34 0.65 52.62 10.17 -7.80 11.04 -3.58 -6.14 9.70 -3.27 coo 11.36 52.33 5.59 10.18 53.87 6.47 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 7.99 56.74 7.55 6.88 55.39 8.70 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN C 87 ASN.? 10.16 O ACT B 502 B 192 ASP B 54 ASP^? 4.46 O ACT B 502 B 195 HIS B 65 HIS~? -3.69 O ACT B 502s coo -1.08 51.41 10.34 0.65 52.62 10.17 -7.54 12.49 22.38 -6.86 14.54 22.53 coo 11.36 52.33 5.59 10.18 53.87 6.47 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 7.99 56.74 7.55 6.88 55.39 8.70 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 B 74 ASN D 32 ASN~? 25.03 OXT ACT B 502 B 192 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 195 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo -1.08 51.41 10.34 0.65 52.62 10.17 -10.82 37.91 43.31 -9.73 36.12 42.91 coo 11.36 52.33 5.59 10.18 53.87 6.47 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 7.99 56.74 7.55 6.88 55.39 8.70 -17.61 39.97 33.46 -15.64 39.60 32.84 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 5 hits 1pp4_c03 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 68 ALA A 18 ALA~? 17.91 CH3 ACT A 501 A 72 LEU A 20 LEU~? 10.28 CH3 ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 13.66 28.66 16.58 12.51 30.39 17.11 coo 48.88 4.35 16.59 48.73 5.09 15.20 10.55 28.75 21.40 10.60 30.23 21.67 coo 53.89 6.25 15.09 52.88 7.92 14.14 12.31 23.05 20.96 12.31 20.90 20.50 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 68 ALA A 19 ALA~? 15.35 CH3 ACT A 501 A 72 LEU A 20 LEU~? 10.28 CH3 ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 13.66 28.66 16.58 12.51 30.39 17.11 coo 48.88 4.35 16.59 48.73 5.09 15.20 14.13 27.60 20.84 15.17 27.48 21.97 coo 53.89 6.25 15.09 52.88 7.92 14.14 12.31 23.05 20.96 12.31 20.90 20.50 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 68 ALA A 19 ALA~? 15.35 CH3 ACT A 501 A 72 LEU A 81 LEU~? 11.48 CH3 ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 13.66 28.66 16.58 12.51 30.39 17.11 coo 48.88 4.35 16.59 48.73 5.09 15.20 14.13 27.60 20.84 15.17 27.48 21.97 coo 53.89 6.25 15.09 52.88 7.92 14.14 16.37 21.67 22.57 16.91 23.14 21.07 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 68 ALA A 21 ALA~? 13.50 CH3 ACT A 501 A 72 LEU A 20 LEU~? 10.28 CH3 ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 13.66 28.66 16.58 12.51 30.39 17.11 coo 48.88 4.35 16.59 48.73 5.09 15.20 10.21 25.33 17.67 9.13 26.32 18.07 coo 53.89 6.25 15.09 52.88 7.92 14.14 12.31 23.05 20.96 12.31 20.90 20.50 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 68 ALA A 21 ALA~? 13.50 CH3 ACT A 501 A 72 LEU A 24 LEU~? 7.28 CH3 ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 13.66 28.66 16.58 12.51 30.39 17.11 coo 48.88 4.35 16.59 48.73 5.09 15.20 10.21 25.33 17.67 9.13 26.32 18.07 coo 53.89 6.25 15.09 52.88 7.92 14.14 11.36 21.97 14.75 11.23 20.09 15.84 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 68 ALA A 21 ALA~? 13.50 CH3 ACT A 501 A 72 LEU C 94 LEU^? 11.81 OXT ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 13.66 28.66 16.58 12.51 30.39 17.11 coo 48.88 4.35 16.59 48.73 5.09 15.20 10.21 25.33 17.67 9.13 26.32 18.07 coo 53.89 6.25 15.09 52.88 7.92 14.14 7.13 24.33 13.23 6.84 24.73 15.37 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP A 54 ASP^? -3.76 O ACT A 501s A 68 ALA A 5 ALA^? 10.14 O ACT A 501 A 72 LEU A 4 LEU^? 13.25 O ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 9.47 12.33 8.26 10.66 11.45 9.76 coo 48.88 4.35 16.59 48.73 5.09 15.20 7.07 6.48 8.63 5.64 7.02 8.72 coo 53.89 6.25 15.09 52.88 7.92 14.14 8.55 3.15 6.15 9.04 1.07 6.04 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP A 54 ASP^? -3.76 O ACT A 501s A 68 ALA A 55 ALA^? 10.68 O ACT A 501 A 72 LEU A 4 LEU^? 13.25 O ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 9.47 12.33 8.26 10.66 11.45 9.76 coo 48.88 4.35 16.59 48.73 5.09 15.20 7.41 9.36 5.53 6.02 9.63 4.91 coo 53.89 6.25 15.09 52.88 7.92 14.14 8.55 3.15 6.15 9.04 1.07 6.04 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP A 58 ASP~? 16.01 O ACT A 501 A 68 ALA A 57 ALA.? 15.81 O ACT A 501 A 72 LEU A 4 LEU^? 13.25 O ACT A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 12.40 1.57 0.95 13.75 2.83 -0.02 coo 48.88 4.35 16.59 48.73 5.09 15.20 9.41 4.77 0.35 10.03 4.98 -1.00 coo 53.89 6.25 15.09 52.88 7.92 14.14 8.55 3.15 6.15 9.04 1.07 6.04 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 68 ALA B 18 ALA~? 17.30 CH3 ACT B 502 A 72 LEU B 20 LEU~? 9.69 CH3 ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 48.88 4.35 16.59 48.73 5.09 15.20 -32.52 18.49 22.18 -34.00 18.14 22.14 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.53 17.55 21.49 -24.31 17.63 21.33 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 11 3 # 11 A 67 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 68 ALA B 19 ALA~? 14.51 CH3 ACT B 502 A 72 LEU B 20 LEU~? 9.69 CH3 ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 48.88 4.35 16.59 48.73 5.09 15.20 -30.70 15.16 22.26 -30.61 14.22 21.09 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.53 17.55 21.49 -24.31 17.63 21.33 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 12 3 # 12 A 67 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 68 ALA B 19 ALA~? 14.51 CH3 ACT B 502 A 72 LEU B 81 LEU~? 10.91 CH3 ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 48.88 4.35 16.59 48.73 5.09 15.20 -30.70 15.16 22.26 -30.61 14.22 21.09 coo 53.89 6.25 15.09 52.88 7.92 14.14 -25.04 13.21 19.33 -26.14 13.15 21.16 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 13 3 # 13 A 67 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 68 ALA B 21 ALA~? 12.87 CH3 ACT B 502 A 72 LEU B 20 LEU~? 9.69 CH3 ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 48.88 4.35 16.59 48.73 5.09 15.20 -28.48 19.17 25.23 -29.56 20.27 25.13 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.53 17.55 21.49 -24.31 17.63 21.33 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 14 3 # 14 A 67 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 68 ALA B 21 ALA~? 12.87 CH3 ACT B 502 A 72 LEU B 24 LEU~? 6.56 CH3 ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 48.88 4.35 16.59 48.73 5.09 15.20 -28.48 19.17 25.23 -29.56 20.27 25.13 coo 53.89 6.25 15.09 52.88 7.92 14.14 -24.36 18.43 27.48 -22.79 18.77 26.04 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 15 3 # 15 A 67 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 68 ALA B 21 ALA~? 12.87 CH3 ACT B 502 A 72 LEU D 94 LEU^? 11.70 CH3 ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 48.88 4.35 16.59 48.73 5.09 15.20 -28.48 19.17 25.23 -29.56 20.27 25.13 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.70 22.40 29.65 -27.56 22.74 27.68 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 16 3 # 16 A 67 ASP B 54 ASP^? 4.46 O ACT B 502 A 68 ALA B 5 ALA^? 10.59 O ACT B 502 A 72 LEU B 4 LEU^? 13.79 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 48.88 4.35 16.59 48.73 5.09 15.20 -8.23 23.07 30.89 -8.86 24.45 30.93 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.33 21.83 32.71 -2.25 21.43 32.20 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 17 3 # 17 A 67 ASP B 54 ASP^? 4.46 O ACT B 502 A 68 ALA B 55 ALA^? 11.29 O ACT B 502 A 72 LEU B 4 LEU^? 13.79 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 48.88 4.35 16.59 48.73 5.09 15.20 -10.47 22.59 34.42 -10.69 23.88 35.17 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.33 21.83 32.71 -2.25 21.43 32.20 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 18 3 # 18 A 67 ASP B 58 ASP~? 16.37 O ACT B 502 A 68 ALA B 57 ALA.? 16.24 O ACT B 502 A 72 LEU B 4 LEU^? 13.79 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -1.77 17.89 37.44 -2.74 16.22 38.35 coo 48.88 4.35 16.59 48.73 5.09 15.20 -5.07 20.59 38.68 -5.03 19.85 40.01 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.33 21.83 32.71 -2.25 21.43 32.20 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 19 3 # 19 A 67 ASP C 22 ASP~? 16.98 O ACT C 503 A 68 ALA C 18 ALA~? 19.16 O ACT C 503 A 72 LEU C 20 LEU~? 11.98 O ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 -8.65 -6.22 10.38 -8.99 -7.68 9.86 coo 53.89 6.25 15.09 52.88 7.92 14.14 -9.72 -0.76 12.76 -9.40 1.30 13.45 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 20 3 # 20 A 67 ASP C 22 ASP~? 16.98 O ACT C 503 A 68 ALA C 19 ALA~? 16.63 O ACT C 503 A 72 LEU C 20 LEU~? 11.98 O ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 -11.90 -4.29 10.11 -13.13 -4.48 10.96 coo 53.89 6.25 15.09 52.88 7.92 14.14 -9.72 -0.76 12.76 -9.40 1.30 13.45 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 21 3 # 21 A 67 ASP C 22 ASP~? 16.98 O ACT C 503 A 68 ALA C 19 ALA~? 16.63 O ACT C 503 A 72 LEU C 81 LEU~? 13.31 CH3 ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 -11.90 -4.29 10.11 -13.13 -4.48 10.96 coo 53.89 6.25 15.09 52.88 7.92 14.14 -13.81 0.26 14.63 -14.07 -0.23 12.45 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 22 3 # 22 A 67 ASP C 22 ASP~? 16.98 O ACT C 503 A 68 ALA C 21 ALA~? 14.41 O ACT C 503 A 72 LEU A 94 LEU^? 12.48 O ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 -7.13 -1.49 9.10 -6.18 -2.70 9.16 coo 53.89 6.25 15.09 52.88 7.92 14.14 -2.91 1.29 6.24 -3.13 -0.15 7.92 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 23 3 # 23 A 67 ASP C 22 ASP~? 16.98 O ACT C 503 A 68 ALA C 21 ALA~? 14.41 O ACT C 503 A 72 LEU C 20 LEU~? 11.98 O ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 -7.13 -1.49 9.10 -6.18 -2.70 9.16 coo 53.89 6.25 15.09 52.88 7.92 14.14 -9.72 -0.76 12.76 -9.40 1.30 13.45 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 24 3 # 24 A 67 ASP C 22 ASP~? 16.98 O ACT C 503 A 68 ALA C 21 ALA~? 14.41 O ACT C 503 A 72 LEU C 24 LEU~? 8.02 O ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 -7.13 -1.49 9.10 -6.18 -2.70 9.16 coo 53.89 6.25 15.09 52.88 7.92 14.14 -7.47 3.10 8.14 -7.63 3.99 10.11 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 25 3 # 25 A 67 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 68 ALA C 5 ALA^? 9.06 OXT ACT C 503 A 72 LEU C 4 LEU^? 12.31 OXT ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 48.88 4.35 16.59 48.73 5.09 15.20 -2.55 19.26 10.92 -1.13 18.63 10.99 coo 53.89 6.25 15.09 52.88 7.92 14.14 -3.44 23.59 10.14 -4.00 25.47 11.11 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 26 3 # 26 A 67 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 68 ALA C 55 ALA^? 9.92 OXT ACT C 503 A 72 LEU C 4 LEU^? 12.31 OXT ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 48.88 4.35 16.59 48.73 5.09 15.20 -2.12 18.19 6.82 -0.67 18.10 6.39 coo 53.89 6.25 15.09 52.88 7.92 14.14 -3.44 23.59 10.14 -4.00 25.47 11.11 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 27 3 # 27 A 67 ASP C 58 ASP~? 15.48 OXT ACT C 503 A 68 ALA C 57 ALA.? 15.19 OXT ACT C 503 A 72 LEU C 4 LEU^? 12.31 OXT ACT C 503 coo 46.76 7.59 18.65 45.27 6.01 18.52 -5.93 27.71 5.50 -7.21 27.13 3.90 coo 48.88 4.35 16.59 48.73 5.09 15.20 -3.08 24.68 4.00 -3.38 25.21 2.59 coo 53.89 6.25 15.09 52.88 7.92 14.14 -3.44 23.59 10.14 -4.00 25.47 11.11 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 28 3 # 28 A 67 ASP D 22 ASP~? 30.56 O ACT B 502 A 68 ALA D 18 ALA~? 28.83 CH3 ACT A 501 A 72 LEU D 20 LEU~? 25.79 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 1.48 40.46 31.50 1.79 41.35 33.38 coo 48.88 4.35 16.59 48.73 5.09 15.20 3.51 38.38 26.48 5.02 38.72 26.60 coo 53.89 6.25 15.09 52.88 7.92 14.14 -2.30 39.44 25.21 -4.48 39.25 24.91 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 29 3 # 29 A 67 ASP D 22 ASP~? 30.56 O ACT B 502 A 68 ALA D 19 ALA~? 31.29 O ACT B 502 A 72 LEU D 20 LEU~? 25.79 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 1.48 40.46 31.50 1.79 41.35 33.38 coo 48.88 4.35 16.59 48.73 5.09 15.20 1.65 41.64 27.12 1.68 42.87 26.22 coo 53.89 6.25 15.09 52.88 7.92 14.14 -2.30 39.44 25.21 -4.48 39.25 24.91 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 30 3 # 30 A 67 ASP D 22 ASP~? 30.56 O ACT B 502 A 68 ALA D 19 ALA~? 31.29 O ACT B 502 A 72 LEU D 81 LEU~? 29.87 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 1.48 40.46 31.50 1.79 41.35 33.38 coo 48.88 4.35 16.59 48.73 5.09 15.20 1.65 41.64 27.12 1.68 42.87 26.22 coo 53.89 6.25 15.09 52.88 7.92 14.14 -3.68 43.73 23.64 -2.93 43.88 25.65 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 31 3 # 31 A 67 ASP D 22 ASP~? 30.56 O ACT B 502 A 68 ALA D 21 ALA~? 24.89 O ACT B 502 A 72 LEU B 94 LEU^? 21.11 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 1.48 40.46 31.50 1.79 41.35 33.38 coo 48.88 4.35 16.59 48.73 5.09 15.20 -0.84 37.06 28.89 0.29 36.02 28.70 coo 53.89 6.25 15.09 52.88 7.92 14.14 -2.99 32.95 32.24 -1.90 33.08 30.38 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 32 3 # 32 A 67 ASP D 22 ASP~? 30.56 O ACT B 502 A 68 ALA D 21 ALA~? 24.89 O ACT B 502 A 72 LEU D 20 LEU~? 25.79 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 1.48 40.46 31.50 1.79 41.35 33.38 coo 48.88 4.35 16.59 48.73 5.09 15.20 -0.84 37.06 28.89 0.29 36.02 28.70 coo 53.89 6.25 15.09 52.88 7.92 14.14 -2.30 39.44 25.21 -4.48 39.25 24.91 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 33 3 # 33 A 67 ASP D 22 ASP~? 30.56 O ACT B 502 A 68 ALA D 21 ALA~? 24.89 O ACT B 502 A 72 LEU D 24 LEU~? 22.86 O ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 1.48 40.46 31.50 1.79 41.35 33.38 coo 48.88 4.35 16.59 48.73 5.09 15.20 -0.84 37.06 28.89 0.29 36.02 28.70 coo 53.89 6.25 15.09 52.88 7.92 14.14 -5.20 37.32 30.57 -6.52 37.42 28.87 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 34 3 # 34 A 67 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 68 ALA D 5 ALA^? 14.91 OXT ACT B 502 A 72 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 48.88 4.35 16.59 48.73 5.09 15.20 -21.50 32.26 30.89 -20.92 30.85 30.70 coo 53.89 6.25 15.09 52.88 7.92 14.14 -25.67 33.10 32.16 -27.76 33.61 31.64 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 35 3 # 35 A 67 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 68 ALA D 55 ALA^? 15.53 OXT ACT B 502 A 72 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 48.88 4.35 16.59 48.73 5.09 15.20 -19.84 32.00 34.67 -19.79 30.59 35.12 coo 53.89 6.25 15.09 52.88 7.92 14.14 -25.67 33.10 32.16 -27.76 33.61 31.64 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 36 3 # 36 A 67 ASP D 58 ASP~? 25.46 OXT ACT B 502 A 68 ALA D 57 ALA.? 22.00 OXT ACT B 502 A 72 LEU D 4 LEU^? 19.61 OXT ACT B 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -28.98 35.91 37.37 -28.15 37.30 38.76 coo 48.88 4.35 16.59 48.73 5.09 15.20 -25.78 33.10 38.45 -26.02 33.44 39.92 coo 53.89 6.25 15.09 52.88 7.92 14.14 -25.67 33.10 32.16 -27.76 33.61 31.64 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 36 hits 1q6l_c05 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 54 ASP^? -3.76 O ACT A 501s A 147 THR A 37 THR^? 7.38 OXT ACT A 501 A 294 ASP A 58 ASP~? 16.01 O ACT A 501 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 9.47 12.33 8.26 10.66 11.45 9.76 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 12.45 11.59 2.88 13.04 12.51 4.77 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 54 ASP^? -3.76 O ACT A 501s A 147 THR A 38 THR^? 13.66 O ACT A 501 A 294 ASP A 58 ASP~? 16.01 O ACT A 501 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 9.47 12.33 8.26 10.66 11.45 9.76 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 9.25 11.88 0.86 8.30 10.33 -0.29 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP A 58 ASP~? 16.01 O ACT A 501 A 147 THR A 2 THR.? 15.11 O ACT A 501 A 294 ASP A 54 ASP^? -3.76 O ACT A 501s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 12.40 1.57 0.95 13.75 2.83 -0.02 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 5.28 5.47 0.38 4.81 7.57 0.79 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP B 54 ASP^? 4.46 O ACT B 502 A 147 THR B 37 THR^? 7.60 OXT ACT B 502 A 294 ASP B 58 ASP~? 16.37 O ACT B 502 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -11.91 17.46 37.30 -13.16 16.95 35.64 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP B 54 ASP^? 4.46 O ACT B 502 A 147 THR B 38 THR^? 13.93 OXT ACT B 502 A 294 ASP B 58 ASP~? 16.37 O ACT B 502 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP B 58 ASP~? 16.37 O ACT B 502 A 147 THR B 2 THR.? 15.37 O ACT B 502 A 294 ASP B 54 ASP^? 4.46 O ACT B 502 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -1.77 17.89 37.44 -2.74 16.22 38.35 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.19 24.78 38.76 -8.31 24.86 38.78 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 147 THR C 37 THR^? 7.26 O ACT C 503 A 294 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.53 17.89 2.50 -7.37 16.24 3.61 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 147 THR C 38 THR^? 13.13 OXT ACT C 503 A 294 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -2.96 18.29 1.33 -1.80 20.06 1.28 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 9 3 # 9 A 49 ASP C 58 ASP~? 15.48 OXT ACT C 503 A 147 THR C 2 THR.? 13.94 OXT ACT C 503 A 294 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -5.93 27.71 5.50 -7.21 27.13 3.90 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 0.78 23.36 4.70 1.16 21.29 4.14 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 10 3 # 10 A 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 147 THR D 37 THR^? 22.30 OXT ACT B 502 A 294 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -18.75 36.43 38.66 -17.35 37.30 37.28 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -28.98 35.91 37.37 -28.15 37.30 38.76 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 11 3 # 11 A 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 147 THR D 38 THR^? 19.44 OXT ACT B 502 A 294 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -18.99 32.97 40.14 -20.81 31.88 40.43 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -28.98 35.91 37.37 -28.15 37.30 38.76 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 12 3 # 12 A 49 ASP D 58 ASP~? 25.46 OXT ACT B 502 A 147 THR D 2 THR.? 16.35 OXT ACT B 502 A 294 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -28.98 35.91 37.37 -28.15 37.30 38.76 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -24.65 28.96 37.92 -22.54 28.87 38.29 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -16.29 34.40 33.40 -16.55 35.85 31.87 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 12 hits 1qgx_c02 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 31 ALA~? 6.46 OXT ACT A 501 A 148 HIS A 65 HIS~? -3.60 O ACT A 501s A 163 ASP A 54 ASP^? -3.76 O ACT A 501s coo 1.42 19.18 21.84 1.11 19.57 23.28 14.76 17.72 5.17 13.41 17.92 5.92 coo 0.71 19.67 27.92 2.43 19.16 26.83 14.91 11.26 8.66 14.30 12.93 9.76 coo 7.15 16.22 27.50 6.15 18.00 27.94 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA B 31 ALA~? 6.26 OXT ACT B 502 A 148 HIS B 65 HIS~? -3.69 O ACT B 502s A 163 ASP B 54 ASP^? 4.46 O ACT B 502 coo 1.42 19.18 21.84 1.11 19.57 23.28 -18.22 15.01 35.83 -18.55 16.36 35.14 coo 0.71 19.67 27.92 2.43 19.16 26.83 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 7.15 16.22 27.50 6.15 18.00 27.94 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA C 31 ALA~? 7.01 O ACT C 503 A 148 HIS C 65 HIS~? -3.55 C ACT C 503s A 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 1.42 19.18 21.84 1.11 19.57 23.28 -8.94 11.70 1.14 -7.76 11.12 1.95 coo 0.71 19.67 27.92 2.43 19.16 26.83 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 7.15 16.22 27.50 6.15 18.00 27.94 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 A 51 ALA C 71 ALA~? 3.85 CH3 ACT C 503 A 148 HIS C 65 HIS~? -3.55 C ACT C 503s A 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 1.42 19.18 21.84 1.11 19.57 23.28 -14.49 11.86 9.72 -14.32 13.36 10.09 coo 0.71 19.67 27.92 2.43 19.16 26.83 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 7.15 16.22 27.50 6.15 18.00 27.94 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 A 51 ALA D 31 ALA~? 23.53 OXT ACT B 502 A 148 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 163 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 1.42 19.18 21.84 1.11 19.57 23.28 -12.33 38.97 38.82 -11.89 37.76 37.95 coo 0.71 19.67 27.92 2.43 19.16 26.83 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 7.15 16.22 27.50 6.15 18.00 27.94 -16.29 34.40 33.40 -16.55 35.85 31.87 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 31 ALA~? 6.46 OXT ACT A 501 B 148 HIS A 65 HIS~? -3.60 O ACT A 501s B 163 ASP A 54 ASP^? -3.76 O ACT A 501s coo -33.97 19.78 54.18 -33.40 20.11 52.82 14.76 17.72 5.17 13.41 17.92 5.92 coo -33.17 20.01 48.16 -34.95 19.37 49.06 14.91 11.26 8.66 14.30 12.93 9.76 coo -39.82 16.62 48.85 -38.59 18.24 48.48 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA B 31 ALA~? 6.26 OXT ACT B 502 B 148 HIS B 65 HIS~? -3.69 O ACT B 502s B 163 ASP B 54 ASP^? 4.46 O ACT B 502 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -18.22 15.01 35.83 -18.55 16.36 35.14 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA C 31 ALA~? 7.01 O ACT C 503 B 148 HIS C 65 HIS~? -3.55 C ACT C 503s B 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -33.97 19.78 54.18 -33.40 20.11 52.82 -8.94 11.70 1.14 -7.76 11.12 1.95 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA D 31 ALA~? 23.53 OXT ACT B 502 B 148 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 163 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -12.33 38.97 38.82 -11.89 37.76 37.95 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -16.29 34.40 33.40 -16.55 35.85 31.87 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 31 ALA~? 6.46 OXT ACT A 501 C 148 HIS A 65 HIS~? -3.60 O ACT A 501s C 163 ASP A 54 ASP^? -3.76 O ACT A 501s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 14.76 17.72 5.17 13.41 17.92 5.92 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 14.91 11.26 8.66 14.30 12.93 9.76 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA B 31 ALA~? 6.26 OXT ACT B 502 C 148 HIS B 65 HIS~? -3.69 O ACT B 502s C 163 ASP B 54 ASP^? 4.46 O ACT B 502 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -18.22 15.01 35.83 -18.55 16.36 35.14 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA C 31 ALA~? 7.01 O ACT C 503 C 148 HIS C 65 HIS~? -3.55 C ACT C 503s C 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -8.94 11.70 1.14 -7.76 11.12 1.95 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 C 51 ALA C 71 ALA~? 3.85 CH3 ACT C 503 C 148 HIS C 65 HIS~? -3.55 C ACT C 503s C 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -14.49 11.86 9.72 -14.32 13.36 10.09 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 C 51 ALA D 31 ALA~? 23.53 OXT ACT B 502 C 148 HIS D 65 HIS~? 23.58 OXT ACT B 502 C 163 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -12.33 38.97 38.82 -11.89 37.76 37.95 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -16.29 34.40 33.40 -16.55 35.85 31.87 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 31 ALA~? 6.46 OXT ACT A 501 D 148 HIS A 65 HIS~? -3.60 O ACT A 501s D 163 ASP A 54 ASP^? -3.76 O ACT A 501s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 14.76 17.72 5.17 13.41 17.92 5.92 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 14.91 11.26 8.66 14.30 12.93 9.76 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA B 31 ALA~? 6.26 OXT ACT B 502 D 148 HIS B 65 HIS~? -3.69 O ACT B 502s D 163 ASP B 54 ASP^? 4.46 O ACT B 502 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -18.22 15.01 35.83 -18.55 16.36 35.14 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA C 31 ALA~? 7.01 O ACT C 503 D 148 HIS C 65 HIS~? -3.55 C ACT C 503s D 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -8.94 11.70 1.14 -7.76 11.12 1.95 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA D 31 ALA~? 23.53 OXT ACT B 502 D 148 HIS D 65 HIS~? 23.58 OXT ACT B 502 D 163 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -12.33 38.97 38.82 -11.89 37.76 37.95 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -16.29 34.40 33.40 -16.55 35.85 31.87 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 31 ALA~? 6.46 OXT ACT A 501 E 148 HIS A 65 HIS~? -3.60 O ACT A 501s E 163 ASP A 54 ASP^? -3.76 O ACT A 501s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 14.76 17.72 5.17 13.41 17.92 5.92 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 14.91 11.26 8.66 14.30 12.93 9.76 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA B 31 ALA~? 6.26 OXT ACT B 502 E 148 HIS B 65 HIS~? -3.69 O ACT B 502s E 163 ASP B 54 ASP^? 4.46 O ACT B 502 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -18.22 15.01 35.83 -18.55 16.36 35.14 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA C 31 ALA~? 7.01 O ACT C 503 E 148 HIS C 65 HIS~? -3.55 C ACT C 503s E 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -8.94 11.70 1.14 -7.76 11.12 1.95 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 E 51 ALA D 31 ALA~? 23.53 OXT ACT B 502 E 148 HIS D 65 HIS~? 23.58 OXT ACT B 502 E 163 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -12.33 38.97 38.82 -11.89 37.76 37.95 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -16.29 34.40 33.40 -16.55 35.85 31.87 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 31 ALA~? 6.46 OXT ACT A 501 F 148 HIS A 65 HIS~? -3.60 O ACT A 501s F 163 ASP A 54 ASP^? -3.76 O ACT A 501s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 14.76 17.72 5.17 13.41 17.92 5.92 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 14.91 11.26 8.66 14.30 12.93 9.76 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA B 31 ALA~? 6.26 OXT ACT B 502 F 148 HIS B 65 HIS~? -3.69 O ACT B 502s F 163 ASP B 54 ASP^? 4.46 O ACT B 502 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -18.22 15.01 35.83 -18.55 16.36 35.14 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA C 31 ALA~? 7.01 O ACT C 503 F 148 HIS C 65 HIS~? -3.55 C ACT C 503s F 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -8.94 11.70 1.14 -7.76 11.12 1.95 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 F 51 ALA D 31 ALA~? 23.53 OXT ACT B 502 F 148 HIS D 65 HIS~? 23.58 OXT ACT B 502 F 163 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -12.33 38.97 38.82 -11.89 37.76 37.95 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -16.29 34.40 33.40 -16.55 35.85 31.87 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 31 ALA~? 6.46 OXT ACT A 501 G 148 HIS A 65 HIS~? -3.60 O ACT A 501s G 163 ASP A 54 ASP^? -3.76 O ACT A 501s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 14.76 17.72 5.17 13.41 17.92 5.92 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 14.91 11.26 8.66 14.30 12.93 9.76 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA B 31 ALA~? 6.26 OXT ACT B 502 G 148 HIS B 65 HIS~? -3.69 O ACT B 502s G 163 ASP B 54 ASP^? 4.46 O ACT B 502 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -18.22 15.01 35.83 -18.55 16.36 35.14 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA C 31 ALA~? 7.01 O ACT C 503 G 148 HIS C 65 HIS~? -3.55 C ACT C 503s G 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -8.94 11.70 1.14 -7.76 11.12 1.95 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA D 31 ALA~? 23.53 OXT ACT B 502 G 148 HIS D 65 HIS~? 23.58 OXT ACT B 502 G 163 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -12.33 38.97 38.82 -11.89 37.76 37.95 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -16.29 34.40 33.40 -16.55 35.85 31.87 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 31 ALA~? 6.46 OXT ACT A 501 H 148 HIS A 65 HIS~? -3.60 O ACT A 501s H 163 ASP A 54 ASP^? -3.76 O ACT A 501s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 14.76 17.72 5.17 13.41 17.92 5.92 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 14.91 11.26 8.66 14.30 12.93 9.76 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA B 31 ALA~? 6.26 OXT ACT B 502 H 148 HIS B 65 HIS~? -3.69 O ACT B 502s H 163 ASP B 54 ASP^? 4.46 O ACT B 502 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -18.22 15.01 35.83 -18.55 16.36 35.14 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA C 31 ALA~? 7.01 O ACT C 503 H 148 HIS C 65 HIS~? -3.55 C ACT C 503s H 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -8.94 11.70 1.14 -7.76 11.12 1.95 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 H 51 ALA C 71 ALA~? 3.85 CH3 ACT C 503 H 148 HIS C 65 HIS~? -3.55 C ACT C 503s H 163 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -14.49 11.86 9.72 -14.32 13.36 10.09 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 H 51 ALA D 31 ALA~? 23.53 OXT ACT B 502 H 148 HIS D 65 HIS~? 23.58 OXT ACT B 502 H 163 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -12.33 38.97 38.82 -11.89 37.76 37.95 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -16.29 34.40 33.40 -16.55 35.85 31.87 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c07 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 7 PHE^? 10.76 O ACT A 501 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.11 9.93 15.65 2.48 11.68 17.17 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 23 PHE~? 7.88 CH3 ACT A 501 A 201 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 227 LYS A 13 LYS.? 18.34 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 16.47 22.52 16.41 17.88 20.31 15.44 coo 25.52 45.12 37.98 23.98 46.65 37.85 13.66 28.66 16.58 12.51 30.39 17.11 coo 12.68 46.83 36.69 18.26 48.67 34.51 13.03 21.95 28.39 18.88 21.48 30.19 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 23 PHE~? 7.88 CH3 ACT A 501 A 201 ASP A 22 ASP~? 16.31 OXT ACT A 501 A 227 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 16.47 22.52 16.41 17.88 20.31 15.44 coo 25.52 45.12 37.98 23.98 46.65 37.85 13.66 28.66 16.58 12.51 30.39 17.11 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE A 41 PHE^? 11.20 OXT ACT A 501 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.28 16.86 7.90 2.95 16.20 5.48 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE A 41 PHE^? 11.20 OXT ACT A 501 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 97 LYS^? 11.17 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.28 16.86 7.90 2.95 16.20 5.48 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE A 41 PHE^? 11.20 OXT ACT A 501 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.28 16.86 7.90 2.95 16.20 5.48 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE A 53 PHE^? 10.03 O ACT A 501 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 3 LYS.? 15.82 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE A 53 PHE^? 10.03 O ACT A 501 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE A 53 PHE^? 10.03 O ACT A 501 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 97 LYS^? 11.17 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1qz9_c02 KYNURENINASE user 10 3 # 10 A 129 PHE A 53 PHE^? 10.03 O ACT A 501 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1qz9_c02 KYNURENINASE user 11 3 # 11 A 129 PHE A 53 PHE^? 10.03 O ACT A 501 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 1qz9_c02 KYNURENINASE user 12 3 # 12 A 129 PHE A 53 PHE^? 10.03 O ACT A 501 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS C 44 LYS^? 18.40 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1qz9_c02 KYNURENINASE user 13 3 # 13 A 129 PHE A 53 PHE^? 10.03 O ACT A 501 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.01 11.96 10.37 3.05 9.75 8.94 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1qz9_c02 KYNURENINASE user 14 3 # 14 A 129 PHE B 7 PHE^? 10.67 O ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1qz9_c02 KYNURENINASE user 15 3 # 15 A 129 PHE B 7 PHE^? 10.67 O ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS D 44 LYS^? 22.72 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1qz9_c02 KYNURENINASE user 16 3 # 16 A 129 PHE B 23 PHE~? 6.98 CH3 ACT B 502 A 201 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 227 LYS B 13 LYS.? 14.39 CH3 ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 -24.62 13.39 25.68 -22.12 12.22 26.21 coo 25.52 45.12 37.98 23.98 46.65 37.85 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 12.68 46.83 36.69 18.26 48.67 34.51 -26.83 16.89 13.78 -24.80 11.17 11.99 ULMN 3 1qz9_c02 KYNURENINASE user 17 3 # 17 A 129 PHE B 23 PHE~? 6.98 CH3 ACT B 502 A 201 ASP B 22 ASP~? 15.53 CH3 ACT B 502 A 227 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -24.62 13.39 25.68 -22.12 12.22 26.21 coo 25.52 45.12 37.98 23.98 46.65 37.85 -31.00 15.29 26.70 -32.94 16.13 26.51 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1qz9_c02 KYNURENINASE user 18 3 # 18 A 129 PHE B 41 PHE^? 11.14 OXT ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1qz9_c02 KYNURENINASE user 19 3 # 19 A 129 PHE B 41 PHE^? 11.14 OXT ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS B 97 LYS^? 23.77 OXT ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -11.27 32.20 40.12 -15.59 36.50 41.95 ULMN 3 1qz9_c02 KYNURENINASE user 20 3 # 20 A 129 PHE B 41 PHE^? 11.14 OXT ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1qz9_c02 KYNURENINASE user 21 3 # 21 A 129 PHE B 53 PHE^? 10.51 O ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1qz9_c02 KYNURENINASE user 22 3 # 22 A 129 PHE B 53 PHE^? 10.51 O ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 1qz9_c02 KYNURENINASE user 23 3 # 23 A 129 PHE B 53 PHE^? 10.51 O ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS D 44 LYS^? 22.72 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1qz9_c02 KYNURENINASE user 24 3 # 24 A 129 PHE B 53 PHE^? 10.51 O ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -19.69 21.43 38.53 -15.42 16.83 39.89 ULMN 3 1qz9_c02 KYNURENINASE user 25 3 # 25 A 129 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1qz9_c02 KYNURENINASE user 26 3 # 26 A 129 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS C 44 LYS^? 18.40 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1qz9_c02 KYNURENINASE user 27 3 # 27 A 129 PHE C 23 PHE~? 8.79 O ACT C 503 A 201 ASP C 22 ASP~? 16.98 O ACT C 503 A 227 LYS C 13 LYS.? 19.45 CH3 ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -12.75 2.52 8.44 -13.71 5.16 8.55 coo 25.52 45.12 37.98 23.98 46.65 37.85 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 -11.54 -3.66 19.68 -17.53 -2.26 21.10 ULMN 3 1qz9_c02 KYNURENINASE user 28 3 # 28 A 129 PHE C 23 PHE~? 8.79 O ACT C 503 A 201 ASP C 22 ASP~? 16.98 O ACT C 503 A 227 LYS C 44 LYS^? 18.40 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 -12.75 2.52 8.44 -13.71 5.16 8.55 coo 25.52 45.12 37.98 23.98 46.65 37.85 -10.30 -3.42 5.95 -9.18 -5.30 6.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1qz9_c02 KYNURENINASE user 29 3 # 29 A 129 PHE C 41 PHE^? 10.92 O ACT C 503 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS C 44 LYS^? 18.40 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 0.59 10.20 5.98 2.26 11.80 4.40 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 -0.37 1.29 11.81 -0.77 -4.95 10.90 ULMN 3 1qz9_c02 KYNURENINASE user 30 3 # 30 A 129 PHE C 41 PHE^? 10.92 O ACT C 503 A 201 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 227 LYS C 97 LYS^? 10.89 OXT ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 0.59 10.20 5.98 2.26 11.80 4.40 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 8.20 19.20 3.14 12.89 15.65 0.85 ULMN 3 1qz9_c02 KYNURENINASE user 31 3 # 31 A 129 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 3 LYS.? 15.82 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 0.16 13.32 10.36 1.32 15.86 10.31 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 1qz9_c02 KYNURENINASE user 32 3 # 32 A 129 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 44 LYS^? 17.14 CH3 ACT A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 0.16 13.32 10.36 1.32 15.86 10.31 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.76 21.56 17.68 3.38 25.65 21.29 ULMN 3 1qz9_c02 KYNURENINASE user 33 3 # 33 A 129 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 201 ASP A 54 ASP^? -3.76 O ACT A 501s A 227 LYS A 97 LYS^? 11.17 O ACT C 503 coo 23.39 49.81 32.16 21.33 51.68 32.26 0.16 13.32 10.36 1.32 15.86 10.31 coo 25.52 45.12 37.98 23.98 46.65 37.85 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 -2.14 10.71 -0.07 -6.35 15.40 -1.27 ULMN 3 1qz9_c02 KYNURENINASE user 34 3 # 34 A 129 PHE D 7 PHE^? 14.53 O ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1qz9_c02 KYNURENINASE user 35 3 # 35 A 129 PHE D 7 PHE^? 14.53 O ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS D 44 LYS^? 22.72 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1qz9_c02 KYNURENINASE user 36 3 # 36 A 129 PHE D 23 PHE~? 28.18 O ACT B 502 A 201 ASP D 22 ASP~? 30.56 O ACT B 502 A 227 LYS D 13 LYS.? 35.09 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -4.82 42.68 30.05 -7.42 43.67 30.37 coo 25.52 45.12 37.98 23.98 46.65 37.85 1.48 40.46 31.50 1.79 41.35 33.38 coo 12.68 46.83 36.69 18.26 48.67 34.51 -1.12 41.20 17.82 -1.77 47.26 17.33 ULMN 3 1qz9_c02 KYNURENINASE user 37 3 # 37 A 129 PHE D 23 PHE~? 28.18 O ACT B 502 A 201 ASP D 22 ASP~? 30.56 O ACT B 502 A 227 LYS D 44 LYS^? 22.72 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -4.82 42.68 30.05 -7.42 43.67 30.37 coo 25.52 45.12 37.98 23.98 46.65 37.85 1.48 40.46 31.50 1.79 41.35 33.38 coo 12.68 46.83 36.69 18.26 48.67 34.51 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1qz9_c02 KYNURENINASE user 38 3 # 38 A 129 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS D 44 LYS^? 22.72 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1qz9_c02 KYNURENINASE user 39 3 # 39 A 129 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS D 44 LYS^? 22.72 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -4.01 30.39 26.69 2.27 30.95 26.10 ULMN 3 1qz9_c02 KYNURENINASE user 40 3 # 40 A 129 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 201 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 227 LYS D 97 LYS^? 10.92 OXT ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 -19.69 21.43 38.53 -15.42 16.83 39.89 ULMN 3 1qz9_c02 KYNURENINASE user 41 3 # 41 A 129 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS B 3 LYS.? 21.07 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 1qz9_c02 KYNURENINASE user 42 3 # 42 A 129 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS B 44 LYS^? 16.99 CH3 ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.96 26.06 24.81 -31.04 25.82 23.05 ULMN 3 1qz9_c02 KYNURENINASE user 43 3 # 43 A 129 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS B 97 LYS^? 23.77 OXT ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -11.27 32.20 40.12 -15.59 36.50 41.95 ULMN 3 1qz9_c02 KYNURENINASE user 44 3 # 44 A 129 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 201 ASP B 54 ASP^? 4.46 O ACT B 502 A 227 LYS D 44 LYS^? 22.72 O ACT B 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.68 46.83 36.69 18.26 48.67 34.51 -4.01 30.39 26.69 2.27 30.95 26.10 1qz9_c02 source 1qz9 KYNURENINASE : 44 hits 1qz9_c02 naa= 3 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 1 3 # 1 A 39 HIS A 65 HIS~? -3.60 O ACT A 501s A 43 TRP A 40 TRP^? -4.11 OXT ACT A 501s A 108 GLU A 34 GLU.? 6.40 OXT ACT A 501 coo 33.67 25.97 25.39 31.70 26.60 25.75 14.91 11.26 8.66 14.30 12.93 9.76 coo 29.43 26.12 28.46 27.08 29.25 29.01 11.31 15.47 8.53 11.49 19.29 9.59 coo 29.13 31.14 24.26 29.28 29.08 24.66 17.44 14.34 4.36 16.78 13.78 6.33 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 2 3 # 2 A 39 HIS B 65 HIS~? -3.69 O ACT B 502s A 43 TRP B 40 TRP^? -4.17 OXT ACT B 502s A 108 GLU B 34 GLU.? 6.39 OXT ACT B 502 coo 33.67 25.97 25.39 31.70 26.60 25.75 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 29.43 26.12 28.46 27.08 29.25 29.01 -16.95 18.54 32.38 -20.88 18.36 32.14 coo 29.13 31.14 24.26 29.28 29.08 24.66 -14.54 12.40 35.90 -14.50 13.22 33.94 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 3 3 # 3 A 39 HIS C 65 HIS~? -3.55 C ACT C 503s A 43 TRP C 40 TRP^? -4.44 O ACT C 503s A 108 GLU C 34 GLU~? 6.63 O ACT C 503 coo 33.67 25.97 25.39 31.70 26.60 25.75 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 29.43 26.12 28.46 27.08 29.25 29.01 -6.43 11.77 5.82 -6.69 7.89 5.04 coo 29.13 31.14 24.26 29.28 29.08 24.66 -11.68 15.33 1.66 -11.38 14.84 3.76 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 4 3 # 4 A 39 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 43 TRP D 40 TRP^? 21.29 O ACT B 502 A 108 GLU D 34 GLU.? 25.91 OXT ACT B 502 coo 33.67 25.97 25.39 31.70 26.60 25.75 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 29.43 26.12 28.46 27.08 29.25 29.01 -13.32 36.33 34.40 -9.38 36.60 34.55 coo 29.13 31.14 24.26 29.28 29.08 24.66 -16.00 41.58 38.86 -16.04 41.30 36.71 1rhc_c00 source 1rhc F420-DEPENDENT ALCOHOL DEHYDROGENASE : 4 hits 1rhc_c00 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 70 ILE~? -3.69 OXT ACT A 501s A 106 HIS A 65 HIS~? -3.60 O ACT A 501s A 142 ASP A 54 ASP^? -3.76 O ACT A 501s coo -15.54 60.72 29.56 -16.71 61.53 30.10 17.24 16.51 10.78 15.91 17.04 10.37 coo -17.00 64.03 23.46 -18.21 65.65 22.90 14.91 11.26 8.66 14.30 12.93 9.76 coo -17.05 67.91 26.85 -18.66 66.47 26.76 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE B 70 ILE~? -3.68 OXT ACT B 502s A 106 HIS B 65 HIS~? -3.69 O ACT B 502s A 142 ASP B 54 ASP^? 4.46 O ACT B 502 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -17.96 12.66 29.87 -18.35 13.82 30.46 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 3 # 3 A 104 ILE C 70 ILE~? 4.18 O ACT C 503 A 106 HIS C 65 HIS~? -3.55 C ACT C 503s A 142 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -12.31 10.52 6.18 -11.04 10.24 5.76 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 4 3 # 4 A 104 ILE D 70 ILE~? 26.10 O ACT B 502 A 106 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 142 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -11.91 42.42 33.55 -11.60 41.17 34.03 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -16.29 34.40 33.40 -16.55 35.85 31.87 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 4 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP B 54 ASP^? 4.46 O ACT B 502 64 HIS B 65 HIS~? -3.69 O ACT B 502s 155 ASN C 87 ASN.? 10.16 O ACT B 502 coo 80.16 73.25 62.48 80.01 71.25 61.82 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 78.27 67.69 61.83 79.58 67.76 60.19 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 80.34 61.88 52.75 81.25 63.19 54.35 -7.54 12.49 22.38 -6.86 14.54 22.53 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP C 54 ASP^? -3.02 OXT ACT C 503s 64 HIS C 65 HIS~? -3.55 C ACT C 503s 155 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 80.16 73.25 62.48 80.01 71.25 61.82 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 78.27 67.69 61.83 79.58 67.76 60.19 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 80.34 61.88 52.75 81.25 63.19 54.35 -13.79 21.31 17.73 -12.12 22.50 17.15 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 2 hits 1sca_c01 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 62 ARG~? 11.91 O ACT A 501 A 89 HIS A 65 HIS~? -3.60 O ACT A 501s A 119 ASN A 67 ASN~? 11.66 O ACT A 501 coo 28.44 23.52 73.95 30.13 24.84 76.11 11.34 4.43 9.06 9.97 1.81 9.84 coo 21.34 20.13 69.47 22.14 19.11 71.12 14.91 11.26 8.66 14.30 12.93 9.76 coo 19.69 29.00 71.61 19.80 26.98 72.20 22.25 7.80 9.68 22.12 6.01 10.80 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG B 62 ARG~? 12.26 O ACT B 502 A 89 HIS B 65 HIS~? -3.69 O ACT B 502s A 119 ASN B 67 ASN~? 11.44 O ACT B 502 coo 28.44 23.52 73.95 30.13 24.84 76.11 -6.19 18.92 29.62 -3.70 20.53 28.83 coo 21.34 20.13 69.47 22.14 19.11 71.12 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 19.69 29.00 71.61 19.80 26.98 72.20 -8.90 8.17 29.36 -7.21 8.51 28.12 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG B 62 ARG~? 12.26 O ACT B 502 A 89 HIS B 65 HIS~? -3.69 O ACT B 502s A 119 ASN C 87 ASN.? 10.16 O ACT B 502 coo 28.44 23.52 73.95 30.13 24.84 76.11 -6.19 18.92 29.62 -3.70 20.53 28.83 coo 21.34 20.13 69.47 22.14 19.11 71.12 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 19.69 29.00 71.61 19.80 26.98 72.20 -7.54 12.49 22.38 -6.86 14.54 22.53 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 A 87 ARG C 62 ARG~? 10.88 OXT ACT C 503 A 89 HIS C 65 HIS~? -3.55 C ACT C 503s A 119 ASN C 67 ASN~? 10.88 CH3 ACT C 503 coo 28.44 23.52 73.95 30.13 24.84 76.11 -6.61 21.24 11.49 -5.46 23.07 13.64 coo 21.34 20.13 69.47 22.14 19.11 71.12 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 19.69 29.00 71.61 19.80 26.98 72.20 -17.40 19.51 8.11 -17.74 20.65 9.88 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 A 87 ARG D 62 ARG~? 20.52 OXT ACT B 502 A 89 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 119 ASN D 67 ASN~? 31.47 OXT ACT B 502 coo 28.44 23.52 73.95 30.13 24.84 76.11 -23.58 36.44 30.28 -25.75 35.10 28.58 coo 21.34 20.13 69.47 22.14 19.11 71.12 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 19.69 29.00 71.61 19.80 26.98 72.20 -21.35 47.13 33.03 -22.85 47.39 31.52 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 5 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 62 ARG~? 11.91 O ACT A 501 B 89 HIS A 65 HIS~? -3.60 O ACT A 501s B 119 ASN A 67 ASN~? 11.66 O ACT A 501 coo -30.08 23.20 29.48 -31.80 24.60 27.35 11.34 4.43 9.06 9.97 1.81 9.84 coo -22.85 19.92 33.92 -23.63 18.94 32.24 14.91 11.26 8.66 14.30 12.93 9.76 coo -21.28 28.91 31.84 -21.35 26.90 31.17 22.25 7.80 9.68 22.12 6.01 10.80 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG B 62 ARG~? 12.26 O ACT B 502 B 89 HIS B 65 HIS~? -3.69 O ACT B 502s B 119 ASN B 67 ASN~? 11.44 O ACT B 502 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -6.19 18.92 29.62 -3.70 20.53 28.83 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -8.90 8.17 29.36 -7.21 8.51 28.12 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 B 87 ARG B 62 ARG~? 12.26 O ACT B 502 B 89 HIS B 65 HIS~? -3.69 O ACT B 502s B 119 ASN C 87 ASN.? 10.16 O ACT B 502 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -6.19 18.92 29.62 -3.70 20.53 28.83 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -7.54 12.49 22.38 -6.86 14.54 22.53 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 B 87 ARG C 62 ARG~? 10.88 OXT ACT C 503 B 89 HIS C 65 HIS~? -3.55 C ACT C 503s B 119 ASN C 67 ASN~? 10.88 CH3 ACT C 503 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -6.61 21.24 11.49 -5.46 23.07 13.64 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -17.40 19.51 8.11 -17.74 20.65 9.88 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 B 87 ARG D 62 ARG~? 20.52 OXT ACT B 502 B 89 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 119 ASN D 67 ASN~? 31.47 OXT ACT B 502 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -23.58 36.44 30.28 -25.75 35.10 28.58 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -21.35 47.13 33.03 -22.85 47.39 31.52 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 5 hits 1smn_c01 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 54 ASP^? -3.76 O ACT A 501s E 168 LYS C 97 LYS^? 10.89 OXT ACT A 501 E 201 THR A 37 THR^? 7.38 OXT ACT A 501 coo 5.36 16.20 22.10 3.88 17.00 23.31 9.47 12.33 8.26 10.66 11.45 9.76 coo 5.06 22.32 18.11 1.02 22.08 22.74 8.20 19.20 3.14 12.89 15.65 0.85 coo -1.79 18.29 19.05 -1.19 20.28 19.71 12.45 11.59 2.88 13.04 12.51 4.77 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 54 ASP^? -3.76 O ACT A 501s E 168 LYS C 97 LYS^? 10.89 OXT ACT A 501 E 201 THR A 38 THR^? 13.66 O ACT A 501 coo 5.36 16.20 22.10 3.88 17.00 23.31 9.47 12.33 8.26 10.66 11.45 9.76 coo 5.06 22.32 18.11 1.02 22.08 22.74 8.20 19.20 3.14 12.89 15.65 0.85 coo -1.79 18.29 19.05 -1.19 20.28 19.71 9.25 11.88 0.86 8.30 10.33 -0.29 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 54 ASP^? 4.46 O ACT B 502 E 168 LYS D 97 LYS^? 10.92 OXT ACT B 502 E 201 THR B 37 THR^? 7.60 OXT ACT B 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 5.06 22.32 18.11 1.02 22.08 22.74 -19.69 21.43 38.53 -15.42 16.83 39.89 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -11.91 17.46 37.30 -13.16 16.95 35.64 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 54 ASP^? 4.46 O ACT B 502 E 168 LYS D 97 LYS^? 10.92 OXT ACT B 502 E 201 THR B 38 THR^? 13.93 OXT ACT B 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 5.06 22.32 18.11 1.02 22.08 22.74 -19.69 21.43 38.53 -15.42 16.83 39.89 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -12.00 20.67 39.32 -10.38 21.81 40.17 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP C 54 ASP^? -3.02 OXT ACT C 503s E 168 LYS A 97 LYS^? 11.17 O ACT C 503 E 201 THR C 37 THR^? 7.26 O ACT C 503 coo 5.36 16.20 22.10 3.88 17.00 23.31 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 5.06 22.32 18.11 1.02 22.08 22.74 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -6.53 17.89 2.50 -7.37 16.24 3.61 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP C 54 ASP^? -3.02 OXT ACT C 503s E 168 LYS A 97 LYS^? 11.17 O ACT C 503 E 201 THR C 38 THR^? 13.13 OXT ACT C 503 coo 5.36 16.20 22.10 3.88 17.00 23.31 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 5.06 22.32 18.11 1.02 22.08 22.74 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -2.96 18.29 1.33 -1.80 20.06 1.28 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 7 3 # 7 E 166 ASP D 54 ASP^? 19.49 OXT ACT B 502 E 168 LYS B 97 LYS^? 23.77 OXT ACT B 502 E 201 THR D 37 THR^? 22.30 OXT ACT B 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 5.06 22.32 18.11 1.02 22.08 22.74 -11.27 32.20 40.12 -15.59 36.50 41.95 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -18.75 36.43 38.66 -17.35 37.30 37.28 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 8 3 # 8 E 166 ASP D 54 ASP^? 19.49 OXT ACT B 502 E 168 LYS B 97 LYS^? 23.77 OXT ACT B 502 E 201 THR D 38 THR^? 19.44 OXT ACT B 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 5.06 22.32 18.11 1.02 22.08 22.74 -11.27 32.20 40.12 -15.59 36.50 41.95 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -18.99 32.97 40.14 -20.81 31.88 40.43 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 8 hits 1stc_c02 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 60 ALA~? 15.50 O ACT A 501 A 251 GLY A 61 GLY~? 11.65 O ACT A 501 A 252 ASP A 58 ASP~? 16.01 O ACT A 501 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 16.92 2.68 3.35 17.44 2.38 1.97 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 15.25 6.14 3.18 15.29 5.59 3.87 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 60 ALA~? 15.70 O ACT B 502 A 251 GLY B 61 GLY~? 11.96 O ACT B 502 A 252 ASP B 58 ASP~? 16.37 O ACT B 502 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -3.13 13.34 34.99 -2.65 12.71 36.31 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA C 60 ALA~? 15.14 OXT ACT C 503 A 251 GLY C 61 GLY~? 11.24 OXT ACT C 503 A 252 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -10.85 26.04 6.18 -11.08 26.98 4.99 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA D 60 ALA~? 28.12 OXT ACT B 502 A 251 GLY D 61 GLY~? 24.96 OXT ACT B 502 A 252 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -27.42 40.78 36.27 -28.14 40.94 37.58 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -28.98 35.91 37.37 -28.15 37.30 38.76 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 60 ALA~? 15.50 O ACT A 501 B 251 GLY A 61 GLY~? 11.65 O ACT A 501 B 252 ASP A 58 ASP~? 16.01 O ACT A 501 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 16.92 2.68 3.35 17.44 2.38 1.97 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 15.25 6.14 3.18 15.29 5.59 3.87 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 60 ALA~? 15.70 O ACT B 502 B 251 GLY B 61 GLY~? 11.96 O ACT B 502 B 252 ASP B 58 ASP~? 16.37 O ACT B 502 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -3.13 13.34 34.99 -2.65 12.71 36.31 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA C 60 ALA~? 15.14 OXT ACT C 503 B 251 GLY C 61 GLY~? 11.24 OXT ACT C 503 B 252 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -10.85 26.04 6.18 -11.08 26.98 4.99 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA D 60 ALA~? 28.12 OXT ACT B 502 B 251 GLY D 61 GLY~? 24.96 OXT ACT B 502 B 252 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -27.42 40.78 36.27 -28.14 40.94 37.58 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -28.98 35.91 37.37 -28.15 37.30 38.76 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c03 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 97 LYS^? 11.17 O ACT C 503 138 ASN C 32 ASN~? 12.55 O ACT C 503 183 HIS C 65 HIS~? -3.55 C ACT C 503s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -7.80 11.04 -3.58 -6.14 9.70 -3.27 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS B 90 LYS^? 12.84 O ACT B 502 138 ASN C 87 ASN.? 10.16 O ACT B 502 183 HIS B 65 HIS~? -3.69 O ACT B 502s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -7.54 12.49 22.38 -6.86 14.54 22.53 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS B 97 LYS^? 23.77 OXT ACT B 502 138 ASN D 32 ASN~? 25.03 OXT ACT B 502 183 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -11.27 32.20 40.12 -15.59 36.50 41.95 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -10.82 37.91 43.31 -9.73 36.12 42.91 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -17.61 39.97 33.46 -15.64 39.60 32.84 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 4 3 # 4 115 LYS C 90 LYS^? 10.56 OXT ACT C 503 138 ASN B 87 ASN^? 12.23 OXT ACT C 503 183 HIS C 65 HIS~? -3.55 C ACT C 503s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -13.79 21.31 17.73 -12.12 22.50 17.15 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 5 3 # 5 115 LYS C 97 LYS^? 10.89 OXT ACT A 501 138 ASN A 32 ASN~? 11.90 OXT ACT A 501 183 HIS A 65 HIS~? -3.60 O ACT A 501s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 8.20 19.20 3.14 12.89 15.65 0.85 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 14.28 20.69 1.30 12.48 21.71 1.89 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 6 3 # 6 115 LYS D 97 LYS^? 10.92 OXT ACT B 502 138 ASN B 32 ASN~? 11.83 OXT ACT B 502 183 HIS B 65 HIS~? -3.69 O ACT B 502s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -19.69 21.43 38.53 -15.42 16.83 39.89 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -20.40 15.31 40.23 -21.60 17.04 39.97 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -12.58 15.14 31.21 -14.46 15.75 30.51 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 6 hits 1uag_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 17 GLU~? 18.98 CH3 ACT A 501 A 126 LYS A 13 LYS.? 18.34 CH3 ACT A 501 A 171 ALA A 18 ALA~? 17.91 CH3 ACT A 501 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 8.46 25.60 25.93 9.21 26.72 27.59 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 13.03 21.95 28.39 18.88 21.48 30.19 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 10.55 28.75 21.40 10.60 30.23 21.67 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 1 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU B 17 GLU~? 18.31 CH3 ACT B 502 B 126 LYS B 13 LYS.? 14.39 CH3 ACT C 503 B 171 ALA B 18 ALA~? 17.30 CH3 ACT B 502 coo 20.47 87.42 16.54 20.16 87.17 14.45 -30.37 21.21 17.22 -31.47 20.28 15.66 coo 24.73 94.37 14.59 21.08 89.84 11.98 -26.83 16.89 13.78 -24.80 11.17 11.99 coo 24.38 86.32 12.71 22.88 86.54 12.71 -32.52 18.49 22.18 -34.00 18.14 22.14 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU D 17 GLU~? 25.97 OXT ACT A 501 B 126 LYS D 13 LYS.? 35.09 O ACT B 502 B 171 ALA D 18 ALA~? 28.83 CH3 ACT A 501 coo 20.47 87.42 16.54 20.16 87.17 14.45 2.12 36.56 21.03 3.60 37.59 19.89 coo 24.73 94.37 14.59 21.08 89.84 11.98 -1.12 41.20 17.82 -1.77 47.26 17.33 coo 24.38 86.32 12.71 22.88 86.54 12.71 3.51 38.38 26.48 5.02 38.72 26.60 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 31 ALA~? 6.46 OXT ACT A 501 A 224 ASP A 54 ASP^? -3.76 O ACT A 501s A 252 HIS A 65 HIS~? -3.60 O ACT A 501s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 14.76 17.72 5.17 13.41 17.92 5.92 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 9.47 12.33 8.26 10.66 11.45 9.76 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA A 64 ALA~? 11.15 O ACT A 501 A 224 ASP A 54 ASP^? -3.76 O ACT A 501s A 252 HIS A 65 HIS~? -3.60 O ACT A 501s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 19.24 7.69 5.99 19.07 7.91 4.49 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 9.47 12.33 8.26 10.66 11.45 9.76 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA A 71 ALA~? 5.64 CH3 ACT A 501 A 224 ASP A 54 ASP^? -3.76 O ACT A 501s A 252 HIS A 65 HIS~? -3.60 O ACT A 501s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 19.26 13.81 13.63 19.24 12.28 13.23 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 9.47 12.33 8.26 10.66 11.45 9.76 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 3 1uk7_c00 3.07.01.0009 user 4 3 # 4 A 103 ALA B 31 ALA~? 6.26 OXT ACT B 502 A 224 ASP B 54 ASP^? 4.46 O ACT B 502 A 252 HIS B 65 HIS~? -3.69 O ACT B 502s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -18.22 15.01 35.83 -18.55 16.36 35.14 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1uk7_c00 3.07.01.0009 user 5 3 # 5 A 103 ALA B 64 ALA~? 11.22 O ACT B 502 A 224 ASP B 54 ASP^? 4.46 O ACT B 502 A 252 HIS B 65 HIS~? -3.69 O ACT B 502s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -8.30 11.03 33.15 -8.32 11.11 34.69 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1uk7_c00 3.07.01.0009 user 6 3 # 6 A 103 ALA B 71 ALA~? 6.33 O ACT B 502 A 224 ASP B 54 ASP^? 4.46 O ACT B 502 A 252 HIS B 65 HIS~? -3.69 O ACT B 502s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -15.58 10.60 26.60 -14.06 10.51 26.75 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1uk7_c00 3.07.01.0009 user 7 3 # 7 A 103 ALA C 31 ALA~? 7.01 O ACT C 503 A 224 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 252 HIS C 65 HIS~? -3.55 C ACT C 503s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -8.94 11.70 1.14 -7.76 11.12 1.95 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1uk7_c00 3.07.01.0009 user 8 3 # 8 A 103 ALA C 64 ALA~? 10.90 CH3 ACT C 503 A 224 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 252 HIS C 65 HIS~? -3.55 C ACT C 503s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -13.66 20.75 5.77 -13.26 21.25 4.37 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1uk7_c00 3.07.01.0009 user 9 3 # 9 A 103 ALA C 71 ALA~? 3.85 CH3 ACT C 503 A 224 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 252 HIS C 65 HIS~? -3.55 C ACT C 503s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -14.49 11.86 9.72 -14.32 13.36 10.09 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1uk7_c00 3.07.01.0009 user 10 3 # 10 A 103 ALA D 31 ALA~? 23.53 OXT ACT B 502 A 224 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 252 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -12.33 38.97 38.82 -11.89 37.76 37.95 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -17.61 39.97 33.46 -15.64 39.60 32.84 ULMN 3 1uk7_c00 3.07.01.0009 user 11 3 # 11 A 103 ALA D 64 ALA~? 28.22 OXT ACT B 502 A 224 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 252 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -22.15 43.56 35.71 -22.30 43.07 37.15 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -17.61 39.97 33.46 -15.64 39.60 32.84 ULMN 3 1uk7_c00 3.07.01.0009 user 12 3 # 12 A 103 ALA D 71 ALA~? 28.01 O ACT B 502 A 224 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 252 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -13.96 44.65 30.21 -15.47 44.54 30.10 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -17.61 39.97 33.46 -15.64 39.60 32.84 1uk7_c00 source 1uk7 3.07.01.0009 : 12 hits 1uk7_c00 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 65 HIS~? -3.60 O ACT A 501s 89 GLU A 34 GLU.? 6.40 OXT ACT A 501 243 ASN A 77 ASN~? 12.80 CH3 ACT A 501 coo 5.83 15.74 17.38 6.41 17.70 17.86 14.91 11.26 8.66 14.30 12.93 9.76 coo 3.11 16.19 13.44 4.96 17.09 13.42 17.44 14.34 4.36 16.78 13.78 6.33 coo 0.53 21.81 31.33 1.05 20.47 29.70 21.26 21.39 19.94 22.82 22.39 18.87 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS A 65 HIS~? -3.60 O ACT A 501s 89 GLU A 34 GLU.? 6.40 OXT ACT A 501 243 ASN A 87 ASN^? 12.58 CH3 ACT A 501 coo 5.83 15.74 17.38 6.41 17.70 17.86 14.91 11.26 8.66 14.30 12.93 9.76 coo 3.11 16.19 13.44 4.96 17.09 13.42 17.44 14.34 4.36 16.78 13.78 6.33 coo 0.53 21.81 31.33 1.05 20.47 29.70 9.12 9.51 22.49 8.21 7.58 22.71 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS B 65 HIS~? -3.69 O ACT B 502s 89 GLU B 34 GLU.? 6.39 OXT ACT B 502 243 ASN B 77 ASN~? 11.66 CH3 ACT B 502 coo 5.83 15.74 17.38 6.41 17.70 17.86 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 3.11 16.19 13.44 4.96 17.09 13.42 -14.54 12.40 35.90 -14.50 13.22 33.94 coo 0.53 21.81 31.33 1.05 20.47 29.70 -24.03 9.36 21.93 -25.16 8.32 23.38 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS B 65 HIS~? -3.69 O ACT B 502s 89 GLU B 34 GLU.? 6.39 OXT ACT B 502 243 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 5.83 15.74 17.38 6.41 17.70 17.86 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 3.11 16.19 13.44 4.96 17.09 13.42 -14.54 12.40 35.90 -14.50 13.22 33.94 coo 0.53 21.81 31.33 1.05 20.47 29.70 -13.79 21.31 17.73 -12.12 22.50 17.15 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 5 3 # 5 86 HIS C 65 HIS~? -3.55 C ACT C 503s 89 GLU C 34 GLU~? 6.63 O ACT C 503 243 ASN C 77 ASN~? 12.75 CH3 ACT C 503 coo 5.83 15.74 17.38 6.41 17.70 17.86 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 3.11 16.19 13.44 4.96 17.09 13.42 -11.68 15.33 1.66 -11.38 14.84 3.76 coo 0.53 21.81 31.33 1.05 20.47 29.70 -17.36 2.60 11.84 -18.59 2.53 10.10 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 6 3 # 6 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 89 GLU D 34 GLU.? 25.91 OXT ACT B 502 243 ASN D 77 ASN~? 33.96 O ACT B 502 coo 5.83 15.74 17.38 6.41 17.70 17.86 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 3.11 16.19 13.44 4.96 17.09 13.42 -16.00 41.58 38.86 -16.04 41.30 36.71 coo 0.53 21.81 31.33 1.05 20.47 29.70 -5.21 47.64 26.62 -4.70 48.89 28.29 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 6 hits 1ula_c00 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN B 67 ASN~? 11.44 O ACT B 502 457 GLY B 61 GLY~? 11.96 O ACT B 502 459 GLU B 59 GLU~? 13.30 O ACT B 502 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -8.90 8.17 29.36 -7.21 8.51 28.12 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN C 32 ASN~? 12.55 O ACT C 503 457 GLY C 36 GLY.? 12.29 OXT ACT C 503 459 GLU C 34 GLU~? 6.63 O ACT C 503 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -7.80 11.04 -3.58 -6.14 9.70 -3.27 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -8.05 21.04 0.95 -7.98 20.22 0.87 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -11.68 15.33 1.66 -11.38 14.84 3.76 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN C 67 ASN~? 10.88 CH3 ACT C 503 457 GLY C 61 GLY~? 11.24 OXT ACT C 503 459 GLU C 59 GLU~? 12.18 OXT ACT C 503 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -17.40 19.51 8.11 -17.74 20.65 9.88 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -9.42 26.68 11.15 -8.43 25.11 12.27 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN D 32 ASN~? 25.03 OXT ACT B 502 457 GLY D 36 GLY.? 24.91 OXT ACT B 502 459 GLU D 34 GLU.? 25.91 OXT ACT B 502 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -10.82 37.91 43.31 -9.73 36.12 42.91 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -21.51 38.16 40.64 -20.69 38.06 40.58 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -16.00 41.58 38.86 -16.04 41.30 36.71 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN D 67 ASN~? 31.47 OXT ACT B 502 457 GLY D 61 GLY~? 24.96 OXT ACT B 502 459 GLU D 59 GLU~? 24.17 OXT ACT B 502 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -21.35 47.13 33.03 -22.85 47.39 31.52 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -28.95 39.32 31.59 -27.70 38.19 30.22 1vom_c00 source 1vom MYOSIN : 5 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 7 PHE^? 10.76 O ACT A 501 A 197 ASN A 87 ASN^? 12.58 CH3 ACT A 501 A 198 PRO A 86 PRO.? 7.52 CH3 ACT A 501 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 4.11 9.93 15.65 2.48 11.68 17.17 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 9.12 9.51 22.49 8.21 7.58 22.71 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 15.04 13.04 20.43 13.78 11.98 21.98 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE B 7 PHE^? 10.67 O ACT B 502 A 197 ASN B 87 ASN^? 12.23 OXT ACT C 503 A 198 PRO B 86 PRO.? 7.56 CH3 ACT B 502 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -13.79 21.31 17.73 -12.12 22.50 17.15 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -16.41 15.08 20.10 -15.74 16.49 18.50 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 197 ASN C 87 ASN.? 10.16 O ACT B 502 A 198 PRO C 86 PRO.? 10.39 CH3 ACT C 503 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -7.54 12.49 22.38 -6.86 14.54 22.53 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -11.27 8.27 18.69 -10.47 8.34 20.82 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE D 7 PHE^? 14.53 O ACT B 502 A 197 ASN D 87 ASN^? 20.96 CH3 ACT B 502 A 198 PRO D 86 PRO.? 25.34 O ACT B 502 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -16.31 36.38 18.28 -18.33 35.57 18.38 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -12.49 41.25 21.41 -12.70 40.16 19.43 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 7 PHE^? 10.76 O ACT A 501 B 197 ASN A 87 ASN^? 12.58 CH3 ACT A 501 B 198 PRO A 86 PRO.? 7.52 CH3 ACT A 501 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 4.11 9.93 15.65 2.48 11.68 17.17 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 9.12 9.51 22.49 8.21 7.58 22.71 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 15.04 13.04 20.43 13.78 11.98 21.98 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE B 7 PHE^? 10.67 O ACT B 502 B 197 ASN B 87 ASN^? 12.23 OXT ACT C 503 B 198 PRO B 86 PRO.? 7.56 CH3 ACT B 502 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -13.79 21.31 17.73 -12.12 22.50 17.15 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -16.41 15.08 20.10 -15.74 16.49 18.50 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE C 7 PHE^? 9.59 OXT ACT C 503 B 197 ASN C 87 ASN.? 10.16 O ACT B 502 B 198 PRO C 86 PRO.? 10.39 CH3 ACT C 503 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -7.54 12.49 22.38 -6.86 14.54 22.53 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -11.27 8.27 18.69 -10.47 8.34 20.82 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE D 7 PHE^? 14.53 O ACT B 502 B 197 ASN D 87 ASN^? 20.96 CH3 ACT B 502 B 198 PRO D 86 PRO.? 25.34 O ACT B 502 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -16.31 36.38 18.28 -18.33 35.57 18.38 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -12.49 41.25 21.41 -12.70 40.16 19.43 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 0 HIS.? 19.86 O ACT C 503 A 169 ASP A 58 ASP~? 16.01 O ACT A 501 A 288 GLU A 59 GLU~? 13.04 O ACT A 501 coo 67.72 35.99 30.87 69.77 36.13 31.33 0.63 2.65 -4.88 1.54 2.35 -6.74 coo 73.17 30.66 22.56 72.87 30.30 20.46 12.40 1.57 0.95 13.75 2.83 -0.02 coo 74.06 28.51 15.92 73.77 29.56 17.73 14.64 -0.22 6.93 13.24 0.65 8.32 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 1 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 36 GLY.? 12.36 O ACT A 501 B 419 GLY A 61 GLY~? 11.65 O ACT A 501 B 420 ALA A 60 ALA~? 15.50 O ACT A 501 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 14.67 9.55 0.54 14.51 10.27 0.79 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 15.25 6.14 3.18 15.29 5.59 3.87 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 16.92 2.68 3.35 17.44 2.38 1.97 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 36 GLY.? 12.36 O ACT A 501 B 419 GLY A 61 GLY~? 11.65 O ACT A 501 B 420 ALA A 64 ALA~? 11.15 O ACT A 501 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 14.67 9.55 0.54 14.51 10.27 0.79 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 15.25 6.14 3.18 15.29 5.59 3.87 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 19.24 7.69 5.99 19.07 7.91 4.49 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY A 101 GLY.? 20.59 OXT ACT A 501 B 419 GLY C 101 GLY.? 20.32 O ACT C 503 B 420 ALA C 100 ALA.? 20.12 OXT ACT A 501 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 5.94 13.82 -7.41 5.72 13.42 -6.75 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 2.17 17.98 -6.90 2.76 18.17 -7.42 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 5.08 19.85 -5.23 5.99 20.85 -6.03 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY B 36 GLY.? 12.65 OXT ACT B 502 B 419 GLY B 61 GLY~? 11.96 O ACT B 502 B 420 ALA B 60 ALA~? 15.70 O ACT B 502 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -9.31 15.33 39.06 -10.10 15.43 38.93 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -3.13 13.34 34.99 -2.65 12.71 36.31 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY B 36 GLY.? 12.65 OXT ACT B 502 B 419 GLY B 61 GLY~? 11.96 O ACT B 502 B 420 ALA B 64 ALA~? 11.22 O ACT B 502 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -9.31 15.33 39.06 -10.10 15.43 38.93 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -8.30 11.03 33.15 -8.32 11.11 34.69 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY C 36 GLY.? 12.29 OXT ACT C 503 B 419 GLY C 61 GLY~? 11.24 OXT ACT C 503 B 420 ALA C 60 ALA~? 15.14 OXT ACT C 503 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -8.05 21.04 0.95 -7.98 20.22 0.87 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -10.85 26.04 6.18 -11.08 26.98 4.99 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 183 GLY C 36 GLY.? 12.29 OXT ACT C 503 B 419 GLY C 61 GLY~? 11.24 OXT ACT C 503 B 420 ALA C 64 ALA~? 10.90 CH3 ACT C 503 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -8.05 21.04 0.95 -7.98 20.22 0.87 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -13.66 20.75 5.77 -13.26 21.25 4.37 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 183 GLY D 36 GLY.? 24.91 OXT ACT B 502 B 419 GLY D 61 GLY~? 24.96 OXT ACT B 502 B 420 ALA D 60 ALA~? 28.12 OXT ACT B 502 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -21.51 38.16 40.64 -20.69 38.06 40.58 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -27.42 40.78 36.27 -28.14 40.94 37.58 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 183 GLY D 36 GLY.? 24.91 OXT ACT B 502 B 419 GLY D 61 GLY~? 24.96 OXT ACT B 502 B 420 ALA D 64 ALA~? 28.22 OXT ACT B 502 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -21.51 38.16 40.64 -20.69 38.06 40.58 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -22.15 43.56 35.71 -22.30 43.07 37.15 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 9 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 39 ALA^? 11.24 O ACT A 501 B 182 GLY A 61 GLY~? 11.65 O ACT A 501 B 183 GLY A 36 GLY.? 12.36 O ACT A 501 coo 38.36-101.47-135.52 39.62-101.29-136.35 7.33 14.03 3.41 5.84 13.61 3.59 coo 41.93-102.35-126.87 41.52-101.89-126.30 15.25 6.14 3.18 15.29 5.59 3.87 coo 38.37-101.99-128.11 38.63-102.24-127.37 14.67 9.55 0.54 14.51 10.27 0.79 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 55 ALA^? 10.68 O ACT A 501 B 182 GLY A 36 GLY.? 12.36 O ACT A 501 B 183 GLY A 61 GLY~? 11.65 O ACT A 501 coo 38.36-101.47-135.52 39.62-101.29-136.35 7.41 9.36 5.53 6.02 9.63 4.91 coo 41.93-102.35-126.87 41.52-101.89-126.30 14.67 9.55 0.54 14.51 10.27 0.79 coo 38.37-101.99-128.11 38.63-102.24-127.37 15.25 6.14 3.18 15.29 5.59 3.87 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA A 55 ALA^? 10.68 O ACT A 501 B 182 GLY A 61 GLY~? 11.65 O ACT A 501 B 183 GLY A 36 GLY.? 12.36 O ACT A 501 coo 38.36-101.47-135.52 39.62-101.29-136.35 7.41 9.36 5.53 6.02 9.63 4.91 coo 41.93-102.35-126.87 41.52-101.89-126.30 15.25 6.14 3.18 15.29 5.59 3.87 coo 38.37-101.99-128.11 38.63-102.24-127.37 14.67 9.55 0.54 14.51 10.27 0.79 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA B 39 ALA^? 11.25 OXT ACT B 502 B 182 GLY B 61 GLY~? 11.96 O ACT B 502 B 183 GLY B 36 GLY.? 12.65 OXT ACT B 502 coo 38.36-101.47-135.52 39.62-101.29-136.35 -14.73 22.42 37.35 -14.52 23.94 37.22 coo 41.93-102.35-126.87 41.52-101.89-126.30 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 38.37-101.99-128.11 38.63-102.24-127.37 -9.31 15.33 39.06 -10.10 15.43 38.93 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA B 55 ALA^? 11.29 O ACT B 502 B 182 GLY B 36 GLY.? 12.65 OXT ACT B 502 B 183 GLY B 61 GLY~? 11.96 O ACT B 502 coo 38.36-101.47-135.52 39.62-101.29-136.35 -10.47 22.59 34.42 -10.69 23.88 35.17 coo 41.93-102.35-126.87 41.52-101.89-126.30 -9.31 15.33 39.06 -10.10 15.43 38.93 coo 38.37-101.99-128.11 38.63-102.24-127.37 -6.51 14.94 35.79 -6.11 14.91 35.04 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA B 55 ALA^? 11.29 O ACT B 502 B 182 GLY B 61 GLY~? 11.96 O ACT B 502 B 183 GLY B 36 GLY.? 12.65 OXT ACT B 502 coo 38.36-101.47-135.52 39.62-101.29-136.35 -10.47 22.59 34.42 -10.69 23.88 35.17 coo 41.93-102.35-126.87 41.52-101.89-126.30 -6.51 14.94 35.79 -6.11 14.91 35.04 coo 38.37-101.99-128.11 38.63-102.24-127.37 -9.31 15.33 39.06 -10.10 15.43 38.93 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA C 39 ALA^? 10.95 OXT ACT C 503 B 182 GLY C 61 GLY~? 11.24 OXT ACT C 503 B 183 GLY C 36 GLY.? 12.29 OXT ACT C 503 coo 38.36-101.47-135.52 39.62-101.29-136.35 -1.54 15.11 2.79 -0.14 15.33 3.34 coo 41.93-102.35-126.87 41.52-101.89-126.30 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 38.37-101.99-128.11 38.63-102.24-127.37 -8.05 21.04 0.95 -7.98 20.22 0.87 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA C 55 ALA^? 9.92 OXT ACT C 503 B 182 GLY C 36 GLY.? 12.29 OXT ACT C 503 B 183 GLY C 61 GLY~? 11.24 OXT ACT C 503 coo 38.36-101.47-135.52 39.62-101.29-136.35 -2.12 18.19 6.82 -0.67 18.10 6.39 coo 41.93-102.35-126.87 41.52-101.89-126.30 -8.05 21.04 0.95 -7.98 20.22 0.87 coo 38.37-101.99-128.11 38.63-102.24-127.37 -9.15 22.88 4.87 -9.37 23.08 5.65 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 420 ALA C 55 ALA^? 9.92 OXT ACT C 503 B 182 GLY C 61 GLY~? 11.24 OXT ACT C 503 B 183 GLY C 36 GLY.? 12.29 OXT ACT C 503 coo 38.36-101.47-135.52 39.62-101.29-136.35 -2.12 18.19 6.82 -0.67 18.10 6.39 coo 41.93-102.35-126.87 41.52-101.89-126.30 -9.15 22.88 4.87 -9.37 23.08 5.65 coo 38.37-101.99-128.11 38.63-102.24-127.37 -8.05 21.04 0.95 -7.98 20.22 0.87 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 420 ALA D 39 ALA^? 16.23 OXT ACT B 502 B 182 GLY D 61 GLY~? 24.96 OXT ACT B 502 B 183 GLY D 36 GLY.? 24.91 OXT ACT B 502 coo 38.36-101.47-135.52 39.62-101.29-136.35 -15.99 31.61 38.26 -16.01 30.11 37.98 coo 41.93-102.35-126.87 41.52-101.89-126.30 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 38.37-101.99-128.11 38.63-102.24-127.37 -21.51 38.16 40.64 -20.69 38.06 40.58 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 11 3 # 11 A 420 ALA D 55 ALA^? 15.53 OXT ACT B 502 B 182 GLY D 36 GLY.? 24.91 OXT ACT B 502 B 183 GLY D 61 GLY~? 24.96 OXT ACT B 502 coo 38.36-101.47-135.52 39.62-101.29-136.35 -19.84 32.00 34.67 -19.79 30.59 35.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 -21.51 38.16 40.64 -20.69 38.06 40.58 coo 38.37-101.99-128.11 38.63-102.24-127.37 -24.10 39.09 37.14 -24.42 39.30 36.39 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 12 3 # 12 A 420 ALA D 55 ALA^? 15.53 OXT ACT B 502 B 182 GLY D 61 GLY~? 24.96 OXT ACT B 502 B 183 GLY D 36 GLY.? 24.91 OXT ACT B 502 coo 38.36-101.47-135.52 39.62-101.29-136.35 -19.84 32.00 34.67 -19.79 30.59 35.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 -24.10 39.09 37.14 -24.42 39.30 36.39 coo 38.37-101.99-128.11 38.63-102.24-127.37 -21.51 38.16 40.64 -20.69 38.06 40.58 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 12 hits 1xny_c01 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 31 ALA~? 6.46 OXT ACT A 501 A 244 ASP A 54 ASP^? -3.76 O ACT A 501s A 271 HIS A 65 HIS~? -3.60 O ACT A 501s coo 15.05 3.71 6.93 14.58 4.88 7.78 14.76 17.72 5.17 13.41 17.92 5.92 coo 9.85 8.15 0.76 10.61 7.04 2.39 9.47 12.33 8.26 10.66 11.45 9.76 coo 10.61 7.65 6.01 12.39 6.55 6.23 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA A 64 ALA~? 11.15 O ACT A 501 A 244 ASP A 54 ASP^? -3.76 O ACT A 501s A 271 HIS A 65 HIS~? -3.60 O ACT A 501s coo 15.05 3.71 6.93 14.58 4.88 7.78 19.24 7.69 5.99 19.07 7.91 4.49 coo 9.85 8.15 0.76 10.61 7.04 2.39 9.47 12.33 8.26 10.66 11.45 9.76 coo 10.61 7.65 6.01 12.39 6.55 6.23 14.91 11.26 8.66 14.30 12.93 9.76 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA B 31 ALA~? 6.26 OXT ACT B 502 A 244 ASP B 54 ASP^? 4.46 O ACT B 502 A 271 HIS B 65 HIS~? -3.69 O ACT B 502s coo 15.05 3.71 6.93 14.58 4.88 7.78 -18.22 15.01 35.83 -18.55 16.36 35.14 coo 9.85 8.15 0.76 10.61 7.04 2.39 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 10.61 7.65 6.01 12.39 6.55 6.23 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 105 ALA B 64 ALA~? 11.22 O ACT B 502 A 244 ASP B 54 ASP^? 4.46 O ACT B 502 A 271 HIS B 65 HIS~? -3.69 O ACT B 502s coo 15.05 3.71 6.93 14.58 4.88 7.78 -8.30 11.03 33.15 -8.32 11.11 34.69 coo 9.85 8.15 0.76 10.61 7.04 2.39 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 10.61 7.65 6.01 12.39 6.55 6.23 -12.58 15.14 31.21 -14.46 15.75 30.51 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 105 ALA C 31 ALA~? 7.01 O ACT C 503 A 244 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 271 HIS C 65 HIS~? -3.55 C ACT C 503s coo 15.05 3.71 6.93 14.58 4.88 7.78 -8.94 11.70 1.14 -7.76 11.12 1.95 coo 9.85 8.15 0.76 10.61 7.04 2.39 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 10.61 7.65 6.01 12.39 6.55 6.23 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 6 3 # 6 A 105 ALA C 64 ALA~? 10.90 CH3 ACT C 503 A 244 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 271 HIS C 65 HIS~? -3.55 C ACT C 503s coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.66 20.75 5.77 -13.26 21.25 4.37 coo 9.85 8.15 0.76 10.61 7.04 2.39 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 10.61 7.65 6.01 12.39 6.55 6.23 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 7 3 # 7 A 105 ALA C 71 ALA~? 3.85 CH3 ACT C 503 A 244 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 271 HIS C 65 HIS~? -3.55 C ACT C 503s coo 15.05 3.71 6.93 14.58 4.88 7.78 -14.49 11.86 9.72 -14.32 13.36 10.09 coo 9.85 8.15 0.76 10.61 7.04 2.39 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 10.61 7.65 6.01 12.39 6.55 6.23 -10.13 15.85 7.28 -9.82 13.80 7.57 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 8 3 # 8 A 105 ALA D 31 ALA~? 23.53 OXT ACT B 502 A 244 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 271 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 15.05 3.71 6.93 14.58 4.88 7.78 -12.33 38.97 38.82 -11.89 37.76 37.95 coo 9.85 8.15 0.76 10.61 7.04 2.39 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 10.61 7.65 6.01 12.39 6.55 6.23 -17.61 39.97 33.46 -15.64 39.60 32.84 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 9 3 # 9 A 105 ALA D 64 ALA~? 28.22 OXT ACT B 502 A 244 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 271 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 15.05 3.71 6.93 14.58 4.88 7.78 -22.15 43.56 35.71 -22.30 43.07 37.15 coo 9.85 8.15 0.76 10.61 7.04 2.39 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 10.61 7.65 6.01 12.39 6.55 6.23 -17.61 39.97 33.46 -15.64 39.60 32.84 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 10 3 # 10 A 105 ALA D 71 ALA~? 28.01 O ACT B 502 A 244 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 271 HIS D 65 HIS~? 23.58 OXT ACT B 502 coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.96 44.65 30.21 -15.47 44.54 30.10 coo 9.85 8.15 0.76 10.61 7.04 2.39 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 10.61 7.65 6.01 12.39 6.55 6.23 -17.61 39.97 33.46 -15.64 39.60 32.84 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 10 hits 1xqw_c00 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 54 ASP^? -3.76 O ACT A 501s A 371 LYS C 97 LYS^? 10.89 OXT ACT A 501 A 407 THR A 37 THR^? 7.38 OXT ACT A 501 coo -5.17 31.09 15.73 -7.07 31.12 16.73 9.47 12.33 8.26 10.66 11.45 9.76 coo -4.43 30.92 22.89 -6.61 31.91 19.71 8.20 19.20 3.14 12.89 15.65 0.85 coo -8.38 36.02 19.06 -8.83 34.10 19.89 12.45 11.59 2.88 13.04 12.51 4.77 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 54 ASP^? -3.76 O ACT A 501s A 371 LYS C 97 LYS^? 10.89 OXT ACT A 501 A 407 THR A 38 THR^? 13.66 O ACT A 501 coo -5.17 31.09 15.73 -7.07 31.12 16.73 9.47 12.33 8.26 10.66 11.45 9.76 coo -4.43 30.92 22.89 -6.61 31.91 19.71 8.20 19.20 3.14 12.89 15.65 0.85 coo -8.38 36.02 19.06 -8.83 34.10 19.89 9.25 11.88 0.86 8.30 10.33 -0.29 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP B 54 ASP^? 4.46 O ACT B 502 A 371 LYS D 97 LYS^? 10.92 OXT ACT B 502 A 407 THR B 37 THR^? 7.60 OXT ACT B 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -19.69 21.43 38.53 -15.42 16.83 39.89 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -11.91 17.46 37.30 -13.16 16.95 35.64 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP B 54 ASP^? 4.46 O ACT B 502 A 371 LYS D 97 LYS^? 10.92 OXT ACT B 502 A 407 THR B 38 THR^? 13.93 OXT ACT B 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -19.69 21.43 38.53 -15.42 16.83 39.89 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -12.00 20.67 39.32 -10.38 21.81 40.17 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 371 LYS A 97 LYS^? 11.17 O ACT C 503 A 407 THR C 37 THR^? 7.26 O ACT C 503 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -6.53 17.89 2.50 -7.37 16.24 3.61 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 371 LYS A 97 LYS^? 11.17 O ACT C 503 A 407 THR C 38 THR^? 13.13 OXT ACT C 503 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -2.96 18.29 1.33 -1.80 20.06 1.28 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 7 3 # 7 A 369 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 371 LYS B 97 LYS^? 23.77 OXT ACT B 502 A 407 THR D 37 THR^? 22.30 OXT ACT B 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -11.27 32.20 40.12 -15.59 36.50 41.95 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -18.75 36.43 38.66 -17.35 37.30 37.28 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 8 3 # 8 A 369 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 371 LYS B 97 LYS^? 23.77 OXT ACT B 502 A 407 THR D 38 THR^? 19.44 OXT ACT B 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -11.27 32.20 40.12 -15.59 36.50 41.95 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -18.99 32.97 40.14 -20.81 31.88 40.43 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 8 hits 1zrz_c02 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU B 59 GLU~? 13.30 O ACT B 502 A 156 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 194 ASN B 67 ASN~? 11.44 O ACT B 502 coo 74.14 15.91 8.55 72.08 15.36 8.63 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.90 8.17 29.36 -7.21 8.51 28.12 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU B 89 GLU^? 13.28 O ACT B 502 A 156 GLU C 59 GLU~? 12.18 OXT ACT C 503 A 194 ASN D 87 ASN^? 20.96 CH3 ACT B 502 coo 74.14 15.91 8.55 72.08 15.36 8.63 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 67.47 20.07 1.34 65.99 20.06 2.88 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 67.44 25.26 13.91 67.54 23.65 15.28 -16.31 36.38 18.28 -18.33 35.57 18.38 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU C 17 GLU~? 20.89 O ACT C 503 A 156 GLU C 11 GLU^? 15.94 OXT ACT C 503 A 194 ASN C 77 ASN~? 12.75 CH3 ACT C 503 coo 74.14 15.91 8.55 72.08 15.36 8.63 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo 67.47 20.07 1.34 65.99 20.06 2.88 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 67.44 25.26 13.91 67.54 23.65 15.28 -17.36 2.60 11.84 -18.59 2.53 10.10 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU C 59 GLU~? 12.18 OXT ACT C 503 A 156 GLU B 89 GLU^? 13.28 O ACT B 502 A 194 ASN D 87 ASN^? 20.96 CH3 ACT B 502 coo 74.14 15.91 8.55 72.08 15.36 8.63 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 67.47 20.07 1.34 65.99 20.06 2.88 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 67.44 25.26 13.91 67.54 23.65 15.28 -16.31 36.38 18.28 -18.33 35.57 18.38 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 156 GLU B 59 GLU~? 13.30 O ACT B 502 A 194 ASN A 87 ASN^? 12.58 CH3 ACT A 501 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 67.47 20.07 1.34 65.99 20.06 2.88 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 67.44 25.26 13.91 67.54 23.65 15.28 9.12 9.51 22.49 8.21 7.58 22.71 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 156 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 194 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 67.47 20.07 1.34 65.99 20.06 2.88 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 67.44 25.26 13.91 67.54 23.65 15.28 -13.79 21.31 17.73 -12.12 22.50 17.15 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU C 92 GLU^? 15.67 OXT ACT C 503 A 156 GLU C 89 GLU^? 12.32 OXT ACT C 503 A 194 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 74.14 15.91 8.55 72.08 15.36 8.63 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 67.44 25.26 13.91 67.54 23.65 15.28 -13.79 21.31 17.73 -12.12 22.50 17.15 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU D 17 GLU~? 25.97 OXT ACT A 501 A 156 GLU D 11 GLU.? 21.84 O ACT B 502 A 194 ASN D 77 ASN~? 33.96 O ACT B 502 coo 74.14 15.91 8.55 72.08 15.36 8.63 2.12 36.56 21.03 3.60 37.59 19.89 coo 67.47 20.07 1.34 65.99 20.06 2.88 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 67.44 25.26 13.91 67.54 23.65 15.28 -5.21 47.64 26.62 -4.70 48.89 28.29 2dbt_c00 source 2dbt CHITINASE C : 8 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 17 GLU~? 18.98 CH3 ACT A 501 B 156 GLU A 11 GLU.? 15.43 CH3 ACT A 501 B 194 ASN A 77 ASN~? 12.80 CH3 ACT A 501 coo 45.64 63.11 17.20 47.48 62.43 16.45 8.46 25.60 25.93 9.21 26.72 27.59 coo 54.43 67.89 19.82 55.62 67.90 18.07 8.65 17.34 27.29 6.65 18.05 26.99 coo 49.79 70.75 7.78 50.10 68.90 6.86 21.26 21.39 19.94 22.82 22.39 18.87 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU B 11 GLU.? 14.84 CH3 ACT B 502 B 156 GLU B 17 GLU~? 18.31 CH3 ACT B 502 B 194 ASN B 77 ASN~? 11.66 CH3 ACT B 502 coo 45.64 63.11 17.20 47.48 62.43 16.45 -22.40 21.62 14.44 -23.19 23.50 15.06 coo 54.43 67.89 19.82 55.62 67.90 18.07 -30.37 21.21 17.22 -31.47 20.28 15.66 coo 49.79 70.75 7.78 50.10 68.90 6.86 -24.03 9.36 21.93 -25.16 8.32 23.38 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU B 17 GLU~? 18.31 CH3 ACT B 502 B 156 GLU B 11 GLU.? 14.84 CH3 ACT B 502 B 194 ASN B 77 ASN~? 11.66 CH3 ACT B 502 coo 45.64 63.11 17.20 47.48 62.43 16.45 -30.37 21.21 17.22 -31.47 20.28 15.66 coo 54.43 67.89 19.82 55.62 67.90 18.07 -22.40 21.62 14.44 -23.19 23.50 15.06 coo 49.79 70.75 7.78 50.10 68.90 6.86 -24.03 9.36 21.93 -25.16 8.32 23.38 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 59 GLU~? 13.30 O ACT B 502 B 156 GLU C 89 GLU^? 12.32 OXT ACT C 503 B 194 ASN B 67 ASN~? 11.44 O ACT B 502 coo 45.64 63.11 17.20 47.48 62.43 16.45 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.90 8.17 29.36 -7.21 8.51 28.12 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU B 89 GLU^? 13.28 O ACT B 502 B 156 GLU C 59 GLU~? 12.18 OXT ACT C 503 B 194 ASN D 87 ASN^? 20.96 CH3 ACT B 502 coo 45.64 63.11 17.20 47.48 62.43 16.45 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 54.43 67.89 19.82 55.62 67.90 18.07 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 49.79 70.75 7.78 50.10 68.90 6.86 -16.31 36.38 18.28 -18.33 35.57 18.38 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU C 11 GLU^? 15.94 OXT ACT C 503 B 156 GLU C 17 GLU~? 20.89 O ACT C 503 B 194 ASN C 77 ASN~? 12.75 CH3 ACT C 503 coo 45.64 63.11 17.20 47.48 62.43 16.45 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 54.43 67.89 19.82 55.62 67.90 18.07 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo 49.79 70.75 7.78 50.10 68.90 6.86 -17.36 2.60 11.84 -18.59 2.53 10.10 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU C 17 GLU~? 20.89 O ACT C 503 B 156 GLU C 11 GLU^? 15.94 OXT ACT C 503 B 194 ASN C 77 ASN~? 12.75 CH3 ACT C 503 coo 45.64 63.11 17.20 47.48 62.43 16.45 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo 54.43 67.89 19.82 55.62 67.90 18.07 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 49.79 70.75 7.78 50.10 68.90 6.86 -17.36 2.60 11.84 -18.59 2.53 10.10 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU C 59 GLU~? 12.18 OXT ACT C 503 B 156 GLU B 89 GLU^? 13.28 O ACT B 502 B 194 ASN D 87 ASN^? 20.96 CH3 ACT B 502 coo 45.64 63.11 17.20 47.48 62.43 16.45 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 54.43 67.89 19.82 55.62 67.90 18.07 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 49.79 70.75 7.78 50.10 68.90 6.86 -16.31 36.38 18.28 -18.33 35.57 18.38 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU C 89 GLU^? 12.32 OXT ACT C 503 B 156 GLU B 59 GLU~? 13.30 O ACT B 502 B 194 ASN A 87 ASN^? 12.58 CH3 ACT A 501 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 54.43 67.89 19.82 55.62 67.90 18.07 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 49.79 70.75 7.78 50.10 68.90 6.86 9.12 9.51 22.49 8.21 7.58 22.71 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU C 89 GLU^? 12.32 OXT ACT C 503 B 156 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 194 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 54.43 67.89 19.82 55.62 67.90 18.07 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.79 21.31 17.73 -12.12 22.50 17.15 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 156 GLU C 89 GLU^? 12.32 OXT ACT C 503 B 194 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 45.64 63.11 17.20 47.48 62.43 16.45 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.79 21.31 17.73 -12.12 22.50 17.15 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU D 17 GLU~? 25.97 OXT ACT A 501 B 156 GLU D 11 GLU.? 21.84 O ACT B 502 B 194 ASN D 77 ASN~? 33.96 O ACT B 502 coo 45.64 63.11 17.20 47.48 62.43 16.45 2.12 36.56 21.03 3.60 37.59 19.89 coo 54.43 67.89 19.82 55.62 67.90 18.07 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 49.79 70.75 7.78 50.10 68.90 6.86 -5.21 47.64 26.62 -4.70 48.89 28.29 2dbt_c01 source 2dbt CHITINASE C : 12 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU B 59 GLU~? 13.30 O ACT B 502 C 156 GLU C 89 GLU^? 12.32 OXT ACT C 503 C 194 ASN B 67 ASN~? 11.44 O ACT B 502 coo 41.23 29.31 13.28 43.03 29.85 12.29 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.90 8.17 29.36 -7.21 8.51 28.12 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU B 89 GLU^? 13.28 O ACT B 502 C 156 GLU C 59 GLU~? 12.18 OXT ACT C 503 C 194 ASN D 87 ASN^? 20.96 CH3 ACT B 502 coo 41.23 29.31 13.28 43.03 29.85 12.29 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 44.75 23.09 5.51 46.77 22.91 6.12 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 49.75 21.00 18.12 50.45 23.02 18.26 -16.31 36.38 18.28 -18.33 35.57 18.38 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU C 11 GLU^? 15.94 OXT ACT C 503 C 156 GLU C 17 GLU~? 20.89 O ACT C 503 C 194 ASN C 77 ASN~? 12.75 CH3 ACT C 503 coo 41.23 29.31 13.28 43.03 29.85 12.29 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 44.75 23.09 5.51 46.77 22.91 6.12 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo 49.75 21.00 18.12 50.45 23.02 18.26 -17.36 2.60 11.84 -18.59 2.53 10.10 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU C 17 GLU~? 20.89 O ACT C 503 C 156 GLU C 11 GLU^? 15.94 OXT ACT C 503 C 194 ASN C 77 ASN~? 12.75 CH3 ACT C 503 coo 41.23 29.31 13.28 43.03 29.85 12.29 -7.18 -6.10 16.13 -8.28 -7.84 16.85 coo 44.75 23.09 5.51 46.77 22.91 6.12 -6.14 2.53 21.46 -4.11 2.08 21.09 coo 49.75 21.00 18.12 50.45 23.02 18.26 -17.36 2.60 11.84 -18.59 2.53 10.10 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU C 59 GLU~? 12.18 OXT ACT C 503 C 156 GLU B 89 GLU^? 13.28 O ACT B 502 C 194 ASN C 67 ASN~? 10.88 CH3 ACT C 503 coo 41.23 29.31 13.28 43.03 29.85 12.29 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 44.75 23.09 5.51 46.77 22.91 6.12 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 49.75 21.00 18.12 50.45 23.02 18.26 -17.40 19.51 8.11 -17.74 20.65 9.88 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU C 59 GLU~? 12.18 OXT ACT C 503 C 156 GLU B 89 GLU^? 13.28 O ACT B 502 C 194 ASN D 87 ASN^? 20.96 CH3 ACT B 502 coo 41.23 29.31 13.28 43.03 29.85 12.29 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 44.75 23.09 5.51 46.77 22.91 6.12 -9.24 24.07 20.62 -9.79 26.07 20.27 coo 49.75 21.00 18.12 50.45 23.02 18.26 -16.31 36.38 18.28 -18.33 35.57 18.38 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU C 89 GLU^? 12.32 OXT ACT C 503 C 156 GLU B 59 GLU~? 13.30 O ACT B 502 C 194 ASN A 87 ASN^? 12.58 CH3 ACT A 501 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 44.75 23.09 5.51 46.77 22.91 6.12 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 49.75 21.00 18.12 50.45 23.02 18.26 9.12 9.51 22.49 8.21 7.58 22.71 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU C 89 GLU^? 12.32 OXT ACT C 503 C 156 GLU C 92 GLU^? 15.67 OXT ACT C 503 C 194 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 44.75 23.09 5.51 46.77 22.91 6.12 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.79 21.31 17.73 -12.12 22.50 17.15 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU C 92 GLU^? 15.67 OXT ACT C 503 C 156 GLU C 89 GLU^? 12.32 OXT ACT C 503 C 194 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 41.23 29.31 13.28 43.03 29.85 12.29 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.72 14.77 20.03 -1.73 14.43 20.69 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.79 21.31 17.73 -12.12 22.50 17.15 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU D 17 GLU~? 25.97 OXT ACT A 501 C 156 GLU D 11 GLU.? 21.84 O ACT B 502 C 194 ASN D 77 ASN~? 33.96 O ACT B 502 coo 41.23 29.31 13.28 43.03 29.85 12.29 2.12 36.56 21.03 3.60 37.59 19.89 coo 44.75 23.09 5.51 46.77 22.91 6.12 -7.35 35.76 17.53 -6.53 33.80 17.57 coo 49.75 21.00 18.12 50.45 23.02 18.26 -5.21 47.64 26.62 -4.70 48.89 28.29 2dbt_c02 source 2dbt CHITINASE C : 10 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 90 LYS^? 10.86 O ACT A 501 B 184 LYS C 44 LYS^? 18.40 O ACT C 503 B 345 ASP A 58 ASP~? 16.01 O ACT A 501 coo 38.76 2.27 4.00 34.00 5.99 4.37 8.29 3.28 13.77 13.67 2.39 14.04 coo 40.63 7.13 9.06 35.85 7.36 8.95 -0.37 1.29 11.81 -0.77 -4.95 10.90 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS B 90 LYS^? 12.84 O ACT B 502 B 184 LYS D 44 LYS^? 22.72 O ACT B 502 B 345 ASP B 58 ASP~? 16.37 O ACT B 502 coo 38.76 2.27 4.00 34.00 5.99 4.37 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 40.63 7.13 9.06 35.85 7.36 8.95 -4.01 30.39 26.69 2.27 30.95 26.10 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 B 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 B 345 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 38.76 2.27 4.00 34.00 5.99 4.37 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 40.63 7.13 9.06 35.85 7.36 8.95 3.76 21.56 17.68 3.38 25.65 21.29 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 B 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 B 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 38.76 2.27 4.00 34.00 5.99 4.37 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 40.63 7.13 9.06 35.85 7.36 8.95 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 C 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 C 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 0.95 12.72 73.51 1.58 12.72 68.31 -24.96 26.06 24.81 -31.04 25.82 23.05 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS B 90 LYS^? 12.84 O ACT B 502 D 184 LYS D 44 LYS^? 22.72 O ACT B 502 D 345 ASP B 54 ASP^? 4.46 O ACT B 502 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -4.01 30.39 26.69 2.27 30.95 26.10 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 D 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 D 345 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 3.76 21.56 17.68 3.38 25.65 21.29 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 D 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 D 345 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -16.29 34.40 33.40 -16.55 35.85 31.87 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 D 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 D 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS B 90 LYS^? 12.84 O ACT B 502 E 184 LYS D 44 LYS^? 22.72 O ACT B 502 E 345 ASP B 54 ASP^? 4.46 O ACT B 502 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -4.01 30.39 26.69 2.27 30.95 26.10 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 E 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 E 345 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo -21.16 62.58 121.86 -16.35 60.33 119.23 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -23.22 55.98 120.74 -18.11 55.31 120.43 3.76 21.56 17.68 3.38 25.65 21.29 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 E 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 E 345 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -23.03 34.53 25.25 -26.25 39.79 25.56 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -24.96 26.06 24.81 -31.04 25.82 23.05 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -16.29 34.40 33.40 -16.55 35.85 31.87 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 E 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 E 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -23.03 34.53 25.25 -26.25 39.79 25.56 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -24.96 26.06 24.81 -31.04 25.82 23.05 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 90 LYS^? 10.86 O ACT A 501 F 184 LYS C 44 LYS^? 18.40 O ACT C 503 F 345 ASP A 54 ASP^? -3.76 O ACT A 501s coo 10.64 34.02 91.30 6.30 35.60 95.11 8.29 3.28 13.77 13.67 2.39 14.04 coo 13.75 39.76 94.12 11.42 37.23 97.89 -0.37 1.29 11.81 -0.77 -4.95 10.90 coo 16.35 26.90 99.56 16.81 25.90 97.75 9.47 12.33 8.26 10.66 11.45 9.76 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS B 90 LYS^? 12.84 O ACT B 502 F 184 LYS D 44 LYS^? 22.72 O ACT B 502 F 345 ASP B 54 ASP^? 4.46 O ACT B 502 coo 10.64 34.02 91.30 6.30 35.60 95.11 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 13.75 39.76 94.12 11.42 37.23 97.89 -4.01 30.39 26.69 2.27 30.95 26.10 coo 16.35 26.90 99.56 16.81 25.90 97.75 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 F 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 F 345 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 10.64 34.02 91.30 6.30 35.60 95.11 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 13.75 39.76 94.12 11.42 37.23 97.89 3.76 21.56 17.68 3.38 25.65 21.29 coo 16.35 26.90 99.56 16.81 25.90 97.75 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 F 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 F 345 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 10.64 34.02 91.30 6.30 35.60 95.11 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 13.75 39.76 94.12 11.42 37.23 97.89 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 16.35 26.90 99.56 16.81 25.90 97.75 -16.29 34.40 33.40 -16.55 35.85 31.87 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS B 90 LYS^? 12.84 O ACT B 502 G 184 LYS D 44 LYS^? 22.72 O ACT B 502 G 345 ASP B 54 ASP^? 4.46 O ACT B 502 coo 39.68 42.04 76.11 43.42 46.43 74.96 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 36.69 47.69 78.93 39.38 50.40 75.35 -4.01 30.39 26.69 2.27 30.95 26.10 coo 33.43 44.37 65.47 33.10 42.30 65.37 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 G 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 G 345 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 39.68 42.04 76.11 43.42 46.43 74.96 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 36.69 47.69 78.93 39.38 50.40 75.35 3.76 21.56 17.68 3.38 25.65 21.29 coo 33.43 44.37 65.47 33.10 42.30 65.37 -4.59 14.55 7.45 -6.01 14.57 8.99 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS B 90 LYS^? 12.84 O ACT B 502 H 184 LYS D 44 LYS^? 22.72 O ACT B 502 H 345 ASP B 54 ASP^? 4.46 O ACT B 502 coo 71.58 83.18 80.51 66.88 79.77 79.84 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 73.65 78.64 75.66 68.14 79.07 75.04 -4.01 30.39 26.69 2.27 30.95 26.10 coo 67.43 90.73 71.39 68.27 92.30 72.52 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 H 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 H 345 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 71.58 83.18 80.51 66.88 79.77 79.84 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 73.65 78.64 75.66 68.14 79.07 75.04 3.76 21.56 17.68 3.38 25.65 21.29 coo 67.43 90.73 71.39 68.27 92.30 72.52 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 H 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 H 345 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 71.58 83.18 80.51 66.88 79.77 79.84 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 73.65 78.64 75.66 68.14 79.07 75.04 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 67.43 90.73 71.39 68.27 92.30 72.52 -16.29 34.40 33.40 -16.55 35.85 31.87 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS B 90 LYS^? 12.84 O ACT B 502 I 184 LYS D 44 LYS^? 22.72 O ACT B 502 I 345 ASP B 54 ASP^? 4.46 O ACT B 502 coo 60.20 96.92 42.53 57.60 93.13 38.67 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 54.31 95.46 46.01 55.34 91.59 42.65 -4.01 30.39 26.69 2.27 30.95 26.10 coo 66.35 87.81 48.53 68.10 89.01 48.77 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 I 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 I 345 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 60.20 96.92 42.53 57.60 93.13 38.67 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 54.31 95.46 46.01 55.34 91.59 42.65 3.76 21.56 17.68 3.38 25.65 21.29 coo 66.35 87.81 48.53 68.10 89.01 48.77 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 I 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 I 345 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 60.20 96.92 42.53 57.60 93.13 38.67 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 54.31 95.46 46.01 55.34 91.59 42.65 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 66.35 87.81 48.53 68.10 89.01 48.77 -16.29 34.40 33.40 -16.55 35.85 31.87 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 I 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 I 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 60.20 96.92 42.53 57.60 93.13 38.67 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 54.31 95.46 46.01 55.34 91.59 42.65 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 66.35 87.81 48.53 68.10 89.01 48.77 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS B 90 LYS^? 12.84 O ACT B 502 J 184 LYS D 44 LYS^? 22.72 O ACT B 502 J 345 ASP B 58 ASP~? 16.37 O ACT B 502 coo 25.22 70.55 14.03 27.64 73.07 18.65 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 31.73 69.87 11.50 32.73 70.19 16.40 -4.01 30.39 26.69 2.27 30.95 26.10 coo 25.87 58.42 18.79 23.95 58.54 17.90 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 J 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 J 345 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 25.22 70.55 14.03 27.64 73.07 18.65 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 31.73 69.87 11.50 32.73 70.19 16.40 3.76 21.56 17.68 3.38 25.65 21.29 coo 25.87 58.42 18.79 23.95 58.54 17.90 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 J 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 J 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 25.22 70.55 14.03 27.64 73.07 18.65 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 31.73 69.87 11.50 32.73 70.19 16.40 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 25.87 58.42 18.79 23.95 58.54 17.90 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 K 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 K 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 90 LYS^? 10.86 O ACT A 501 L 184 LYS C 44 LYS^? 18.40 O ACT C 503 L 345 ASP A 58 ASP~? 16.01 O ACT A 501 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 8.29 3.28 13.77 13.67 2.39 14.04 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -0.37 1.29 11.81 -0.77 -4.95 10.90 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 12.40 1.57 0.95 13.75 2.83 -0.02 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS B 90 LYS^? 12.84 O ACT B 502 L 184 LYS D 44 LYS^? 22.72 O ACT B 502 L 345 ASP B 58 ASP~? 16.37 O ACT B 502 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -4.01 30.39 26.69 2.27 30.95 26.10 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 L 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 L 345 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 3.76 21.56 17.68 3.38 25.65 21.29 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 L 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 L 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS B 90 LYS^? 12.84 O ACT B 502 M 184 LYS D 44 LYS^? 22.72 O ACT B 502 M 345 ASP B 58 ASP~? 16.37 O ACT B 502 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -6.01 21.92 25.13 -2.78 16.45 24.93 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -4.01 30.39 26.69 2.27 30.95 26.10 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 M 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 M 345 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 3.76 21.56 17.68 3.38 25.65 21.29 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 M 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 M 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -23.03 34.53 25.25 -26.25 39.79 25.56 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -24.96 26.06 24.81 -31.04 25.82 23.05 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS B 90 LYS^? 12.84 O ACT B 502 N 184 LYS D 44 LYS^? 22.72 O ACT B 502 N 345 ASP B 54 ASP^? 4.46 O ACT B 502 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -4.01 30.39 26.69 2.27 30.95 26.10 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 N 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 N 345 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 3.76 21.56 17.68 3.38 25.65 21.29 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 N 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 N 345 ASP D 54 ASP^? 19.49 OXT ACT B 502 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -16.29 34.40 33.40 -16.55 35.85 31.87 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS B 90 LYS^? 12.84 O ACT B 502 O 184 LYS D 44 LYS^? 22.72 O ACT B 502 O 345 ASP B 54 ASP^? 4.46 O ACT B 502 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -4.01 30.39 26.69 2.27 30.95 26.10 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -13.85 20.61 32.18 -13.16 19.46 30.55 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 O 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 O 345 ASP C 54 ASP^? -3.02 OXT ACT C 503s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 3.76 21.56 17.68 3.38 25.65 21.29 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -4.59 14.55 7.45 -6.01 14.57 8.99 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 O 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 O 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS B 90 LYS^? 12.84 O ACT B 502 P 184 LYS D 44 LYS^? 22.72 O ACT B 502 P 345 ASP B 58 ASP~? 16.37 O ACT B 502 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -4.01 30.39 26.69 2.27 30.95 26.10 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -1.77 17.89 37.44 -2.74 16.22 38.35 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS C 90 LYS^? 10.56 OXT ACT C 503 P 184 LYS A 44 LYS^? 17.14 CH3 ACT A 501 P 345 ASP C 58 ASP~? 15.48 OXT ACT C 503 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 3.76 21.56 17.68 3.38 25.65 21.29 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -5.93 27.71 5.50 -7.21 27.13 3.90 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS D 90 LYS^? 25.07 CH3 ACT B 502 P 184 LYS B 44 LYS^? 16.99 CH3 ACT B 502 P 345 ASP D 58 ASP~? 25.46 OXT ACT B 502 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -24.96 26.06 24.81 -31.04 25.82 23.05 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -28.98 35.91 37.37 -28.15 37.30 38.76 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 41 PHE^? 11.20 OXT ACT A 501 A 245 ASP A 54 ASP^? -3.76 O ACT A 501s A 273 LYS A 90 LYS^? 10.86 O ACT A 501 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 4.28 16.86 7.90 2.95 16.20 5.48 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.47 12.33 8.26 10.66 11.45 9.76 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE B 41 PHE^? 11.14 OXT ACT B 502 A 245 ASP B 54 ASP^? 4.46 O ACT B 502 A 273 LYS B 3 LYS.? 21.07 O ACT B 502 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE B 41 PHE^? 11.14 OXT ACT B 502 A 245 ASP B 54 ASP^? 4.46 O ACT B 502 A 273 LYS B 90 LYS^? 12.84 O ACT B 502 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 245 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 273 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE C 41 PHE^? 10.92 O ACT C 503 A 245 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 273 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 0.59 10.20 5.98 2.26 11.80 4.40 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE C 41 PHE^? 10.92 O ACT C 503 A 245 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 273 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 0.59 10.20 5.98 2.26 11.80 4.40 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 245 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 273 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 245 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 273 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -23.03 34.53 25.25 -26.25 39.79 25.56 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 8 hits 2gsa_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 7 PHE^? 10.76 O ACT A 501 A 263 ASP A 54 ASP^? -3.76 O ACT A 501s A 292 LYS A 3 LYS.? 15.82 O ACT C 503 coo 51.51 50.32 16.39 52.13 49.68 13.75 4.11 9.93 15.65 2.48 11.68 17.17 coo 54.43 44.82 23.74 55.21 45.06 21.80 9.47 12.33 8.26 10.66 11.45 9.76 coo 63.95 45.30 16.71 59.11 49.15 16.05 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 41 PHE^? 11.20 OXT ACT A 501 A 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 292 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 51.51 50.32 16.39 52.13 49.68 13.75 4.28 16.86 7.90 2.95 16.20 5.48 coo 54.43 44.82 23.74 55.21 45.06 21.80 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 63.95 45.30 16.71 59.11 49.15 16.05 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 53 PHE^? 10.03 O ACT A 501 A 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 292 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 51.51 50.32 16.39 52.13 49.68 13.75 4.01 11.96 10.37 3.05 9.75 8.94 coo 54.43 44.82 23.74 55.21 45.06 21.80 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 63.95 45.30 16.71 59.11 49.15 16.05 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE A 53 PHE^? 10.03 O ACT A 501 A 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 292 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 51.51 50.32 16.39 52.13 49.68 13.75 4.01 11.96 10.37 3.05 9.75 8.94 coo 54.43 44.82 23.74 55.21 45.06 21.80 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 63.95 45.30 16.71 59.11 49.15 16.05 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE B 7 PHE^? 10.67 O ACT B 502 A 263 ASP B 54 ASP^? 4.46 O ACT B 502 A 292 LYS B 3 LYS.? 21.07 O ACT B 502 coo 51.51 50.32 16.39 52.13 49.68 13.75 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 63.95 45.30 16.71 59.11 49.15 16.05 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE B 41 PHE^? 11.14 OXT ACT B 502 A 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 292 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 51.51 50.32 16.39 52.13 49.68 13.75 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 54.43 44.82 23.74 55.21 45.06 21.80 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE B 53 PHE^? 10.51 O ACT B 502 A 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 292 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 51.51 50.32 16.39 52.13 49.68 13.75 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 54.43 44.82 23.74 55.21 45.06 21.80 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE B 53 PHE^? 10.51 O ACT B 502 A 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 292 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 51.51 50.32 16.39 52.13 49.68 13.75 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 54.43 44.82 23.74 55.21 45.06 21.80 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE C 7 PHE^? 9.59 OXT ACT C 503 A 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 292 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 51.51 50.32 16.39 52.13 49.68 13.75 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 54.43 44.82 23.74 55.21 45.06 21.80 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 63.95 45.30 16.71 59.11 49.15 16.05 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE C 41 PHE^? 10.92 O ACT C 503 A 263 ASP A 54 ASP^? -3.76 O ACT A 501s A 292 LYS A 90 LYS^? 10.86 O ACT A 501 coo 51.51 50.32 16.39 52.13 49.68 13.75 0.59 10.20 5.98 2.26 11.80 4.40 coo 54.43 44.82 23.74 55.21 45.06 21.80 9.47 12.33 8.26 10.66 11.45 9.76 coo 63.95 45.30 16.71 59.11 49.15 16.05 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 263 ASP A 54 ASP^? -3.76 O ACT A 501s A 292 LYS A 3 LYS.? 15.82 O ACT C 503 coo 51.51 50.32 16.39 52.13 49.68 13.75 0.16 13.32 10.36 1.32 15.86 10.31 coo 54.43 44.82 23.74 55.21 45.06 21.80 9.47 12.33 8.26 10.66 11.45 9.76 coo 63.95 45.30 16.71 59.11 49.15 16.05 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 177 PHE C 53 PHE^? 9.13 OXT ACT C 503 A 263 ASP A 54 ASP^? -3.76 O ACT A 501s A 292 LYS A 90 LYS^? 10.86 O ACT A 501 coo 51.51 50.32 16.39 52.13 49.68 13.75 0.16 13.32 10.36 1.32 15.86 10.31 coo 54.43 44.82 23.74 55.21 45.06 21.80 9.47 12.33 8.26 10.66 11.45 9.76 coo 63.95 45.30 16.71 59.11 49.15 16.05 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 177 PHE D 7 PHE^? 14.53 O ACT B 502 A 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 292 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 51.51 50.32 16.39 52.13 49.68 13.75 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 54.43 44.82 23.74 55.21 45.06 21.80 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 177 PHE D 41 PHE^? 14.15 OXT ACT B 502 A 263 ASP B 54 ASP^? 4.46 O ACT B 502 A 292 LYS B 90 LYS^? 12.84 O ACT B 502 coo 51.51 50.32 16.39 52.13 49.68 13.75 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 63.95 45.30 16.71 59.11 49.15 16.05 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 177 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 263 ASP B 54 ASP^? 4.46 O ACT B 502 A 292 LYS B 3 LYS.? 21.07 O ACT B 502 coo 51.51 50.32 16.39 52.13 49.68 13.75 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 63.95 45.30 16.71 59.11 49.15 16.05 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 177 PHE D 53 PHE^? 12.57 OXT ACT B 502 A 263 ASP B 54 ASP^? 4.46 O ACT B 502 A 292 LYS B 90 LYS^? 12.84 O ACT B 502 coo 51.51 50.32 16.39 52.13 49.68 13.75 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 63.95 45.30 16.71 59.11 49.15 16.05 -6.01 21.92 25.13 -2.78 16.45 24.93 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 7 PHE^? 10.76 O ACT A 501 B 263 ASP A 54 ASP^? -3.76 O ACT A 501s B 292 LYS A 3 LYS.? 15.82 O ACT C 503 coo 49.99 26.05 6.28 51.46 26.87 8.49 4.11 9.93 15.65 2.48 11.68 17.17 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 9.47 12.33 8.26 10.66 11.45 9.76 coo 60.53 31.67 0.97 57.79 27.51 3.63 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 41 PHE^? 11.20 OXT ACT A 501 B 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 292 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 49.99 26.05 6.28 51.46 26.87 8.49 4.28 16.86 7.90 2.95 16.20 5.48 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 60.53 31.67 0.97 57.79 27.51 3.63 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 53 PHE^? 10.03 O ACT A 501 B 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 292 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 49.99 26.05 6.28 51.46 26.87 8.49 4.01 11.96 10.37 3.05 9.75 8.94 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 60.53 31.67 0.97 57.79 27.51 3.63 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE A 53 PHE^? 10.03 O ACT A 501 B 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 292 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 49.99 26.05 6.28 51.46 26.87 8.49 4.01 11.96 10.37 3.05 9.75 8.94 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 60.53 31.67 0.97 57.79 27.51 3.63 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE B 7 PHE^? 10.67 O ACT B 502 B 263 ASP B 54 ASP^? 4.46 O ACT B 502 B 292 LYS B 3 LYS.? 21.07 O ACT B 502 coo 49.99 26.05 6.28 51.46 26.87 8.49 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 60.53 31.67 0.97 57.79 27.51 3.63 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE B 41 PHE^? 11.14 OXT ACT B 502 B 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 292 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 49.99 26.05 6.28 51.46 26.87 8.49 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE B 53 PHE^? 10.51 O ACT B 502 B 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 292 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 49.99 26.05 6.28 51.46 26.87 8.49 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE B 53 PHE^? 10.51 O ACT B 502 B 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 292 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 49.99 26.05 6.28 51.46 26.87 8.49 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE C 7 PHE^? 9.59 OXT ACT C 503 B 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 292 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 49.99 26.05 6.28 51.46 26.87 8.49 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 60.53 31.67 0.97 57.79 27.51 3.63 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE C 41 PHE^? 10.92 O ACT C 503 B 263 ASP A 54 ASP^? -3.76 O ACT A 501s B 292 LYS A 90 LYS^? 10.86 O ACT A 501 coo 49.99 26.05 6.28 51.46 26.87 8.49 0.59 10.20 5.98 2.26 11.80 4.40 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 9.47 12.33 8.26 10.66 11.45 9.76 coo 60.53 31.67 0.97 57.79 27.51 3.63 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE C 53 PHE^? 9.13 OXT ACT C 503 B 263 ASP A 54 ASP^? -3.76 O ACT A 501s B 292 LYS A 3 LYS.? 15.82 O ACT C 503 coo 49.99 26.05 6.28 51.46 26.87 8.49 0.16 13.32 10.36 1.32 15.86 10.31 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 9.47 12.33 8.26 10.66 11.45 9.76 coo 60.53 31.67 0.97 57.79 27.51 3.63 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE C 53 PHE^? 9.13 OXT ACT C 503 B 263 ASP A 54 ASP^? -3.76 O ACT A 501s B 292 LYS A 90 LYS^? 10.86 O ACT A 501 coo 49.99 26.05 6.28 51.46 26.87 8.49 0.16 13.32 10.36 1.32 15.86 10.31 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 9.47 12.33 8.26 10.66 11.45 9.76 coo 60.53 31.67 0.97 57.79 27.51 3.63 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE D 7 PHE^? 14.53 O ACT B 502 B 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 292 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 49.99 26.05 6.28 51.46 26.87 8.49 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 177 PHE D 41 PHE^? 14.15 OXT ACT B 502 B 263 ASP B 54 ASP^? 4.46 O ACT B 502 B 292 LYS B 90 LYS^? 12.84 O ACT B 502 coo 49.99 26.05 6.28 51.46 26.87 8.49 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 60.53 31.67 0.97 57.79 27.51 3.63 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 B 177 PHE D 53 PHE^? 12.57 OXT ACT B 502 B 263 ASP B 54 ASP^? 4.46 O ACT B 502 B 292 LYS B 3 LYS.? 21.07 O ACT B 502 coo 49.99 26.05 6.28 51.46 26.87 8.49 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 60.53 31.67 0.97 57.79 27.51 3.63 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 B 177 PHE D 53 PHE^? 12.57 OXT ACT B 502 B 263 ASP B 54 ASP^? 4.46 O ACT B 502 B 292 LYS B 90 LYS^? 12.84 O ACT B 502 coo 49.99 26.05 6.28 51.46 26.87 8.49 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 60.53 31.67 0.97 57.79 27.51 3.63 -6.01 21.92 25.13 -2.78 16.45 24.93 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 7 PHE^? 10.76 O ACT A 501 C 263 ASP A 54 ASP^? -3.76 O ACT A 501s C 292 LYS A 3 LYS.? 15.82 O ACT C 503 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 4.11 9.93 15.65 2.48 11.68 17.17 coo 19.84 12.02 9.33 18.68 11.23 7.75 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.82 3.49 4.98 17.80 5.59 1.90 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 41 PHE^? 11.20 OXT ACT A 501 C 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 292 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 4.28 16.86 7.90 2.95 16.20 5.48 coo 19.84 12.02 9.33 18.68 11.23 7.75 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.82 3.49 4.98 17.80 5.59 1.90 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 53 PHE^? 10.03 O ACT A 501 C 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 292 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 4.01 11.96 10.37 3.05 9.75 8.94 coo 19.84 12.02 9.33 18.68 11.23 7.75 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.82 3.49 4.98 17.80 5.59 1.90 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE A 53 PHE^? 10.03 O ACT A 501 C 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 292 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 4.01 11.96 10.37 3.05 9.75 8.94 coo 19.84 12.02 9.33 18.68 11.23 7.75 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.82 3.49 4.98 17.80 5.59 1.90 -4.89 19.64 16.75 -9.74 21.90 15.98 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE B 7 PHE^? 10.67 O ACT B 502 C 263 ASP B 54 ASP^? 4.46 O ACT B 502 C 292 LYS B 3 LYS.? 21.07 O ACT B 502 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -13.12 25.81 24.52 -15.22 27.15 23.26 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.82 3.49 4.98 17.80 5.59 1.90 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE B 41 PHE^? 11.14 OXT ACT B 502 C 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 292 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -18.49 25.54 33.44 -17.51 26.84 35.75 coo 19.84 12.02 9.33 18.68 11.23 7.75 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE B 53 PHE^? 10.51 O ACT B 502 C 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 292 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 19.84 12.02 9.33 18.68 11.23 7.75 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE B 53 PHE^? 10.51 O ACT B 502 C 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 292 LYS D 90 LYS^? 25.07 CH3 ACT B 502 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -14.14 25.96 30.22 -11.77 26.92 31.36 coo 19.84 12.02 9.33 18.68 11.23 7.75 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 -23.03 34.53 25.25 -26.25 39.79 25.56 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE C 7 PHE^? 9.59 OXT ACT C 503 C 263 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 292 LYS C 3 LYS.? 18.11 OXT ACT C 503 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -1.42 12.30 15.81 -0.58 9.77 16.67 coo 19.84 12.02 9.33 18.68 11.23 7.75 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 12.82 3.49 4.98 17.80 5.59 1.90 0.38 25.07 8.12 -1.77 29.22 5.24 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE C 41 PHE^? 10.92 O ACT C 503 C 263 ASP A 54 ASP^? -3.76 O ACT A 501s C 292 LYS A 90 LYS^? 10.86 O ACT A 501 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 0.59 10.20 5.98 2.26 11.80 4.40 coo 19.84 12.02 9.33 18.68 11.23 7.75 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.82 3.49 4.98 17.80 5.59 1.90 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE C 53 PHE^? 9.13 OXT ACT C 503 C 263 ASP A 54 ASP^? -3.76 O ACT A 501s C 292 LYS A 3 LYS.? 15.82 O ACT C 503 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 0.16 13.32 10.36 1.32 15.86 10.31 coo 19.84 12.02 9.33 18.68 11.23 7.75 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.82 3.49 4.98 17.80 5.59 1.90 5.08 2.81 3.00 0.95 1.12 1.99 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE C 53 PHE^? 9.13 OXT ACT C 503 C 263 ASP A 54 ASP^? -3.76 O ACT A 501s C 292 LYS A 90 LYS^? 10.86 O ACT A 501 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 0.16 13.32 10.36 1.32 15.86 10.31 coo 19.84 12.02 9.33 18.68 11.23 7.75 9.47 12.33 8.26 10.66 11.45 9.76 coo 12.82 3.49 4.98 17.80 5.59 1.90 8.29 3.28 13.77 13.67 2.39 14.04 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 177 PHE D 7 PHE^? 14.53 O ACT B 502 C 263 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 292 LYS D 3 LYS.? 15.58 OXT ACT B 502 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -15.56 31.04 24.88 -13.19 30.30 23.55 coo 19.84 12.02 9.33 18.68 11.23 7.75 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 -26.73 29.41 34.74 -28.62 25.37 34.54 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 177 PHE D 41 PHE^? 14.15 OXT ACT B 502 C 263 ASP B 54 ASP^? 4.46 O ACT B 502 C 292 LYS B 90 LYS^? 12.84 O ACT B 502 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -11.67 29.30 34.26 -13.10 27.65 36.08 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.82 3.49 4.98 17.80 5.59 1.90 -6.01 21.92 25.13 -2.78 16.45 24.93 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 177 PHE D 53 PHE^? 12.57 OXT ACT B 502 C 263 ASP B 54 ASP^? 4.46 O ACT B 502 C 292 LYS B 3 LYS.? 21.07 O ACT B 502 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.82 3.49 4.98 17.80 5.59 1.90 -3.66 25.02 35.95 -1.49 26.64 40.22 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 177 PHE D 53 PHE^? 12.57 OXT ACT B 502 C 263 ASP B 54 ASP^? 4.46 O ACT B 502 C 292 LYS B 90 LYS^? 12.84 O ACT B 502 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -15.59 29.59 30.35 -18.10 28.47 30.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 12.82 3.49 4.98 17.80 5.59 1.90 -6.01 21.92 25.13 -2.78 16.45 24.93 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 54 ASP^? -3.76 O ACT A 501s A 151 LYS C 97 LYS^? 10.89 OXT ACT A 501 A 186 THR A 37 THR^? 7.38 OXT ACT A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 9.47 12.33 8.26 10.66 11.45 9.76 coo 45.75 16.58 39.61 47.43 18.26 45.54 8.20 19.20 3.14 12.89 15.65 0.85 coo 45.88 23.02 44.72 46.99 21.16 44.68 12.45 11.59 2.88 13.04 12.51 4.77 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 54 ASP^? -3.76 O ACT A 501s A 151 LYS C 97 LYS^? 10.89 OXT ACT A 501 A 186 THR A 38 THR^? 13.66 O ACT A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 9.47 12.33 8.26 10.66 11.45 9.76 coo 45.75 16.58 39.61 47.43 18.26 45.54 8.20 19.20 3.14 12.89 15.65 0.85 coo 45.88 23.02 44.72 46.99 21.16 44.68 9.25 11.88 0.86 8.30 10.33 -0.29 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 54 ASP^? 4.46 O ACT B 502 A 151 LYS D 97 LYS^? 10.92 OXT ACT B 502 A 186 THR B 37 THR^? 7.60 OXT ACT B 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 45.75 16.58 39.61 47.43 18.26 45.54 -19.69 21.43 38.53 -15.42 16.83 39.89 coo 45.88 23.02 44.72 46.99 21.16 44.68 -11.91 17.46 37.30 -13.16 16.95 35.64 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 54 ASP^? 4.46 O ACT B 502 A 151 LYS D 97 LYS^? 10.92 OXT ACT B 502 A 186 THR B 38 THR^? 13.93 OXT ACT B 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 45.75 16.58 39.61 47.43 18.26 45.54 -19.69 21.43 38.53 -15.42 16.83 39.89 coo 45.88 23.02 44.72 46.99 21.16 44.68 -12.00 20.67 39.32 -10.38 21.81 40.17 ULMN 3 2phk_c02 MC-PEPTIDE user 5 3 # 5 A 149 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 151 LYS A 97 LYS^? 11.17 O ACT C 503 A 186 THR C 37 THR^? 7.26 O ACT C 503 coo 41.42 17.90 44.98 43.39 18.36 45.61 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 45.75 16.58 39.61 47.43 18.26 45.54 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo 45.88 23.02 44.72 46.99 21.16 44.68 -6.53 17.89 2.50 -7.37 16.24 3.61 ULMN 3 2phk_c02 MC-PEPTIDE user 6 3 # 6 A 149 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 151 LYS A 97 LYS^? 11.17 O ACT C 503 A 186 THR C 38 THR^? 13.13 OXT ACT C 503 coo 41.42 17.90 44.98 43.39 18.36 45.61 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 45.75 16.58 39.61 47.43 18.26 45.54 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo 45.88 23.02 44.72 46.99 21.16 44.68 -2.96 18.29 1.33 -1.80 20.06 1.28 ULMN 3 2phk_c02 MC-PEPTIDE user 7 3 # 7 A 149 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 151 LYS B 97 LYS^? 23.77 OXT ACT B 502 A 186 THR D 37 THR^? 22.30 OXT ACT B 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 45.75 16.58 39.61 47.43 18.26 45.54 -11.27 32.20 40.12 -15.59 36.50 41.95 coo 45.88 23.02 44.72 46.99 21.16 44.68 -18.75 36.43 38.66 -17.35 37.30 37.28 ULMN 3 2phk_c02 MC-PEPTIDE user 8 3 # 8 A 149 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 151 LYS B 97 LYS^? 23.77 OXT ACT B 502 A 186 THR D 38 THR^? 19.44 OXT ACT B 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 45.75 16.58 39.61 47.43 18.26 45.54 -11.27 32.20 40.12 -15.59 36.50 41.95 coo 45.88 23.02 44.72 46.99 21.16 44.68 -18.99 32.97 40.14 -20.81 31.88 40.43 2phk_c02 source 2phk MC-PEPTIDE : 8 hits 2phk_c02 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 54 ASP^? -3.76 O ACT A 501s 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU B 59 GLU~? 13.30 O ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.47 12.33 8.26 10.66 11.45 9.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 54 ASP^? -3.76 O ACT A 501s 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU B 89 GLU^? 13.28 O ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.47 12.33 8.26 10.66 11.45 9.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.24 24.07 20.62 -9.79 26.07 20.27 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 54 ASP^? -3.76 O ACT A 501s 166 GLY C 46 GLY^? 18.28 O ACT C 503 169 GLU C 17 GLU~? 20.89 O ACT C 503 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.47 12.33 8.26 10.66 11.45 9.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.89 -2.26 16.02 0.23 -1.95 15.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 58 ASP~? 16.01 O ACT A 501 166 GLY C 46 GLY^? 18.28 O ACT C 503 169 GLU C 17 GLU~? 20.89 O ACT C 503 coo 8.28 6.87 1.62 10.08 5.77 1.34 12.40 1.57 0.95 13.75 2.83 -0.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.89 -2.26 16.02 0.23 -1.95 15.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.18 -6.10 16.13 -8.28 -7.84 16.85 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 54 ASP^? 4.46 O ACT B 502 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 54 ASP^? 4.46 O ACT B 502 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 54 ASP^? 4.46 O ACT B 502 166 GLY D 46 GLY^? 19.42 O ACT B 502 169 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.44 28.82 21.75 -1.65 29.54 22.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 54 ASP^? 4.46 O ACT B 502 166 GLY D 46 GLY^? 19.42 O ACT B 502 169 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.44 28.82 21.75 -1.65 29.54 22.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 58 ASP~? 16.37 O ACT B 502 166 GLY D 46 GLY^? 19.42 O ACT B 502 169 GLU D 17 GLU~? 25.97 OXT ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.77 17.89 37.44 -2.74 16.22 38.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.44 28.82 21.75 -1.65 29.54 22.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.12 36.56 21.03 3.60 37.59 19.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP C 54 ASP^? -3.02 OXT ACT C 503s 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP C 54 ASP^? -3.02 OXT ACT C 503s 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 54 ASP^? -3.02 OXT ACT C 503s 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU B 59 GLU~? 13.30 O ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -1.11 15.84 31.13 -2.15 17.21 29.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP C 54 ASP^? -3.02 OXT ACT C 503s 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU B 92 GLU^? 19.37 O ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP C 58 ASP~? 15.48 OXT ACT C 503 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -5.93 27.71 5.50 -7.21 27.13 3.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP C 58 ASP~? 15.48 OXT ACT C 503 166 GLY A 46 GLY.? 17.52 CH3 ACT A 501 169 GLU B 92 GLU^? 19.37 O ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 -5.93 27.71 5.50 -7.21 27.13 3.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.14 22.13 22.93 1.91 22.23 22.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP C 58 ASP~? 15.48 OXT ACT C 503 166 GLY D 46 GLY^? 19.42 O ACT B 502 169 GLU A 17 GLU~? 18.98 CH3 ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -5.93 27.71 5.50 -7.21 27.13 3.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.44 28.82 21.75 -1.65 29.54 22.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.46 25.60 25.93 9.21 26.72 27.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP C 58 ASP~? 15.48 OXT ACT C 503 166 GLY D 46 GLY^? 19.42 O ACT B 502 169 GLU B 92 GLU^? 19.37 O ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 -5.93 27.71 5.50 -7.21 27.13 3.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.44 28.82 21.75 -1.65 29.54 22.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.80 26.07 29.41 1.12 26.90 28.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP D 22 ASP~? 30.56 O ACT B 502 166 GLY A 15 GLY.? 20.25 CH3 ACT A 501 169 GLU A 11 GLU.? 15.43 CH3 ACT A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 1.48 40.46 31.50 1.79 41.35 33.38 coo -8.58 13.22 3.21 -8.90 13.15 4.05 12.33 28.07 28.83 12.21 27.38 28.38 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.65 17.34 27.29 6.65 18.05 26.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP D 54 ASP^? 19.49 OXT ACT B 502 166 GLY B 46 GLY.? 16.69 CH3 ACT B 502 169 GLU B 11 GLU.? 14.84 CH3 ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -26.60 28.48 19.87 -26.58 27.73 20.31 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.40 21.62 14.44 -23.19 23.50 15.06 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP D 54 ASP^? 19.49 OXT ACT B 502 166 GLY B 46 GLY.? 16.69 CH3 ACT B 502 169 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -26.60 28.48 19.87 -26.58 27.73 20.31 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.37 21.21 17.22 -31.47 20.28 15.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP D 58 ASP~? 25.46 OXT ACT B 502 166 GLY B 46 GLY.? 16.69 CH3 ACT B 502 169 GLU B 17 GLU~? 18.31 CH3 ACT B 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 -28.98 35.91 37.37 -28.15 37.30 38.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -26.60 28.48 19.87 -26.58 27.73 20.31 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.37 21.21 17.22 -31.47 20.28 15.66 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 21 hits 2tdt_c00 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG C 62 ARG~? 10.88 OXT ACT C 503 A 130 SER B 84 SER.? 10.45 CH3 ACT C 503 A 159 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 18.35 45.84 20.99 16.20 47.83 21.89 -6.61 21.24 11.49 -5.46 23.07 13.64 coo 15.14 43.67 10.77 15.61 44.43 13.04 -18.41 16.52 13.06 -18.12 18.87 13.61 coo 11.57 48.49 22.18 13.51 49.99 17.21 -4.89 19.64 16.75 -9.74 21.90 15.98 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG C 62 ARG~? 10.88 OXT ACT C 503 B 130 SER B 84 SER.? 10.45 CH3 ACT C 503 B 159 LYS C 90 LYS^? 10.56 OXT ACT C 503 coo 58.72 31.58 20.45 60.80 29.39 20.94 -6.61 21.24 11.49 -5.46 23.07 13.64 coo 61.66 35.17 10.39 61.29 34.14 12.56 -18.41 16.52 13.06 -18.12 18.87 13.61 coo 65.38 28.77 21.17 63.49 28.03 16.12 -4.89 19.64 16.75 -9.74 21.90 15.98 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 32 ASN~? 11.90 OXT ACT A 501 coo 5.80 63.03 55.85 5.52 65.03 56.45 14.28 20.69 1.30 12.48 21.71 1.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 67 ASN~? 11.66 O ACT A 501 coo 5.80 63.03 55.85 5.52 65.03 56.45 22.25 7.80 9.68 22.12 6.01 10.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 77 ASN~? 12.80 CH3 ACT A 501 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.26 21.39 19.94 22.82 22.39 18.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 87 ASN^? 12.58 CH3 ACT A 501 coo 5.80 63.03 55.85 5.52 65.03 56.45 9.12 9.51 22.49 8.21 7.58 22.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 32 ASN~? 11.83 OXT ACT B 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -20.40 15.31 40.23 -21.60 17.04 39.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 67 ASN~? 11.44 O ACT B 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.90 8.17 29.36 -7.21 8.51 28.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 77 ASN~? 11.66 CH3 ACT B 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.03 9.36 21.93 -25.16 8.32 23.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 87 ASN^? 12.23 OXT ACT C 503 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.79 21.31 17.73 -12.12 22.50 17.15 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN C 32 ASN~? 12.55 O ACT C 503 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.80 11.04 -3.58 -6.14 9.70 -3.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN C 67 ASN~? 10.88 CH3 ACT C 503 coo 5.80 63.03 55.85 5.52 65.03 56.45 -17.40 19.51 8.11 -17.74 20.65 9.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN C 77 ASN~? 12.75 CH3 ACT C 503 coo 5.80 63.03 55.85 5.52 65.03 56.45 -17.36 2.60 11.84 -18.59 2.53 10.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN C 87 ASN.? 10.16 O ACT B 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.54 12.49 22.38 -6.86 14.54 22.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN D 32 ASN~? 25.03 OXT ACT B 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -10.82 37.91 43.31 -9.73 36.12 42.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN D 67 ASN~? 31.47 OXT ACT B 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.35 47.13 33.03 -22.85 47.39 31.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN D 77 ASN~? 33.96 O ACT B 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -5.21 47.64 26.62 -4.70 48.89 28.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN D 87 ASN^? 20.96 CH3 ACT B 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.31 36.38 18.28 -18.33 35.57 18.38 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 16 hits 1kbk_p00 naa= 1 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 86 PRO.? 7.52 CH3 ACT A 501 A 272 LEU A 10 LEU^? 6.64 CH3 ACT A 501 A 276 ARG A 9 ARG^? 14.14 OXT ACT C 503 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 15.04 13.04 20.43 13.78 11.98 21.98 coo 10.97 0.43 16.73 11.31 2.11 18.06 10.60 16.78 20.41 11.87 16.18 18.78 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 4.15 12.93 21.45 1.14 13.40 20.88 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO B 85 PRO.? 6.93 CH3 ACT C 503 A 272 LEU C 66 LEU~? 6.34 CH3 ACT C 503 A 276 ARG C 62 ARG~? 10.88 OXT ACT C 503 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -14.80 14.04 13.98 -16.32 15.31 15.07 coo 10.97 0.43 16.73 11.31 2.11 18.06 -13.32 18.37 11.26 -11.61 18.18 12.61 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -6.61 21.24 11.49 -5.46 23.07 13.64 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO B 86 PRO.? 7.56 CH3 ACT B 502 A 272 LEU B 10 LEU^? 6.13 CH3 ACT B 502 A 276 ARG B 9 ARG^? 13.94 CH3 ACT B 502 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -16.41 15.08 20.10 -15.74 16.49 18.50 coo 10.97 0.43 16.73 11.31 2.11 18.06 -20.42 19.50 21.03 -19.38 18.14 22.35 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -17.57 25.75 18.49 -17.57 28.52 19.90 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO C 85 PRO.? 10.66 O ACT B 502 A 272 LEU B 66 LEU~? 7.38 O ACT B 502 A 276 ARG B 62 ARG~? 12.26 O ACT B 502 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -12.86 7.52 25.10 -12.33 6.45 23.17 coo 10.97 0.43 16.73 11.31 2.11 18.06 -8.76 12.87 27.46 -8.23 14.84 26.54 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -6.19 18.92 29.62 -3.70 20.53 28.83 1emh_d00 source 1emh HYDROLASE/DNA : 4 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 62 ARG~? 11.91 O ACT A 501 C 71 LYS A 90 LYS^? 10.86 O ACT A 501 C 72 VAL A 91 VAL^? 12.29 O ACT A 501 coo 23.89 33.54 29.21 26.59 34.86 28.68 11.34 4.43 9.06 9.97 1.81 9.84 coo 25.82 26.89 29.68 23.33 22.98 25.84 8.29 3.28 13.77 13.67 2.39 14.04 coo 28.86 29.08 30.37 28.04 31.02 29.93 5.07 3.40 11.79 3.73 5.11 12.19 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 62 ARG~? 12.26 O ACT B 502 C 71 LYS B 90 LYS^? 12.84 O ACT B 502 C 72 VAL B 91 VAL^? 12.57 O ACT B 502 coo 23.89 33.54 29.21 26.59 34.86 28.68 -6.19 18.92 29.62 -3.70 20.53 28.83 coo 25.82 26.89 29.68 23.33 22.98 25.84 -6.01 21.92 25.13 -2.78 16.45 24.93 coo 28.86 29.08 30.37 28.04 31.02 29.93 -5.72 25.10 27.22 -7.55 26.37 27.21 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG C 62 ARG~? 10.88 OXT ACT C 503 C 71 LYS C 90 LYS^? 10.56 OXT ACT C 503 C 72 VAL C 91 VAL^? 10.98 OXT ACT C 503 coo 23.89 33.54 29.21 26.59 34.86 28.68 -6.61 21.24 11.49 -5.46 23.07 13.64 coo 25.82 26.89 29.68 23.33 22.98 25.84 -4.89 19.64 16.75 -9.74 21.90 15.98 coo 28.86 29.08 30.37 28.04 31.02 29.93 -1.36 20.26 15.48 -0.12 18.41 15.18 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG D 62 ARG~? 20.52 OXT ACT B 502 C 71 LYS D 90 LYS^? 25.07 CH3 ACT B 502 C 72 VAL D 91 VAL^? 14.94 CH3 ACT B 502 coo 23.89 33.54 29.21 26.59 34.86 28.68 -23.58 36.44 30.28 -25.75 35.10 28.58 coo 25.82 26.89 29.68 23.33 22.98 25.84 -23.03 34.53 25.25 -26.25 39.79 25.56 coo 28.86 29.08 30.37 28.04 31.02 29.93 -23.38 31.04 26.64 -21.58 29.78 26.75 1hwt_d00 source 1hwt GENE REGULATION/DNA : 4 hits 1hwt_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS D 97 LYS^? 10.92 OXT ACT B 502 D 25 THR B 37 THR^? 7.60 OXT ACT B 502 D 27 SER B 35 SER.? 14.98 OXT ACT B 502 coo 86.60 33.38 44.00 87.05 39.52 42.71 -19.69 21.43 38.53 -15.42 16.83 39.89 coo 81.20 31.58 48.03 79.23 32.24 47.54 -11.91 17.46 37.30 -13.16 16.95 35.64 coo 79.09 29.82 54.20 77.17 28.90 53.05 -11.93 13.69 41.33 -10.41 11.83 41.69 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS D 97 LYS^? 10.92 OXT ACT B 502 D 25 THR B 38 THR^? 13.93 OXT ACT B 502 D 27 SER B 35 SER.? 14.98 OXT ACT B 502 coo 86.60 33.38 44.00 87.05 39.52 42.71 -19.69 21.43 38.53 -15.42 16.83 39.89 coo 81.20 31.58 48.03 79.23 32.24 47.54 -12.00 20.67 39.32 -10.38 21.81 40.17 coo 79.09 29.82 54.20 77.17 28.90 53.05 -11.93 13.69 41.33 -10.41 11.83 41.69 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 2 hits 1mjo_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 97 LYS^? 11.17 O ACT C 503 A1294 ASN C 32 ASN~? 12.55 O ACT C 503 A1297 GLU C 34 GLU~? 6.63 O ACT C 503 coo 39.24 18.84-161.99 36.62 21.47-165.99 -2.14 10.71 -0.07 -6.35 15.40 -1.27 coo 33.53 17.37-161.81 34.31 17.81-163.76 -7.80 11.04 -3.58 -6.14 9.70 -3.27 coo 29.78 23.31-161.30 31.23 23.66-162.84 -11.68 15.33 1.66 -11.38 14.84 3.76 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS B 97 LYS^? 23.77 OXT ACT B 502 A1294 ASN D 32 ASN~? 25.03 OXT ACT B 502 A1297 GLU D 34 GLU.? 25.91 OXT ACT B 502 coo 39.24 18.84-161.99 36.62 21.47-165.99 -11.27 32.20 40.12 -15.59 36.50 41.95 coo 33.53 17.37-161.81 34.31 17.81-163.76 -10.82 37.91 43.31 -9.73 36.12 42.91 coo 29.78 23.31-161.30 31.23 23.66-162.84 -16.00 41.58 38.86 -16.04 41.30 36.71 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS C 97 LYS^? 10.89 OXT ACT A 501 A1294 ASN A 32 ASN~? 11.90 OXT ACT A 501 A1297 GLU A 34 GLU.? 6.40 OXT ACT A 501 coo 39.24 18.84-161.99 36.62 21.47-165.99 8.20 19.20 3.14 12.89 15.65 0.85 coo 33.53 17.37-161.81 34.31 17.81-163.76 14.28 20.69 1.30 12.48 21.71 1.89 coo 29.78 23.31-161.30 31.23 23.66-162.84 17.44 14.34 4.36 16.78 13.78 6.33 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS D 97 LYS^? 10.92 OXT ACT B 502 A1294 ASN B 32 ASN~? 11.83 OXT ACT B 502 A1297 GLU B 34 GLU.? 6.39 OXT ACT B 502 coo 39.24 18.84-161.99 36.62 21.47-165.99 -19.69 21.43 38.53 -15.42 16.83 39.89 coo 33.53 17.37-161.81 34.31 17.81-163.76 -20.40 15.31 40.23 -21.60 17.04 39.97 coo 29.78 23.31-161.30 31.23 23.66-162.84 -14.54 12.40 35.90 -14.50 13.22 33.94 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 4 hits 1xpx_d00 naa= 3 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 1 4 # 1 D 41 HIS A 0 HIS.? 19.86 O ACT C 503 D 67 LYS A 90 LYS^? 10.86 O ACT A 501 D 69 ILE A 88 ILE^? 7.27 O ACT A 501 D 70 VAL A 8 VAL^? 5.63 O ACT A 501 coo 33.21 28.24 12.68 34.93 27.24 13.36 0.63 2.65 -4.88 1.54 2.35 -6.74 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 8.29 3.28 13.77 13.67 2.39 14.04 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 11.94 7.53 17.59 12.98 7.96 16.77 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 8.66 11.39 16.90 10.73 11.70 16.28 1zme_d00 source 1zme TRANSCRIPTION/DNA : 1 hits 1zme_d00 naa= 4 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG C 62 ARG~? 10.88 OXT ACT C 503 A 32 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 46 ARG B 9 ARG^? 13.94 CH3 ACT B 502 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -6.61 21.24 11.49 -5.46 23.07 13.64 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -17.57 25.75 18.49 -17.57 28.52 19.90 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG C 62 ARG~? 10.88 OXT ACT C 503 A 32 LYS C 90 LYS^? 10.56 OXT ACT C 503 A 46 ARG D 9 ARG^? 15.08 O ACT B 502 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -6.61 21.24 11.49 -5.46 23.07 13.64 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -4.89 19.64 16.75 -9.74 21.90 15.98 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -10.16 31.68 19.32 -10.74 28.83 20.23 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 2 hits 2ky8_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER B 84 SER.? 10.45 CH3 ACT C 503 B 37 ASN C 67 ASN~? 10.88 CH3 ACT C 503 B 45 THR C 37 THR^? 7.26 O ACT C 503 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -18.41 16.52 13.06 -18.12 18.87 13.61 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -17.40 19.51 8.11 -17.74 20.65 9.88 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -6.53 17.89 2.50 -7.37 16.24 3.61 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 1 hits 2z3x_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 0 HIS.? 19.86 O ACT C 503 A 208 ASP A 58 ASP~? 16.01 O ACT A 501 A 296 SER C 48 SER.? 19.11 O ACT C 503 coo 12.72 17.48 24.71 12.80 19.37 23.81 0.63 2.65 -4.88 1.54 2.35 -6.74 coo 18.47 29.19 29.68 19.30 29.17 27.75 12.40 1.57 0.95 13.75 2.83 -0.02 coo 6.89 17.22 46.63 5.08 16.21 47.91 -4.38 -3.19 17.46 -4.11 -3.50 19.78 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS C 65 HIS~? -3.55 C ACT C 503s A 208 ASP C 58 ASP~? 15.48 OXT ACT C 503 A 296 SER B 48 SER.? 16.63 CH3 ACT B 502 coo 12.72 17.48 24.71 12.80 19.37 23.81 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 18.47 29.19 29.68 19.30 29.17 27.75 -5.93 27.71 5.50 -7.21 27.13 3.90 coo 6.89 17.22 46.63 5.08 16.21 47.91 -27.05 23.61 17.32 -26.38 24.08 15.04 2odj_o00 source 2ODJ PORIN D : 2 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 0 HIS.? 19.86 O ACT C 503 B 208 ASP A 58 ASP~? 16.01 O ACT A 501 B 296 SER C 48 SER.? 19.11 O ACT C 503 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 0.63 2.65 -4.88 1.54 2.35 -6.74 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 12.40 1.57 0.95 13.75 2.83 -0.02 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -4.38 -3.19 17.46 -4.11 -3.50 19.78 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS B 65 HIS~? -3.69 O ACT B 502s B 208 ASP B 58 ASP~? 16.37 O ACT B 502 B 296 SER D 48 SER.? 23.18 OXT ACT C 503 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -1.77 17.89 37.44 -2.74 16.22 38.35 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -0.72 34.09 20.26 -1.13 33.83 17.85 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS C 65 HIS~? -3.55 C ACT C 503s B 208 ASP C 58 ASP~? 15.48 OXT ACT C 503 B 296 SER B 48 SER.? 16.63 CH3 ACT B 502 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -5.93 27.71 5.50 -7.21 27.13 3.90 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -27.05 23.61 17.32 -26.38 24.08 15.04 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 208 ASP D 58 ASP~? 25.46 OXT ACT B 502 B 296 SER B 48 SER.? 16.63 CH3 ACT B 502 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -28.98 35.91 37.37 -28.15 37.30 38.76 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -27.05 23.61 17.32 -26.38 24.08 15.04 2odj_o01 source 2ODJ PORIN D : 4 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 83 SER.? 15.27 CH3 ACT A 501 A 166 PHE A 50 PHE^? 12.40 CH3 ACT A 501 A 182 PHE A 23 PHE~? 7.88 CH3 ACT A 501 coo -46.28 37.24 81.97 -44.96 39.32 82.40 13.81 17.41 28.85 11.46 17.47 28.69 coo -36.62 39.62 84.60 -38.76 41.24 85.25 7.69 21.36 19.99 7.24 23.96 20.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 16.47 22.52 16.41 17.88 20.31 15.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER B 83 SER.? 13.83 CH3 ACT C 503 A 166 PHE B 50 PHE^? 11.63 CH3 ACT B 502 A 182 PHE B 23 PHE~? 6.98 CH3 ACT B 502 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -22.22 16.61 12.63 -22.48 19.01 12.87 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -25.01 22.05 22.40 -27.79 22.30 21.98 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -24.62 13.39 25.68 -22.12 12.22 26.21 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER B 83 SER.? 13.83 CH3 ACT C 503 A 166 PHE B 50 PHE^? 11.63 CH3 ACT B 502 A 182 PHE B 45 PHE.? 12.46 CH3 ACT B 502 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -22.22 16.61 12.63 -22.48 19.01 12.87 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -25.01 22.05 22.40 -27.79 22.30 21.98 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -21.33 28.13 22.13 -18.90 27.61 23.45 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER C 83 SER.? 17.75 CH3 ACT C 503 A 166 PHE C 50 PHE^? 13.69 O ACT C 503 A 182 PHE C 23 PHE~? 8.79 O ACT C 503 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.89 0.03 22.35 -9.55 -0.34 22.50 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.75 2.52 8.44 -13.71 5.16 8.55 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER C 83 SER.? 17.75 CH3 ACT C 503 A 166 PHE C 50 PHE^? 13.69 O ACT C 503 A 182 PHE C 45 PHE^? 13.49 OXT ACT C 503 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.89 0.03 22.35 -9.55 -0.34 22.50 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo -36.55 45.66 79.22 -38.34 43.94 80.53 1.23 3.65 15.97 1.00 6.45 15.50 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER D 83 SER.? 27.11 OXT ACT C 503 A 166 PHE D 50 PHE^? 22.38 O ACT B 502 A 182 PHE D 23 PHE~? 28.18 O ACT B 502 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -4.98 41.81 16.11 -5.10 39.49 15.62 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -3.75 34.75 25.13 -0.96 34.63 25.02 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -4.82 42.68 30.05 -7.42 43.67 30.37 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER D 83 SER.? 27.11 OXT ACT C 503 A 166 PHE D 50 PHE^? 22.38 O ACT B 502 A 182 PHE D 45 PHE^? 14.56 O ACT B 502 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -4.98 41.81 16.11 -5.10 39.49 15.62 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -3.75 34.75 25.13 -0.96 34.63 25.02 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -7.17 28.78 23.13 -9.80 28.82 24.18 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 7 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 83 SER.? 15.27 CH3 ACT A 501 B 166 PHE A 50 PHE^? 12.40 CH3 ACT A 501 B 182 PHE A 23 PHE~? 7.88 CH3 ACT A 501 coo -19.94 46.29 97.83 -22.38 46.56 97.60 13.81 17.41 28.85 11.46 17.47 28.69 coo -29.59 43.40 95.66 -28.22 45.54 94.50 7.69 21.36 19.99 7.24 23.96 20.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 16.47 22.52 16.41 17.88 20.31 15.44 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 83 SER.? 15.27 CH3 ACT A 501 B 166 PHE A 50 PHE^? 12.40 CH3 ACT A 501 B 182 PHE A 45 PHE.? 13.07 O ACT A 501 coo -19.94 46.29 97.83 -22.38 46.56 97.60 13.81 17.41 28.85 11.46 17.47 28.69 coo -29.59 43.40 95.66 -28.22 45.54 94.50 7.69 21.36 19.99 7.24 23.96 20.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 1.73 17.38 19.47 2.25 15.34 17.62 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER B 83 SER.? 13.83 CH3 ACT C 503 B 166 PHE B 50 PHE^? 11.63 CH3 ACT B 502 B 182 PHE B 23 PHE~? 6.98 CH3 ACT B 502 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -22.22 16.61 12.63 -22.48 19.01 12.87 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -25.01 22.05 22.40 -27.79 22.30 21.98 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -24.62 13.39 25.68 -22.12 12.22 26.21 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER B 83 SER.? 13.83 CH3 ACT C 503 B 166 PHE B 50 PHE^? 11.63 CH3 ACT B 502 B 182 PHE B 45 PHE.? 12.46 CH3 ACT B 502 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -22.22 16.61 12.63 -22.48 19.01 12.87 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -25.01 22.05 22.40 -27.79 22.30 21.98 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -21.33 28.13 22.13 -18.90 27.61 23.45 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER C 83 SER.? 17.75 CH3 ACT C 503 B 166 PHE C 50 PHE^? 13.69 O ACT C 503 B 182 PHE C 23 PHE~? 8.79 O ACT C 503 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.89 0.03 22.35 -9.55 -0.34 22.50 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.75 2.52 8.44 -13.71 5.16 8.55 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER C 83 SER.? 17.75 CH3 ACT C 503 B 166 PHE C 50 PHE^? 13.69 O ACT C 503 B 182 PHE C 45 PHE^? 13.49 OXT ACT C 503 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.89 0.03 22.35 -9.55 -0.34 22.50 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo -32.72 50.15 98.46 -30.32 48.85 97.77 1.23 3.65 15.97 1.00 6.45 15.50 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER D 83 SER.? 27.11 OXT ACT C 503 B 166 PHE D 50 PHE^? 22.38 O ACT B 502 B 182 PHE D 23 PHE~? 28.18 O ACT B 502 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -4.98 41.81 16.11 -5.10 39.49 15.62 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -3.75 34.75 25.13 -0.96 34.63 25.02 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -4.82 42.68 30.05 -7.42 43.67 30.37 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER D 83 SER.? 27.11 OXT ACT C 503 B 166 PHE D 50 PHE^? 22.38 O ACT B 502 B 182 PHE D 45 PHE^? 14.56 O ACT B 502 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -4.98 41.81 16.11 -5.10 39.49 15.62 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -3.75 34.75 25.13 -0.96 34.63 25.02 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -7.17 28.78 23.13 -9.80 28.82 24.18 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 83 SER.? 15.27 CH3 ACT A 501 C 166 PHE A 50 PHE^? 12.40 CH3 ACT A 501 C 182 PHE A 23 PHE~? 7.88 CH3 ACT A 501 coo -2.19 64.27 51.12 -3.34 62.10 50.60 13.81 17.41 28.85 11.46 17.47 28.69 coo -11.14 61.91 46.89 -9.88 60.30 48.76 7.69 21.36 19.99 7.24 23.96 20.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 16.47 22.52 16.41 17.88 20.31 15.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER B 83 SER.? 13.83 CH3 ACT C 503 C 166 PHE B 50 PHE^? 11.63 CH3 ACT B 502 C 182 PHE B 23 PHE~? 6.98 CH3 ACT B 502 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -22.22 16.61 12.63 -22.48 19.01 12.87 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -25.01 22.05 22.40 -27.79 22.30 21.98 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -24.62 13.39 25.68 -22.12 12.22 26.21 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER B 83 SER.? 13.83 CH3 ACT C 503 C 166 PHE B 50 PHE^? 11.63 CH3 ACT B 502 C 182 PHE B 45 PHE.? 12.46 CH3 ACT B 502 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -22.22 16.61 12.63 -22.48 19.01 12.87 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -25.01 22.05 22.40 -27.79 22.30 21.98 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -21.33 28.13 22.13 -18.90 27.61 23.45 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER C 83 SER.? 17.75 CH3 ACT C 503 C 166 PHE C 50 PHE^? 13.69 O ACT C 503 C 182 PHE C 23 PHE~? 8.79 O ACT C 503 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.89 0.03 22.35 -9.55 -0.34 22.50 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.75 2.52 8.44 -13.71 5.16 8.55 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER C 83 SER.? 17.75 CH3 ACT C 503 C 166 PHE C 50 PHE^? 13.69 O ACT C 503 C 182 PHE C 45 PHE^? 13.49 OXT ACT C 503 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.89 0.03 22.35 -9.55 -0.34 22.50 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo -7.71 55.92 42.70 -7.18 57.60 44.85 1.23 3.65 15.97 1.00 6.45 15.50 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER D 83 SER.? 27.11 OXT ACT C 503 C 166 PHE D 50 PHE^? 22.38 O ACT B 502 C 182 PHE D 23 PHE~? 28.18 O ACT B 502 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -4.98 41.81 16.11 -5.10 39.49 15.62 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -3.75 34.75 25.13 -0.96 34.63 25.02 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -4.82 42.68 30.05 -7.42 43.67 30.37 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER D 83 SER.? 27.11 OXT ACT C 503 C 166 PHE D 50 PHE^? 22.38 O ACT B 502 C 182 PHE D 45 PHE^? 14.56 O ACT B 502 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -4.98 41.81 16.11 -5.10 39.49 15.62 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -3.75 34.75 25.13 -0.96 34.63 25.02 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -7.17 28.78 23.13 -9.80 28.82 24.18 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 7 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 83 SER.? 15.27 CH3 ACT A 501 D 166 PHE A 50 PHE^? 12.40 CH3 ACT A 501 D 182 PHE A 23 PHE~? 7.88 CH3 ACT A 501 coo -32.42 55.27 46.18 -30.51 54.94 47.67 13.81 17.41 28.85 11.46 17.47 28.69 coo -23.62 58.20 50.84 -23.76 56.14 48.96 7.69 21.36 19.99 7.24 23.96 20.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 16.47 22.52 16.41 17.88 20.31 15.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 83 SER.? 15.27 CH3 ACT A 501 D 166 PHE A 50 PHE^? 12.40 CH3 ACT A 501 D 182 PHE A 45 PHE.? 13.07 O ACT A 501 coo -32.42 55.27 46.18 -30.51 54.94 47.67 13.81 17.41 28.85 11.46 17.47 28.69 coo -23.62 58.20 50.84 -23.76 56.14 48.96 7.69 21.36 19.99 7.24 23.96 20.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 1.73 17.38 19.47 2.25 15.34 17.62 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER B 83 SER.? 13.83 CH3 ACT C 503 D 166 PHE B 50 PHE^? 11.63 CH3 ACT B 502 D 182 PHE B 23 PHE~? 6.98 CH3 ACT B 502 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -22.22 16.61 12.63 -22.48 19.01 12.87 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -25.01 22.05 22.40 -27.79 22.30 21.98 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -24.62 13.39 25.68 -22.12 12.22 26.21 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER B 83 SER.? 13.83 CH3 ACT C 503 D 166 PHE B 50 PHE^? 11.63 CH3 ACT B 502 D 182 PHE B 45 PHE.? 12.46 CH3 ACT B 502 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -22.22 16.61 12.63 -22.48 19.01 12.87 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -25.01 22.05 22.40 -27.79 22.30 21.98 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -21.33 28.13 22.13 -18.90 27.61 23.45 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER C 83 SER.? 17.75 CH3 ACT C 503 D 166 PHE C 50 PHE^? 13.69 O ACT C 503 D 182 PHE C 23 PHE~? 8.79 O ACT C 503 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.89 0.03 22.35 -9.55 -0.34 22.50 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.75 2.52 8.44 -13.71 5.16 8.55 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER C 83 SER.? 17.75 CH3 ACT C 503 D 166 PHE C 50 PHE^? 13.69 O ACT C 503 D 182 PHE C 45 PHE^? 13.49 OXT ACT C 503 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.89 0.03 22.35 -9.55 -0.34 22.50 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -4.73 0.52 13.27 -4.50 -2.25 12.87 coo -23.08 51.44 54.96 -24.43 52.71 52.88 1.23 3.65 15.97 1.00 6.45 15.50 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER D 83 SER.? 27.11 OXT ACT C 503 D 166 PHE D 50 PHE^? 22.38 O ACT B 502 D 182 PHE D 23 PHE~? 28.18 O ACT B 502 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -4.98 41.81 16.11 -5.10 39.49 15.62 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -3.75 34.75 25.13 -0.96 34.63 25.02 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -4.82 42.68 30.05 -7.42 43.67 30.37 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER D 83 SER.? 27.11 OXT ACT C 503 D 166 PHE D 50 PHE^? 22.38 O ACT B 502 D 182 PHE D 45 PHE^? 14.56 O ACT B 502 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -4.98 41.81 16.11 -5.10 39.49 15.62 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -3.75 34.75 25.13 -0.96 34.63 25.02 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -7.17 28.78 23.13 -9.80 28.82 24.18 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o03 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 54 ASP^? -3.76 O ACT A 501s A 86 HIS A 65 HIS~? -3.60 O ACT A 501s A 250 ALA A 64 ALA~? 11.15 O ACT A 501 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 9.47 12.33 8.26 10.66 11.45 9.76 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 14.91 11.26 8.66 14.30 12.93 9.76 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 19.24 7.69 5.99 19.07 7.91 4.49 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 54 ASP^? -3.76 O ACT A 501s A 86 HIS A 65 HIS~? -3.60 O ACT A 501s A 250 ALA A 71 ALA~? 5.64 CH3 ACT A 501 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 9.47 12.33 8.26 10.66 11.45 9.76 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 14.91 11.26 8.66 14.30 12.93 9.76 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 19.26 13.81 13.63 19.24 12.28 13.23 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 54 ASP^? 4.46 O ACT B 502 A 86 HIS B 65 HIS~? -3.69 O ACT B 502s A 250 ALA B 64 ALA~? 11.22 O ACT B 502 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -8.30 11.03 33.15 -8.32 11.11 34.69 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 54 ASP^? 4.46 O ACT B 502 A 86 HIS B 65 HIS~? -3.69 O ACT B 502s A 250 ALA B 71 ALA~? 6.33 O ACT B 502 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -15.58 10.60 26.60 -14.06 10.51 26.75 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 86 HIS C 65 HIS~? -3.55 C ACT C 503s A 250 ALA C 64 ALA~? 10.90 CH3 ACT C 503 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -13.66 20.75 5.77 -13.26 21.25 4.37 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 86 HIS C 65 HIS~? -3.55 C ACT C 503s A 250 ALA C 71 ALA~? 3.85 CH3 ACT C 503 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -14.49 11.86 9.72 -14.32 13.36 10.09 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 250 ALA D 64 ALA~? 28.22 OXT ACT B 502 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -22.15 43.56 35.71 -22.30 43.07 37.15 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 250 ALA D 71 ALA~? 28.01 O ACT B 502 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -13.96 44.65 30.21 -15.47 44.54 30.10 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 54 ASP^? -3.76 O ACT A 501s B 86 HIS A 65 HIS~? -3.60 O ACT A 501s B 250 ALA A 64 ALA~? 11.15 O ACT A 501 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 9.47 12.33 8.26 10.66 11.45 9.76 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 14.91 11.26 8.66 14.30 12.93 9.76 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 19.24 7.69 5.99 19.07 7.91 4.49 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP A 54 ASP^? -3.76 O ACT A 501s B 86 HIS A 65 HIS~? -3.60 O ACT A 501s B 250 ALA A 71 ALA~? 5.64 CH3 ACT A 501 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 9.47 12.33 8.26 10.66 11.45 9.76 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 14.91 11.26 8.66 14.30 12.93 9.76 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 19.26 13.81 13.63 19.24 12.28 13.23 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 B 49 ASP B 54 ASP^? 4.46 O ACT B 502 B 86 HIS B 65 HIS~? -3.69 O ACT B 502s B 250 ALA B 64 ALA~? 11.22 O ACT B 502 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -8.30 11.03 33.15 -8.32 11.11 34.69 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 B 49 ASP B 54 ASP^? 4.46 O ACT B 502 B 86 HIS B 65 HIS~? -3.69 O ACT B 502s B 250 ALA B 71 ALA~? 6.33 O ACT B 502 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -15.58 10.60 26.60 -14.06 10.51 26.75 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 B 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 86 HIS C 65 HIS~? -3.55 C ACT C 503s B 250 ALA C 64 ALA~? 10.90 CH3 ACT C 503 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -13.66 20.75 5.77 -13.26 21.25 4.37 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 B 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 86 HIS C 65 HIS~? -3.55 C ACT C 503s B 250 ALA C 71 ALA~? 3.85 CH3 ACT C 503 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -14.49 11.86 9.72 -14.32 13.36 10.09 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 B 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 250 ALA D 64 ALA~? 28.22 OXT ACT B 502 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -22.15 43.56 35.71 -22.30 43.07 37.15 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 B 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 250 ALA D 71 ALA~? 28.01 O ACT B 502 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -13.96 44.65 30.21 -15.47 44.54 30.10 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 54 ASP^? -3.76 O ACT A 501s C 86 HIS A 65 HIS~? -3.60 O ACT A 501s C 250 ALA A 64 ALA~? 11.15 O ACT A 501 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 9.47 12.33 8.26 10.66 11.45 9.76 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 14.91 11.26 8.66 14.30 12.93 9.76 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 19.24 7.69 5.99 19.07 7.91 4.49 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP A 54 ASP^? -3.76 O ACT A 501s C 86 HIS A 65 HIS~? -3.60 O ACT A 501s C 250 ALA A 71 ALA~? 5.64 CH3 ACT A 501 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 9.47 12.33 8.26 10.66 11.45 9.76 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 14.91 11.26 8.66 14.30 12.93 9.76 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 19.26 13.81 13.63 19.24 12.28 13.23 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 C 49 ASP B 54 ASP^? 4.46 O ACT B 502 C 86 HIS B 65 HIS~? -3.69 O ACT B 502s C 250 ALA B 64 ALA~? 11.22 O ACT B 502 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -8.30 11.03 33.15 -8.32 11.11 34.69 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 C 49 ASP B 54 ASP^? 4.46 O ACT B 502 C 86 HIS B 65 HIS~? -3.69 O ACT B 502s C 250 ALA B 71 ALA~? 6.33 O ACT B 502 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -15.58 10.60 26.60 -14.06 10.51 26.75 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 C 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 86 HIS C 65 HIS~? -3.55 C ACT C 503s C 250 ALA C 64 ALA~? 10.90 CH3 ACT C 503 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -13.66 20.75 5.77 -13.26 21.25 4.37 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 C 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 86 HIS C 65 HIS~? -3.55 C ACT C 503s C 250 ALA C 71 ALA~? 3.85 CH3 ACT C 503 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -14.49 11.86 9.72 -14.32 13.36 10.09 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 C 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 C 250 ALA D 64 ALA~? 28.22 OXT ACT B 502 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -22.15 43.56 35.71 -22.30 43.07 37.15 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 C 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 C 250 ALA D 71 ALA~? 28.01 O ACT B 502 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -13.96 44.65 30.21 -15.47 44.54 30.10 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 54 ASP^? -3.76 O ACT A 501s D 86 HIS A 65 HIS~? -3.60 O ACT A 501s D 250 ALA A 31 ALA~? 6.46 OXT ACT A 501 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 9.47 12.33 8.26 10.66 11.45 9.76 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 14.91 11.26 8.66 14.30 12.93 9.76 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 14.76 17.72 5.17 13.41 17.92 5.92 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP A 54 ASP^? -3.76 O ACT A 501s D 86 HIS A 65 HIS~? -3.60 O ACT A 501s D 250 ALA A 64 ALA~? 11.15 O ACT A 501 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 9.47 12.33 8.26 10.66 11.45 9.76 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 14.91 11.26 8.66 14.30 12.93 9.76 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 19.24 7.69 5.99 19.07 7.91 4.49 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 D 49 ASP A 54 ASP^? -3.76 O ACT A 501s D 86 HIS A 65 HIS~? -3.60 O ACT A 501s D 250 ALA A 71 ALA~? 5.64 CH3 ACT A 501 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 9.47 12.33 8.26 10.66 11.45 9.76 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 14.91 11.26 8.66 14.30 12.93 9.76 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 19.26 13.81 13.63 19.24 12.28 13.23 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 D 49 ASP B 54 ASP^? 4.46 O ACT B 502 D 86 HIS B 65 HIS~? -3.69 O ACT B 502s D 250 ALA B 64 ALA~? 11.22 O ACT B 502 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -8.30 11.03 33.15 -8.32 11.11 34.69 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 D 49 ASP B 54 ASP^? 4.46 O ACT B 502 D 86 HIS B 65 HIS~? -3.69 O ACT B 502s D 250 ALA B 71 ALA~? 6.33 O ACT B 502 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -12.58 15.14 31.21 -14.46 15.75 30.51 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -15.58 10.60 26.60 -14.06 10.51 26.75 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 D 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s D 86 HIS C 65 HIS~? -3.55 C ACT C 503s D 250 ALA C 31 ALA~? 7.01 O ACT C 503 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -8.94 11.70 1.14 -7.76 11.12 1.95 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 D 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s D 86 HIS C 65 HIS~? -3.55 C ACT C 503s D 250 ALA C 64 ALA~? 10.90 CH3 ACT C 503 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -13.66 20.75 5.77 -13.26 21.25 4.37 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 D 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s D 86 HIS C 65 HIS~? -3.55 C ACT C 503s D 250 ALA C 71 ALA~? 3.85 CH3 ACT C 503 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -10.13 15.85 7.28 -9.82 13.80 7.57 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -14.49 11.86 9.72 -14.32 13.36 10.09 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 D 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 D 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 D 250 ALA D 31 ALA~? 23.53 OXT ACT B 502 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -12.33 38.97 38.82 -11.89 37.76 37.95 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 D 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 D 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 D 250 ALA D 64 ALA~? 28.22 OXT ACT B 502 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -22.15 43.56 35.71 -22.30 43.07 37.15 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 D 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 D 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 D 250 ALA D 71 ALA~? 28.01 O ACT B 502 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -17.61 39.97 33.46 -15.64 39.60 32.84 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -13.96 44.65 30.21 -15.47 44.54 30.10 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 11 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 54 ASP^? -3.76 O ACT A 501s E 86 HIS A 65 HIS~? -3.60 O ACT A 501s E 250 ALA A 64 ALA~? 11.15 O ACT A 501 coo -36.18 24.97 18.78 -36.93 26.11 17.11 9.47 12.33 8.26 10.66 11.45 9.76 coo -36.85 29.32 15.06 -38.90 29.14 15.48 14.91 11.26 8.66 14.30 12.93 9.76 coo -44.49 29.68 13.98 -43.47 28.67 13.52 19.24 7.69 5.99 19.07 7.91 4.49 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP A 54 ASP^? -3.76 O ACT A 501s E 86 HIS A 65 HIS~? -3.60 O ACT A 501s E 250 ALA A 71 ALA~? 5.64 CH3 ACT A 501 coo -36.18 24.97 18.78 -36.93 26.11 17.11 9.47 12.33 8.26 10.66 11.45 9.76 coo -36.85 29.32 15.06 -38.90 29.14 15.48 14.91 11.26 8.66 14.30 12.93 9.76 coo -44.49 29.68 13.98 -43.47 28.67 13.52 19.26 13.81 13.63 19.24 12.28 13.23 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP B 54 ASP^? 4.46 O ACT B 502 E 86 HIS B 65 HIS~? -3.69 O ACT B 502s E 250 ALA B 64 ALA~? 11.22 O ACT B 502 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -8.30 11.03 33.15 -8.32 11.11 34.69 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 E 49 ASP B 54 ASP^? 4.46 O ACT B 502 E 86 HIS B 65 HIS~? -3.69 O ACT B 502s E 250 ALA B 71 ALA~? 6.33 O ACT B 502 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -15.58 10.60 26.60 -14.06 10.51 26.75 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 E 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s E 86 HIS C 65 HIS~? -3.55 C ACT C 503s E 250 ALA C 64 ALA~? 10.90 CH3 ACT C 503 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -13.66 20.75 5.77 -13.26 21.25 4.37 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 E 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s E 86 HIS C 65 HIS~? -3.55 C ACT C 503s E 250 ALA C 71 ALA~? 3.85 CH3 ACT C 503 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -14.49 11.86 9.72 -14.32 13.36 10.09 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 E 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 E 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 E 250 ALA D 64 ALA~? 28.22 OXT ACT B 502 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -22.15 43.56 35.71 -22.30 43.07 37.15 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 E 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 E 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 E 250 ALA D 71 ALA~? 28.01 O ACT B 502 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -13.96 44.65 30.21 -15.47 44.54 30.10 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 54 ASP^? -3.76 O ACT A 501s F 86 HIS A 65 HIS~? -3.60 O ACT A 501s F 250 ALA A 64 ALA~? 11.15 O ACT A 501 coo -82.12 8.55 35.60 -81.93 9.84 37.19 9.47 12.33 8.26 10.66 11.45 9.76 coo -84.21 11.81 39.90 -82.43 12.70 39.26 14.91 11.26 8.66 14.30 12.93 9.76 coo -78.49 17.13 41.31 -79.25 15.85 41.61 19.24 7.69 5.99 19.07 7.91 4.49 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 54 ASP^? -3.76 O ACT A 501s F 86 HIS A 65 HIS~? -3.60 O ACT A 501s F 250 ALA A 71 ALA~? 5.64 CH3 ACT A 501 coo -82.12 8.55 35.60 -81.93 9.84 37.19 9.47 12.33 8.26 10.66 11.45 9.76 coo -84.21 11.81 39.90 -82.43 12.70 39.26 14.91 11.26 8.66 14.30 12.93 9.76 coo -78.49 17.13 41.31 -79.25 15.85 41.61 19.26 13.81 13.63 19.24 12.28 13.23 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP B 54 ASP^? 4.46 O ACT B 502 F 86 HIS B 65 HIS~? -3.69 O ACT B 502s F 250 ALA B 64 ALA~? 11.22 O ACT B 502 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -8.30 11.03 33.15 -8.32 11.11 34.69 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP B 54 ASP^? 4.46 O ACT B 502 F 86 HIS B 65 HIS~? -3.69 O ACT B 502s F 250 ALA B 71 ALA~? 6.33 O ACT B 502 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -15.58 10.60 26.60 -14.06 10.51 26.75 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 F 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s F 86 HIS C 65 HIS~? -3.55 C ACT C 503s F 250 ALA C 64 ALA~? 10.90 CH3 ACT C 503 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -13.66 20.75 5.77 -13.26 21.25 4.37 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 F 49 ASP C 54 ASP^? -3.02 OXT ACT C 503s F 86 HIS C 65 HIS~? -3.55 C ACT C 503s F 250 ALA C 71 ALA~? 3.85 CH3 ACT C 503 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -14.49 11.86 9.72 -14.32 13.36 10.09 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 F 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 F 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 F 250 ALA D 64 ALA~? 28.22 OXT ACT B 502 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -22.15 43.56 35.71 -22.30 43.07 37.15 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 F 49 ASP D 54 ASP^? 19.49 OXT ACT B 502 F 86 HIS D 65 HIS~? 23.58 OXT ACT B 502 F 250 ALA D 71 ALA~? 28.01 O ACT B 502 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -13.96 44.65 30.21 -15.47 44.54 30.10 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o05 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 34 GLU.? 6.40 OXT ACT A 501 A 44 ASP A 54 ASP^? -3.76 O ACT A 501s A 50 THR A 38 THR^? 13.66 O ACT A 501 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 17.44 14.34 4.36 16.78 13.78 6.33 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 9.47 12.33 8.26 10.66 11.45 9.76 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 9.25 11.88 0.86 8.30 10.33 -0.29 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 34 GLU.? 6.39 OXT ACT B 502 A 44 ASP B 54 ASP^? 4.46 O ACT B 502 A 50 THR B 38 THR^? 13.93 OXT ACT B 502 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -14.54 12.40 35.90 -14.50 13.22 33.94 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -12.00 20.67 39.32 -10.38 21.81 40.17 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU C 34 GLU~? 6.63 O ACT C 503 A 44 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 50 THR C 38 THR^? 13.13 OXT ACT C 503 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -11.68 15.33 1.66 -11.38 14.84 3.76 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -2.96 18.29 1.33 -1.80 20.06 1.28 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU D 34 GLU.? 25.91 OXT ACT B 502 A 44 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 50 THR D 38 THR^? 19.44 OXT ACT B 502 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -16.00 41.58 38.86 -16.04 41.30 36.71 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -18.99 32.97 40.14 -20.81 31.88 40.43 3hde_o00 source 3HDE LYSOZYME : 4 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 59 GLU~? 13.04 O ACT A 501 B 44 ASP A 54 ASP^? -3.76 O ACT A 501s B 50 THR A 37 THR^? 7.38 OXT ACT A 501 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 14.64 -0.22 6.93 13.24 0.65 8.32 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 9.47 12.33 8.26 10.66 11.45 9.76 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 12.45 11.59 2.88 13.04 12.51 4.77 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 92 GLU^? 18.57 O ACT A 501 B 44 ASP A 58 ASP~? 16.01 O ACT A 501 B 50 THR A 2 THR.? 15.11 O ACT A 501 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 4.60 -0.94 9.20 4.21 -3.02 9.21 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 12.40 1.57 0.95 13.75 2.83 -0.02 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 5.28 5.47 0.38 4.81 7.57 0.79 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU B 59 GLU~? 13.30 O ACT B 502 B 44 ASP B 54 ASP^? 4.46 O ACT B 502 B 50 THR B 37 THR^? 7.60 OXT ACT B 502 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -1.11 15.84 31.13 -2.15 17.21 29.83 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -11.91 17.46 37.30 -13.16 16.95 35.64 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU C 59 GLU~? 12.18 OXT ACT C 503 B 44 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 50 THR C 37 THR^? 7.26 O ACT C 503 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -9.42 26.68 11.15 -8.43 25.11 12.27 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -6.53 17.89 2.50 -7.37 16.24 3.61 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU C 92 GLU^? 15.67 OXT ACT C 503 B 44 ASP C 58 ASP~? 15.48 OXT ACT C 503 B 50 THR C 2 THR.? 13.94 OXT ACT C 503 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -0.44 25.21 15.82 -1.51 26.57 14.58 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -5.93 27.71 5.50 -7.21 27.13 3.90 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 0.78 23.36 4.70 1.16 21.29 4.14 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU D 59 GLU~? 24.17 OXT ACT B 502 B 44 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 50 THR D 37 THR^? 22.30 OXT ACT B 502 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -28.95 39.32 31.59 -27.70 38.19 30.22 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -18.75 36.43 38.66 -17.35 37.30 37.28 3hde_o01 source 3HDE LYSOZYME : 6 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 59 GLU~? 13.04 O ACT A 501 C 44 ASP A 54 ASP^? -3.76 O ACT A 501s C 50 THR A 37 THR^? 7.38 OXT ACT A 501 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 14.64 -0.22 6.93 13.24 0.65 8.32 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 9.47 12.33 8.26 10.66 11.45 9.76 coo 25.48 4.87 1.60 23.90 4.95 0.15 12.45 11.59 2.88 13.04 12.51 4.77 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 92 GLU^? 18.57 O ACT A 501 C 44 ASP A 58 ASP~? 16.01 O ACT A 501 C 50 THR A 2 THR.? 15.11 O ACT A 501 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 4.60 -0.94 9.20 4.21 -3.02 9.21 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 12.40 1.57 0.95 13.75 2.83 -0.02 coo 25.48 4.87 1.60 23.90 4.95 0.15 5.28 5.47 0.38 4.81 7.57 0.79 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU B 59 GLU~? 13.30 O ACT B 502 C 44 ASP B 54 ASP^? 4.46 O ACT B 502 C 50 THR B 37 THR^? 7.60 OXT ACT B 502 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -1.11 15.84 31.13 -2.15 17.21 29.83 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -13.85 20.61 32.18 -13.16 19.46 30.55 coo 25.48 4.87 1.60 23.90 4.95 0.15 -11.91 17.46 37.30 -13.16 16.95 35.64 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU B 92 GLU^? 19.37 O ACT B 502 C 44 ASP B 58 ASP~? 16.37 O ACT B 502 C 50 THR B 2 THR.? 15.37 O ACT B 502 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -0.80 26.07 29.41 1.12 26.90 28.84 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -1.77 17.89 37.44 -2.74 16.22 38.35 coo 25.48 4.87 1.60 23.90 4.95 0.15 -6.19 24.78 38.76 -8.31 24.86 38.78 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU C 59 GLU~? 12.18 OXT ACT C 503 C 44 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 50 THR C 37 THR^? 7.26 O ACT C 503 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -9.42 26.68 11.15 -8.43 25.11 12.27 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -4.59 14.55 7.45 -6.01 14.57 8.99 coo 25.48 4.87 1.60 23.90 4.95 0.15 -6.53 17.89 2.50 -7.37 16.24 3.61 ULMN 3 3hde_o02 LYSOZYME user 6 3 # 6 C 35 GLU C 92 GLU^? 15.67 OXT ACT C 503 C 44 ASP C 58 ASP~? 15.48 OXT ACT C 503 C 50 THR C 2 THR.? 13.94 OXT ACT C 503 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -0.44 25.21 15.82 -1.51 26.57 14.58 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -5.93 27.71 5.50 -7.21 27.13 3.90 coo 25.48 4.87 1.60 23.90 4.95 0.15 0.78 23.36 4.70 1.16 21.29 4.14 ULMN 3 3hde_o02 LYSOZYME user 7 3 # 7 C 35 GLU D 59 GLU~? 24.17 OXT ACT B 502 C 44 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 50 THR D 37 THR^? 22.30 OXT ACT B 502 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -28.95 39.32 31.59 -27.70 38.19 30.22 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -16.29 34.40 33.40 -16.55 35.85 31.87 coo 25.48 4.87 1.60 23.90 4.95 0.15 -18.75 36.43 38.66 -17.35 37.30 37.28 ULMN 3 3hde_o02 LYSOZYME user 8 3 # 8 C 35 GLU D 92 GLU^? 17.21 CH3 ACT B 502 C 44 ASP D 58 ASP~? 25.46 OXT ACT B 502 C 50 THR D 2 THR.? 16.35 OXT ACT B 502 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -28.60 28.26 28.67 -30.38 27.63 27.65 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -28.98 35.91 37.37 -28.15 37.30 38.76 coo 25.48 4.87 1.60 23.90 4.95 0.15 -24.65 28.96 37.92 -22.54 28.87 38.29 3hde_o02 source 3HDE LYSOZYME : 8 hits 3hde_o02 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS A 65 HIS~? -3.60 O ACT A 501s A 250 ASP A 54 ASP^? -3.76 O ACT A 501s A 328 SER A 35 SER.? 14.88 OXT ACT A 501 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 14.91 11.26 8.66 14.30 12.93 9.76 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 9.47 12.33 8.26 10.66 11.45 9.76 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 16.04 12.56 -1.31 17.97 11.29 -2.00 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 2 3 # 2 A 220 HIS B 65 HIS~? -3.69 O ACT B 502s A 250 ASP B 54 ASP^? 4.46 O ACT B 502 A 328 SER B 35 SER.? 14.98 OXT ACT B 502 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -11.93 13.69 41.33 -10.41 11.83 41.69 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 3 3 # 3 A 220 HIS C 65 HIS~? -3.55 C ACT C 503s A 250 ASP C 54 ASP^? -3.02 OXT ACT C 503s A 328 SER C 35 SER.? 15.52 O ACT C 503 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 4 3 # 4 A 220 HIS D 65 HIS~? 23.58 OXT ACT B 502 A 250 ASP D 54 ASP^? 19.49 OXT ACT B 502 A 328 SER D 35 SER.? 28.88 OXT ACT B 502 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -19.19 38.97 43.50 -19.09 40.18 45.58 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 4 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS A 65 HIS~? -3.60 O ACT A 501s B 250 ASP A 54 ASP^? -3.76 O ACT A 501s B 328 SER A 35 SER.? 14.88 OXT ACT A 501 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 14.91 11.26 8.66 14.30 12.93 9.76 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 9.47 12.33 8.26 10.66 11.45 9.76 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 16.04 12.56 -1.31 17.97 11.29 -2.00 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 2 3 # 2 B 220 HIS B 65 HIS~? -3.69 O ACT B 502s B 250 ASP B 54 ASP^? 4.46 O ACT B 502 B 328 SER B 35 SER.? 14.98 OXT ACT B 502 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -11.93 13.69 41.33 -10.41 11.83 41.69 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 3 3 # 3 B 220 HIS C 65 HIS~? -3.55 C ACT C 503s B 250 ASP C 54 ASP^? -3.02 OXT ACT C 503s B 328 SER C 35 SER.? 15.52 O ACT C 503 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 4 3 # 4 B 220 HIS D 65 HIS~? 23.58 OXT ACT B 502 B 250 ASP D 54 ASP^? 19.49 OXT ACT B 502 B 328 SER D 35 SER.? 28.88 OXT ACT B 502 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -19.19 38.97 43.50 -19.09 40.18 45.58 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 4 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS A 65 HIS~? -3.60 O ACT A 501s C 250 ASP A 54 ASP^? -3.76 O ACT A 501s C 328 SER A 35 SER.? 14.88 OXT ACT A 501 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 14.91 11.26 8.66 14.30 12.93 9.76 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 9.47 12.33 8.26 10.66 11.45 9.76 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 16.04 12.56 -1.31 17.97 11.29 -2.00 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 2 3 # 2 C 220 HIS B 65 HIS~? -3.69 O ACT B 502s C 250 ASP B 54 ASP^? 4.46 O ACT B 502 C 328 SER B 35 SER.? 14.98 OXT ACT B 502 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -12.58 15.14 31.21 -14.46 15.75 30.51 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -13.85 20.61 32.18 -13.16 19.46 30.55 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -11.93 13.69 41.33 -10.41 11.83 41.69 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 3 3 # 3 C 220 HIS C 65 HIS~? -3.55 C ACT C 503s C 250 ASP C 54 ASP^? -3.02 OXT ACT C 503s C 328 SER C 35 SER.? 15.52 O ACT C 503 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -10.13 15.85 7.28 -9.82 13.80 7.57 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -4.59 14.55 7.45 -6.01 14.57 8.99 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -8.75 19.12 -2.29 -9.86 19.39 -4.43 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 4 3 # 4 C 220 HIS D 65 HIS~? 23.58 OXT ACT B 502 C 250 ASP D 54 ASP^? 19.49 OXT ACT B 502 C 328 SER D 35 SER.? 28.88 OXT ACT B 502 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -17.61 39.97 33.46 -15.64 39.60 32.84 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -16.29 34.40 33.40 -16.55 35.85 31.87 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -19.19 38.97 43.50 -19.09 40.18 45.58 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 4 hits 3nwu_o02 naa= 3